{"doc_id": 0, "abstract": ["The emergence of SARS-CoV-2 and the ensuing explosive epidemic of COVID-19 disease has generated a need for assays to rapidly and conveniently measure the antiviral activity of SARS-CoV-2-specific antibodies.", "Here, we describe a collection of approaches based on SARS-CoV-2 spike-pseudotyped, single-cycle, replication-defective human immunodeficiency virus type-1 (HIV-1), and vesicular stomatitis virus (VSV), as well as a replication-competent VSV/SARS-CoV-2 chimeric virus.", "While each surrogate virus exhibited subtle differences in the sensitivity with which neutralizing activity was detected, the neutralizing activity of both convalescent plasma and human monoclonal antibodies measured using each virus correlated quantitatively with neutralizing activity measured using an authentic SARS-CoV-2 neutralization assay.", "The assays described herein are adaptable to high throughput and are useful tools in the evaluation of serologic immunity conferred by vaccination or prior SARS-CoV-2 infection, as well as the potency of convalescent plasma or human monoclonal antibodies."], "title": "Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses"}
{"doc_id": 1, "abstract": ["The emergence of SARS-CoV-2 and the ensuing explosive epidemic of COVID19 disease has generated a need for assays to rapidly and conveniently measure the antiviral activity of SARSCoV-2-specific antibodies.", "Here, we describe a collection of approaches based on SARS-CoV-2 spike-pseudotyped, single-cycle, replication-defective human immunodeficiency virus type-1 (HIV-1) and vesicular stomatitis virus (VSV), as well as a replication-competent VSV/SARS-CoV-2 chimeric virus.", "While each surrogate virus exhibited subtle differences in the sensitivity with which neutralizing activity was detected, the neutralizing activity of both convalescent plasma and human monoclonal antibodies measured using each virus correlated quantitatively with neutralizing activity measured using an authentic SARS-CoV-2 neutralization assay.", "The assays described herein are adaptable to high throughput and are useful tools in the evaluation of serologic immunity conferred by vaccination or prior SARS-CoV-2 infection, as well as the potency of convalescent plasma or human monoclonal antibodies."], "title": "Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses"}
{"doc_id": 2, "abstract": ["BACKGROUND: The ongoing worldwide outbreak of the 2019-nCoV is markedly similar to the severe acute respiratory syndrome (SARS) outbreak 17 years ago.", "During the 2002-2003 SARS outbreak, healthcare workers formed a special population of patients.", "Although virus-specific IgG play important roles in virus neutralization and prevention against future infection, limited information is available regarding the long term persistence of IgG after infection with SARS-like coronavirus.", "METHODS: A long-term prospective cohort study followed 34 SARS-CoV-infected healthcare workers from a hospital with clustered infected cases during the 2002-2003 SARS outbreak in Guangzhou, China, with a 13-year follow-up.", "Serum samples were collected annually from 2003-2015.", "Twenty SARS-CoV-infected and 40 non-infected healthcare workers were enrolled in 2015, and their serum samples were collected.", "All sera were tested for IgG antibodies with ELISA using whole virus and a recombinant nucleocapsid protein of SARS-CoV, as a diagnostic antigen.", "RESULTS: Anti SARS-CoV IgG was found to persist for up to 12 years.", "IgG titers typically peaked in 2004, declining rapidly from 2004-2006, and then continued to decline at a slower rate.", "IgG titers in SARS-CoV-infected healthcare workers remained at a significantly high level until 2015.", "Patients treated with corticosteroids at the time of infection were found to have lower IgG titers than those without.", "CONCLUSIONS: IgG antibodies against SARS-CoV can persist for at least 12 years.", "The presence of SARS-CoV IgG might provide protection against SARS-CoV and other betacoronavirus.", "This study provides valuable information regarding humoral immune responses against SARS-CoV and the 2019-nCoV."], "title": "Long-Term Persistence of IgG Antibodies in SARS-CoV Infected Healthcare Workers"}
{"doc_id": 3, "abstract": ["Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2/2019-nCoV) has spread quickly worldwide, with more than 29 million cases and 920,000 deaths.", "Interestingly, coronaviruses were found to subvert and hijack the autophagic process to allow their viral replication.", "One of the spotlights had been focused on the autophagy inhibitors as a target mechanism effective in the inhibition of SARS-CoV-2 infection.", "Consequently, chloroquine (CQ) and hydroxychloroquine (HCQ), a derivative of CQ, was suggested as the first potentially be therapeutic strategies as they are known to be autophagy inhibitors.", "Then, they were used as therapeutics in SARS-CoV-2 infection along with remdesivir, for which the FDA approved emergency use authorization.", "Here, we investigated the antiviral activity and associated mechanism of GNS561, a small basic lipophilic molecule inhibitor of late-stage autophagy, against SARS-CoV-2.", "Our data indicated that GNS561 showed the highest antiviral effect for two SARS-CoV-2 strains compared to CQ and remdesivir.", "Focusing on the autophagy mechanism, we showed that GNS561, located in LAMP2-positive lysosomes, together with SARS-CoV-2, blocked autophagy by increasing the size of LC3-II spots and the accumulation of autophagic vacuoles in the cytoplasm with the presence of multilamellar bodies characteristic of a complexed autophagy.", "Finally, our study revealed that the combination of GNS561 and remdesivir was associated with a strong synergistic antiviral effect against SARS-CoV-2.", "Overall, our study highlights GNS561 as a powerful drug in SARS-CoV-2 infection and supports that the hypothesis that autophagy inhibitors could be an alternative strategy for SARS-CoV-2 infection."], "title": "GNS561 exhibits potent in vitro antiviral activity against SARS-CoV-2 through autophagy inhibition"}
{"doc_id": 4, "abstract": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged as a new human pathogen in late 2019 and has infected an estimated 10% of the global population in less than a year.", "There is a clear need for effective antiviral drugs to complement current preventive measures including vaccines.", "In this study, we demonstrate that berberine and obatoclax, two broad-spectrum antiviral compounds, are effective against multiple isolates of SARS-CoV-2.", "Berberine, a plant-derived alkaloid, inhibited SARS-CoV-2 at low micromolar concentrations and obatoclax, originally developed as an anti-apoptotic protein antagonist, was effective at sub-micromolar concentrations.", "Time-of-addition studies indicated that berberine acts on the late stage of the viral life cycle.", "In agreement, berberine mildly affected viral RNA synthesis, but strongly reduced infectious viral titers, leading to an increase in the particle-to-pfu ratio.", "In contrast, obatoclax acted at the early stage of the infection, in line with its activity to neutralize the acidic environment in endosomes.", "We assessed infection of primary human nasal epithelial cells cultured on an air-liquid interface and found that SARS-CoV-2 infection induced and repressed expression of a specific set of cytokines and chemokines.", "Moreover, both obatoclax and berberine inhibited SARS-CoV-2 replication in these primary target cells.", "We propose berberine and obatoclax as potential antiviral drugs against SARS-CoV-2 that could be considered for further efficacy testing."], "title": "Berberine and obatoclax inhibit SARS-CoV-2 replication in primary human nasal epithelial cells in vitro"}
{"doc_id": 5, "abstract": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged as a new human pathogen in late 2019 and it has infected over 100 million people in less than a year.", "There is a clear need for effective antiviral drugs to complement current preventive measures, including vaccines.", "In this study, we demonstrate that berberine and obatoclax, two broad-spectrum antiviral compounds, are effective against multiple isolates of SARS-CoV-2.", "Berberine, a plant-derived alkaloid, inhibited SARS-CoV-2 at low micromolar concentrations and obatoclax, which was originally developed as an anti-apoptotic protein antagonist, was effective at sub-micromolar concentrations.", "Time-of-addition studies indicated that berberine acts on the late stage of the viral life cycle.", "In agreement, berberine mildly affected viral RNA synthesis, but it strongly reduced infectious viral titers, leading to an increase in the particle-to-pfu ratio.", "In contrast, obatoclax acted at the early stage of the infection, which is in line with its activity to neutralize the acidic environment in endosomes.", "We assessed infection of primary human nasal epithelial cells that were cultured on an air-liquid interface and found that SARS-CoV-2 infection induced and repressed expression of specific sets of cytokines and chemokines.", "Moreover, both obatoclax and berberine inhibited SARS-CoV-2 replication in these primary target cells.", "We propose berberine and obatoclax as potential antiviral drugs against SARS-CoV-2 that could be considered for further efficacy testing."], "title": "Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro"}
{"doc_id": 6, "abstract": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), with a clinical outcome ranging from mild to severe, including death.", "To date, it is unclear why some patients develop severe symptoms.", "Many authors have suggested the involvement of vitamin D in reducing the risk of infections; thus, we retrospectively investigated the 25-hydroxyvitamin D (25(OH)D) concentrations in plasma obtained from a cohort of patients from Switzerland.", "In this cohort, significantly lower 25(OH)D levels (p = 0.004) were found in PCR-positive for SARS-CoV-2 (median value 11.1 ng/mL) patients compared with negative patients (24.6 ng/mL); this was also confirmed by stratifying patients according to age >70 years.", "On the basis of this preliminary observation, vitamin D supplementation might be a useful measure to reduce the risk of infection.", "Randomized controlled trials and large population studies should be conducted to evaluate these recommendations and to confirm our preliminary observation."], "title": "25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2"}
{"doc_id": 7, "abstract": ["The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently the most pressing medical and socioeconomic challenge.", "Constituting important correlates of protection, the determination of virus-neutralizing antibodies (NAbs) is indispensable for convalescent plasma selection, vaccine candidate evaluation, and immunity certificates.", "In contrast to standard serological ELISAs, plaque reduction neutralization tests (PRNTs) are laborious, time-consuming, expensive, and restricted to specialized laboratories.", "To replace microscopic counting-based SARS-CoV-2 PRNTs by a novel assay exempt from genetically modified viruses, which are inapplicable in most diagnostics departments, we established a simple, rapid, and automated SARS-CoV-2 neutralization assay employing an in-cell ELISA (icELISA) approach.", "After optimization of various parameters such as virus-specific antibodies, cell lines, virus doses, and duration of infection, SARS-CoV-2-infected cells became amenable as direct antigen source for quantitative icELISA.", "Antiviral agents such as human sera containing NAbs or antiviral interferons dose dependently reduced the SARS-CoV-2-specific signal.", "Applying increased infectious doses, the icELISA-based neutralization test (icNT) was superior to PRNT in discriminating convalescent sera with high from those with intermediate neutralizing capacities.", "In addition, the icNT was found to be specific, discriminating between SARS-CoV-2-specific NAbs and those raised against other coronaviruses.", "Altogether, the SARS-CoV-2 icELISA test allows rapid (<48 h in total, read-out in seconds) and automated quantification of virus infection in cell culture to evaluate the efficacy of NAbs and antiviral drugs using reagents and equipment present in most routine diagnostics departments."], "title": "A Novel In-Cell ELISA Assay Allows Rapid and Automated Quantification of SARS-CoV-2 to Analyze Neutralizing Antibodies and Antiviral Compounds"}
{"doc_id": 8, "abstract": ["In the absence of a vaccine and other effective prophylactic or therapeutic countermeasures the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) remains a significant public health threat.", "Attachment and entry of coronaviruses including SARS-CoV-2 is mediated by the spike glycoprotein (SGP).", "Recently, a SARS-CoV-2 Spike Pseudotyped Lentivirus (SSPL) was developed that allows studying spike-mediated cell entry via luciferase reporter activity in a BSL2 environment.", "Here, we show that iota-carrageenan can inhibit the cell entry of SSPL in a dose dependent manner.", "SSPL particles were efficiently neutralized with an IC50 value of 2.6 \u00b5g/ml iota-carrageenan.", "In vitro data on iota-carrageenan against various Rhino-and Coronaviruses showed similar IC50 values and translated readily into clinical effectiveness when a nasal spray containing iota-carrageenan demonstrated a reduction in severity and duration of symptoms of common cold caused by various respiratory viruses.", "Accordingly, our in vitro data on SSPL suggest that administration of iota-carrageenan may be an effective and safe prophylaxis or treatment for SARS-CoV-2 infections."], "title": "SARS-CoV-2 in-vitro neutralization assay reveals inhibition of virus entry by iota-carrageenan"}
{"doc_id": 9, "abstract": ["Steroid compounds, which are expected to have dual functions in blocking host inflammation and MERS-CoV replication, were screened from a chemical library.", "Within this library, ciclesonide, an inhaled corticosteroid, suppressed human coronavirus replication in cultured cells, but did not suppress replication of respiratory syncytial virus or influenza virus.", "The effective concentration of ciclesonide to block SARS-CoV-2 (the cause of COVID-19) replication (EC90) was 6.3 \u03bcM. After the eleventh consecutive MERS-CoV passage in the presence of ciclesonide, a resistant mutation was generated, which resulted in an amino acid substitution (A25V) in nonstructural protein (NSP) 15, as identified using reverse genetics.", "A recombinant virus with the mutation was also resistant to ciclesonide suppression of viral replication.", "These observations suggest that the effect of ciclesonide was specific to coronavirus, suggesting this is a candidate drug for treatment of patients suffering MERS or COVID-19."], "title": "The inhaled corticosteroid ciclesonide blocks coronavirus RNA replication by targeting viral NSP15"}
{"doc_id": 10, "abstract": ["Viral respiratory diseases (VRDs), such as influenza and COVID-19, are thought to spread faster over winter than during summer.", "It has been previously argued that cold and dry conditions were more conducive to the transmission of VRD than warm and humid climates, although this relationship appears restricted to temperate regions, and the causal relationship is not well understood.", "The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing COVID-19 has emerged as a serious global public health problem after the first COVID-19 reports in Wuhan, China, in late 2019.", "It is still unclear whether this novel respiratory disease will ultimately prove to be a seasonal endemic disease.", "Here, we suggest that Air Drying Capacity (ADC;an atmospheric state-variable known to control the fate/evolution of the virus-laden droplets) and ultraviolet radiation (UV) are probable environmental determinants in shaping the transmission of COVID-19 at the seasonal time scale.", "These variables, unlike temperature and humidity, provide a physically-based framework consistent with the apparent seasonal variability in COVID-19 prevalence across a broad range of climates (e.g., Germany and India).", "Since this disease is known to be influenced by the compounding effect of social, biological, and environmental determinants, this study does not claim that these environmental determinants exclusively shape the seasonality of COVID-19.", "However, we argue that ADC and UV play a significant role in COVID-19 dynamics at the seasonal scale.", "These findings could help guide the development of a sound adaptation strategy against the pandemic over the coming seasons.", "Plain Language Summary There is growing scientific interest in the potential seasonality of COVID-19 and its links to climate variables.", "This study aims to determine whether four environmental variables, namely temperature, humidity, Air Drying Capacity (ADC), and ultraviolet radiation (UV), are probable environmental determinants for the observed seasonal dynamics of COVID-19 prevalence, based on extensive country-level data spanning the first year of the pandemic.", "Although the influence of socio-economic factors may be dominant, we here suggest that ADC and UV are key environmental determinants of COVID-19 and can potentially affect the transmission and seasonality of the disease across a wide range of climates.", "Key Points ### Competing Interest Statement The authors have declared no competing interest.", "### Funding Statement We acknowledge support from the Breene M Kerr chair at MIT.", "### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.", "Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: N/A All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.", "Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov.", "I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).", "Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.", "Yes 6-hourly temperature, dew point temperature and surface pressure data, and hourly UV fields are taken from the ERA5 reanalysis (Hersbach et al. 2018) at 0.25 by 0.25 horizontal resolution, for the period ranging from March 1st, 2020 to January 13th, 2021.", "With this data we calculate daily mean temperature, specific humidity, and ADC (see Section 2.2).", "Since population is not uniformly distributed within each country, we avoid simple country-averaged climate variables which do not correctly reflect the climate conditions to which the population is exposed.", "Instead, we calculate population-weighted average temperature, specific humidity, ADC, and UV across all grid cells contained in a given country, based on weights obtained from a gridded distribution of population density, following Carleton et al. (2021).", "Population density data is taken from the gridded population of the world (GPW) v4 dataset (CIESIN, 2018).", "Daily data on confirmed COVID-19 cases, number of tests, stringency index (i.e., a composite index of political measures) and population for each country are from the Our World in Data database (available at https://ourworldindata.org/).", "Subnational-level COVID-19 epidemiological data for the Australia, China, and Canada are available at the Johns Hopkins University Center for Systems Science and Engineering (JHU CCSE;https://data.humdata.org/).", "Daily COVID-19 data at the scale of different states within the United States are provided at the COVID Tracking Project (available at https://covidtracking.com/).", "A threshold of at least 10,000 cumulative COVID-19 tests per 1 million people was retained to discard countries with unrepresentative data.", "This criterion can somewhat ensure the reliability of the data, although it still has severe limitations (see discussion).", "This approach yields 54 countries in the temperate Northern Hemisphere, and six tropical countries (Table 1), which are predominantly influenced by tropical monsoon systems with hot-humid summers.", "To isolate the role of environmental factors in modulating the spread and potential seasonality of COVID-19, five representative countries are carefully selected, which have different climate conditions and constant social controls (i.e., stringency index does not change significantly) over the analysis period (Fig. S1).", "The list of analyzed countries are provided in Table 1.", "To consider the incubation period of COVID-19 which is generally regarded as 4 to 7 days but can be as long as 10 days and uncommonly even longer, we mainly use biweekly average or biweekly cumulative values (Li et al., 2020). &lt;https://ourworldindata.org/&gt; &lt;https://data.humdata.org/&gt; &lt;https://covidtracking.com/&gt;"], "title": "On the Environmental Determinants of COVID\u201019 Seasonality"}
{"doc_id": 11, "abstract": ["INTRODUCTION: Genomic alterations in a viral genome can lead to either better or worse outcome and identifying these mutations is of utmost importance.", "Here, we correlated protein-level mutations in the SARS-CoV-2 virus to clinical outcome.", "METHODS: Mutations in viral sequences from the GISAID virus repository were evaluated by using \"hCoV-19/Wuhan/WIV04/2019\" as the reference.", "Patient outcomes were classified as mild disease, hospitalization and severe disease (death or documented treatment in an intensive-care unit).", "Chi-square test was applied to examine the association between each mutation and patient outcome.", "False discovery rate was computed to correct for multiple hypothesis testing and results passing FDR cutoff of 5% were accepted as significant.", "RESULTS: Mutations were mapped to amino acid changes for 3,733 non-silent mutations.", "Mutations correlated to mild outcome were located in the ORF8, NSP6, ORF3a, NSP4, and in the nucleocapsid phosphoprotein N. Mutations associated with inferior outcome were located in the surface (S) glycoprotein, in the RNA dependent RNA polymerase, in ORF3a, NSP3, ORF6 and N. Mutations leading to severe outcome with low prevalence were found in the ORF3A and in NSP7 proteins.", "Four out of 22 of the most significant mutations mapped onto a 10 amino acid long phosphorylated stretch of N indicating that in spite of obvious sampling restrictions the approach can find functionally relevant sites in the viral genome.", "CONCLUSIONS: We demonstrate that mutations in the viral genes may have a direct correlation to clinical outcome.", "Our results help to quickly identify SARS-CoV-2 infections harboring mutations related to severe outcome."], "title": "Different mutations in SARS-CoV-2 associate with severe and mild outcome"}
{"doc_id": 12, "abstract": ["Remdesivir was recently demonstrated to decrease recovery time in hospitalized patients with SARS-CoV-2 infection.", "In rhesus macaques, early initiation of remdesivir therapy prevented pneumonia and lowered viral loads in the lung, but viral loads increased in the nasal passages five days after therapy.", "We developed mathematical models to explain these results.", "We identified that 1) drug potency is slightly higher in nasal passages than in lungs, 2) viral load decrease in lungs relative to nasal passages during therapy because of infection-dependent generation of refractory cells in the lung, 3) incomplete drug potency in the lung that decreases viral loads even slightly may allow substantially less lung damage, and 4) increases in nasal viral load may occur due to a slight blunting of peak viral load and subsequent decrease of the intensity of the innate immune response, as well as a lack of refractory cells.", "We also hypothesize that direct inoculation of the trachea in rhesus macaques may not recapitulate natural infection as lung damage occurs more abruptly in this model than in human infection.", "We demonstrate with sensitivity analysis that a drug with higher potency could completely suppress viral replication and lower viral loads abruptly in the nasal passages as well as the lung.", "One Sentence Summary We developed a mathematical model to explain why remdesivir has a greater antiviral effect on SARS CoV-2 in lung versus nasal passages in rhesus macaques."], "title": "Mathematical modeling explains differential SARS CoV-2 kinetics in lung and nasal passages in remdesivir treated rhesus macaques"}
{"doc_id": 13, "abstract": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread within the human population.", "Although SARS-CoV-2 is a novel coronavirus, most humans had been previously exposed to other antigenically distinct common seasonal human coronaviruses (hCoVs) before the COVID-19 pandemic.", "Here, we quantified levels of SARS-CoV-2-reactive antibodies and hCoV-reactive antibodies in serum samples collected from 204 humans before the COVID-19 pandemic.", "We then quantified pre-pandemic antibody levels in serum from a separate cohort of 252 individuals who became PCR-confirmed infected with SARS-CoV-2.", "Finally, we longitudinally measured hCoV and SARS-CoV-2 antibodies in the serum of hospitalized COVID-19 patients.", "Our studies indicate that most individuals possessed hCoV-reactive antibodies before the COVID-19 pandemic.", "We determined that ~23% of these individuals possessed non-neutralizing antibodies that cross-reacted with SARS-CoV-2 spike and nucleocapsid proteins.", "These antibodies were not associated with protection against SARS-CoV-2 infections or hospitalizations, but paradoxically these hCoV cross-reactive antibodies were boosted upon SARS-CoV-2 infection."], "title": "Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection"}
{"doc_id": 14, "abstract": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread within the human population.", "Although SARS-CoV-2 is a novel coronavirus, most humans had been previously exposed to other antigenically distinct common seasonal human coronaviruses (hCoVs) before the COVID-19 pandemic.", "Here, we quantified levels of SARS-CoV-2-reactive antibodies and hCoV-reactive antibodies in serum samples collected from 431 humans before the COVID-19 pandemic.", "We then quantified pre-pandemic antibody levels in serum from a separate cohort of 251 individuals who became PCR-confirmed infected with SARS-CoV-2.", "Finally, we longitudinally measured hCoV and SARS-CoV-2 antibodies in the serum of hospitalized COVID-19 patients.", "Our studies indicate that most individuals possessed hCoV-reactive antibodies before the COVID-19 pandemic.", "We determined that \u223c20% of these individuals possessed non-neutralizing antibodies that cross-reacted with SARS-CoV-2 spike and nucleocapsid proteins.", "These antibodies were not associated with protection against SARS-CoV-2 infections or hospitalizations, but they were boosted upon SARS-CoV-2 infection."], "title": "Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection"}
{"doc_id": 15, "abstract": ["Background: Healthcare systems globally has been challenged following the COVID-19 pandemic, since late 2019.", "Multiple approaches and strategies have been performed to relieve the pressure and support existing healthcare systems.", "The Saudi Arabian Ministry of Health (MOH) launched an initiative to support the National Healthcare System.", "Since the 5th of June 2020, 238 outpatient fever clinics were established across Saudi Arabia.", "Methods: A cross-sectional study included 2,733 eligible patients subjected to MOH treatment protocol (hydroxychloroquine and zinc) and revisited the clinics within 3-7 days after treatment initiation.", "This study aimed to assess the safety outcome and reported adverse events from hydroxychloroquine use among suspected COVID-19 patients.", "The data was collected through an electronic link and cross-checked with that of the national database (Health Electronic Surveillance Network, HESN) and reports from the MOH Morbidity and Mortality (M&M) Committee.", "Results: Majority of the cases were males (70.4%).", "Upon reassessing the studied participants within 3-7 days, 240 patients (8.8%) discontinued the treatment protocol because of the development of side effects (4.1%) and for non-clinical reasons in the remaining (4.7%).", "Medication side effects overall were reported among (6.7%) of all studied participants, including mainly cardiovascular adverse events (2.5%), followed by gastrointestinal (GI) symptoms (2.4%).", "No Intensive Care Unit (ICU) admission or death were reported among these patients.", "Conclusion: In our study, results show that the use of hydroxychloroquine for COVID-19 patients in mild to moderate cases in an outpatient setting, within the protocol recommendation and inclusion/exclusion criteria, is safe, highly tolerable, and with minimum side effects."], "title": "Hydroxychloroquine Safety Outcome within Approved Therapeutic Protocol for COVID-19 Outpatients in Saudi Arabia"}
{"doc_id": 16, "abstract": ["Cell entry of the pandemic virus SARS-CoV-2 is mediated by its spike protein S. As main antigenic determinant, S protein is in focus of antibody-based prophylactic and therapeutic strategies.", "Besides particle-cell fusion, S mediates fusion between infected and uninfected cells resulting in syncytia formation.", "Here we present quantitative assay systems covering not only particle-cell and cell-cell fusion, but also demonstrating fusion-from-without (FFWO), the formation of syncytia induced by S-containing viral particles in absence of newly synthesized S protein.", "Based on complementation of split \u03b2-galactosidase and virus-like-particles (VLPs) displaying S protein, this assay can be performed at BSL-1.", "All three assays provided readouts with a high dynamic range and signal-to-noise ratios covering several orders of magnitude.", "The data obtained confirm the enhancing effect of trypsin and overexpression of angiotensin-converting enzyme 2 (ACE2) on membrane fusion.", "Neutralizing antibodies as well as sera from convalescent patients inhibited particle-cell fusion with high efficiency.", "Cell-cell fusion, in contrast, was only moderately inhibited despite requiring much lower levels of S protein, which were below the detection limit of flow cytometry and Western blot.", "The data indicate that syncytia formation as a pathological consequence in tissues of Covid-19 patients can proceed at low levels of S protein and may not be effectively prevented by antibodies."], "title": "Quantitative Assays Reveal Cell Fusion at Minimal Levels of SARS-CoV-2 Spike Protein and Fusion-from-Without"}
{"doc_id": 17, "abstract": ["In 2019, a new coronavirus (2019-nCoV) infecting Humans has emerged in Wuhan, China.", "Its genome has been sequenced and the genomic information promptly released.", "Despite a high similarity with the genome sequence of SARS-CoV and SARS-like CoVs, we identified a peculiar furin-like cleavage site in the Spike protein of the 2019-nCoV, lacking in the other SARS-like CoVs.", "In this article, we discuss the possible functional consequences of this cleavage site in the viral cycle, pathogenicity and its potential implication in the development of antivirals."], "title": "The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade"}
{"doc_id": 18, "abstract": ["Seasonal variation in COVID-19 incidence could impact the trajectory of the pandemic.", "Using global line-list data on COVID-19 cases reported until 29th February 2020 and global gridded temperature data, and after adjusting for surveillance capacity and time since first imported case, higher average temperature was strongly associated with lower COVID-19 incidence for temperatures of 1\u00b0C and higher.", "However, temperature explained a relatively modest amount of the total variation in COVID-19 incidence.", "These preliminary findings support stringent containment efforts in Europe and elsewhere."], "title": "Preliminary evidence that higher temperatures are associated with lower incidence of COVID-19, for cases reported globally up to 29th February 2020"}
{"doc_id": 19, "abstract": ["BACKGROUND: Governments are preparing for a potential influenza pandemic.", "Therefore they need data to assess the possible impact of interventions.", "Face-masks worn by the general population could be an accessible and affordable intervention, if effective when worn under routine circumstances.", "METHODOLOGY: We assessed transmission reduction potential provided by personal respirators, surgical masks and home-made masks when worn during a variety of activities by healthy volunteers and a simulated patient.", "PRINCIPAL FINDINGS: All types of masks reduced aerosol exposure, relatively stable over time, unaffected by duration of wear or type of activity, but with a high degree of individual variation.", "Personal respirators were more efficient than surgical masks, which were more efficient than home-made masks.", "Regardless of mask type, children were less well protected.", "Outward protection (mask wearing by a mechanical head) was less effective than inward protection (mask wearing by healthy volunteers).", "CONCLUSIONS/SIGNIFICANCE: Any type of general mask use is likely to decrease viral exposure and infection risk on a population level, in spite of imperfect fit and imperfect adherence, personal respirators providing most protection.", "Masks worn by patients may not offer as great a degree of protection against aerosol transmission."], "title": "Professional and Home-Made Face Masks Reduce Exposure to Respiratory Infections among the General Population"}
{"doc_id": 20, "abstract": ["Analysis of genetic sequence data from the SARS-CoV-2 pandemic can provide insights into epidemic origins, worldwide dispersal, and epidemiological history.", "With few exceptions, genomic epidemiological analysis has focused on geographically distributed data sets with few isolates in any given location.", "Here, we report an analysis of 20 whole SARS-CoV-2 genomes from a single relatively small and geographically constrained outbreak in Weifang, People\u2019s Republic of China.", "Using Bayesian model-based phylodynamic methods, we estimate a mean basic reproduction number (R(0)) of 3.4 (95% highest posterior density interval: 2.1\u20135.2) in Weifang, and a mean effective reproduction number (R(t)) that falls below 1 on 4 February.", "We further estimate the number of infections through time and compare these estimates to confirmed diagnoses by the Weifang Centers for Disease Control.", "We find that these estimates are consistent with reported cases and there is unlikely to be a large undiagnosed burden of infection over the period we studied."], "title": "Genomic epidemiology of a densely sampled COVID-19 outbreak in China"}
{"doc_id": 21, "abstract": ["Analysis of genetic sequence data from the pandemic SARS Coronavirus 2 can provide insights into epidemic origins, worldwide dispersal, and epidemiological history.", "With few exceptions, genomic epidemiological analysis has focused on geographically distributed data sets with few isolates in any given location.", "Here we report an analysis of 20 whole SARS-CoV 2 genomes from a single relatively small and geographically constrained outbreak in Weifang, People's Republic of China.", "Using Bayesian model-based phylodynamic methods, we estimate the reproduction number for the outbreak to be 1.99(95% CI:1.48-3.14).", "We further estimate the number of infections through time and compare these estimates to confirmed diagnoses by the Weifang Centers for Disease Control.", "We find that these estimates are consistent with reported cases and there is unlikely to be a large undiagnosed burden of infection over the period we studied."], "title": "Genomic epidemiology of a densely sampled COVID19 outbreak in China"}
{"doc_id": 22, "abstract": ["Since the outbreak of COVID-19, over 200 vaccine candidates have been documented and some of them have advanced to clinical trials with encouraging results.", "However, the antibody persistence over 3 months post immunization and the long-term memory have been rarely reported.", "Here, we report that a ferritin nanoparticle based SARS-CoV-2 RBD vaccine induced in mice an efficient antibody response which lasts for at least 7 months post immunization.", "Significantly higher number of memory B cells were maintained and a significantly higher level of recall response was induced upon antigen challenge.", "Thus, we believe our current study provide the first information about the long-term antibody persistence and memory response of a COVID-19 vaccine.", "This information would be also timely useful for the development and evaluation of other vaccines."], "title": "Ferritin nanoparticle based SARS-CoV-2 RBD vaccine induces persistent antibody response and long-term memory in mice"}
{"doc_id": 23, "abstract": ["The evolutionary mechanisms by which SARS-CoV-2 viruses adapt to mammalian hosts and, potentially, undergo antigenic evolution depend on the ways genetic variation is generated and selected within and between individual hosts.", "Using domestic cats as a model, we show that SARS-CoV-2 consensus sequences remain largely unchanged over time within hosts, while dynamic sub-consensus diversity reveals processes of genetic drift and weak purifying selection.", "We further identify a notable variant at amino acid position 655 in Spike (H655Y), which was previously shown to confer escape from human monoclonal antibodies.", "This variant arises rapidly and persists at intermediate frequencies in index cats.", "It also becomes fixed following transmission in two of three pairs.", "These dynamics suggest this site may be under positive selection in this system and illustrate how a variant can quickly arise and become fixed in parallel across multiple transmission pairs.", "Transmission of SARS-CoV-2 in cats involved a narrow bottleneck, with new infections founded by fewer than ten viruses.", "In RNA virus evolution, stochastic processes like narrow transmission bottlenecks and genetic drift typically act to constrain the overall pace of adaptive evolution.", "Our data suggest that here, positive selection in index cats followed by a narrow transmission bottleneck may have instead accelerated the fixation of S H655Y, a potentially beneficial SARS-CoV-2 variant.", "Overall, our study suggests species-and context-specific adaptations are likely to continue to emerge.", "This underscores the importance of continued genomic surveillance for new SARS-CoV-2 variants as well as heightened scrutiny for signatures of SARS-CoV-2 positive selection in humans and mammalian model systems."], "title": "Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneck"}
{"doc_id": 24, "abstract": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the ongoing pandemic coronavirus disease 2019 (COVID-19).", "The majority of patients with COVID-19 have a good prognosis, but variable percentages in different countries develop pneumonia associated with lymphocytopenia and severe inflammatory response due to uncontrolled release of cytokines.", "These immune mediators are transcriptionally regulated by JAK-STAT molecular pathways, which can be disabled by small molecules.", "Here, we provide evidences on the efficacy of baricitinib, a JAK1/JAK2 inhibitor, in correcting the immune abnormalities observed in patients hospitalized with COVID-19.", "Indeed, we demonstrate a significant reduction in serum levels of interleukin (IL)-6, IL-1{beta} and tumor necrosis factor (TNF), a rapid recovery in circulating T and B cell frequencies and an increased antibody production against SARS-CoV-2 spike protein in baricitinib-treated patients.", "Moreover, treated patients underwent a rapid reduction in oxygen flow need and progressive increase in the P/F. Our work provides the basis on developing effective treatments against COVID-19 pathogenesis using on-target therapy."], "title": "Baricitinib restrains the immune dysregulation in COVID-19 patients"}
{"doc_id": 25, "abstract": ["Antiviral drugs for managing infections with human coronaviruses are not yet approved, posing a serious challenge to current global efforts aimed at containing the outbreak of severe acute respiratory syndrome-coronavirus 2 (CoV-2).", "Remdesivir (RDV) is an investigational compound with a broad spectrum of antiviral activities against RNA viruses, including severe acute respiratory syndrome-CoV and Middle East respiratory syndrome (MERS-CoV).", "RDV is a nucleotide analog inhibitor of RNA-dependent RNA polymerases (RdRps).", "Here, we co-expressed the MERS-CoV nonstructural proteins nsp5, nsp7, nsp8, and nsp12 (RdRp) in insect cells as a part a polyprotein to study the mechanism of inhibition of MERS-CoV RdRp by RDV.", "We initially demonstrated that nsp8 and nsp12 form an active complex.", "The triphosphate form of the inhibitor (RDV-TP) competes with its natural counterpart ATP.", "Of note, the selectivity value for RDV-TP obtained here with a steady-state approach suggests that it is more efficiently incorporated than ATP and two other nucleotide analogs.", "Once incorporated at position i, the inhibitor caused RNA synthesis arrest at position i + 3.", "Hence, the likely mechanism of action is delayed RNA chain termination.", "The additional three nucleotides may protect the inhibitor from excision by the viral 3'-5' exonuclease activity.", "Together, these results help to explain the high potency of RDV against RNA viruses in cell-based assays."], "title": "The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus"}
{"doc_id": 26, "abstract": ["The covid-19 infection rates for a large number of infections collected from a large number of different sites are well defined with a negligible scatter.", "The simplest invertible iterated map, exponential growth and decay, emerges from country-wide histograms whenever Tchebychev's inequality is satisfied to within several decimal places.", "This is one point.", "Another is that failed covid-19 pandemic model predictions have been reported repeatedly by the news media.", "Model predictions fail because the observed infection rates are beyond modeling: any model that uses fixed rates or uses memory or averages of past rates cannot reproduce the data on active infections.", "When those possibilities are ruled out, then little is left.", "Under lockdown and social distancing, the rates unfold daily in small but unforeseeable steps, they are algorithmically complex.", "We can, however, use two days in the daily data, today and any single day in the past (generally yesterday), to make a useful forecast of future infections.", "No model provides results better than this simple forecast.", "We analyze the actual doubling times for covid-19 data and compare them with our predicted doubling times.", "Flattening and peaking are precisely defined.", "We identify and study the separate effects of social distancing vs recoveries in the daily infection rates.", "Social distancing can only cause flattening but recoveries are required in order for the active infections to peak and decay.", "Three models and their predictions are analyzed.", "Pandemic data for Austria, Germany, Italy, the USA, the UK, Finland, China, Taiwan, and Sweden are discussed."], "title": "Pandemic infection rates are deterministic but cannot be modeled"}
{"doc_id": 27, "abstract": ["Pneumonia caused by coronavirus, which originated in Wuhan, China, in late 2019, has been spread around the world already becoming a pandemic.", "Unfortunately, there is not yet a specific vaccine or effective antiviral drug for treating COVID-19.", "Many of these patients deteriorate rapidly and require intubation and are mechanically ventilated, which is causing the collapse of the health system in many countries due to lack of ventilators and intensive care beds.", "In this document we review two simple adjuvant therapies to administer, without side effects, and low cost that could be useful for the treatment of acute severe coronavirus infection associated with acute respiratory syndrome (SARS-CoV-2).", "VitaminC, a potent antioxidant, has emerged as a relevant therapy due to its potential benefits when administered intravenous.", "The potential effect of vitaminC in reducing inflammation in the lungs could play a key role in lung injury caused by coronavirus infection.", "Another potential effective therapy is ozone: it has been extensively studied and used for many years and its effectiveness has been demonstrated so far in multiples studies.", "Nevertheless, our goal is not to make an exhaustive review of these therapies but spread the beneficial effects themselves.", "Obviously clinical trials are necessaries, but due to the potential benefit of these two therapies we highly recommended to add to the therapeutic arsenal."], "title": "Dos terapias conocidas podr\u00edan ser efectivas como adyuvantes en el paciente cr\u00edtico infectado por COVID-19./ Dos terapias conocidas podr\u00edan ser efectivas como adyuvantes en el paciente cr\u00edtico infectado por COVID-19./ Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19"}
{"doc_id": 28, "abstract": ["As the infection of 2019-nCoV coronavirus is quickly developing into a global pneumonia epidemic, the careful analysis of its transmission and cellular mechanisms is sorely needed.", "In this Communication, we first analyzed two recent studies that concluded that snakes are the intermediate hosts of 2019-nCoV and that the 2019-nCoV spike protein insertions share a unique similarity to HIV-1.", "However, the reimplementation of the analyses, built on larger scale data sets using state-of-the-art bioinformatics methods and databases, presents clear evidence that rebuts these conclusions.", "Next, using metagenomic samples from Manis javanica, we assembled a draft genome of the 2019-nCoV-like coronavirus, which shows 73% coverage and 91% sequence identity to the 2019-nCoV genome.", "In particular, the alignments of the spike surface glycoprotein receptor binding domain revealed four times more variations in the bat coronavirus RaTG13 than in the Manis coronavirus compared with 2019-nCoV, suggesting the pangolin as a missing link in the transmission of 2019-nCoV from bats to human."], "title": "Protein Structure and Sequence Reanalysis of 2019-nCoV Genome Refutes Snakes as Its Intermediate Host and the Unique Similarity between Its Spike Protein Insertions and HIV-1"}
{"doc_id": 29, "abstract": ["BACKGROUND: Understanding viral infection of the olfactory epithelium is essential because the olfactory nerve is an important route of entry for viruses to the central nervous system.", "Specialized chemosensory epithelial cells that express the transient receptor potential cation channel subfamily M member 5 (TRPM5) are found throughout the airways and intestinal epithelium and are involved in responses to viral infection.", "RESULTS: Herein we performed deep transcriptional profiling of olfactory epithelial cells sorted by flow cytometry based on the expression of mCherry as a marker for olfactory sensory neurons and for eGFP in OMP-H2B::mCherry/TRPM5-eGFP transgenic mice (Mus musculus).", "We find profuse expression of transcripts involved in inflammation, immunity and viral infection in TRPM5-expressing microvillous cells compared to olfactory sensory neurons.", "CONCLUSION: Our study provides new insights into a potential role for TRPM5-expressing microvillous cells in viral infection of the olfactory epithelium.", "We find that, as found for solitary chemosensory cells (SCCs) and brush cells in the airway epithelium, and for tuft cells in the intestine, the transcriptome of TRPM5-expressing microvillous cells indicates that they are likely involved in the inflammatory response elicited by viral infection of the olfactory epithelium.", "SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12864-021-07528-y."], "title": "Transcriptional profiling reveals potential involvement of microvillous TRPM5-expressing cells in viral infection of the olfactory epithelium"}
{"doc_id": 30, "abstract": ["Severe acute respiratory syndrome virus 2 (SARS-CoV-2) is the cause of the current coronavirus disease 19 (COVID-19) pandemic.", "Protease inhibitors are under consideration as virus entry inhibitors that prevent the cleavage of the coronavirus spike (S) protein by cellular proteases.", "Herein, we showed that the protease inhibitor aprotinin (but not the protease inhibitor SERPINA1/alpha-1 antitrypsin) inhibited SARS-CoV-2 replication in therapeutically achievable concentrations.", "An analysis of proteomics and translatome data indicated that SARS-CoV-2 replication is associated with a downregulation of host cell protease inhibitors.", "Hence, aprotinin may compensate for downregulated host cell proteases during later virus replication cycles.", "Aprotinin displayed anti-SARS-CoV-2 activity in different cell types (Caco2, Calu-3, and primary bronchial epithelial cell air-liquid interface cultures) and against four virus isolates.", "In conclusion, therapeutic aprotinin concentrations exert anti-SARS-CoV-2 activity.", "An approved aprotinin aerosol may have potential for the early local control of SARS-CoV-2 replication and the prevention of COVID-19 progression to a severe, systemic disease."], "title": "Aprotinin Inhibits SARS-CoV-2 Replication"}
{"doc_id": 31, "abstract": ["Severe acute respiratory syndrome (SARS) is caused by infection of a previously undescribed coronavirus (CoV).", "L-SIGN, encoded by CLEC4M (also known as CD209L), is a SARS-CoV binding receptor that has polymorphism in its extracellular neck region encoded by the tandem repeat domain in exon 4.", "Our genetic risk association study shows that individuals homozygous for CLEC4M tandem repeats are less susceptible to SARS infection.", "L-SIGN is expressed in both non-SARS and SARS-CoV\u2013infected lung.", "Compared with cells heterozygous for L-SIGN, cells homozygous for L-SIGN show higher binding capacity for SARS-CoV, higher proteasome-dependent viral degradation and a lower capacity for trans infection.", "Thus, homozygosity for L-SIGN plays a protective role during SARS infection.", "SUPPLEMENTARY INFORMATION: The online version of this article (doi:10.1038/ng1698) contains supplementary material, which is available to authorized users."], "title": "Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection"}
{"doc_id": 32, "abstract": ["Sex can be an important determinant of cancer phenotype, and exploring sex-biased tumor biology holds promise for identifying novel therapeutic targets and new approaches to cancer treatment.", "In an established isogenic murine model of glioblastoma, we discovered correlated transcriptome-wide sex differences in gene expression, H3K27ac marks, large Brd4-bound enhancer usage, and Brd4 localization to Myc and p53 genomic binding sites.", "These sex-biased gene expression patterns were also evident in human glioblastoma stem cells (GSCs).", "These observations led us to hypothesize that Brd4-bound enhancers might underlie sex differences in stem cell function and tumorigenicity in GBM.", "We found that male and female GBM cells exhibited opposing responses to pharmacological or genetic inhibition of Brd4.", "Brd4 knockdown or pharmacologic inhibition decreased male GBM cell clonogenicity and in vivo tumorigenesis, while increasing both in female GBM cells.", "These results were validated in male and female patient-derived GBM cell lines.", "Furthermore, analysis of the Cancer Therapeutic Response Portal of human GBM samples segregated by sex revealed that male GBM cells are significantly more sensitive to BET inhibitors than are female cells.", "Thus, for the first time, Brd4 activity is revealed to drive a sex differences in stem cell and tumorigenic phenotype, resulting in diametrically opposite responses to BET inhibition in male and female GBM cells.", "This has important implications for the clinical evaluation and use of BET inhibitors.", "Significance Consistent sex differences in incidence and outcome have been reported in numerous cancers including brain tumors.", "GBM, the most common and aggressive primary brain tumor, occurs with higher incidence and shorter survival in males compared to females.", "Brd4 is essential for regulating transcriptome-wide gene expression and specifying cell identity, including that of GBM.", "We report that sex-biased Brd4 activity drive sex differences in GBM and render male and female tumor cells differentially sensitive to BET inhibitors.", "The observed sex differences in BETi treatment strongly indicate that sex differences in disease biology translate into sex differences in therapeutic responses.", "This has critical implications for clinical use of BET inhibitors further affirming the importance of inclusion of sex as a biological variable."], "title": "Brd4-bound enhancers drive cell intrinsic sex differences in glioblastoma"}
{"doc_id": 33, "abstract": ["Cytokine release syndrome (CRS) is a life-threatening complication induced by systemic inflammatory responses to infections, including bacteria and chimeric antigen receptor T cell therapy.", "There are currently no immunotherapies with proven clinical efficacy and understanding of the molecular mechanisms of CRS pathogenesis is limited.", "Here, we found that patients diagnosed with CRS from sepsis, acute respiratory distress syndrome (ARDS), or burns showed common manifestations: strikingly elevated levels of the four proinflammatory cytokines interleukin (IL)-6, IL-8, monocyte chemotactic protein-1 (MCP-1), and IL-10 and the coagulation cascade activator plasminogen activator inhibitor-1 (PAI-1).", "Our in vitro data indicate that endothelial IL-6 trans-signaling formed an inflammation circuit for robust IL-6, IL-8, and MCP-1 production and promoted PAI-1 production; additionally, an IL-6 signaling blockade by the human monoclonal antibody tocilizumab blunted endothelial cell activation.", "Plasma from severe COVID-19 patients similarly exhibited increased IL-6, IL-10, and MCP-1 levels, but these levels were not as high as those in patients with CRS from other causes.", "In contrast, the PAI-1 levels in COVID-19 patients were as highly elevated as those in patients with bacterial sepsis or ARDS.", "Tocilizumab treatment decreased the PAI-1 levels and alleviated critical illness in severe COVID-19 patients.", "Our findings suggest that distinct levels of cytokine production are associated with CRS induced by bacterial infection and COVID-19, but both CRS types are accompanied by endotheliopathy through IL-6 trans-signaling.", "Thus, the present study highlights the crucial role of IL-6 signaling in endothelial dysfunction during bacterial infection and COVID-19."], "title": "IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome"}
{"doc_id": 34, "abstract": ["Humoral immune responses are typically characterized by primary IgM antibody responses followed by secondary antibody responses associated with immune memory and comprised of of IgG, IgA and IgE. Here we measured acute humoral responses to SARS-CoV-2, including the frequency of antibody-secreting cells and the presence of SARS-CoV-2-specific neutralizing antibodies in the serum, saliva and broncho-alveolar fluid of 159 patients with COVID-19.", "Early SARS-CoV-2-specific humoral responses were dominated by IgA antibodies.", "Peripheral expansion of IgA plasmablasts with mucosal-homing potential was detected shortly after the onset of symptoms and peaked during the third week of the disease.", "The virus-specific antibody responses included IgG, IgM and IgA, but IgA contributed to virus neutralization to a greater extent compared with IgG. Specific IgA serum concentrations decreased notably one month after the onset of symptoms, but neutralizing IgA remained detectable in saliva for a longer time (days 49 to 73 post symptoms).", "These results represent a critical observation given the emerging information as to the types of antibodies associated with optimal protection against re-infection, and whether vaccine regimens should consider targeting a potent but potentially short-lived IgA response."], "title": "IgA dominates the early neutralizing antibody response to SARS-CoV-2"}
{"doc_id": 35, "abstract": ["We investigated the expression and subcellular localization of the SARS-CoV-2 receptor, angiotensin-converting enzyme 2 (ACE2), within the upper (nasal) and lower (pulmonary) respiratory tracts of healthy human donors.", "We detected ACE2 protein expression within the cilia organelle of ciliated airway epithelial cells, which likely represents the initial or early subcellular site of SARS-CoV-2 viral entry during respiratory transmission.", "We further determined whether ACE2 expression in the cilia of upper respiratory cells was influenced by patient demographics, clinical characteristics, co-morbidities, or medication use, and found no evidence that the use of angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II receptor blockers (ARBs) increases ACE2 protein expression."], "title": "Robust ACE2 protein expression localizes to the motile cilia of the respiratory tract epithelia and is not increased by ACE inhibitors or angiotensin receptor blockers"}
{"doc_id": 36, "abstract": ["Person-to-person transmission of SARS-CoV-2 virus has triggered a global emergency because of its potential to cause life-threatening Covid-19 disease.", "By comparison to pauci-symptomatic virus clearance by most individuals, Covid-19 has been proposed to reflect insufficient and/or pathologically exaggerated immune responses.", "Here we identify a consensus peripheral blood immune signature across 63 hospital-treated Covid-19 patients who were otherwise highly heterogeneous.", "The core signature conspicuously blended adaptive B cell responses typical of virus infection or vaccination with discrete traits hitherto associated with sepsis, including monocyte and dendritic cell dampening, and hyperactivation and depletion of discrete T cell subsets.", "This blending of immuno-protective and immuno-pathogenic potentials was exemplified by near-universal CXCL10/IP10 upregulation, as occurred in SARS1 and MERS.", "Moreover, specific parameters including CXCL10/IP10 over-expression, T cell proliferation, and basophil and plasmacytoid dendritic cell depletion correlated, often prognostically, with Covid-19 progression, collectively composing a resource to inform SARS-CoV-2 pathobiology and risk-based patient stratification."], "title": "A consensus Covid-19 immune signature combines immuno-protection with discrete sepsis-like traits associated with poor prognosis"}
{"doc_id": 37, "abstract": ["The Chinese horseshoe bat (Rhinolophus sinicus), reservoir host of severe acute respiratory syndrome coronavirus (SARS-CoV), carries many bat SARS-related CoVs (SARSr-CoVs) with high genetic diversity, particularly in the spike gene.", "Despite these variations, some bat SARSr-CoVs can utilize the orthologs of the human SARS-CoV receptor, angiotensin-converting enzyme 2 (ACE2), for entry.", "It is speculated that the interaction between bat ACE2 and SARSr-CoV spike proteins drives diversity.", "Here, we identified a series of R. sinicus ACE2 variants with some polymorphic sites involved in the interaction with the SARS-CoV spike protein.", "Pseudoviruses or SARSr-CoVs carrying different spike proteins showed different infection efficiencies in cells transiently expressing bat ACE2 variants.", "Consistent results were observed by binding affinity assays between SARS-CoV and SARSr-CoV spike proteins and receptor molecules from bats and humans.", "All tested bat SARSr-CoV spike proteins had a higher binding affinity to human ACE2 than to bat ACE2, although they showed a 10-fold lower binding affinity to human ACE2 compared with that of their SARS-CoV counterpart.", "Structure modeling revealed that the difference in binding affinity between spike and ACE2 might be caused by the alteration of some key residues in the interface of these two molecules.", "Molecular evolution analysis indicates that some key residues were under positive selection.", "These results suggest that the SARSr-CoV spike protein and R. sinicus ACE2 may have coevolved over time and experienced selection pressure from each other, triggering the evolutionary arms race dynamics.", "IMPORTANCE Evolutionary arms race dynamics shape the diversity of viruses and their receptors.", "Identification of key residues which are involved in interspecies transmission is important to predict potential pathogen spillover from wildlife to humans.", "Previously, we have identified genetically diverse SARSr-CoVs in Chinese horseshoe bats.", "Here, we show the highly polymorphic ACE2 in Chinese horseshoe bat populations.", "These ACE2 variants support SARS-CoV and SARSr-CoV infection but with different binding affinities to different spike proteins.", "The higher binding affinity of SARSr-CoV spike to human ACE2 suggests that these viruses have the capacity for spillover to humans.", "The positive selection of residues at the interface between ACE2 and SARSr-CoV spike protein suggests long-term and ongoing coevolutionary dynamics between them.", "Continued surveillance of this group of viruses in bats is necessary for the prevention of the next SARS-like disease."], "title": "Evolutionary Arms Race between Virus and Host Drives Genetic Diversity in Bat Severe Acute Respiratory Syndrome-Related Coronavirus Spike Genes"}
{"doc_id": 38, "abstract": ["In several hospitals worldwide, healthcare workers are currently at the forefront against coronavirus disease 2019 (COVID-19).", "Since Fondazione Policlinico Universitario A. Gemelli (FPG) IRCCS has been enlisted as a COVID hospital, healthcare workers deployed to COVID wards were separated from those with limited or no exposure, whereas administrative staff was destined to work-from-home.", "Between June 4 and July 3 2020, an investigation was carried out to evaluate seroprevalence of SARS-CoV-2 IgG antibodies among employees of the FPG using point-of-care (POC) and venous blood tests.", "Sensitivity, specificity and predictive values were determined with reverse-transcription polymerase chain reaction (RT-PCR) on nasal/oropharyngeal swabs as gold standard.", "Four thousand, seven hundred seventy-seven participants were enrolled.", "Seroprevalence was 3.66% using the POC test and 1.19% using venous blood test, with a significant difference between the two (p < 0.05).", "POC sensitivity and specificity were, respectively, 63.64% (95% confidence interval (CI): 62.20% to 65.04%) and 96.64% (95% CI: 96.05% to 97.13%), while those of the venous blood test were, respectively, 78.79% (95% CI: 77.58% to 79.94%) and 99.36% (95% CI: 99.07% to 99.55%).", "Among low-risk population, point-of-care's predictive values were 58.33% (positive) and 98.23% (negative) whereas venous blood test's were 92.86% (positive) and 98.53% (negative).", "In conclusion, point-of-care tests have low diagnostic accuracy, while venous blood tests seem to show an overall poor reliability."], "title": "COVID-19 seroprevalence among healthcare workers of a large COVID Hospital in Rome reveals strengths and limits of two different serological tests"}
{"doc_id": 39, "abstract": ["In December 2019, a new coronavirus disease (COVID-19) outbreak occurred in Wuhan, China.", "Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), which is the seventh coronavirus known to infect humans, is highly contagious and has rapidly expanded worldwide since its discovery.", "Quantitative nucleic acid testing has become the gold standard for diagnosis and guiding clinical decisions regarding the use of antiviral therapy.", "However, the RT-qPCR assays targeting SARS-CoV-2 have a number of challenges, especially in terms of primer design.", "Primers are the pivotal components of a RT-qPCR assay.", "Once virus mutation and recombination occur, it is difficult to effectively diagnose viral infection by existing RT-qPCR primers.", "Some primers and probes have also been made available on the WHO website for reference.", "However, no previous review has systematically compared the previously reported primers and probes and described how to design new primers in the event of a new coronavirus infection.", "This review focuses on how primers and probes can be designed methodically and rationally, and how the sensitivity and specificity of the detection process can be improved.", "This brief review will be useful for the accurate diagnosis and timely treatment of the new coronavirus pneumonia."], "title": "Primer design for quantitative real-time PCR for the emerging Coronavirus SARS-CoV-2"}
{"doc_id": 40, "abstract": ["Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, laboratory testing to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by real-time reverse transcription PCR (RT-qPCR) has played a central role in mitigating the spread of the virus (1).", "Soon after the viral genome sequences were available, several RT-qPCR assays were developed and made available by World Health Organization (WHO) for public use (https://www.who.int/docs/default-source/coronaviruse/whoinhouseassays.pdf).", "The primer and probe sequences for these assays were chosen from multiple target genes within the viral genome such as the E gene, RdRp gene, ORF1ab and N gene.", "Many commercial and laboratory-developed assays were developed for SARS-CoV-2 detection based on these primer and probe sequences.", "The large-scale sustained person-to-person transmission of SARS-CoV-2 has led to many mutational events, some of which may affect the sensitivity and specificity of available PCR assays (2).", "Recently, mutations in the E gene (C26340T) and N gene (C29200T) were reported affecting the detection of target genes by two commercial assays in 8 and 1 patients, respectively.", "Interestingly, both mutations are of C>T type, a common single nucleotide polymorphism (SNP) that may be associated with strong host cell mRNA editing mechanisms known as APOBEC cytidine deaminase (3, 4).", "Another study found a G to U substitution in position 29140 that affected the sensitivity of detection of N gene-based assays (5).", "Here we report a novel N gene mutation (C29200A) seen in 3 patients, which affected the detection of SARS-CoV-2 N gene by a commercial assay."], "title": "A novel point mutation in the N gene of SARS-CoV-2 may affect the detection of the virus by RT-qPCR"}
{"doc_id": 41, "abstract": ["BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is spread mainly through respiratory droplets or direct contact.", "However, the infection condition of the genital system is unknown.", "Our aim in this study was to determine if SARS-CoV-2 is present in the vaginal fluid of women with coronavirus disease 2019 (COVID-19).", "METHODS: Ten women with confirmed severe COVID-19 pneumonia admitted to the Tongji Zhongfa Hospital intensive care unit from 4 February 2020 through 24 February 2020 were included.", "Clinical records, laboratory results, and computed tomography examinations were retrospectively reviewed.", "The potential for genital infection was accessed by testing for the presence of SARS-CoV-2 in vaginal fluids obtained from vaginal swab samples.", "Reverse transcriptase polymerase chain reaction was used to confirm the SARS-CoV-2 infection in vaginal fluids.", "RESULTS: The clinical characteristics of the 10 women were similar to those reported in other severe COVID-19 patients.", "All 10 patients were tested for SARS-CoV-2 in vaginal fluid, and all samples tested negative for the virus.", "CONCLUSIONS: Findings from this small group of cases suggest that SARS-CoV-2 virus does not exist in the vaginal fluids of severe COVID-19 patients."], "title": "SARS-CoV-2 Is Not Detectable in the Vaginal Fluid of Women With Severe COVID-19 Infection"}
{"doc_id": 42, "abstract": ["SARS-CoV-2 has intricate mechanisms for initiating infection, immune evasion/suppression, and replication, which depend on the structure and dynamics of its constituent proteins.", "Many protein structures have been solved, but far less is known about their relevant conformational changes.", "To address this challenge, over a million citizen scientists banded together through the Folding@home distributed computing project to create the first exascale computer and simulate an unprecedented 0.1 seconds of the viral proteome.", "Our simulations capture dramatic opening of the apo Spike complex, far beyond that seen experimentally, which explains and successfully predicts the existence of \u2018cryptic\u2019 epitopes.", "Different Spike homologues modulate the probabilities of open versus closed structures, balancing receptor binding and immune evasion.", "We also observe dramatic conformational changes across the proteome, which reveal over 50 \u2018cryptic\u2019 pockets that expand targeting options for the design of antivirals.", "All data and models are freely available online, providing a quantitative structural atlas."], "title": "SARS-CoV-2 Simulations Go Exascale to Capture Spike Opening and Reveal Cryptic Pockets Across the Proteome"}
{"doc_id": 43, "abstract": ["The COVID-19 pandemic, caused by SARS coronavirus 2 (SARS-CoV-2), has resulted in excess morbidity and mortality as well as economic decline.", "To characterise the systemic host immune response to SARS-CoV-2, we performed single-cell RNA-sequencing coupled with analysis of cell surface proteins, providing molecular profiling of over 800,000 peripheral blood mononuclear cells from a cohort of 130 patients with COVID-19.", "Our cohort, from three UK centres, spans the spectrum of clinical presentations and disease severities ranging from asymptomatic to critical.", "Three control groups were included: healthy volunteers, patients suffering from a non-COVID-19 severe respiratory illness and healthy individuals administered with intravenous lipopolysaccharide to model an acute inflammatory response.", "Full single cell transcriptomes coupled with quantification of 188 cell surface proteins, and T and B lymphocyte antigen receptor repertoires have provided several insights into COVID-19: 1. a new non-classical monocyte state that sequesters platelets and replenishes the alveolar macrophage pool; 2. platelet activation accompanied by early priming towards megakaryopoiesis in immature haematopoietic stem/progenitor cells and expansion of megakaryocyte-primed progenitors; 3. increased clonally expanded CD8+ effector:effector memory T cells, and proliferating CD4+ and CD8+ T cells in patients with more severe disease; and 4. relative increase of IgA plasmablasts in asymptomatic stages that switches to expansion of IgG plasmablasts and plasma cells, accompanied with higher incidence of BCR sharing, as disease severity increases.", "All data and analysis results are available for interrogation and data mining through an intuitive web portal.", "Together, these data detail the cellular processes present in peripheral blood during an acute immune response to COVID-19, and serve as a template for multi-omic single cell data integration across multiple centers to rapidly build powerful resources to help combat diseases such as COVID-19."], "title": "The cellular immune response to COVID-19 deciphered by single cell multi-omics across three UK centres"}
{"doc_id": 44, "abstract": ["Masks are a vital tool for limiting SARS-CoV-2 spread in the population.", "Here we utilize a mathematical model to assess the impact of masking on transmission within individual transmission pairs and at the population level.", "Our model quantitatively links mask efficacy to reductions in viral load and subsequent transmission risk.", "Our results reinforce that the use of masks by both a potential transmitter and exposed person substantially reduces the probability of successful transmission, even if masks only lower exposure viral load by ~ 50%.", "Slight increases in mask adherence and/or efficacy above current levels would reduce the effective reproductive number (Re) substantially below 1, particularly if implemented comprehensively in potential super-spreader environments.", "Our model predicts that moderately efficacious masks will also lower exposure viral load tenfold among people who get infected despite masking, potentially limiting infection severity.", "Because peak viral load tends to occur pre-symptomatically, we also identify that antiviral therapy targeting symptomatic individuals is unlikely to impact transmission risk.", "Instead, antiviral therapy would only lower Re if dosed as post-exposure prophylaxis and if given to ~ 50% of newly infected people within 3 days of an exposure.", "These results highlight the primacy of masking relative to other biomedical interventions under consideration for limiting the extent of the COVID-19 pandemic prior to widespread implementation of a vaccine.", "To confirm this prediction, we used a regression model of King County, Washington data and simulated the counterfactual scenario without mask wearing to estimate that in the absence of additional interventions, mask wearing decreased Re from 1.3-1.5 to ~ 1.0 between June and September 2020."], "title": "Slight reduction in SARS-CoV-2 exposure viral load due to masking results in a significant reduction in transmission with widespread implementation"}
{"doc_id": 45, "abstract": ["Following its emergence in Wuhan, China, in late November or early December 2019, the SARS-CoV-2 virus has rapidly spread throughout the world.", "Genome sequencing of SARS-CoV-2 strains allows for the reconstruction of transmission history connecting these infections.", "Here, we analyze 346 SARS-CoV-2 genomes from samples collected between 20 February and 15 March 2020 from infected patients in Washington State, USA.", "We found that the large majority of SARS-CoV-2 infections sampled during this time frame appeared to have derived from a single introduction event into the state in late January or early February 2020 and subsequent local spread, indicating cryptic spread of COVID-19 before active community surveillance was implemented.", "We estimate a common ancestor of this outbreak clade as occurring between 18 January and 9 February 2020.", "From genomic data, we estimate an exponential doubling between 2.4 and 5.1 days.", "These results highlight the need for large-scale community surveillance for SARS-CoV-2 and the power of pathogen genomics to inform epidemiological understanding."], "title": "Cryptic transmission of SARS-CoV-2 in Washington State"}
{"doc_id": 46, "abstract": ["Both cellular and humoral immunities are critically important to control COVID19 infection but little is known about the kinetics of those responses and, in particular, in patients who will go on to develop a severe form of the disease over several weeks.", "We herein report the first set of data of our prospective cohort study of 90 hospitalized cases.", "Serological surveys were thoroughly performed over 2 month period by assessing IgG and IgM responses by immunofluorescence, immunoblot, Western blot and conventional ELISA using clinical RUN isolates of SARS-CoV-2 immobilized on 96 well plates.", "While the IgM and, unexpectedly, the IgG responses were readily detected early during the course of the disease (5-7 days post-first symptoms), our results (n=3-5 and over the full dilution set of the plasma 1/200 to 1/12800) demonstrated a significant decrease (over 2.5-fold) of IgG levels in severe (ICU) hospitalized patients (exemplified in patient 1) by WB and ELISA.", "In contrast, mild non-ICU patients had a steady and yet robust rise in their specific IgG levels against the virus.", "Interestingly, both responses (IgM and IgG) were initially against the nucleocapsid (50kDa band on the WB) and spreading to other major viral protein S and domains (S1 and S2.", "In conclusion, serological testing may be helpful for the diagnosis of patients with negative RT-PCR results and for the identification of asymptomatic cases.", "Moreover, medical care and protections should be maintained particularly for recovered patients (severe cases) who may remain at risk of relapsing or reinfection.", "Experiments to ascertain T cell responses but although their kinetics overtime are now highly warranted.", "All in all, these studies will help to delineate the best routes for vaccination."], "title": "Serological surveys in Reunion Island of the first hospitalized patients revealed that long-lived immunoglobulin G antibodies specific against SARS-CoV2 virus are rapidly vanishing in severe cases"}
{"doc_id": 47, "abstract": ["There is pressing urgency to understand the pathogenesis of the severe acute respiratory syndrome coronavirus clade 2 (SARS-CoV-2), which causes the disease COVID-19.", "SARS-CoV-2 spike (S) protein binds angiotensin-converting enzyme 2 (ACE2), and in concert with host proteases, principally transmembrane serine protease 2 (TMPRSS2), promotes cellular entry.", "The cell subsets targeted by SARS-CoV-2 in host tissues and the factors that regulate ACE2 expression remain unknown.", "Here, we leverage human, non-human primate, and mouse single-cell RNA-sequencing (scRNA-seq) datasets across health and disease to uncover putative targets of SARS-CoV-2 among tissue-resident cell subsets.", "We identify ACE2 and TMPRSS2 co-expressing cells within lung type II pneumocytes, ileal absorptive enterocytes, and nasal goblet secretory cells.", "Strikingly, we discovered that ACE2 is a human interferon-stimulated gene (ISG) in vitro using airway epithelial cells and extend our findings to in vivo viral infections.", "Our data suggest that SARS-CoV-2 could exploit species-specific interferon-driven upregulation of ACE2, a tissue-protective mediator during lung injury, to enhance infection."], "title": "SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues"}
{"doc_id": 48, "abstract": ["The molecular basis for the severity and rapid spread of the COVID-19 disease caused by SARS-CoV-2 is largely unknown.", "ORF8 is a rapidly evolving accessory protein that has been proposed to interfere with immune responses.", "The crystal structure of SARS-CoV-2 ORF8 was determined at 2.04 \u00c5 resolution by x-ray crystallography.", "The structure reveals a ~60 residue core similar to SARS-CoV ORF7a with the addition of two dimerization interfaces unique to SARS-CoV-2 ORF8.", "A covalent disulfide-linked dimer is formed through an N-terminal sequence specific to SARS-CoV-2, while a separate non-covalent interface is formed by another SARS-CoV-2-specific sequence, (73)YIDI(76).", "Together the presence of these interfaces shows how SARS-CoV-2 ORF8 can form unique large-scale assemblies not possible for SARS-CoV, potentially mediating unique immune suppression and evasion activities."], "title": "Structure of SARS-CoV-2 ORF8, a rapidly evolving coronavirus protein implicated in immune evasion"}
{"doc_id": 49, "abstract": ["Hypoxemia and coagulopathy are common in severe symptomatic patients of coronavirus disease 2019 (COVID-19).", "Histological evidence shows implication of complement activation and lung injury.", "We research sign of complement activation and presence of thrombotic microangiopathy in 8 severe patients.", "Six of them presented moderate elevation of final pathway of complement / sC5b-9 (median value : 350 ng/mL [IQR : 300,5-514,95 ng/mL]).", "Two patients have been autopsied and presence of thrombotic microvascular injury have been found.", "Interestingly, none the 8 patients had signs of mechanical hemolytic anemia (median value of hemoglobin : 10,5 gr/dL[IQR : 8,1-1,9], median value of haptoglobuline 4,49 [IQR 3,55-4,66], none of the patients has schistocyte) and thrombocytopenia (median value: 348000/mL [IQR : 266 000-401 000).", "Finally, all 8 patients had elevated d-dimer (median value : 2226 microgr/l [IQR : 1493-2362]) and soluble fibrin monomer complex (median value : 8.5 mg/mL, IQR[ <6-10.6]).", "In summary, this study show moderate activation of complement and coagulation with presence of thrombotic microvascular injury in patients with severe COVID-19 without evidence of systemic thrombotic microangiopathy."], "title": "Thrombotic microvascular injury is not mediated by thrombotic microangiopathy despite systemic complement activation in Covid-19 patients"}
{"doc_id": 50, "abstract": ["SARS-CoV-2 is a single stranded RNA (ssRNA) virus and contains GU-rich sequences distributed abundantly in the genome.", "In COVID-19, the infection and immune hyperactivation causes accumulation of inflammatory immune cells, blood clots, and protein aggregates in lung fluid, increased lung alveolar wall thickness, and upregulation of serum cytokine levels.", "A serum protein called serum amyloid P (SAP) has a calming effect on the innate immune system and shows efficacy as a therapeutic for fibrosis in animal models and clinical trials.", "In this report, we show that aspiration of the GU-rich ssRNA oligonucleotide ORN06 into mouse lungs induces all of the above COVID-19-like symptoms.", "Men tend to have more severe COVID-19 symptoms than women, and in the aspirated ORN06 model, male mice tended to have more severe symptoms than female mice.", "Intraperitoneal injections of SAP starting from day 1 post ORN06 aspiration attenuated the ORN06-induced increase in the number of inflammatory cells and formation of clot-like aggregates in the mouse lung fluid, reduced ORN06-increased alveolar wall thickness and accumulation of exudates in the alveolar airspace, and attenuated an ORN06-induced upregulation of the inflammatory cytokines IL-1\u03b2, IL-6, IL-12p70, IL-23, and IL-27 in serum.", "Together, these results suggest that aspiration of ORN06 is a simple model for both COVID-19 as well as cytokine storm in general, and that SAP is a potential therapeutic for diseases with COVID-19-like symptoms as well as diseases that generate a cytokine storm."], "title": "Serum Amyloid P inhibits single stranded RNA-induced lung inflammation, lung damage, and cytokine storm in mice"}
{"doc_id": 51, "abstract": ["SARS-CoV-2 is a single stranded RNA (ssRNA) virus and contains GU-rich sequences distributed abundantly in the genome.", "In COVID-19, the infection and immune hyperactivation causes accumulation of inflammatory immune cells, blood clots, and protein aggregates in lung fluid, increased lung alveolar wall thickness, and upregulation of serum cytokine levels.", "A serum protein called serum amyloid P (SAP) has a calming effect on the innate immune system and shows efficacy as a therapeutic for fibrosis in animal models and clinical trials.", "Here we show that aspiration of the GU-rich ssRNA oligonucleotide ORN06 into mouse lungs induces all of the above COVID-19-like symptoms.", "Men tend to have more severe COVID-19 symptoms than women, and in the aspirated ORN06 model, male mice tended to have more severe symptoms than female mice.", "Intraperitoneal injections of SAP starting from day 1 post ORN06 aspiration attenuated the ORN06-induced increase in the number of inflammatory cells and formation of clot-like aggregates in the mouse lung fluid, reduced ORN06-increased alveolar wall thickness and accumulation of exudates in the alveolar airspace, and attenuated an ORN06-induced upregulation of the inflammatory cytokines IL-1\u00df, IL-6, IL-12p70, IL-23, and IL-27 in serum.", "SAP also reduced D-dimer levels in the lung fluid.", "In human peripheral blood mononuclear cells, SAP attenuated ORN06-induced extracellular accumulation of IL-6.", "Together, these results suggest that aspiration of ORN06 is a simple model for both COVID-19 as well as cytokine storm in general, and that SAP is a potential therapeutic for diseases with COVID-19-like symptoms and/or a cytokine storm."], "title": "Serum Amyloid P inhibits single stranded RNA-induced lung inflammation, lung damage, and cytokine storm in mice"}
{"doc_id": 52, "abstract": ["The current outbreak of viral pneumonia in the city of Wuhan, China, was caused by a novel coronavirus designated 2019-nCoV by the World Health Organization, as determined by sequencing the viral RNA genome.", "Many initial patients were exposed to wildlife animals at the Huanan seafood wholesale market, where poultry, snake, bats, and other farm animals were also sold.", "To investigate possible virus reservoir, we have carried out comprehensive sequence analysis and comparison in conjunction with relative synonymous codon usage (RSCU) bias among different animal species based on the 2019-nCoV sequence.", "Results obtained from our analyses suggest that the 2019-nCoV may appear to be a recombinant virus between the bat coronavirus and an origin-unknown coronavirus.", "The recombination may occurred within the viral spike glycoprotein, which recognizes a cell surface receptor.", "Additionally, our findings suggest that 2019-nCoV has most similar genetic information with bat coronovirus and most similar codon usage bias with snake.", "Taken together, our results suggest that homologous recombination may occur and contribute to the 2019-nCoV cross-species transmission."], "title": "Cross-species transmission of the newly identified coronavirus 2019-nCoV"}
{"doc_id": 53, "abstract": ["The SARS (severe acute respiratory syndrome) outbreak was caused by a coronavirus (CoV) named the SARS-CoV. SARS pathology is propagated both by direct cytotoxic effects of the virus and aberrant activation of the innate immune response.", "Here, we identify several mechanisms by which a SARS-CoV open reading frame (ORF) activates intracellular stress pathways and targets the innate immune response.", "We show that ORF8b forms insoluble intracellular aggregates dependent on a valine at residue 77.", "Aggregated ORF8b induces endoplasmic reticulum (ER) stress, lysosomal damage, and subsequent activation of the master regulator of the autophagy and lysosome machinery, Transcription factor EB (TFEB).", "ORF8b causes cell death in epithelial cells, which is partially rescued by reducing its ability to aggregate.", "In macrophages, ORF8b robustly activates the NLRP3 inflammasome by providing a potent signal 2 required for activation.", "Mechanistically, ORF8b interacts directly with the Leucine Rich Repeat domain of NLRP3 and localizes with NLRP3 and ASC in cytosolic dot-like structures.", "ORF8b triggers cell death consistent with pyroptotic cell death in macrophages.", "While in those cells lacking NLRP3 accumulating ORF8b cytosolic aggregates cause ER stress, mitochondrial dysfunction, and caspase-independent cell death."], "title": "SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes"}
{"doc_id": 54, "abstract": ["Background Due to the large number of patients with coronavirus disease 19 (COVID-19), rapid diagnosis at the emergency department (ED) is of critical importance.", "In this study we have developed a flowchart based on two well-known diagnostic methods: the 'corona-score' and the 'CO-RADS'.", "This flowchart can be used in hospitals that use chest-CT, instead of chest X-ray, for COVID-19 suspected patients at the ED.", "Methods ED patients (n=1904) from the Jeroen Bosch Hospital, Amphia Hospital, HagaHospital, Elisabeth TweeSteden Hospital, Bernhoven Hospital and Slingeland Hospital were included.", "A laboratory-based 'corona-score', without radiology, called the 'lab-corona-score' was combined with a chest-CT based radiology scoring system (CO-RADS), to develop a flowchart.", "The performance was assessed by sensitivity/specificity analyses using the RT-PCR outcome or the physician's final diagnosis as golden standard.", "Results Out of the 1904 patients, 611 (32.1%) patients tested positive for the SARS-CoV-2 virus.", "The lab-corona-score alone had an AUC of 0.86, a sensitivity of 87% and a specificity of 88% using cut-off values of 0-2 (negative) and 8-10 (positive).", "Of 255 patients, from the Amphia and Slingeland Hospitals, a CO-RADS score was determined.", "The flowchart, which combined the 'CO-RADS' with the 'lab-corona-score', was developed based on data from Slingeland Hospital (sensitivity 97%, specificity 96%).", "Hereafter, the performance of the flowchart was validated using an independent dataset from Amphia hospital, and reached a sensitivity of 98% and specificity of 93%.", "A decision could be made in 79% of the patients, which was correct in 95% of the cases.", "Conclusion This flowchart, based on radiology (CO-RADS) and clinical chemistry parameters (lab-corona-score), results in a rapid and accurate diagnosis of COVID-19 at the ED."], "title": "A chest-CT and clinical chemistry based flowchart for rapid COVID-19 triage at emergency departments - a multicenter study"}
{"doc_id": 55, "abstract": ["The 2020 SARS-CoV-2 pandemic is caused by a zoonotic coronavirus transmitted to humans, similar to earlier events.", "Whether the other, seasonally circulating coronaviruses induce cross-reactive, potentially even cross-neutralizing antibodies to the new species in humans is unclear.", "The question is of particular relevance for people with immune deficiencies, as their health depends on treatment with immunoglobulin preparations that need to contain neutralizing antibodies against the pathogens in their environment.", "Testing 54 IVIG preparations, produced from plasma collected in Europe and the US, highly potent neutralization of a seasonal coronavirus was confirmed, yet no cross-neutralization of the new SARS-CoV-2 was seen.", "SUMMARYIVIG products manufactured from pre-pandemic plasma do not neutralize SARS-CoV-2 but contain high neutralizing titers for seasonal coronavirus hCoV-229E."], "title": "No SARS-CoV-2 cross-neutralization by intravenous immunoglobulins produced from plasma collected before the 2020 pandemic"}
{"doc_id": 56, "abstract": ["Background.", "COVID-19 infection has led to an overwhelming effort by health institutions to meet the high demand for hospital admissions.", "Aim.", "To analyse the clinical variables associated with readmission of patients who had previously been discharged after admission for COVID-19.", "Design and methods.", "We studied a retrospective cohort of patients with laboratory-confirmed SARS-CoV-2 infection who were admitted and subsequently discharged alive.", "We then conducted a nested case-control study paired (1:1 ratio) by age, sex and period of admission.", "Results.", "Out of 1368 patients who were discharged during the study period, 61 patients (4.4%) were readmitted.", "Immunocompromised patients were at increased risk for readmission.", "There was also a trend towards a higher probability of readmission in hypertensive patients (p=0.07).", "Cases had had a shorter hospital stay and a higher prevalence of fever during the 48 hours prior to discharge.", "There were no significant differences in oxygen levels measured at admission and discharge by pulse oximetry intra-subject or between the groups.", "Neutrophil/lymphocyte ratio at hospital admission tended to be higher in cases than in controls (p=0.06).", "The motive for readmission in 10 patients (16.4%), was a thrombotic event in venous or arterial territory (p<0.001).", "Neither glucocorticoids nor anticoagulants prescribed at hospital discharge were associated with a lower readmission rate.", "Conclusions.", "The rate of readmission after discharge from hospital for COVID-19 was low.", "Immunocompromised patients and those presenting with fever during the 48 hours prior to discharge are at greater risk of readmission to hospital."], "title": "Hospital readmissions of discharged patients with COVID-19"}
{"doc_id": 57, "abstract": ["The recently emerged SARS-CoV-2 virus is currently causing a global pandemic and cases continue to rise.", "The majority of infected individuals experience mildly symptomatic coronavirus disease 2019 (COVID-19), but it is unknown whether this can induce persistent immune memory that might contribute to herd immunity.", "Thus, we performed a longitudinal assessment of individuals recovered from mildly symptomatic COVID-19 to determine if they develop and sustain immunological memory against the virus.", "We found that recovered individuals developed SARS-CoV-2-specific IgG antibody and neutralizing plasma, as well as virus-specific memory B and T cells that not only persisted, but in some cases increased numerically over three months following symptom onset.", "Furthermore, the SARS-CoV-2-specific memory lymphocytes exhibited characteristics associated with potent antiviral immunity: memory T cells secreted IFN-\u03b3 and expanded upon antigen re-encounter, while memory B cells expressed receptors capable of neutralizing virus when expressed as antibodies.", "These findings demonstrate that mild COVID-19 elicits memory lymphocytes that persist and display functional hallmarks associated with antiviral protective immunity."], "title": "Functional SARS-CoV-2-specific immune memory persists after mild COVID-19"}
{"doc_id": 58, "abstract": ["Many antibody and immune escape variants in SARS-CoV-2 are now documented in literature.", "The availability of SARS-CoV-2 genome sequences enabled us to investigate the occurrence and genetic epidemiology of the variants globally.", "Our analysis suggests that a number of genetic variants associated with immune escape have emerged in global populations."], "title": "Genetic epidemiology of variants associated with immune escape from global SARS-CoV-2 genomes"}
{"doc_id": 59, "abstract": ["As in past pandemics, co-circulating pathogens may play a role in the epidemiology of coronavirus disease 2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).", "Here we hypothesized that influenza interacted with SARS-CoV-2 during the early 2020 epidemic of COVID-19 in Europe.", "We developed a population-based model of SARS-CoV-2 transmission, combined with mortality incidence data in four European countries, to test a range of assumptions about the impact of influenza.", "We found consistent evidence for a 2-2.5-fold population-level increase in SARS-CoV-2 transmission associated with influenza during the period of co-circulation.", "These results suggest the need to increase vaccination against influenza, not only to reduce the burden due to influenza viruses, but also to counteract their facilitatory impact on SARS-CoV-2."], "title": "Influenza may facilitate the spread of SARS-CoV-2"}
{"doc_id": 60, "abstract": ["As the novel coronavirus outbreak spreads globally with devastating effects on human health, pets are also becoming unnecessary victims amidst the pandemic panic.", "Many have been reluctantly left home alone by owners who have been forced to temporarily evacuate their homes. And, although no evidence exists to indicate that they can either transmit the virus or develop its associated coronavirus disease 2019 (COVID-19), fear among the public that pets might play a role in spreading COVID-19 has resulted in pets being abandoned or even killed.", "This article outlines some of the ways in which the current pandemic has negatively impacted the welfare of pets.", "It also highlights the relationships between animal, human, and environmental health, as well as the importance of taking a collaborative transdisciplinary One Health approach to help prevent future COVID-19 outbreaks."], "title": "COVID-19 and pets: When pandemic meets panic"}
{"doc_id": 61, "abstract": ["Olfactory dysfunction caused by SARS-CoV-2 infection represents as one of the most predictive and common symptoms in COVID-19 patients.", "However, the causal link between SARS-CoV-2 infection and olfactory disorders remains lacking.", "Herein we demonstrate intranasal inoculation of SARS-CoV-2 induces robust viral replication in the olfactory epithelium (OE), resulting in transient olfactory dysfunction in humanized ACE2 mice.", "The sustentacular cells and Bowman\u2019s gland cells in OE were identified as the major targets of SARS-CoV-2 before the invasion into olfactory sensory neurons.", "Remarkably, SARS-CoV-2 infection triggers cell death and immune cell infiltration, and impairs the uniformity of OE structure.", "Combined transcriptomic and proteomic analyses reveal the induction of antiviral and inflammatory responses, as well as the downregulation of olfactory receptors in OE from the infected animals.", "Overall, our mouse model recapitulates the olfactory dysfunction in COVID-19 patients, and provides critical clues to understand the physiological basis for extrapulmonary manifestations of COVID-19."], "title": "SARS-CoV-2 infection causes transient olfactory dysfunction in mice"}
{"doc_id": 62, "abstract": ["SARS-CoV-2 enters host cells through an interaction between the spike glycoprotein and the angiotensin converting enzyme 2 (ACE2) receptor.", "Directly preventing this interaction presents an attractive possibility for suppressing SARS-CoV-2 replication.", "Here, we report the isolation and characterization of an alpaca-derived single domain antibody fragment, Ty1, that specifically targets the receptor binding domain (RBD) of the SARS-CoV-2 spike, directly preventing ACE2 engagement.", "Ty1 binds the RBD with high affinity, occluding ACE2.", "A cryo-electron microscopy structure of the bound complex at 2.9 \u00c5 resolution reveals that Ty1 binds to an epitope on the RBD accessible in both the 'up' and 'down' conformations, sterically hindering RBD-ACE2 binding.", "While fusion to an Fc domain renders Ty1 extremely potent, Ty1 neutralizes SARS-CoV-2 spike pseudovirus as a 12.8 kDa nanobody, which can be expressed in high quantities in bacteria, presenting opportunities for manufacturing at scale.", "Ty1 is therefore an excellent candidate as an intervention against COVID-19."], "title": "An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction"}
{"doc_id": 63, "abstract": ["2019-Novel Coronavirus (2019-nCoV) is the pathogen of Corona Virus Disease 2019.", "Nucleic acid detection of 2019-nCoV is one of the key indicators for clinical diagnosis.", "However, the positive rate is only 30-50%.", "Currently, fluorescent quantitative RT-PCR technology is mainly used to detect 2019-nCoV. According to \u201cThe Laboratory Technical Guidelines for Detection 2019-nCoV (Fourth Edition)\u201d issued by National Health and Commission of China and \u201cThe Experts\u2019 Consensus on Nucleic Acid Detection of 2019-nCoV\u201d released by Chinese Society of Laboratory Medicine, the human samples must be placed under 56\u00b0C or higher to inactivate the viruses in order to keep the inspectors from virus infection before the nucleic acids were isolated as the template of qRT-PCR.", "In this study, we demonstrated that the virus inactivation treatment disrupts its genome integrity seriously when using porcine epidemic diarrhea virus (vaccine), a kind of coronavirus, as a model.", "Our results showed that only 50.11% of the detectable viral templates left after the inactivation of 56 \u00b0C for 30 minutes and only 3.36% left after the inactivation of 92 \u00b0C for 5 minutes when the samples were preserved by Hank\u2019s solution, one of an isotonic salt solutions currently suggested.", "However, the detectable templates of viral nucleic acids can be unchanged after the samples were incubated at 56 \u00b0C or higher if the samples were preserved with an optimized solution to protect the RNA from being disrupted.", "We therefore highly recommend to carry out systematic investigation on the impact of high temperature inactivation on the integrity of 2019-nCoV genome and develop a sample preservation solution to protect the detectable templates of 2019-nCoV nucleic acids from high temperature inactivation damage."], "title": "Inactivating porcine coronavirus before nuclei acid isolation with the temperature higher than 56 \u00b0C damages its genome integrity seriously"}
{"doc_id": 64, "abstract": ["Protection against SARS-CoV-2 and SARS-related zoonotic coronaviruses with pandemic potential is urgently needed.", "To evaluate immunization strategies, we made nanoparticles displaying the receptor-binding domain (RBD) of only SARS-CoV-2 (homotypic nanoparticles) or co-displaying the SARS-CoV-2 RBD along with RBDs from animal betacoronaviruses that represent threats to humans (mosaic nanoparticles; 4\u20138 distinct RBDs).", "Mice immunized with RBD-nanoparticles, but not soluble antigen, elicited cross-reactive antibody binding and neutralization responses, confirming increased immunogenicity from multimerization.", "Mosaic-RBD-nanoparticles elicited antibodies with superior cross-reactive recognition of heterologous RBDs compared to sera from immunizations with homotypic SARS-CoV-2-RBD-nanoparticles or antibodies from COVID-19 convalescent human plasmas.", "Moreover, sera from mosaic-RBD-immunized mice neutralized heterologous pseudotyped coronaviruses equivalently or better after priming than sera from homotypic SARS-CoV-2-RBD-nanoparticle immunizations, demonstrating no loss of immunogenicity against any particular RBD resulting from co-display.", "Thus, a single immunization with mosaic-RBD-nanoparticles provides a potential strategy to simultaneously protect against SARS-CoV-2 and emerging zoonotic coronaviruses."], "title": "Mosaic RBD nanoparticles elicit neutralizing antibodies against SARS-CoV-2 and zoonotic coronaviruses"}
{"doc_id": 65, "abstract": ["To combat viral pandemics, there is an urgent need for inexpensive new technologies that enable fast, reliable, and scalable detection of viruses.", "Here we repurposed the type III CRISPR-Cas system for sensitive and sequence specific detection of SARS-CoV-2 in an assay that can be performed in one hour or less.", "RNA recognition by type III systems triggers Cas10-mediated polymerase activity, which simultaneously generates pyrophosphates, protons and cyclic oligonucleotides.", "We show that amplified products of the Cas10-polymerase are detectable using colorimetric or fluorometric readouts."], "title": "Intrinsic Signal Amplification by Type-III CRISPR-Cas Systems Provides a Sequence-Specific Viral Diagnostic"}
{"doc_id": 66, "abstract": ["SARS-CoV-2-specific antibodies, particularly those preventing viral spike receptor binding domain (RBD) interaction with host angiotensin-converting enzyme 2 (ACE2) receptor, could offer protective immunity, and may affect clinical outcomes of COVID-19 patients.", "We analyzed 625 serial plasma samples from 40 hospitalized COVID-19 patients and 170 SARS-CoV-2-infected outpatients and asymptomatic individuals.", "Severely ill patients developed significantly higher SARS-CoV-2-specific antibody responses than outpatients and asymptomatic individuals.", "The development of plasma antibodies was correlated with decreases in viral RNAemia, consistent with potential humoral immune clearance of virus.", "Using a novel competition ELISA, we detected antibodies blocking RBD-ACE2 interactions in 68% of inpatients and 40% of outpatients tested.", "Cross-reactive antibodies recognizing SARS-CoV RBD were found almost exclusively in hospitalized patients.", "Outpatient and asymptomatic individuals\u2019 serological responses to SARS-CoV-2 decreased within 2 months, suggesting that humoral protection may be short-lived."], "title": "SARS-CoV-2 Antibody Responses Correlate with Resolution of RNAemia But Are Short-Lived in Patients with Mild Illness"}
{"doc_id": 67, "abstract": ["Rapid and accurate SARS-CoV-2 diagnostic testing is essential for controlling the ongoing COVID-19 pandemic.", "The current gold standard for COVID-19 diagnosis is real-time RT-PCR detection of SARS-CoV-2 from nasopharyngeal swabs.", "Low sensitivity, exposure risks to healthcare workers, and global shortages of swabs and personal protective equipment, however, necessitate the validation of new diagnostic approaches.", "Saliva is a promising candidate for SARS-CoV-2 diagnostics because (1) collection is minimally invasive and can reliably be self-administered and (2) saliva has exhibited comparable sensitivity to nasopharyngeal swabs in detection of other respiratory pathogens, including endemic human coronaviruses, in previous studies.", "To validate the use of saliva for SARS-CoV-2 detection, we tested nasopharyngeal and saliva samples from confirmed COVID-19 patients and self-collected samples from healthcare workers on COVID-19 wards.", "When we compared SARS-CoV-2 detection from patient-matched nasopharyngeal and saliva samples, we found that saliva yielded greater detection sensitivity and consistency throughout the course of infection.", "Furthermore, we report less variability in self-sample collection of saliva.", "Taken together, our findings demonstrate that saliva is a viable and more sensitive alternative to nasopharyngeal swabs and could enable at-home self-administered sample collection for accurate large-scale SARS-CoV-2 testing."], "title": "Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs"}
{"doc_id": 68, "abstract": ["A recent genome-wide association study of European ancestry has identified 3p21.31 and 9q34.2 (ABO gene) to be significantly associated with COVID-19 respiratory failure (1).", "Here, we employed the detailed clinical, immunological and multi-omics data of the Human Functional Genomics Projects (HFGP) to explore the physiological significance of the host genetic variants that influence susceptibility to severe COVID-19.", "A functional genomics investigation based on functional characterization of individuals with high genetic risk for severe COVID-19 susceptibility identified several major patterns: i. a large impact of genetically determined innate immune responses in COVID-19, with increased susceptibility for severe disease in individuals with defective monocyte-derived cytokine production; ii. genetic susceptibility related to ABO blood groups is probably mediated through the von Willebrand factor (VWF) and endothelial dysfunction; and iii.", "the increased susceptibility for severe COVID-19 in men is at least partially mediated by chromosome X-mediated genetic variation.", "These insights allow a physiological understanding of genetic susceptibility to severe COVID-19, and indicate pathways that could be targeted for prevention and therapy."], "title": "A functional genomics approach to understand host genetic regulation ofCOVID-19 severity"}
{"doc_id": 69, "abstract": ["SARS-CoV-02 is a new type of coronavirus capable of rapid transmission and causing severe clinical symptoms; much of which has unknown biological etiology.", "It has prompted researchers to rapidly mobilize their efforts towards identifying and developing anti-viral therapeutics and vaccines.", "Discovering and understanding the virus\u2019 pathways of infection, host-protein interactions, and cytopathic effects will greatly aid in the design of new therapeutics to treat COVID-19.", "While it is known that chloroquine and hydroxychloroquine, extensively explored as clinical agents for COVID-19, have multiple cellular effects including inhibiting autophagy, there are also dose-limiting toxicities in patients that make clearly establishing their potential mechanisms-of-action problematic.", "Therefore, we evaluated a range of other autophagy modulators to identify an alternative autophagy-based drug repurposing opportunity.", "In this work, we found that 6 of these compounds blocked the cytopathic effect of SARS-CoV-2 in Vero-E6 cells with EC(50) values ranging from 2.0 to 13 \u03bcM and selectivity indices ranging from 1.5 to >10-fold.", "Immunofluorescence staining for LC3B and LysoTracker dye staining assays in several cell lines indicated their potency and efficacy for inhibiting autophagy correlated with the measurements in the SARS-CoV-2 cytopathic effect assay.", "Our data suggest that autophagy pathways could be targeted to combat SARS-CoV-2 infections and become an important component of drug combination therapies to improve the treatment outcomes for COVID-19."], "title": "The SARS-CoV-2 cytopathic effect is blocked with autophagy modulators"}
{"doc_id": 70, "abstract": ["The set of mutations observed at the outset of the SARS-CoV-2 pandemic may illuminate how the virus will adapt to humans as it continues to spread.", "Viruses are expected to quickly acquire beneficial mutations upon jumping to a new host species.", "Advantageous nucleotide substitutions can be identified by their parallel occurrence in multiple independent lineages and are likely to result in changes to protein sequences.", "Here we show that SARS-CoV-2 is acquiring mutations more slowly than expected for neutral evolution, suggesting purifying selection is the dominant mode of evolution during the initial phase of the pandemic.", "However, several parallel mutations arose in multiple independent lineages and may provide a fitness advantage over the ancestral genome.", "We propose plausible reasons for several of the most frequent mutations.", "The absence of mutations in other genome regions suggests essential components of SARS-CoV-2 that could be the target of drug development.", "Overall this study provides genomic insights into how SARS-CoV-2 has adapted and will continue to adapt to humans.", "SUMMARY In this study we sought signals of evolution to identify how the SARS-CoV-2 genome has adapted at the outset of the COVID-19 pandemic.", "We find that the genome is largely undergoing purifying selection that maintains its ancestral sequence.", "However, we identified multiple positions on the genome that appear to confer an adaptive advantage based on their repeated evolution in independent lineages.", "This information indicates how SARS-CoV-2 will evolve as it diversifies in an increasing number of hosts."], "title": "SARS-CoV-2 genome evolution exposes early human adaptations"}
{"doc_id": 71, "abstract": ["The global Coronavirus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2 has affected more than eight million people.", "There is an urgent need to investigate how the adaptive immunity is established in COVID-19 patients.", "In this study, we profiled adaptive immune cells of PBMCs from recovered COVID-19 patients with varying disease severity using single-cell RNA and TCR/BCR V(D)J sequencing.", "The sequencing data revealed SARS-CoV-2-specific shuffling of adaptive immune repertories and COVID-19-induced remodeling of peripheral lymphocytes.", "Characterization of variations in the peripheral T and B cells from the COVID-19 patients revealed a positive correlation of humoral immune response and T-cell immune memory with disease severity.", "Sequencing and functional data revealed SARS-CoV-2-specific T-cell immune memory in the convalescent COVID-19 patients.", "Furthermore, we also identified novel antigens that are responsive in the convalescent patients.", "Altogether, our study reveals adaptive immune repertories underlying pathogenesis and recovery in severe versus mild COVID-19 patients, providing valuable information for potential vaccine and therapeutic development against SARS-CoV-2 infection."], "title": "Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals"}
{"doc_id": 72, "abstract": ["Intramuscular vaccination with ChAdOx1 nCoV-19/AZD1222 protected rhesus macaques against pneumonia but did not reduce shedding of SARS-CoV-2.", "Here we investigate whether intranasally administered ChAdOx1 nCoV-19 reduces shedding, using a SARS-CoV-2 virus with the D614G mutation in the spike protein.", "Viral load in swabs obtained from intranasally vaccinated hamsters was significantly decreased compared to controls and no viral RNA or infectious virus was found in lung tissue, both in a direct challenge and a transmission model.", "Intranasal vaccination of rhesus macaques resulted in reduced shedding and a reduction in viral load in bronchoalveolar lavage and lower respiratory tract tissue.", "In conclusion, intranasal vaccination reduced shedding in two different SARS-CoV-2 animal models, justifying further investigation as a potential vaccination route for COVID-19 vaccines."], "title": "Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces shedding of SARS-CoV-2 D614G in rhesus macaques"}
{"doc_id": 73, "abstract": ["Coronavirus disease-19 (COVID-19) transmits by droplets generated from surfaces of airway mucus during processes of respiration within hosts infected by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) virus.", "We studied respiratory droplet generation and exhalation in human and nonhuman primate subjects with and without COVID-19 infection to explore whether SARS-CoV-2 infection, and other changes in physiological state, translates into observable evolution of numbers and sizes of exhaled respiratory droplets in healthy and diseased subjects.", "In our observational cohort study of the exhaled breath particles of 74 healthy human subjects, and in our experimental infection study of eight nonhuman primates infected by aerosol with SARS-CoV-2, we found that exhaled aerosol particles increase one to three orders of magnitude with aging, high BMI, and COVID-19 infection.", "These variances appear to be related to changes in airway mucus surface composition and the propensity for mucus surfaces to breakup into small droplets during acts of breathing.", "We also observed that 20% of those participating in our human study accounted for 80% of the overall exhaled bioaerosol, reflecting a bioaerosol distribution analogous to a classical 20:80 super spreader distribution."], "title": "Exhaled aerosol increases with COVID-19 infection, and risk factors of disease symptom severity"}
{"doc_id": 74, "abstract": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection resulting in the clinical syndrome COVID-19 is associated with an exaggerated immune response and monocyte infiltrates in the lungs and other peripheral tissues.", "It is now increasingly recognised that chronic morbidity persists in some patients.", "We recently demonstrated profound alterations of monocytes in hospitalised COVID-19 patients.", "It is currently unclear whether these abnormalities resolve or progress following patient discharge.", "We show here that blood monocytes in convalescent patients at their 12 week follow up, have a greater propensity to produce pro-inflammatory cytokines TNF and IL-6, which was consistently higher in patients with resolution of lung injury as indicated by a normal chest X-ray and no shortness of breath (a key symptom of lung injury).", "Furthermore, monocytes from convalescent patients also displayed enhanced levels of molecules involved in leucocyte migration, including chemokine receptor CXCR6, adhesion molecule CD31/PECAM and integrins VLA-4 and LFA-1.", "Expression of migration molecules on monocytes was also consistently higher in convalescent patients with a normal chest X-ray.", "These data suggest persistent changes in innate immune function following recovery from COVID-19 and indicate that immune modulating therapies targeting monocytes and leucocyte migration may be useful in recovering COVID-19 patients with persistent symptoms."], "title": "Recovery of monocyte exhaustion is associated with resolution of lung injury in COVID-19 convalescence."}
{"doc_id": 75, "abstract": ["Replication-restricted modified vaccinia virus Ankara (MVA) is a licensed smallpox vaccine and numerous clinical studies investigating recombinant MVAs (rMVAs) as vectors for prevention of other infectious diseases have been completed or are in progress.", "Two rMVA COVID-19 vaccine trials are at an initial stage, though no animal protection studies have been reported.", "Here, we characterize rMVAs expressing the S protein of CoV-2.", "Modifications of full length S individually or in combination included two proline substitutions, mutations of the furin recognition site and deletion of the endoplasmic retrieval signal.", "Another rMVA in which the receptor binding domain (RBD) flanked by the signal peptide and transmembrane domains of S was also constructed.", "Each modified S protein was displayed on the surface of rMVA-infected human cells and was recognized by anti-RBD antibody and by soluble hACE2 receptor.", "Intramuscular injection of mice with the rMVAs induced S-binding and pseudovirus-neutralizing antibodies.", "Boosting occurred following a second homologous rMVA but was higher with adjuvanted purified RBD protein.", "Weight loss and lethality following intranasal infection of transgenic hACE2 mice with CoV-2 was prevented by one or two immunizations with rMVAs or by passive transfer of serum from vaccinated mice.", "One or two rMVA vaccinations also prevented recovery of infectious CoV-2 from the lungs.", "A low amount of virus was detected in the nasal turbinates of only one of eight rMVA-vaccinated mice on day 2 and none later.", "Detection of subgenomic mRNA in turbinates on day 2 only indicated that replication was abortive in immunized animals."], "title": "MVA Vector Vaccines Inhibit SARS CoV-2 Replication in Upper and Lower Respiratory Tracts of Transgenic Mice and Prevent Lethal Disease"}
{"doc_id": 76, "abstract": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic that is a serious global health problem.", "Evasion of IFN-mediated antiviral signaling is a common defense strategy that pathogenic viruses use to replicate and propagate in their host.", "In this study, we show that SARS-CoV-2 is able to efficiently block STAT1 and STAT2 nuclear translocation in order to impair transcriptional induction of IFN-stimulated genes (ISGs).", "Our results demonstrate that the viral accessory protein Orf6 exerts this anti-IFN activity.", "We found that SARS-CoV-2 Orf6 localizes at the nuclear pore complex (NPC) and directly interacts with Nup98-Rae1 via its C-terminal domain to impair docking of cargo-receptor (karyopherin/importin) complex and disrupt nuclear import.", "In addition, we show that a methionine-to-arginine substitution at residue 58 impairs Orf6 binding to the Nup98-Rae1 complex and abolishes its IFN antagonistic function.", "All together our data unravel a mechanism of viral antagonism in which a virus hijacks the Nup98-Rae1 complex to overcome the antiviral action of IFN."], "title": "SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling"}
{"doc_id": 77, "abstract": ["A growing body of evidence indicates sex differences in the clinical outcomes of coronavirus disease 2019 (COVID-19)(1\u20135).", "However, whether immune responses against SARS-CoV-2 differ between sexes, and whether such differences explain male susceptibility to COVID-19, is currently unknown.", "In this study, we examined sex differences in viral loads, SARS-CoV-2-specific antibody titers, plasma cytokines, as well as blood cell phenotyping in COVID-19 patients.", "By focusing our analysis on patients with moderate disease who had not received immunomodulatory medications, our results revealed that male patients had higher plasma levels of innate immune cytokines such as IL-8 and IL-18 along with more robust induction of non-classical monocytes.", "In contrast, female patients mounted significantly more robust T cell activation than male patients during SARS-CoV-2 infection, which was sustained in old age.", "Importantly, we found that a poor T cell response negatively correlated with patients\u2019 age and was associated with worse disease outcome in male patients, but not in female patients.", "Conversely, higher innate immune cytokines in female patients associated with worse disease progression, but not in male patients.", "These findings reveal a possible explanation underlying observed sex biases in COVID-19, and provide important basis for the development of sex-based approach to the treatment and care of men and women with COVID-19."], "title": "Sex differences in immune responses that underlie COVID-19 disease outcomes"}
{"doc_id": 78, "abstract": ["Coronavirus disease-19 (COVID-19), caused by the SARS-CoV-2 virus, leads primarily to respiratory symptoms that can be fatal, particularly in at risk individuals.", "However, neurological symptoms have also been observed in patients, including headache, seizures, stroke, and fatigue.", "The cause of these complications is not yet known, and whether they are due to a direct infection of neural cells, such as neurons and astrocytes, or through indirect effects on supportive brain cells, is unknown.", "Here, we use brain organoids to examine SARS-CoV-2 neurotropism.", "We examine expression of the key viral receptor ACE2 in single-cell RNA sequencing (scRNA-seq) revealing that only a subset of choroid plexus cells but not neurons or neural progenitors express this entry factor.", "We then challenge organoids with both SARS-CoV-2 spike protein pseudovirus and live virus to demonstrate high viral tropism for choroid plexus epithelial cells but not stromal cells, and little to no infection of neurons or glia.", "We find that infected cells of the choroid plexus are an apolipoprotein and ACE2 expressing subset of epithelial barrier cells.", "Finally, we show that infection with live SARS-CoV-2 leads to barrier breakdown of the choroid plexus.", "These findings suggest that neurological complications may result from effects on the choroid plexus, an important barrier that normally prevents entry of immune cells and cytokines into the cerebrospinal fluid (CSF) and brain."], "title": "SARS-CoV-2 infects brain choroid plexus and disrupts the blood-CSF-barrier"}
{"doc_id": 79, "abstract": ["Viruses closely related to SARS-CoV-2, which is the virus responsible of the Covid-19 pandemic, were sequenced in several Sunda pangolins (Manis javanica) seized in the Guangdong and Guangxi provinces of China between 2017 and 20191-3.", "These viruses belong to two lineages: one from Guangdong (GD/P) and the other from Guangxi (GX/P).", "The GD/P viruses are particularly intriguing as the amino-acid sequence of the receptor binding domain of the spike protein is very similar to that of the human SARS-CoV-2 virus (97.4%)2.", "This characteristic suggests that GD/P viruses are capable of binding human ACE2 receptor and may therefore be able to mediate infection of human cells.", "Whereas all six GX/P genomes were deposited as annotated sequences in GenBank, none of the two GD/P genomes assembled in previous studies2,3 are currently available.", "To overcome this absence, I assembled these genomes from the Sequence Read Archive (SRA) data available for SARS-CoV-2-like viruses detected in five captive pangolins from Guangdong.", "I found the genome assemblies of GD/P virus of poor quality, having high levels of missing data.", "Additionally, unexpected reads in the Illumina sequencing data were identified.", "The GD/P2S dataset2 contains reads that are identical to SARS-CoV-2, suggesting either the coexistence of two SARS-CoV-2-like viruses in the same pangolin or contamination by the human virus.", "In the four other GD/P datasets1 many mitochondrial reads from pangolin were identified, as well as from three other species, namely, human, mouse and tiger.", "Importantly, I only identified three polymorphic nucleotide sites between the five GD/P sequences.", "Such low levels of polymorphism may reasonably be accounted for by sequencing errors alone, thus raising the possibility that the five pangolins seized in Guangdong in March 2019 were infected by the same virus strain, most probably during their captivity."], "title": "The SARS-CoV-2-like virus found in captive pangolins from Guangdong should be better sequenced"}
{"doc_id": 80, "abstract": ["SARS-CoV-2 infection causes an inflammatory cytokine storm and acute lung injury.", "Currently there are no effective antiviral and/or anti-inflammatory therapies.", "Here we demonstrate that 2019 SARS-CoV-2 spike protein subunit 1 (CoV2-S1) induces high levels of NF-\u03baB activations, production of pro-inflammatory cytokines and mild epithelial damage, in human bronchial epithelial cells.", "CoV2-S1-induced NF-\u03baB activation requires S1 interaction with human ACE2 receptor and early activation of endoplasmic reticulum (ER) stress, and associated unfolded protein response (UPR), and MAP kinase signalling pathways.", "We developed an antagonistic peptide that inhibits S1-ACE2 interaction and CoV2-S1-induced productions of pro-inflammatory cytokines.", "The existing FDA-approved ER stress inhibitor, 4-phenylburic acid (4-PBA), and MAP kinase inhibitors, trametinib and ulixertinib, ameliorated CoV2-S1-induced inflammation and epithelial damage.", "These novel data highlight the potentials of peptide-based antivirals for novel ACE2-utilising CoVs, while repurposing existing drugs may be used as treatments to dampen elevated inflammation and lung injury mediated by SARS-CoV-2."], "title": "SARS-CoV-2 Spike protein promotes hyper-inflammatory response that can be ameliorated by Spike-antagonistic peptide and FDA-approved ER stress and MAP kinase inhibitors in vitro"}
{"doc_id": 81, "abstract": ["SARS-CoV-2 virus is an infectious agent commonly found in certain mammalian animal species and today also in humans.", "SARS-CoV-2, can cause a pandemic infection with severe acute lung injury respiratory distress syndrome in patients with COVID-19, that can lead to patient death across all ages.", "The pathology associated with pandemic infection is linked to an over-response of immune cells, including virus-activated macrophages and mast cells (MCs).", "The local inflammatory response in the lung that occurs after exposure to SARS-CoV-2 is due to a complex network of activated inflammatory innate immune cells and structural lung cells such as bronchial epithelial cells, endothelial cells and fibroblasts.", "Bronchial epithelial cells and fibroblasts activated by SARS-CoV-2 can result in the up-regulation of pro-inflammatory cytokines and induction of MC differentiation.", "In addition, endothelial cells which control leukocyte traffic through the expression of adhesion molecules are also able to amplify leukocyte activation by generating interleukin (IL)-1, IL-6 and CXC chemokines.", "In this pathologic environment, the activation of mast cells (MCs) causes the release of histamine, proteases, cytokines, chemokines and arachidonic acid compounds, such as prostaglandin D2 and leukotrienes, all of which are involved in the inflammatory network.", "Histamine is stored endogenously within the secretory granules of MCs and is released into the vessels after cell stimulation.", "Histamine is involved in the expression of chemokine IL-8 and cytokine IL-6, an effect that can be inhibited by histamine receptor antagonists.", "IL-1 is a pleiotropic cytokine that is mainly active in inflammation and immunity.", "Alveolar macrophages activated by SARS-CoV-2 through the TLR produce IL-1 which stimulates MCs to produce IL-6.", "IL-1 in combination with IL-6 leads to excessive inflammation which can be lethal.", "In an interesting study published several years ago (by E. Vannier et al., 1993), it was found that histamine as well as IL-1 are implicated in the pathogenesis of pulmonary inflammatory reaction, after micorganism immune cell activation.", "IL-1 in combination with histamine can cause a strong increase of IL-1 levels and, consequently, a higher degree of inflammation.", "However, it has been reported that histamine alone has no effect on IL-1 production.", "Furthermore, histamine enhances IL-1-induced IL-6 gene expression and protein synthesis via H2 receptors in peripheral monocytes.", "Therefore, since MCs are large producers of histamine in inflammatory reactions, this vasoactive amine, by increasing the production of IL-1, can amplify the inflammatory process in the lung infected with SARS-CoV-2.", "Here, we have proposed for the first time an emerging role for histamine released by MCs which in combination with IL-1 can cause an increase in lung inflammation induced by the viral infection SARS-CoV-2."], "title": "Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19."}
{"doc_id": 82, "abstract": ["SARS-CoV-2 enters cells via its spike glycoprotein which must be cleaved sequentially at the S1/S2, then the S2\u2019 cleavage sites (CS) to mediate membrane fusion.", "SARS-CoV-2 has a unique polybasic insertion at the S1/S2 CS, which we demonstrate can be cleaved by furin.", "Using lentiviral pseudotypes and a cell-culture adapted SARS-CoV-2 virus with a S1/S2 deletion, we show that the polybasic insertion is selected for in lung cells and primary human airway epithelial cultures but selected against in Vero E6, a cell line used for passaging SARS-CoV-2.", "We find this selective advantage depends on expression of the cell surface protease, TMPRSS2, that allows virus entry independent of endosomes thus avoiding antiviral IFITM proteins.", "SARS-CoV-2 virus lacking the S1/S2 furin CS was shed to lower titres from infected ferrets and was not transmitted to cohoused sentinel animals.", "Thus, the polybasic CS is a key determinant for efficient SARS-CoV-2 transmission."], "title": "The furin cleavage site of SARS-CoV-2 spike protein is a key determinant for transmission due to enhanced replication in airway cells"}
{"doc_id": 83, "abstract": ["Objectives While COVID-19 is known to be spread by respiratory droplets (which travel <2m horizontally), much less is known about its transmission via aerosols, which can become airborne and be widely distributed throughout room spaces.", "In order to quantify the risk posed by COVID-19 infectors exhaling respiratory aerosols in enclosed spaces, we undertook a computer modelling study to simulate transmission in an office building.", "Methods Respiratory droplet data from four published datasets were analysed to quantify the number and volume of droplets <100m diameter produced by a typical cough and speaking event (i.e. counting from 1 to 100).", "This was used in a stochastic model to simulate (10,000 simulations) the number of respiratory particles, originating from a COVID-19 infector, that would be inhaled in one hour by a susceptible individual practicing socially distancing in a 5 x 5 x 2.75m office space.", "Several scenarios were simulated that mimicked the presence of both symptomatic and asymptomatic COVID-19 infectors.", "Results On average, each cough and speaking event produced similar numbers of droplets <100 m diameter (median range = 955-1010).", "Computer simulations (at ventilation rate = 2AC/h) revealed that sharing the office space with a symptomatic COVID-19 infector (4 coughs per hour) for one hour resulted in the inhalation of 187.3 (median value) respiratory droplets, whereas sharing with an asymptomatic COVID-19 positive person (10 speaking events per hour) resulted in the inhalation of 482.9 droplets.", "Increasing the ventilation rate resulted in only modest reductions in particle numbers inhaled.", "Conclusions Given that live SARS-CoV-2 virions are known to be shed in high concentrations from the nasal cavity of both symptomatic and asymptomatic COVID-19 patients, the results suggest that individuals who share enclosed spaces with an infector may be at risk of contracting COVID-19 by the aerosol route, even when practicing social distancing."], "title": "Is there an airborne component to the transmission of COVID-19? : a quantitative analysis study"}
{"doc_id": 84, "abstract": ["The D614G substitution in the S protein is most prevalent SARS-CoV-2 strain circulating globally, but its effects in viral pathogenesis and transmission remain unclear.", "We engineered SARS-CoV-2 variants harboring the D614G substitution with or without nanoluciferase.", "The D614G variant replicates more efficiency in primary human proximal airway epithelial cells and is more fit than wildtype (WT) virus in competition studies.", "With similar morphology to the WT virion, the D614G virus is also more sensitive to SARS-CoV-2 neutralizing antibodies.", "Infection of human ACE2 transgenic mice and Syrian hamsters with the WT or D614G viruses produced similar titers in respiratory tissue and pulmonary disease.", "However, the D614G variant exhibited significantly faster droplet transmission between hamsters than the WT virus, early after infection.", "Our study demonstrated the SARS-CoV2 D614G substitution enhances infectivity, replication fitness, and early transmission."], "title": "SARS-CoV-2 D614G Variant Exhibits Enhanced Replication ex vivo and Earlier Transmission in vivo"}
{"doc_id": 85, "abstract": ["The SARS-CoV-2 virus emerged in December 2019 and has caused a worldwide pandemic due to the lack of any pre-existing immunity.", "Accurate serology testing is urgently needed to help diagnose infection, determine past exposure of populations and assess the response to a future vaccine.", "The landscape of antibody responses to SARS-CoV-2 is unknown.", "In this study, we utilized the luciferase immunoprecipitation system to assess the antibody responses to 15 different SARS-CoV-2 antigens in patients with COVID-19.", "We identified new targets of the immune response to SARS-CoV-2 and show that nucleocapsid, open reading frame (ORF)8 and ORF3b elicit the strongest specific antibody responses.", "ORF8 and ORF3b antibodies, taken together as a cluster of points, identified 96.5% of COVID-19 samples at early and late time points of disease with 99.5% specificity.", "Our findings could be used to develop second-generation diagnostic tests to improve serological assays for COVID-19 and are important in understanding pathogenicity."], "title": "ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection."}
{"doc_id": 86, "abstract": ["High throughput serological tests that can establish the presence and functional activity of anti-SARS-COV2 antibodies are urgently needed.", "Here we present microsphere-based Flow Cytometry assays that quantify both anti-spike IgGs in plasma, and the ability of plasma to inhibit the binding of spike protein to angiotensin converting enzyme 2 (ACE2).", "First, we detected anti-trimer IgGs in 22/24 and anti-RBD IgGs in 21/24 COVID+ subjects at a median of 36 (range 14-73) days following documented SARS-CoV-2 RNA (+) secretions.", "Next, we find that plasma from all 22/24 subjects with anti-trimer IgGs inhibited ACE2-trimer binding to a greater degree than controls, and that the degree of inhibition correlated with anti-trimer IgG levels.", "Depletion of trimer-reactive Igs from plasma reduced ACE2-trimer inhibitory capacity to a greater degree than depletion of RBD-reactive Igs, suggesting that inhibitory antibodies act by binding both within and outside of the RBD.", "Amongst the 24 subjects, presence of fever was associated with higher levels of anti-trimer IgG and inhibition of binding to human ACE2.", "This inhibition assay may be broadly useful to quantify the functional antibody response of recovered COVID19 patients or vaccine recipients in a cell-free assay system."], "title": "Plasma from recovered COVID19 subjects inhibits spike protein binding to ACE2 in a microsphere-based inhibition assay"}
{"doc_id": 87, "abstract": ["A cohort of laboratorians with positive SARS-CoV2 test results were uncovered during asymptomatic COVID-19 screening programs at six universities.", "Follow-up PCR and antibody tests showed that most of these cases were not true COVID-19 infection but instead arose from reverse-transcribed and amplified viral sequences (amplicons) that are generated during research.", "Environmental testing showed widespread contamination of amplicons in lab spaces including notebooks, keyboards, glasses, and doorknobs.", "Minimizing instances of amplicon contamination and developing protocols for handling suspected cases are critical to propel research efforts and to avoid diverting university and healthcare resources from patients with COVID-19.", "Removal of these individuals from the standard testing protocol, per CDC guidelines for positive cases, risks the spread of true infection.", "We discuss potential prevention and mitigation strategies."], "title": "Amplicon contamination in labs masquerades as COVID19 in surveillance tests"}
{"doc_id": 88, "abstract": ["While lymphocytopenia is a common characteristic of patients infected by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the mechanisms responsible for this depletion are unclear.", "Through careful inspection of the spleens and lymph nodes (LNs) from six cases with postmortem examinations, we observed that SARS-CoV-2 could directly infect secondary lymphoid organs to induce cell death.", "Immunohistochemistry demonstrated ACE2 (angiotensin-converting enzyme 2), the potential receptor of SARS-CoV-2, expresses on tissue-resident CD169+ macrophages in spleens and LNs.", "Immunofluorescent staining confirmed that viral nucleocaspid protein (NP) can be found in ACE2+ cells, CD169+ macrophages, but not in CD3+ T cells or B220+ B cells in spleens and LNs.", "SARS-CoV-2 infection induces severe tissue damage including lymph follicle depletion, splenic nodule atrophy, histiocyte hyperplasia and lymphocyte reductions.", "Moreover, in situ TUNEL staining illustrated that viral infection leads to severe lymphocyte apoptosis, which might be mediated by viral antigens inducing Fas upregulation.", "Furthermore, SARS-CoV-2 also triggers macrophages to produce IL-6, a proinflammatory cytokine that directly promotes lymphocyte necrosis.", "Collectively, these results demonstrate that SARS-CoV-2 directly neutralizes human spleens and LNs through infecting tissue-resident CD169+ macrophages."], "title": "The Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Directly Decimates Human Spleens and Lymph Nodes"}
{"doc_id": 89, "abstract": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can lead to respiratory illness and multi-organ failure in critically ill patients.", "Although the virus-induced lung damage and inflammatory cytokine storm are believed to be directly associated with coronavirus disease 2019 (COVID-19) clinical manifestations, the underlying mechanisms of virus-triggered inflammatory responses are currently unknown.", "Here we report that SARS-CoV-2 infection activates caspase-8 to trigger cell apoptosis and inflammatory cytokine processing in the lung epithelial cells.", "The processed inflammatory cytokines are released through the virus-induced necroptosis pathway.", "Virus-induced apoptosis, necroptosis, and inflammation activation were also observed in the lung sections of SARS-CoV-2-infected HFH4-hACE2 transgenic mouse model, a valid model for studying SARS-CoV-2 pathogenesis.", "Furthermore, analysis of the postmortem lung sections of fatal COVID-19 patients revealed not only apoptosis and necroptosis but also massive inflammatory cell infiltration, necrotic cell debris, and pulmonary interstitial fibrosis, typical of immune pathogenesis in the lung.", "The SARS-CoV-2 infection triggered a dual mode of cell death pathways and caspase-8-dependent inflammatory responses may lead to the lung damage in the COVID-19 patients.", "These discoveries might assist the development of therapeutic strategies to treat COVID-19."], "title": "SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation"}
{"doc_id": 90, "abstract": ["Introduction The management of pneumonia caused by SARS-CoV-2 should rely on early recognition of the risk for progression to severe respiratory failure (SRF) and its prevention.", "We investigated if early suPAR (soluble urokinase plasminogen activator receptor)-guided anakinra treatment could prevent COVID-19-assocated SRF.", "Methods In this open-label prospective trial, 130 patients admitted with SARS-CoV-2 pneumonia SARS-CoV-2 and suPAR levels [\u2265]6 g/l were assigned to subcutaneous anakinra 100mg once daily for 10 days.", "The primary outcome was the incidence of SRF at day 14.", "Secondary outcomes were 30-day mortality, changes in sequential organ failure assessment (SOFA) score, of cytokine-stimulation pattern and of circulating inflammatory mediators.", "Equal number of propensity score-matched comparators for comorbidities, severity on admission and standard-of care (SOC) were studied.", "Results The incidence of SRF was 22.3% (95% CI, 16.0-30.2%) among anakinra-treated patients and 59.2% (95% CI, 50.6-67.3%; P: 4.6 x 10-8) among SOC comparators (hazard ratio, 0.30; 95%CI, 0.20-0.46).", "30-day mortality was 11.5% (95% CI, 7.1-18.2%) and 22.3% (95% CI, 16.0-30.2%) respectively (hazard ratio 0.49; 95% CI 0.25-0.97%; P: 0.041).", "Anakinra treatment was associated with decrease in SOFA score and in circulating interleukin (IL)-6, sCD163 and sIL2-R; the serum IL-10/IL-6 ratio on day 7 was inversely associated with the change in SOFA score.", "Duration of stay at the intensive care unit and at hospital was shortened compared to the SOC group; the cost of hospitalization was decreased.", "Conclusions Early suPAR-guided anakinra treatment is associated with decrease of the risk for SRF and restoration of the pro-/anti-inflammatory balance."], "title": "Anakinra To Prevent Respiratory Failure In COVID-19"}
{"doc_id": 91, "abstract": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19).", "To identify factors of the respiratory tract that suppress SARS-CoV-2, we screened a peptide/protein library derived from bronchoalveolar lavage, and identified \u03b11-antitrypsin (\u03b11-AT) as specific inhibitor of SARS-CoV-2.", "\u03b11-AT targets the viral spike protein and blocks SARS-CoV-2 infection of human airway epithelium at physiological concentrations.", "Our findings show that endogenous \u03b11-AT restricts SARS-CoV-2 and repurposes \u03b11-AT-based drugs for COVID-19 therapy."], "title": "Alpha-1 antitrypsin inhibits SARS-CoV-2 infection"}
{"doc_id": 92, "abstract": ["Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 remains a global threat with few proven efficacious treatments.", "Transfusion of convalescent plasma collected from donors who have recovered from COVID-19 disease has emerged as a promising therapy and has been granted emergency use authorization by the U.S. Food and Drug Administration (FDA).", "We recently reported results from interim analysis of a propensity-score matched study suggesting that early treatment of COVID-19 patients with convalescent plasma containing high titer anti-spike protein receptor binding domain (RBD) IgG significantly decreases mortality.", "We here present results from 60-day follow up of our cohort of 351 transfused hospitalized patients.", "Prospective determination of ELISA anti-RBD IgG titer facilitated selection and transfusion of the highest titer units available.", "Retrospective analysis by the Ortho VITROS IgG assay revealed a median signal/cutoff (S/C) ratio of 24.0 for transfused units, a value far exceeding the recently FDA-required cutoff of 12.0 for designation of high titer convalescent plasma.", "With respect to altering mortality, our analysis identified an optimal window of 44 hours post-hospitalization for transfusing COVID-19 patients with high titer convalescent plasma.", "In the aggregate, the analysis confirms and extends our previous preliminary finding that transfusion of COVID-19 patients soon after hospitalization with high titer anti-spike protein RBD IgG present in convalescent plasma significantly reduces mortality."], "title": "Early transfusion of a large cohort of COVID-19 patients with high titer anti-SARS-CoV-2 spike protein IgG convalescent plasma confirms a signal of significantly decreased mortality"}
{"doc_id": 93, "abstract": ["COVID-19 severity and progression are determined by several host and virological factors that may influence the final outcome of SARS-CoV-2-infected patients.", "The objective of this work is to determine a possible association between the viral load, obtained from nasopharyngeal swabs, and the severity of the infection in a cohort of 448 SARS-CoV-2-infected patients from a hospital in Madrid during the first outbreak of the pandemic in Spain.", "To perform this, we have clinically classified patients as mild, moderate and severe COVID-19 according to a number of clinical parameters such as hospitalization requirement, need of oxygen therapy, admission to intensive care units and/or exitus.", "Here we report a statistically significant correlation between viral load and disease severity, being high viral load associated with worse clinical prognosis, independently of several previously identified risk factors such as age, sex, hypertension, cardiovascular disease, diabetes, obesity, and lung disease (asthma and chronic obstructive pulmonary disease).", "The data presented here reinforce the viral load as a potential biomarker for predicting disease severity in SARS-CoV-2-infected patients.", "It is also an important parameter in viral evolution since it relates to the numbers and types of variant genomes present in a viral population, a potential determinant of disease progression."], "title": "High SARS-CoV-2 viral load is associated with a worse clinical outcome of COVID-19 disease"}
{"doc_id": 94, "abstract": ["Recently emerged beta-coronavirus, SARS-CoV-2 has resulted in the current pandemic designated COVID-19.", "COVID-19 manifests as severe illness exhibiting systemic inflammatory response syndrome, acute respiratory distress syndrome (ARDS), thrombotic events, and shock, exacerbated further by co-morbidities and age1\u20133.", "Recent clinical reports suggested that the pulmonary failure seen in COVID-19 may not be solely driven by acute ARDS, but also microvascular thrombotic events, likely driven by complement activation4,5.", "However, it is not fully understood how the SARS-CoV-2 infection mechanisms mediate thrombotic events, and whether such mechanisms and responses are unique to SARS-CoV-2 infection, compared to other respiratory infections.", "We address these questions here, in the context of normal lung epithelia, in vitro and in vivo, using publicly available data.", "Our results indicate that plasmin is a crucial mediator which primes interactions between complement and platelet-activating systems in lung epithelia upon SARS-CoV-2 infection, with a potential for therapeutic intervention."], "title": "Plasmin cascade mediates thrombolytic events in SARS-CoV-2 infection via complement and platelet-activating systems"}
{"doc_id": 95, "abstract": ["BACKGROUND: Animal models of COVID-19 have been rapidly reported after the start of the pandemic.", "We aimed to assess whether the newly created models reproduce the full spectrum of human COVID-19.", "METHODS: We searched the MEDLINE, as well as BioRxiv and MedRxiv preprint servers for original research published in English from January 1 to May 20, 2020.", "We used the search terms (COVID-19) OR (SARS-CoV-2) AND (animal models), (hamsters), (nonhuman primates), (macaques), (rodent), (mice), (rats), (ferrets), (rabbits), (cats), and (dogs).", "Inclusion criteria were the establishment of animal models of COVID-19 as an endpoint.", "Other inclusion criteria were assessment of prophylaxis, therapies, or vaccines, using animal models of COVID-19.", "RESULT: Thirteen peer-reviewed studies and 14 preprints met the inclusion criteria.", "The animals used were nonhuman primates (n = 13), mice (n = 7), ferrets (n = 4), hamsters (n = 4), and cats (n = 1).", "All animals supported high viral replication in the upper and lower respiratory tract associated with mild clinical manifestations, lung pathology, and full recovery.", "Older animals displayed relatively more severe illness than the younger ones.", "No animal models developed hypoxemic respiratory failure, multiple organ dysfunction, culminating in death.", "All species elicited a specific IgG antibodies response to the spike proteins, which were protective against a second exposure.", "Transient systemic inflammation was observed occasionally in nonhuman primates, hamsters, and mice.", "Notably, none of the animals unveiled a cytokine storm or coagulopathy.", "CONCLUSIONS: Most of the animal models of COVID-19 recapitulated mild pattern of human COVID-19 with full recovery phenotype.", "No severe illness associated with mortality was observed, suggesting a wide gap between COVID-19 in humans and animal models."], "title": "Evidence of a wide gap between COVID-19 in humans and animal models: a systematic review"}
{"doc_id": 96, "abstract": ["Background: Animal models of COVID-19 have been rapidly reported after the start of the pandemic.", "We aimed to assess whether the newly created models reproduce the full spectrum of humans COVID-19.", "Methods: We searched the Medline, as well as BioRxiv and MedRxiv preprint servers for original research published in English from January 1, to May 20, 2020.", "We used the search terms COVID-19 OR SARS-CoV-2 AND, animal models, hamsters, nonhuman primates, macaques, rodent, mice, rats, ferrets, rabbits, cats, and dogs.", "Inclusion criteria were the establishment of animal models of COVID-19 as an endpoint.", "Other inclusion criteria were assessment of prophylaxis, therapies, or vaccines, using animal models of COVID-19.", "Findings: 13 peer-reviewed studies and 14 preprints met inclusion criteria.", "The animals used were nonhuman primates (n=13), mice (n=7), ferrets (n =4), hamsters (n= 4), and cats (n =1).", "All animals supported high viral replication in the upper and lower respiratory tract associated with mild clinical manifestations, lung pathology and full recovery.", "Older animals displayed relatively more severe illness than the younger ones.", "No animal models developed hypoxemic respiratory failure, multiple organ dysfunction, culminating in death.", "All species elicited a specific IgG antibodies response to the spike proteins, which were protective against a second exposure.", "Transient systemic inflammation was observed occasionally in Rhesus macaques, hamsters, and mice.", "Notably, none of the animals unveiled cytokine storm or coagulopathy.", "Conclusions: Most of the animal models of COVID-19 recapitulated mild pattern of human COVID-19 with full recovery phenotype.", "No severe illness associated with mortality was observed, suggesting a wide gap between COVID-19 in humans and animal models."], "title": "A systematic review uncovers a wide-gap between COVID-19 in humans and animal models"}
{"doc_id": 97, "abstract": ["Background Analyses in hospitalized patients and small autopsy series suggest that severe SARS-CoV-2 infection may affect the heart.", "We investigated heart tissue by in situ hybridization, immunohistochemistry and RNA sequencing in consecutive autopsy cases to quantify virus load and characterize cardiac involvement in COVID-19.", "Methods Left ventricular tissue from 95 deceased with diagnosed SARS-CoV-2 infection undergoing autopsy was analyzed and clinical data were collected.", "RNA was isolated to examine virus load of SARS-CoV-2 and its replication in the heart.", "A virus load >1000 copies per {micro}g RNA was defined as relevant.", "Viral RNA and inflammatory cells were assessed using histology.", "RNA sequencing and gene ontology (GO) enrichment were performed in 10 cases with high cardiac virus load and 10 age-matched cases without cardiac infection.", "Results A relevant SARS-CoV-2 virus load was detected in 41 out of 95 deceased (43%).", "The median cardiac virus load was 7952 copies per {micro}g RNA (IQR 2507, 32 005).", "In situ hybridization revealed SARS-CoV-2 RNA primarily in the interstitium or interstitial cells.", "Virus detection was not associated with increased inflammatory cells.", "Relevant cardiac infection was associated with increased expression of the entry factor TMPRSS2.", "Cardiac virus replication was found in 14/95 hearts (15%).", "Remarkably, cardiac virus replication was associated with shorter time between diagnosis and death.", "RNA sequencing revealed clear activation of immune response pathways to virus infection and destruction of cardiomyocytes.", "Hearts with high virus load showed activation of the GO term ''extracellular exosomes''.", "Conclusion SARS-CoV-2 infection including virus replication and distinct transcriptomic alterations without signs of myocarditis demonstrate a cardiac involvement.", "In this autopsy series, cardiac replication of SARS-CoV-2 was associated with early death."], "title": "Cardiac SARS-CoV-2 infection is associated with distinct transcriptomic changes within the heart"}
{"doc_id": 98, "abstract": ["COronaVIrus Disease 19 (COVID-19) is caused by the infection of the Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2).", "Although the main clinical manifestations of COVID-19 are respiratory, many patients also display acute myocardial injury and chronic damage to the cardiovascular system.", "Understanding both direct and indirect damage caused to the heart and the vascular system by SARS-CoV-2 infection is necessary to identify optimal clinical care strategies.", "The homeostasis of the cardiovascular system requires a tight regulation of the gene expression, which is controlled by multiple types of RNA molecules, including RNA encoding proteins (messenger RNAs) (mRNAs) and those lacking protein-coding potential, the noncoding-RNAs.", "In the last few years, dysregulation of noncoding-RNAs has emerged as a crucial component in the pathophysiology of virtually all cardiovascular diseases.", "Here we will discuss the potential role of noncoding RNAs in COVID-19 disease mechanisms and their possible use as biomarkers of clinical use."], "title": "Noncoding RNAs implication in cardiovascular diseases in the COVID-19 era"}
{"doc_id": 99, "abstract": ["Objectives Serological tests detect antibodies against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in the ongoing coronavirus disease-19 (COVID-19) pandemic.", "Independent external clinical validation of performance characteristics is of paramount importance.", "Methods Four fully automated assays, Roche Elecsys Anti-SARS-CoV-2, Abbott SARS-CoV-2 IgG, Siemens SARS-CoV-2 total (COV2T) and SARS-CoV-2 IgG (COV2G) were evaluated using 350 pre-pandemic samples and 700 samples from 245 COVID-19 patients (158 hospitalized, 87 outpatients).", "Results All tests showed very high diagnostic specificity.", "Sensitivities in samples collected at least 14 days after disease onset were slightly lower than manufacturers' claims for Roche (93.0%), Abbott (90.8%), and Siemens COV2T (90.3%), and distinctly lower for Siemens COV2G (78.8%).", "Concordantly negative results were enriched for immunocompromised patients.", "ROC curve analyses suggest a lowering of the cut-off index for the Siemens COV2G assay.", "Finally, the combination of two anti-SARS-CoV-2 antibody assays is feasible when considering borderline reactive results.", "Conclusions Thorough on-site evaluation of commercially available serologic tests for detection of antibodies against SARS-CoV-2 remains imperative for laboratories.", "The potentially impaired sensitivity of the Siemens COV2G necessitates a switch to the company's newly filed SARS-CoV-2 IgG assay for follow-up studies.", "A combination of tests could be considered in clinical practice."], "title": "Evaluation of four commercial, fully automated SARS-CoV-2 antibody tests suggests a revision of the Siemens SARS-CoV-2 IgG assay."}
{"doc_id": 100, "abstract": ["Since December 2019, a viral pneumonia, named coronavirus disease 2019 (COVID-19), from Wuhan, China, has swept the world.", "Although the case fatality rate is not high, the number of people infected is large and there is still a large number of patients dying.", "With the collation and publication of more and more clinical data, a large number of data suggest that there are mild or severe cytokine storms in severe patients, which is an important cause of death.", "Therefore, treatment of the cytokine storm has become an important part of rescuing severe COVID-19 patients.", "Interleukin-6 (IL-6) plays an important role in cytokine release syndrome.", "If it is possible to block the signal transduction pathway of IL-6, it is expected to become a new method for the treatment of severe COVID-19 patients.", "Tocilizumab is an IL-6 receptor (IL-6R) blocker that can effectively block the IL-6 signal transduction pathway and thus is likely to become an effective drug for patients with severe COVID-19."], "title": "Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality"}
{"doc_id": 101, "abstract": ["We analyzed information obtained from 1,192 patients with probable severe acute respiratory syndrome (SARS) reported in Hong Kong.", "Among them, 26.6% were hospital workers, 16.1% were household members of SARS patients and had probable secondary infections, 14.3% were Amoy Garden residents, 4.9% were inpatients, and 20.1% were contacts of SARS patients who were not family members.", "The remaining 347 case-patients (29.1%) did not have \u201cknown\u201d sources of infection.", "Excluding those <16 years of age, 330 patients with cases from \u201cundefined\u201d sources were used in a 1:2 matched case-control study.", "Multivariate analysis of this case-control study showed that having visited mainland China, hospitals, or the Amoy Gardens were risk factors (odds ratio [OR] 1.95 to 7.63).", "In addition, frequent mask use in public venues, frequent hand washing, and disinfecting the living quarters were significant protective factors (OR 0.36 to 0.58).", "In Hong Kong, therefore, community-acquired infection did not make up most transmissions, and public health measures have contributed substantially to the control of the SARS epidemic."], "title": "SARS Transmission, Risk Factors, and Prevention in Hong Kong"}
{"doc_id": 102, "abstract": ["In March 2020, the first cases of COVID-19 were reported in South Africa.", "The epidemic spread very fast despite an early and extreme lockdown and infected over 600,000 people, by far the highest number of infections in an African country.", "To rapidly understand the spread of SARS-CoV-2 in South Africa, we formed the Network for Genomics Surveillance in South Africa (NGS-SA).", "Here, we analyze 1,365 high quality whole genomes and identify 16 new lineages of SARS-CoV-2.", "Most of these unique lineages have mutations that are found hardly anywhere else in the world.", "We also show that three lineages spread widely in South Africa and contributed to ~42% of all of the infections in the country.", "This included the first identified C lineage of SARS-CoV-2, C.1, which has 16 mutations as compared with the original Wuhan sequence.", "C.1 was the most geographically widespread lineage in South Africa, causing infections in multiple provinces and in all of the eleven districts in KwaZulu-Natal (KZN), the most sampled province.", "Interestingly, the first South-African specific lineage, B.1.106, which was identified in April 2020, became extinct after nosocomial outbreaks were controlled.", "Our findings show that genomic surveillance can be implemented on a large scale in Africa to identify and control the spread of SARS-CoV-2."], "title": "Major new lineages of SARS-CoV-2 emerge and spread in South Africa during lockdown."}
{"doc_id": 103, "abstract": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emergent coronavirus that has caused a worldwide pandemic.", "Although human disease is often asymptomatic, some develop severe illnesses such as pneumonia, respiratory failure, and death.", "There is an urgent need for a vaccine to prevent its rapid spread as asymptomatic infections accounting for up to 40% of transmission events.", "Here we further evaluated an inactivated rabies vectored SARS-CoV-2 S1 vaccine CORAVAX in a Syrian hamster model.", "CORAVAX adjuvanted with MPLA-AddaVax, a TRL4 agonist, induced high levels of neutralizing antibodies and generated a strong Th1-biased immune response.", "Vaccinated hamsters were protected from weight loss and viral replication in the lungs and nasal turbinates three days after challenge with SARS-CoV-2.", "CORAVAX also prevented lung disease, as indicated by the significant reduction in lung pathology.", "This study highlights CORAVAX as a safe, immunogenic, and efficacious vaccine that warrants further assessment in human trials."], "title": "Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a Syrian hamster model"}
{"doc_id": 104, "abstract": ["Background Leading to a sustained epidemic spread with >2,000,000 confirmed human infections, including >100,000 deaths, COVID-19 was caused by SARS-CoV-2 and resulted in acute respiratory distress syndrome (ARDS) and sepsis, which brought more challenges to the patient\u2019s treatment.", "The S-glycoprotein, which recognized as the key factor for the entry of SARS-CoV-2 into the cell, contains two functional domains: an ACE2 receptor binding domain and a second domain necessary for fusion of the coronavirus and cell membranes.", "FURIN activity, exposes the binding and fusion domains, is essential for the zoonotic transmission of SARS-CoV-2.", "Moreover, it has been reported that ACE2 is likely to be the receptor for SARS-CoV-2.", "In addition, FURIN enzyme and ACE2 receptor were expressed in airway epithelia, cardiac tissue, and enteric canals, which considered as the potential target organ of the virus.", "However, report about the expression of FURIN and ACE2 in oral tissues was limited.", "Methods In order to investigate the potential infective channel of new coronavirus in oral cavity, we analyze the expression of ACE2 and FURIN that mediate the new coronavirus entry into host cells in oral mucosa using the public single-cell sequence datasets.", "Furthermore, immunohistochemical staining experiment was performed to confirm the expression of ACE2 and FURIN in the protein level.", "Results The bioinformatics results indicated the differential expression of ACE2 and FURIN on epithelial cells of different oral mucosal tissues and the proportion of FURIN-positive cells was obviously higher than that of ACE2-positive cells.", "IHC experiments revealed that both the ACE2-positive and FURIN-positive cells in the target tissues were mainly positioned in the epithelial layers, partly expressed in fibroblasts, which further confirm the bioinformatics results.", "Conclusions Based on these findings, we speculated that SARS-CoV-2 could effectively invade oral mucosal cells though two possible routes: binding to the ACE2 receptor and fusion with cell membrane activated by FURIN protease.", "Our results indicated that oral mucosa tissues are susceptible to SARS-CoV-2, which provides valuable information for virus-prevention strategy in clinical care as well as daily life."], "title": "Significant expression of FURIN and ACE2 on oral epithelial cells may facilitate the efficiency of SARS-CoV-2 entry"}
{"doc_id": 105, "abstract": ["Angiotensin-converting enzyme-2 (ACE2) has been recognized as the binding receptor for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that infects host cells, causing the development of the new coronavirus infectious disease (COVID-19).", "To better understand the pathogenesis of COVID-19 and build up the host anti-viral immunity, we examined the levels of ACE2 expression on different types of immune cells including tissue macrophages.", "Flow cytometry demonstrated that there was little to no expression of ACE2 on most of the human peripheral blood-derived immune cells including CD4+ T, CD8+ T, activated CD4+ T, activated CD8+ T, CD4+CD25+CD127low/\u2212 regulatory T cells (Tregs), Th17 cells, NKT cells, B cells, NK cells, monocytes, dendritic cells (DCs), and granulocytes.", "Additionally, there was no ACE2 expression (< 1%) found on platelets.", "Compared with interleukin-4-treated type 2 macrophages (M2), the ACE2 expression was markedly increased on the activated type 1 macrophages (M1) after the stimulation with lipopolysaccharide (LPS).", "Immunohistochemistry demonstrated that high expressions of ACE2 were colocalized with tissue macrophages, such as alveolar macrophages found within the lungs and Kupffer cells within livers of mice.", "Flow cytometry confirmed the very low level of ACE2 expression on human primary pulmonary alveolar epithelial cells.", "These data indicate that alveolar macrophages, as the frontline immune cells, may be directly targeted by the SARS-CoV-2 infection and therefore need to be considered for the prevention and treatment of COVID-19."], "title": "High expression of angiotensin-converting enzyme-2 (ACE2) on tissue macrophages that may be targeted by virus SARS-CoV-2 in COVID-19 patients"}
{"doc_id": 106, "abstract": ["Pathologic immune hyperactivation is emerging as a key feature of critical illness in COVID-19, but the mechanisms involved remain poorly understood.", "We carried out proteomic profiling of plasma from cross-sectional and longitudinal cohorts of hospitalized patients with COVID-19 and analyzed clinical data from our health system database of over 3,300 patients.", "Using a machine learning algorithm, we identified a prominent signature of neutrophil activation, including resistin, lipocalin-2, HGF, IL-8, and G-CSF, as the strongest predictors of critical illness.", "Neutrophil activation was present on the first day of hospitalization in patients who would only later require transfer to the intensive care unit, thus preceding the onset of critical illness and predicting increased mortality.", "In the health system database, early elevations in developing and mature neutrophil counts also predicted higher mortality rates.", "Altogether, we define an essential role for neutrophil activation in the pathogenesis of severe COVID-19 and identify molecular neutrophil markers that distinguish patients at risk of future clinical decompensation."], "title": "A neutrophil activation signature predicts critical illness and mortality in COVID-19"}
{"doc_id": 107, "abstract": ["IgG antibodies are crucial for protection against invading pathogens.", "A highly conserved N-linked glycan within the IgG-Fc-tail, essential for IgG function, shows variable composition in humans.", "Afucosylated IgG variants are already used in anti-cancer therapeutic antibodies for their elevated binding and killing activity through Fc receptors (Fc\u03b3RIIIa).", "Here, we report that afucosylated IgG which are of minor abundance in humans (\u223c6% of total IgG) are specifically formed against surface epitopes of enveloped viruses after natural infections or immunization with attenuated viruses, while protein subunit immunization does not elicit this low fucose response.", "This can give beneficial strong responses, but can also go awry, resulting in a cytokine-storm and immune-mediated pathologies.", "In the case of COVID-19, the critically ill show aggravated afucosylated-IgG responses against the viral spike protein.", "In contrast, those clearing the infection unaided show higher fucosylation levels of the anti-spike protein IgG. Our findings indicate antibody glycosylation as a potential factor in inflammation and protection in enveloped virus infections including COVID-19."], "title": "Afucosylated immunoglobulin G responses are a hallmark of enveloped virus infections and show an exacerbated phenotype in COVID-19"}
{"doc_id": 108, "abstract": ["Here we report that COVID-19 hospitalisation rates follow an exponential relationship with age, increasing by 4.5% per year of life (95% CI: 4.2-5.2%).", "This mirrors the exponential decline of thymus volume and T-cell production (decreasing by 4.5% per year).", "COVID-19 can therefore be added to the list of other diseases with this property, including those caused by MRSA, West Nile virus, Streptococcus Pneumonia and certain cancers, such as chronic myeloid leukemia and brain cancers.", "In addition, incidence of severe disease and mortality due to COVID-19 are both higher in men, consistent with the degree to which thymic involution (and the decrease in T-cell production with age) is more severe in men compared to women.", "For under 20s, COVID-19 incidence is remarkably low.", "A Bayesian analysis of daily hospitalisations, accounting for contact-based and environmental transmission, indicates that non-adults are the only age group to deviate significantly from the exponential relationship.", "Our model fitting suggests under 20s have 53-77% additional immune protection beyond that predicted by strong thymus function alone.", "We found no evidence for differences between age groups in susceptibility to overall infection, or, relative infectiousness to others.", "The simple inverse relationship between risk and thymus size we report here suggests that therapies based on T-cell mechanisms may be a promising target."], "title": "Risk of COVID-19 hospitalisation rises exponentially with age, inversely proportional to T-cell production"}
{"doc_id": 109, "abstract": ["Gastrointestinal symptoms in COVID-19 are associated with prolonged symptoms and increased severity.", "We employed human intestinal organoids derived from pluripotent stem cells (PSC-HIOs) to analyze SARS-CoV-2 pathogenesis and to validate efficacy of specific drugs in the gut.", "Certain, but not all cell types in PSC-HIOs express SARS-CoV-2 entry factors ACE2 and TMPRSS2, rendering them susceptible to SARS-CoV-2 infection.", "Remdesivir, a promising drug to treat COVID-19, effectively suppressed SARS-CoV-2 infection of PSC-HIOs.", "In contrast, the histamine-2-blocker famotidine showed no effect.", "Thus, PSC-HIOs provide an interesting platform to study SARS-CoV-2 infection and to identify or validate drugs."], "title": "Remdesivir but not famotidine inhibits SARS-CoV-2 replication in human pluripotent stem cell-derived intestinal organoids"}
{"doc_id": 110, "abstract": ["BACKGROUND: The recent SARS-CoV-2 pandemic, which has recently affected Italy since February 21, constitutes a threat to normal subjects, as the coronavirus disease-19 (COVID-19) can manifest with a broad spectrum of clinical phenotypes ranging from asymptomatic cases to pneumonia or even death.", "There is evidence that older age and several comorbidities can affect the risk to develop severe pneumonia and possibly the need of mechanic ventilation in subjects infected with SARS-CoV-2.", "Therefore, we evaluated the outcome of SARS-CoV-2 infection in patients with inborn errors of immunity (IEI) such as X-linked agammaglobulinemia (XLA).", "METHODS: When the SARS-CoV-2 epidemic has reached Italy, we have activated a surveillance protocol of patients with IEI, to perform SARS-CoV-2 search by nasopharyngeal swab in patients presenting with symptoms that could be a manifestation of COVID-19, such as fever, cough, diarrhea, or vomiting.", "RESULTS: We describe two patients with X-linked agammaglobulinemia (XLA) aged 34 and 26 years with complete absence of B cells from peripheral blood who developed COVID-19, as diagnosed by SARS-CoV-2 detection by nasopharyngeal swab, while receiving immunoglobulin infusions.", "Both patients developed interstitial pneumonia characterized by fever, cough, and anorexia and associated with elevation of CRP and ferritin, but have never required oxygen ventilation or intensive care.", "CONCLUSION: Our report suggests that XLA patients might present with high risk to develop pneumonia after SARS-CoV-2 infection, but can recover from infection, suggesting that B-cell response might be important, but is not strictly required to overcome the disease.", "However, there is a need for larger observational studies to extend these conclusions to other patients with similar genetic immune defects."], "title": "Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover"}
{"doc_id": 111, "abstract": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the pandemic respiratory infectious disease COVID-19.", "However, clinical manifestations and outcomes differ significantly among COVID-19 patients, ranging from asymptomatic to extremely severe, and it remains unclear what drives these disparities.", "Here, we studied 159 hospitalized Italian patients with pneumonia from the NIAID-NCI COVID-19 Consortium using a phage-display method to characterize circulating antibodies binding to 93,904 viral peptides encoded by 1,276 strains of human viruses.", "SARS-CoV-2 infection was associated with a marked increase in individual\u2019s immune memory antibody repertoires linked to trajectories of disease severity from the longitudinal analysis also including anti-spike protein antibodies.", "By applying a machine-learning-based strategy, we developed a viral exposure signature predictive of COVID-19-related disease severity linked to patient survival.", "These results provide a basis for understanding the roles of memory B-cell repertoires in COVID-19-related symptoms as well as a predictive tool for monitoring its clinical severity."], "title": "Serological Responses to Human Virome Define Clinical Outcomes of Italian Patients Infected with SARS-CoV-2"}
{"doc_id": 112, "abstract": ["A large number of hospitalized COVID-19 patients show neurological symptoms such as ischemic-and hemorrhagic stroke as well as encephalitis, and SARS-CoV-2 can directly infect endothelial cells leading to endotheliitis across multiple vascular beds.", "These findings suggest an involvement of the brain-and peripheral vasculature in COVID-19, but the underlying molecular mechanisms remain obscure.", "To understand the potential mechanisms underlying SARS-CoV-2 tropism for brain vasculature, we constructed a molecular atlas of the expression patterns of SARS-CoV-2 viral entry-associated genes (receptors and proteases) and SARS-CoV-2 interaction partners in human (and mouse) adult and fetal brain as well as in multiple non-CNS tissues in single-cell RNA-sequencing data across various datasets.", "We observed a distinct expression pattern of the cathepsins B (CTSB) and-L (CTSL)-which are able to substitute for the ACE2 co-receptor TMPRSS2-in the human vasculature with CTSB being mainly expressed in the brain vasculature and CTSL predominantly in the peripheral vasculature, and these observations were confirmed at the protein level in the Human Protein Atlas and using immunofluorescence stainings.", "This expression pattern of SARS-CoV-2 viral-entry associated proteases and SARS-CoV-2 interaction partners was also present in endothelial cells and microglia in the fetal brain, suggesting a developmentally established SARS-CoV-2 entry machinery in the human vasculature.", "At both the adult and fetal stages, we detected a distinct pattern of SARS-CoV-2 entry associated genes\u2019 transcripts in brain vascular endothelial cells and microglia, providing a potential explanation for an inflammatory response in the brain endothelium upon SARS-CoV-2 infection.", "Moreover, CTSB was co-expressed in adult and fetal brain endothelial cells with genes and pathways involved in innate immunity and inflammation, angiogenesis, blood-brain-barrier permeability, vascular metabolism, and coagulation, providing a potential explanation for the role of brain endothelial cells in clinically observed (neuro)vascular symptoms in COVID-19 patients.", "Our study serves as a publicly available single-cell atlas of SARS-CoV-2 related entry factors and interaction partners in human and mouse brain endothelial-and perivascular cells, which can be employed for future studies in clinical samples of COVID-19 patients."], "title": "The human brain vasculature shows a distinct expression pattern of SARS-CoV-2 entry factors"}
{"doc_id": 113, "abstract": ["There is a great need for the development of vaccines for preventing SARS-CoV-2 infection and mitigating the COVID-19 pandemic.", "Here, we developed two modified vaccinia Ankara (MVA) based vaccines which express either a membrane anchored full-length spike protein (MVA/S) stabilized in a prefusion state or the S1 region of the spike (MVA/S1) which forms trimers and is secreted.", "Both immunogens contained the receptor-binding domain (RBD) which is a known target of antibody-mediated neutralization.", "Following immunizations with MVA/S or MVA/S1, both spike protein recombinants induced strong IgG antibodies to purified full-length SARS-CoV-2 spike protein.", "The MVA/S induced a robust antibody response to purified RBD, S1 and S2 whereas MVA/S1 induced an antibody response to the S1 region outside of the RBD region.", "Both vaccines induced an antibody response in the lung and that was associated with induction of bronchus-associated lymphoid tissue.", "MVA/S but not MVA/S1 vaccinated mice generated robust neutralizing antibody responses against SARS-CoV-2 that strongly correlated with RBD antibody binding titers.", "Mechanistically, S1 binding to ACE-2 was strong but reduced following prolonged pre-incubation at room temperature suggesting confirmation changes in RBD with time.", "These results demonstrate MVA/S is a potential vaccine candidate against SARS-CoV-2 infection."], "title": "Modified Vaccinia Ankara Based SARS-CoV-2 Vaccine Expressing Full-Length Spike Induces Strong Neutralizing Antibody Response"}
{"doc_id": 114, "abstract": ["Cytokine storm resulting from a heightened inflammatory response is a prominent feature of severe COVID-19 disease.", "This inflammatory response results from assembly/activation of a cell-intrinsic defense platform known as the inflammasome.", "We report that the SARS-CoV-2 viroporin encoded by ORF3a activates the NLRP3 inflammasome, the most promiscuous of known inflammasomes.", "ORF3a triggers IL-1\u03b2 expression via NF\u03baB, thus priming the inflammasome while also activating it via ASC-dependent and-independent modes.", "ORF3a-mediated inflammasome activation requires efflux of potassium ions and oligomerization between NEK7 and NLRP3.", "With the selective NLRP3 inhibitor MCC950 able to block ORF3a-mediated inflammasome activation and key ORF3a residues needed for virus release and inflammasome activation conserved in SARS-CoV-2 isolates across continents, ORF3a and NLRP3 present prime targets for intervention.", "Summary Development of anti-SARS-CoV-2 therapies is aimed predominantly at blocking infection or halting virus replication.", "Yet, the inflammatory response is a significant contributor towards disease, especially in those severely affected.", "In a pared-down system, we investigate the influence of ORF3a, an essential SARS-CoV-2 protein, on the inflammatory machinery and find that it activates NLRP3, the most prominent inflammasome by causing potassium loss across the cell membrane.", "We also define key amino acid residues on ORF3a needed to activate the inflammatory response, and likely to facilitate virus release, and find that they are conserved in virus isolates across continents.", "These findings reveal ORF3a and NLRP3 to be attractive targets for therapy."], "title": "SARS-CoV-2 viroporin triggers the NLRP3 inflammatory pathway"}
{"doc_id": 115, "abstract": ["Recent epidemiological studies have investigated the potential effects of childhood immunization history on COVID-19 severity.", "Specifically, prior exposure to Bacillus Calmette-Guerin (BCG) vaccine, oral poliovirus vaccine (OPV), or measles vaccine have been postulated to reduce COVID-19 severity-putative mechanism is via stimulation of the innate immune system to provide broader protection against non-specific pathogens.", "While these epidemiological results remain inconclusive, we sought to investigate the potential role of adaptive immunity via cross-reactivity between vaccine preventable diseases (VPDs) with SARS-CoV-2.", "We implemented a comprehensive exploration of immune homology (including sequence homology, immune epitopes, and glycosylation patterns) between SARS-CoV-2 and all pathogens with FDA-approved vaccines.", "Sequence homology did not reveal significant alignments of protein sequences between SARS-CoV-2 with any VPD pathogens, including BCG-related strains.", "We also could not identify any shared T or B cell epitopes between SARS-CoV-2 and VPD pathogens among either experimentally validated epitopes or predicted immune epitopes.", "For N-glycosylation (N-glyc), while sites with the same tripeptides could be found between SARS-CoV-2 and certain VPD pathogens, their glycosylation potentials and positions were different.", "In summary, lack of immune homology between SARS-CoV-2 and VPD pathogens suggests that childhood immunization history (i.e., BCG vaccination or others) does not provide protection from SARS-CoV-2 through adaptive cross-immunity."], "title": "Lack of immune homology with vaccine preventable pathogens suggests childhood immunizations do not protect against SARS-CoV-2 through adaptive cross-immunity"}
{"doc_id": 116, "abstract": ["Shelter-in-place ordinances were the first wide-spread policy measures aimed to mitigate the spread of COVID-19.", "Compliance with shelter-in-place directives is individually costly and requires behavioral changes across diverse sub-populations.", "Leveraging county-day measures on population movement derived from cellphone location data and the staggered introduction of local mandates, we find that economic factors have played an important role in determining the level of compliance with local shelter-in-place ordinances in the US.", "Specifically, residents of low income areas complied with shelter-in-place ordinances less than their counterparts in areas with stronger economic endowments, even after accounting for potential confounding factors including partisanship, population density, exposure to recent trade disputes, unemployment, and other factors.", "Novel results on the local impact of the 2020 CARES Act suggest stimulus transfers that addressed economic dislocation caused by the COVID-19 pandemic significantly increased social distancing."], "title": "Poverty and Economic Dislocation Reduce Compliance with COVID-19 Shelter-in-Place Protocols"}
{"doc_id": 117, "abstract": ["BACKGROUND: Elucidating the role of T cell responses in COVID-19 is of utmost importance to understand the clearance of SARS-CoV-2 infection.", "METHODS: 30 hospitalized COVID-19 patients and 60 age-and gender-matched healthy controls (HC) participated in this study.", "We used two comprehensive 11-colour flow cytometric panels conforming to Good Laboratory Practice and approved for clinical diagnostics.", "FINDINGS: Absolute numbers of lymphocyte subsets were differentially decreased in COVID-19 patients according to clinical severity.", "In severe disease (SD) patients, all lymphocyte subsets were reduced, whilst in mild disease (MD) NK, NKT and \u00ce\u00b3\u00ce\u00b4 T cells were at the level of HC.", "Additionally, we provide evidence of T cell activation in MD but not SD, when compared to HC.", "Follow up samples revealed a marked increase in effector T cells and memory subsets in convalescing but not in non-convalescing patients.", "INTERPRETATION: Our data suggest that activation and expansion of innate and adaptive lymphocytes play a major role in COVID-19.", "Additionally, recovery is associated with formation of T cell memory as suggested by the missing formation of effector and central memory T cells in SD but not in MD.", "Understanding T cell-responses in the context of clinical severity might serve as foundation to overcome the lack of effective anti-viral immune response in severely affected COVID-19 patients and can offer prognostic value as biomarker for disease outcome and control.", "FUNDING: Funded by State of Lower Saxony grant 14-76,103-184CORONA-11/20 and German Research Foundation, Excellence Strategy-EXC2155\"RESIST\"-Project ID39087428, and DFG-SFB900/3-Project ID158989968, grants SFB900-B3, SFB900-B8."], "title": "Reappearance of effector T cells is associated with recovery from COVID-19"}
{"doc_id": 118, "abstract": ["Background Some aspects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission in children and adults remain unclear.", "This report describes different SARS-CoV-2 transmission patterns by age group in Japan.", "Methods and findings This retrospective observational case series study analyzed transmission patterns of real-time polymerase chain reaction (RT-PCR)-confirmed SARS-CoV-2 infections found by local health authorities and commercial laboratories during January 14 through July 31, 2020 in Japan.", "After ascertaining the infection source for every symptomatic case as clusters at households, daycare facilities, schools, hospitals and workplaces etc., their associated transmission patterns were analyzed.", "Identified cases were divided into three groups: underage, < 20; adults, 20-59; and elderly people 60 years old and older.", "The reproductive number (R)s of respective transmission directions found for the respective age groups were compared.", "Of 26,986 total cases, 23,746 unknown cases were found, leaving 3,240 ascertained sources of infection (12.0%) comprising 125 (3.9%) underage, 2350 (72.5%) adult, and 765 (23.6%) elderly people.", "The respective Rs of underage infection sources directed to underage, adult, and elderly people were estimated respectively as 0.0415 (95% CI, 0.0138-0.0691), 1.11 (95% CI, 0.9171-1.3226), and 0.2811 (95% CI, 0.2074-0.3687).", "The respective Rs of adult infection source directed to underage, adult, and elderly people were estimated respectively as 0.0140 (95% CI, 0.0120-0.0162), 0.5392 (95% CI, 0.5236-0.5550), and 0.1135 (95% CI, 0.1074-0.1197).", "The respective Rs of elderly infection source directed to underage, adult, and elderly people were estimated as 0.065 (95% CI, 0.0039-0.0091), 0.3264 (95% CI, 0.3059-0.3474), and 0.3991 (95% CI, 0.3757-0.4229).", "Conclusions The main sources of SARS-CoV-2 infection were adults and elderly people.", "The R of underage people directed to adults was greater than 1 because of close familial contact but they were unlikely to become carriers transmitting SARS-CoV-2 because they accounted for a minority for transmissions.", "Apparently, SARS-CoV-2 was transmitted among adults and elderly people, suggesting that infection control of SARS-CoV-2 should be managed specifically by generation."], "title": "SARS-CoV-2 infection control implementation based on sources of infection showing directions for three age groups in Japan"}
{"doc_id": 119, "abstract": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of coronavirus disease 2019, it binds to angiotensin-converting enzyme 2 (ACE2) to enter into human cells.", "The expression level of ACE2 potentially determine the susceptibility and severity of COVID-19, it is thus of importance to understand the regulatory mechanism of ACE2 expression.", "Tripartite motif containing 28 (TRIM28) is known to be involved in multiple processes including antiviral restriction, endogenous retrovirus latency and immune response, it is recently reported to be co-expressed with SARS-CoV-2 receptor in type II pneumocytes; however, the roles of TRIM28 in ACE2 expression and SARS-CoV-2 cell entry remain unclear.", "This study showed that knockdown of TRIM28 induces ACE2 expression and increases pseudotyped SARS-CoV-2 cell entry of A549 cells and primary pulmonary alveolar epithelial cells (PAEpiCs).", "In a co-culture model of NK cells and lung epithelial cells, our results demonstrated that NK cells inhibit TRIM28 and promote ACE2 expression in lung epithelial cells, which was partially reversed by depletion of interleukin-2 and blocking of granzyme B in the co-culture medium.", "Furthermore, TRIM28 knockdown enhanced interferon-\u00ce\u00b3 (IFN-\u00ce\u00b3)-induced ACE2 expression through a mechanism involving upregulating IFN-\u00ce\u00b3 receptor 2 (IFNGR2) in both A549 and PAEpiCs.", "The upregulated ACE2 induced by TRIM28 knockdown and co-culture of NK cells was partially reversed by dexamethasone in A549 cells.", "Our study identified TRIM28 as a novel regulator of ACE2 expression and SARS-CoV-2 cell entry."], "title": "TRIM28 regulates SARS-CoV-2 cell entry by targeting ACE2"}
{"doc_id": 120, "abstract": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the third highly pathogenic coronavirus to spill over to humans in less than 20 years, after SARS-CoV-1 in 2002-2003 and Middle East respiratory syndrome (MERS)-CoV in 2012.", "SARS-CoV-2 is the etiologic agent of coronavirus disease 19 (COVID-19), which ranges from mild respiratory symptoms to severe lung injury and death in the most severe cases.", "The COVID-19 pandemic is currently a major health issue worldwide.", "Immune dysregulation characterized by altered innate cytokine responses is thought to contribute to the pathology of COVID-19 patients, which is a testimony of the fundamental role of the innate immune response against SARS-CoV-2.", "Here, we further characterized the host cell antiviral response against SARS-CoV-2 by using primary human airway epithelia and immortalized model cell lines.", "We mainly focused on the type I and III interferon (IFN) responses, which lead to the establishment of an antiviral state through the expression of IFN-stimulated genes (ISGs).", "Our results demonstrate that both primary airway epithelial cells and model cell lines elicit a robust immune response characterized by a strong induction of type I and III IFN through the detection of viral pathogen molecular patterns (PAMPs) by melanoma differentiation associated gene (MDA)-5.", "However, despite the high levels of type I and III IFNs produced in response to SARS-CoV-2 infection, the IFN response was unable to control viral replication, whereas IFN pre-treatment strongly inhibited viral replication and de novo production of infectious virions.", "Taken together, these results highlight the complex and ambiguous interplay between viral replication and the timing of IFN responses."], "title": "SARS-CoV-2 replication triggers an MDA-5-dependent interferon production which is unable to efficiently control replication"}
{"doc_id": 121, "abstract": ["Many viruses utilize the host endo-lysosomal network to infect cells.", "Tracing the endocytic itinerary of SARS-CoV2 can provide insights into viral trafficking and aid in designing new therapeutic targets.", "Here, we demonstrate that the receptor binding domain (RBD) of SARS-CoV2 is internalized via the clathrin and dynamin-independent, pH-dependent CLIC/GEEC (CG) endocytic pathway.", "Endosomal acidification inhibitors like BafilomycinA1 and NH4Cl, which inhibit the CG pathway, strongly block the uptake of RBD.", "Using transduction assays with SARS-CoV2 Spike-pseudovirus, we confirmed that these acidification inhibitors also impede viral infection.", "By contrast, Chloroquine neither affects RBD uptake nor extensively alters the endosomal pH, yet attenuates Spike-pseudovirus entry, indicating a pH-independent mechanism of intervention.", "We screened a subset of FDA-approved acidification inhibitors and found Niclosamide to be a potential SARS-CoV2 entry inhibitor.", "Niclosamide, thus, could provide broader applicability in subverting infection of similar category viruses entering host cells via this pH-dependent endocytic pathway."], "title": "Niclosamide inhibits SARS-CoV2 entry by blocking internalization through pH-dependent CLIC/GEEC endocytic pathway"}
{"doc_id": 122, "abstract": ["The 2019 novel coronavirus (2019-nCoV/SARS-CoV-2) originally arose as part of a major outbreak of respiratory disease centered on Hubei province, China.", "It is now a global pandemic and is a major public health concern.", "Taxonomically, SARS-CoV-2 was shown to be a Betacoronavirus (lineage B) closely related to SARS-CoV and SARS-related bat coronaviruses, and it has been reported to share a common receptor with SARS-CoV (ACE-2).", "Subsequently, betacoronaviruses from pangolins were identified as close relatives to SARS-CoV-2.", "Here, we perform structural modeling of the SARS-CoV-2 spike glycoprotein.", "Our data provide support for the similar receptor utilization between SARS-CoV-2 and SARS-CoV, despite a relatively low amino acid similarity in the receptor binding module.", "Compared to SARS-CoV and all other coronaviruses in Betacoronavirus lineage B, we identify an extended structural loop containing basic amino acids at the interface of the receptor binding (S1) and fusion (S2) domains.", "We suggest this loop confers fusion activation and entry properties more in line with betacoronaviruses in lineages A and C, and be a key component in the evolution of SARS-CoV-2 with this structural loop affecting virus stability and transmission."], "title": "Phylogenetic Analysis and Structural Modeling of SARS-CoV-2 Spike Protein Reveals an Evolutionary Distinct and Proteolytically Sensitive Activation Loop"}
{"doc_id": 123, "abstract": ["The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has had a large impact on global health, travel, and economy.", "Therefore, preventative and therapeutic measures are urgently needed.", "Here, we isolated monoclonal antibodies from three convalescent coronavirus disease 2019 (COVID-19) patients using a SARS-CoV-2 stabilized prefusion spike protein.", "These antibodies had low levels of somatic hypermutation and showed a strong enrichment in VH1-69, VH3-30-3, and VH1-24 gene usage.", "A subset of the antibodies was able to potently inhibit authentic SARS-CoV-2 infection at a concentration as low as 0.007 micrograms per milliliter.", "Competition and electron microscopy studies illustrate that the SARS-CoV-2 spike protein contains multiple distinct antigenic sites, including several receptor-binding domain (RBD) epitopes as well as non-RBD epitopes.", "In addition to providing guidance for vaccine design, the antibodies described here are promising candidates for COVID-19 treatment and prevention."], "title": "Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability"}
{"doc_id": 124, "abstract": ["Aim: To evaluate associations of plasma 25(OH)D status with the likelihood of coronavirus disease (COVID-19) infection and hospitalization.", "Methods: The study population included the 14,000 members of Leumit Health Services who were tested for COVID-19 infection from February 1st to April 30th, 2020, and who had at least one previous blood test for plasma 25(OH)D level. \"Suboptimal\" or \"low\" plasma 25(OH)D level was defined as plasma 25-hydroxyvitamin D, or 25(OH)D, concentration below 30 ng/mL. Results: Of 7,807 individuals, 782 (10.1%) were COVID-19-positive, and 7,025 (89.9%) COVID-19-negative.", "The mean plasma vitamin D level was significantly lower among those who tested positive than negative for COVID-19 [19.00 ng/mL (95% confidence interval [CI] 18.41-19.59) vs. 20.55 (95% CI 20.32-20.78)].", "Univariate analysis demonstrated an association between low plasma 25(OH)D level and increased likelihood of COVID-19 infection [crude odds ratio (OR) of 1.58 (95% CI 1.24-2.01, p<0.001)], and of hospitalization due to the SARS-CoV-2 virus [crude OR of 2.09 (95% CI 1.01-4.30, p<0.05)].", "In multivariate analyses that controlled for demographic variables and psychiatric and somatic disorders, the adjusted OR of COVID-19 infection [1.45 (95% CI 1.08-1.95, p<0.001)], and of hospitalization due to the SARS-CoV-2 virus [1.95 (95% CI 0.98-4.845, p=0.061)] were preserved.", "In the multivariate analyses, age over 50 years, male gender and low-medium socioeconomic status were also positively associated with the risk of COVID-19 infection; age over 50 years was positively associated with the likelihood of hospitalization due to COVID-19."], "title": "Low plasma 25(OH) vitamin D3 level is associated with increased risk of COVID-19 infection: an Israeli population-based study"}
{"doc_id": 125, "abstract": ["BACKGROUND: To investigate the association between serum 25-hydroxyvitamin D levels and its effect on adverse clinical outcomes, and parameters of immune function and mortality due to a SARS-CoV-2 infection.", "STUDY DESIGN: The hospital data of 235 patients infected with COVID-19 were analyzed.", "RESULTS: Based on CDC criteria, among our study patients, 74% had severe COVID-19 infection and 32.8% were vitamin D sufficient.", "After adjusting for confounding factors, there was a significant association between vitamin D sufficiency and reduction in clinical severity, inpatient mortality serum levels of C-reactive protein (CRP) and an increase in lymphocyte percentage.", "Only 9.7% of patients older than 40 years who were vitamin D sufficient succumbed to the infection compared to 20% who had a circulating level of 25(OH)D< 30 ng/ml.", "The significant reduction in serum CRP, an inflammatory marker, along with increased lymphocytes percentage suggest that vitamin D sufficiency also may help modulate the immune response possibly by reducing risk for cytokine storm in response to this viral infection.", "CONCLUSION: Therefore, it is recommended that improving vitamin D status in the general population and in particular hospitalized patients has a potential benefit in reducing the severity of morbidities and mortality associated with acquiring COVID-19."], "title": "Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection"}
{"doc_id": 126, "abstract": ["BACKGROUND As effective medication to treat COVID-19 is currently unavailable, preventive remedies may be particularly important.", "OBJECTIVE To examine the relationship between serum 25-hydroxy vitamin D (25(OH)D) level and COVID-19 infection, its severity, and its clinical case characteristics.", "METHODS This case-control study compared serum 25(OH)D levels and rates of vitamin D deficiency (VDD) between 80 healthy controls and 62 patients diagnosed with COVID-19 and admitted to Guangxi People's Hospital, China, 2/16/2020-3/16/2020.", "Cases were categorized into asymptomatic, mild/moderate, and severe/critical disease.", "Logistic regression analysis was conducted to examine the associations between 25(OH)D level, or VDD, and case status/severity of COVID-19 while controlling for demographics and comorbidities.", "A threshold level of vitamin D for conveying COVID-19 risk was estimated.", "RESULTS Severe/critical COVID-19 cases were significantly older and had higher percentages of comorbidity (renal failure) compared to mild cases.", "The serum 25(OH)D concentration in COVID-19 patient was much lower than that in healthy control. And 25(OH)D level was the lowest in severe/critical cases, compared with mild cases.", "In further, significantly higher rates of VDD were found in COVID-19 cases (41.9%) compared to healthy controls (11.1%). And VDD was the greatest in severe/critical cases (80%), compared with mild cases (36%).", "These statistically significant associations remained even after controlling for demographics and comorbidities.", "A potential threshold of 25(OH)D (41.19 nmol/L) to protect against COVID-19 was identified.", "CONCLUSION Elderly and people with comorbidities were susceptible to severe COVID-19 infection.", "VDD was a risk factor for COVID-19, especially for severe/critical cases.", "While further confirmation is needed, vitamin D supplementation may have prevention or treatment potential for COVID-19 disease."], "title": "Does Serum Vitamin D Level Affect COVID-19 Infection and Its Severity?-A Case-Control Study."}
{"doc_id": 127, "abstract": ["An outbreak of the novel coronavirus SARS-CoV-2, the causative agent of COVID-19 respiratory disease, has infected over 290,000 people since the end of 2019, killed over 12,000, and caused worldwide social and economic disruption(1,2).", "There are currently no antiviral drugs with proven efficacy nor are there vaccines for its prevention.", "Unfortunately, the scientific community has little knowledge of the molecular details of SARS-CoV-2 infection.", "To illuminate this, we cloned, tagged and expressed 26 of the 29 viral proteins in human cells and identified the human proteins physically associated with each using affinity-purification mass spectrometry (AP-MS), which identified 332 high confidence SARS-CoV-2-human protein-protein interactions (PPIs).", "Among these, we identify 66 druggable human proteins or host factors targeted by 69 existing FDA-approved drugs, drugs in clinical trials and/or preclinical compounds, that we are currently evaluating for efficacy in live SARS-CoV-2 infection assays.", "The identification of host dependency factors mediating virus infection may provide key insights into effective molecular targets for developing broadly acting antiviral therapeutics against SARS-CoV-2 and other deadly coronavirus strains."], "title": "A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing"}
{"doc_id": 128, "abstract": ["A newly described coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the causative agent of coronavirus disease 2019 (COVID-19), has infected over 2.3 million people, led to the death of more than 160,000 individuals and caused worldwide social and economic disruption1,2.", "There are no antiviral drugs with proven clinical efficacy for the treatment of COVID-19, nor are there any vaccines that prevent infection with SARS-CoV-2, and efforts to develop drugs and vaccines are hampered by the limited knowledge of the molecular details of how SARS-CoV-2 infects cells.", "Here we cloned, tagged and expressed 26 of the 29 SARS-CoV-2 proteins in human cells and identified the human proteins that physically associated with each of the SARS-CoV-2 proteins using affinity-purification mass spectrometry, identifying 332 high-confidence protein-protein interactions between SARS-CoV-2 and human proteins.", "Among these, we identify 66 druggable human proteins or host factors targeted by 69 compounds (of which, 29 drugs are approved by the US Food and Drug Administration, 12 are in clinical trials and 28 are preclinical compounds).", "We screened a subset of these in multiple viral assays and found two sets of pharmacological agents that displayed antiviral activity: inhibitors of mRNA translation and predicted regulators of the sigma-1 and sigma-2 receptors.", "Further studies of these host-factor-targeting agents, including their combination with drugs that directly target viral enzymes, could lead to a therapeutic regimen to treat COVID-19."], "title": "A SARS-CoV-2 protein interaction map reveals targets for drug repurposing"}
{"doc_id": 129, "abstract": ["An urgent global quest for effective therapies to prevent and treat COVID-19 disease is ongoing.", "We previously described REGN-COV2, a cocktail of two potent neutralizing antibodies (REGN10987+REGN10933) targeting non-overlapping epitopes on the SARS-CoV-2 spike protein.", "In this report, we evaluate the in vivo efficacy of this antibody cocktail in both rhesus macaques and golden hamsters and demonstrate that REGN-COV-2 can greatly reduce virus load in lower and upper airway and decrease virus induced pathological sequalae when administered prophylactically or therapeutically.", "Our results provide evidence of the therapeutic potential of this antibody cocktail."], "title": "REGN-COV2 antibody cocktail prevents and treats SARS-CoV-2 infection in rhesus macaques and hamsters"}
{"doc_id": 130, "abstract": ["Caly et al.1 reported that ivermectin inhibited severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) in vitro for up to 48 hours using ivermectin at 5 \u00b5M. The concentration resulting in 50% inhibition (IC50 ; 2 \u00b5M) was > 35\u00d7 higher than the maximum plasma concentration (Cmax ) after oral administration of the approved dose of ivermectin when given fasted.", "Simulations were conducted using an available population pharmacokinetic model to predict total (bound and unbound) and unbound plasma concentration-time profiles after a single and repeat fasted administration of the approved dose of ivermectin (200 \u00b5g/kg), 60 mg, and 120 mg.", "Plasma total Cmax was determined and then multiplied by the lung:plasma ratio reported in cattle to predict the lung Cmax after administration of each single dose.", "Plasma ivermectin concentrations of total (bound and unbound) and unbound concentrations do not reach the IC50 , even for a dose level 10\u00d7 higher than the approved dose.", "Even with the high lung:plasma ratio, ivermectin is unlikely to reach the IC50 in the lungs after single oral administration of the approved dose (predicted lung: 0.0873 \u00b5M) or at doses 10\u00d7 higher that the approved dose administered orally (predicted lung: 0.820 \u00b5M).", "In summary, the likelihood of a successful clinical trial using the approved dose of ivermectin is low.", "Combination therapy should be evaluated in vitro.", "Repurposing drugs for use in coronavirus disease 2019 (COVID-19) treatment is an ideal strategy but is only feasible when product safety has been established and experiments of repurposed drugs are conducted at clinically relevant concentrations."], "title": "The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID-19"}
{"doc_id": 131, "abstract": ["Vaccines are urgently needed to combat the global coronavirus disease 2019 (COVID-19) pandemic, and testing of candidate vaccines in an appropriate non-human primate (NHP) model is a critical step in the process.", "Infection of African green monkeys (AGM) with a low passage human isolate of SARS-CoV-2 by aerosol or mucosal exposure resulted in mild clinical infection with a transient decrease in lung tidal volume.", "Imaging with human clinical-grade 18F-fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG PET) co-registered with computed tomography (CT) revealed pulmonary lesions at 4 days post-infection (dpi) that resolved over time.", "Infectious virus was shed from both respiratory and gastrointestinal (GI) tracts in all animals in a biphasic manner, first between 2-7 dpi followed by a recrudescence at 14-21 dpi.", "Viral RNA (vRNA) was found throughout both respiratory and gastrointestinal systems at necropsy with higher levels of vRNA found within the GI tract tissues.", "All animals seroconverted simultaneously for IgM and IgG, which has also been documented in human COVID-19 cases.", "Young AGM represent an species to study mild/subclinical COVID-19 disease and with possible insights into live virus shedding.", "Future vaccine evaluation can be performed in AGM with correlates of efficacy being lung lesions by PET/CT, virus shedding, and tissue viral load."], "title": "SARS-CoV-2 infection of African green monkeys results in mild respiratory disease discernible by PET/CT imaging and shedding of infectious virus from both respiratory and gastrointestinal tracts"}
{"doc_id": 132, "abstract": ["Vaccines are urgently needed to combat the global coronavirus disease 2019 (COVID-19) pandemic, and testing of candidate vaccines in an appropriate non-human primate (NHP) model is a critical step in the process.", "Infection of African green monkeys (AGM) with a low passage human isolate of SARS-CoV-2 by aerosol or mucosal exposure resulted in mild clinical infection with a transient decrease in lung tidal volume.", "Imaging with human clinical-grade 18F-fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG PET) co-registered with computed tomography (CT) revealed pulmonary lesions at 4 days post-infection (dpi) that resolved over time.", "Infectious virus was shed from both respiratory and gastrointestinal (GI) tracts in all animals in a biphasic manner, first between 2-7 dpi followed by a recrudescence at 14-21 dpi.", "Viral RNA (vRNA) was found throughout both respiratory and gastrointestinal systems at necropsy with higher levels of vRNA found within the GI tract tissues.", "All animals seroconverted simultaneously for IgM and IgG, which has also been documented in human COVID-19 cases.", "Young AGM represent an excellent species to study mild/subclinical COVID-19 disease and have shed light on unknown aspects of long-term virus shedding.", "They are ideally suited for preclinical evaluation of candidate vaccines and therapeutic interventions.", "One Sentence Summary Subclinical infection of African green monkeys infected with SARS-CoV-2 results in prolonged shedding of infectious virus from both respiratory and gastrointestinal tracts."], "title": "SARS-CoV-2 infection of African green monkeys results in mild respiratory disease discernible by PET/CT imaging and prolonged shedding of infectious virus from both respiratory and gastrointestinal tracts"}
{"doc_id": 133, "abstract": ["SARS-CoV-2 infections underlie the current coronavirus disease (COVID-19) pandemic and are causative for a high death toll particularly among elderly subjects and those with comorbidities.", "Selenium (Se) is an essential trace element of high importance for human health and particularly for a well-balanced immune response.", "The mortality risk from a severe disease like sepsis or polytrauma is inversely related to Se status.", "We hypothesized that this relation also applies to COVID-19.", "Serum samples (n = 166) from COVID-19 patients (n = 33) were collected consecutively and analyzed for total Se by X-ray fluorescence and selenoprotein P (SELENOP) by a validated ELISA.", "Both biomarkers showed the expected strong correlation (r = 0.7758, p < 0.001), pointing to an insufficient Se availability for optimal selenoprotein expression.", "In comparison with reference data from a European cross-sectional analysis (EPIC, n = 1915), the patients showed a pronounced deficit in total serum Se (mean \u00b1 SD, 50.8 \u00b1 15.7 vs. 84.4 \u00b1 23.4 \u00b5g/L) and SELENOP (3.0 \u00b1 1.4 vs. 4.3 \u00b1 1.0 mg/L) concentrations.", "A Se status below the 2.5th percentile of the reference population, i.e., [Se] < 45.7 \u00b5g/L and [SELENOP] < 2.56 mg/L, was present in 43.4% and 39.2% of COVID samples, respectively.", "The Se status was significantly higher in samples from surviving COVID patients as compared with non-survivors (Se; 53.3 \u00b1 16.2 vs. 40.8 \u00b1 8.1 \u00b5g/L, SELENOP; 3.3 \u00b1 1.3 vs. 2.1 \u00b1 0.9 mg/L), recovering with time in survivors while remaining low or even declining in non-survivors.", "We conclude that Se status analysis in COVID patients provides diagnostic information.", "However, causality remains unknown due to the observational nature of this study.", "Nevertheless, the findings strengthen the notion of a relevant role of Se for COVID convalescence and support the discussion on adjuvant Se supplementation in severely diseased and Se-deficient patients."], "title": "Selenium Deficiency Is Associated with Mortality Risk from COVID-19"}
{"doc_id": 134, "abstract": ["COVID-19 has caused over 1 million deaths globally, yet the cellular mechanisms underlying severe disease remain poorly understood.", "By analyzing several thousand plasma proteins in 306 COVID-19 patients and 78 symptomatic controls over serial timepoints using two complementary approaches, we uncover COVID-19 host immune and non-immune proteins not previously linked to this disease.", "Integration of plasma proteomics with nine published scRNAseq datasets shows that SARS-CoV-2 infection upregulates monocyte/macrophage, plasmablast, and T cell effector proteins.", "By comparing patients who died to severely ill patients who survived, we identify dynamic immunomodulatory and tissue-associated proteins associated with survival, providing insights into which host responses are beneficial and which are detrimental to survival.", "We identify intracellular death signatures from specific tissues and cell types, and by associating these with angiotensin converting enzyme 2 (ACE2) expression, we map tissue damage associated with severe disease and propose which damage results from direct viral infection rather than from indirect effects of illness.", "We find that disease severity in lung tissue is driven by myeloid cell phenotypes and cell-cell interactions with lung epithelial cells and T cells.", "Based on these results, we propose a model of immune and epithelial cell interactions that drive cell-type specific and tissue-specific damage in severe COVID-19."], "title": "Plasma proteomics reveals tissue-specific cell death and mediators of cell-cell interactions in severe COVID-19 patients"}
{"doc_id": 135, "abstract": ["Objective: The outbreak of Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection has become a global health emergency.", "We aim to decipher SARS-CoV-2 infected cell types, the consequent host immune response and their interplay in the lung of COVID-19 patients.", "Design: We analyzed single-cell RNA sequencing (scRNA-seq) data of lung samples from 17 subjects (6 severe COVID-19 patients, 3 mild patients who recovered and 8 healthy controls).", "The expression of SARS-CoV-2 receptors (ACE2 and TMPRSS2) was examined among different cell types in the lung.", "The immune cells infiltration patterns, their gene expression profiles, and the interplay of immune cells and SARS-CoV-2 target cells were further investigated.", "Results: Compared to healthy controls, the overall ACE2 (receptor of SARS-CoV-2) expression was significantly higher in lung epithelial cells of COVID-19 patients, in particular in ciliated cell, club cell and basal cell.", "Comparative transcriptome analysis of these lung epithelial cells of COVID-19 patients and healthy controls identified that SARS-CoV-2 infection activated pro-inflammatory signaling including interferon pathway and cytokine signaling.", "Moreover, we identified dysregulation of immune response in patients with COVID-19.", "In severe COVID-19 patients, significantly higher neutrophil, but lower T and NK cells in lung were observed along with markedly increased cytokines (CCL2, CCL3, CCL4, CCL7, CCL3L1 and CCL4L2) compared with healthy controls as well as mild patients who recovered.", "The cytotoxic phenotypes were shown in lung T and NK cells of severe patients as evidenced by enhanced IFN{gamma}, Granulysin, Granzyme B and Perforin expression.", "Moreover, SARS-CoV-2 infection altered the community interplay of lung epithelial cells and immune cells: the interaction between epithelial cells with macrophage, T and NK cell was stronger, but their interaction with neutrophils was lost in COVID-19 patients compared to healthy controls.", "Conclusions: SARS-CoV-2 infection activates pro-inflammatory signaling in lung epithelial cells expressing ACE2 and causes dysregulation of immune response to release more pro-inflammatory cytokines.", "Moreover, SARS-CoV-2 infection breaks the interplay of lung epithelial cells and immune cells."], "title": "SARS-CoV-2 activates lung epithelia cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients by single-cell sequencing"}
{"doc_id": 136, "abstract": ["Facemasks are widely used as a protective measure by general public to prevent inhalation of airborne pathogens including seasonal, swine and other forms of influenza and severe acute respiratory syndrome (SARS), etc.", "However, scientific data on effectiveness of facemasks in reducing infections in the community are extremely limited and even inconsistent.", "In this work, two manikins labelled as 'source' and 'susceptible' were used to measure the protection provided by facemasks under various emission scenarios.", "The source was modified to generate polydisperse ultrafine particles, whereas the susceptible was modified to mimic a realistic breathing pattern.", "The facemask was challenged by both pseudo-steady and highly transient emissions generated by an expiratory process where parameters, such as separation distance between manikins, emission velocity and expiratory duration, were controlled and measured systematically.", "Performances of four different types of facemask fits, varying from ideal to normal wearing practice, were also investigated.", "Under the pseudo-steady concentration environment, facemask protection was found to be 45 per cent, while under expiratory emissions, protection varied from 33 to 100 per cent.", "It was also observed that the separation between the source and the manikin was the most influential parameter affecting facemask protection."], "title": "Effectiveness of facemasks to reduce exposure hazards for airborne infections among general populations."}
{"doc_id": 137, "abstract": ["Clinical manifestations of COVID-19 caused by the novel coronavirus SARS-CoV-2 are associated with age.", "While children are largely spared from severe respiratory disease, they can present with a SARS-CoV-2-associated multisystem inflammatory syndrome (MIS-C) similar to Kawasaki's disease.", "Here, we show distinct antibody (Ab) responses in children with MIS-C compared to adults with severe COVID-19 causing acute respiratory distress syndrome (ARDS), and those who recovered from mild disease.", "There was a reduced breadth and specificity of anti-SARS-CoV-2-specific antibodies in MIS-C patients compared to the COVID patient groups; MIS-C predominantly generated IgG Abs specific for the Spike (S) protein but not for the nucleocapsid (N) protein, while both COVID-19 cohorts had anti-S IgG, IgM and IgA Abs, as well as anti-N IgG Abs.", "Moreover, MIS-C patients had reduced neutralizing activity compared to COVID-19 cohorts, indicating a reduced protective serological response.", "These results suggest a distinct infection course and immune response in children and adults who develop severe disease, with implications for optimizing treatments based on symptom and age."], "title": "Antibody responses to SARS-CoV2 are distinct in children with MIS-C compared to adults with COVID-19"}
{"doc_id": 138, "abstract": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in December 20191,2 and is responsible for the coronavirus disease 2019 (COVID-19) pandemic3.", "Vaccines are an essential countermeasure and are urgently needed to control the pandemic4.", "Here we show that the adenovirus-vector-based vaccine ChAdOx1 nCoV-19, which encodes the spike protein of SARS-CoV-2, is immunogenic in mice and elicites a robust humoral and cell-mediated response.", "This response was predominantly mediated by type-1 T helper cells, as demonstrated by the profiling of the IgG subclass and the expression of cytokines.", "Vaccination with ChAdOx1 nCoV-19 (using either a prime-only or a prime-boost regimen) induced a balanced humoral and cellular immune response of type-1 and type-2 T helper cells in rhesus macaques.", "We observed a significantly reduced viral load in the bronchoalveolar lavage fluid and lower respiratory tract tissue of vaccinated rhesus macaques that were challenged with SARS-CoV-2 compared with control animals, and no pneumonia was observed in vaccinated SARS-CoV-2-infected animals.", "However, there was no difference in nasal shedding between vaccinated and control SARS-CoV-2-infected macaques.", "Notably, we found no evidence of immune-enhanced disease after viral challenge in vaccinated SARS-CoV-2-infected animals.", "The safety, immunogenicity and efficacy profiles of ChAdOx1 nCoV-19 against symptomatic PCR-positive COVID-19 disease will now be assessed in randomized controlled clinical trials in humans."], "title": "ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques"}
{"doc_id": 139, "abstract": ["BACKGROUD: COVID-19 coagulopathy linked to increased D-dimer levels has been associated with high mortality (Fei Z et al. in Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.", "Lancet (London, England) 395(10229):1054-62, 2020).", "While D-dimer is accepted as a disseminated intravascular coagulation marker, rotational thromboelastometry (ROTEM) also detects fibrinolysis (Wright FL et al. in Fibrinolysis shutdown correlates to thromboembolic events in severe COVID-19 infection.", "J Am Coll Surg (2020).", "Available from https://pubmed.ncbi.nlm.nih.gov/32422349/ [cited 14 Jun 2020]; Schmitt FCF et al. in Acute fibrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality: results of an observational pilot study.", "Ann Intensive Care 9(1):19, 2019).", "We describe the ROTEM profile in severely ill COVID-19 patients and compare it with the standard laboratory coagulation test.", "METHODS: Adult patients diagnosed with COVID-19 admitted to the ICU were prospectively enrolled after Ethics Committee approval (HCB/2020/0371).", "All patients received venous thromboembolism prophylaxis; those on therapeutic anticoagulation were excluded.", "The standard laboratory coagulation test and ROTEM were performed simultaneously at 24-48 h after ICU admission.", "Sequential organ failure assessment (SOFA), disseminated intravascular coagulation (DIC) and sepsis-induced coagulopathy (SIC) scores were calculated at sample collection.", "RESULTS: Nineteen patients were included with median SOFA-score of 4 (2-6), DIC-score of 1 (0-3) and SIC-score of 1.8 (0.9).", "Median fibrinogen, D-dimer levels and platelet count were 6.2 (4.8-7.6 g/L), 1000 (600-4200 ng/ml) and 236 (136-364 109/L), respectively.", "Clot firmness was above the normal range in the EXTEM and FIBTEM tests while clot lysis was decreased.", "There was no significant correlation between ROTEM or D-dimer parameters and the SOFA score.", "CONCLUSION: In COVID-19 patients, the ROTEM pattern was characterized by a hypercoagulable state with decreased fibrinolytic capacity despite a paradoxical increase in D-dimer levels.", "We suggest that, in COVID-19 patients, the lungs could be the main source of D-dimer, while a systemic hypofibrinolytic state coexists.", "This hypothesis should be confirmed by future studies."], "title": "High D dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there?"}
{"doc_id": 140, "abstract": ["The main protease (3CL Mpro) from SARS-CoV-2, the etiological agent of COVID-19, is an essential enzyme for viral replication, possessing an unusual catalytic dyad composed of His41 and Cys145.", "A long-standing question in the field has been what the protonation states of the ionizable residues in the substrate-binding active site cavity are.", "Here, we present the room-temperature neutron structure of 3CL Mpro from SARS-CoV-2, which allows direct determination of hydrogen atom positions and, hence, protonation states.", "The catalytic site natively adopts a zwitterionic reactive state where His41 is doubly protonated and positively charged, and Cys145 is in the negatively charged thiolate state.", "The neutron structure also identified the protonation states of other amino acid residues, mapping electrical charges and intricate hydrogen bonding networks in the SARS-CoV-2 3CL Mpro active site cavity and dimer interface.", "This structure highlights the ability of neutron protein crystallography for experimentally determining protonation states at near-physiological temperature \u2013 the critical information for structure-assisted and computational drug design."], "title": "Protonation states in SARS-CoV-2 main protease mapped by neutron crystallography"}
{"doc_id": 141, "abstract": ["Background Lymphopenia is a typical symptom in the COVID-19 patients.", "While millions of patients are clinical recovered, little is known about the immune status of lymphocytes in these individuals.", "Methods A clinical recovered cohort (CR) of 55 COVID-19 individuals (discharged from hospital 4 to 11 weeks), and 55 age and sex matched healthy donors cohort (HD) were recruited.", "Detailed analysis on phenotype of the lymphocytes in peripheral blood mononuclear cells (PBMCs) was performed by flow cytometry.", "Findings Compared with cohort HD, the CD8+ T cells in cohort CR had higher Teff and Tem, but lower Tc1 (IFN-{gamma}+), Tc2 (IL-4+) and Tc17 (IL-17A+) frequencies.", "The CD4+ T cells of CR had decreased frequency, especially on the Tcm subset.", "Moreover, CD4+ T cells of CR expressed lower PD-1 and had lower frequencies of Th1 (IFN-{gamma}+), Th2 (IL-4+), Th17 (IL-17A+) as well as circulating Tfh (CXCR5+PD-1+).", "Accordingly, isotype-switched memory B cell (IgM-CD20hi) in CR had significantly lower proportion in B cells, though level of activation marker CD71 elevated.", "For CD3-HLA-DRlo lymphocytes of CR, besides levels of IFN-{gamma}, Granzyme B and T-bet were lower, the correlation between T-bet and IFN-{gamma} became irrelevant.", "In addition, taken into account of discharged days, all the lowered function associated phenotypes showed no recovery tendency within whole observation period.", "Interpretation The CR COVID-19 individuals still showed remarkable phenotypic alterations in lymphocytes after clinical recovery 4 to 11 weeks.", "This suggests SARS-CoV-2 infection imprints profoundly on lymphocytes and results in long-lasting potential dysfunctions."], "title": "Broad phenotypic alterations and potential dysfunctions of lymphocytes in COVID-19 recovered individuals"}
{"doc_id": 142, "abstract": ["Understanding how SARS-CoV-2 spreads within the respiratory tract is important to define the parameters controlling the severity of Covid-19.", "We examined the functional and structural consequences of SARS-CoV-2 infection in a reconstituted human bronchial epithelium model.", "SARSCoV-2 replication caused a transient decrease in epithelial barrier function and disruption of tight junctions, though viral particle crossing remained limited.", "Rather, SARS-CoV-2 replication led to a rapid loss of the ciliary layer, characterized at the ultrastructural level by axoneme loss and misorientation of remaining basal bodies.", "Downregulation of the master regulator of ciliogenesis Foxj1 occurred prior to extensive cilia loss, implicating this transcription factor in the dedifferentiation of ciliated cells.", "Motile cilia functionwas compromised by SARS-CoV-2 infection, as measured in a mucociliary clearance assay.", "Epithelial defense mechanisms, including basal cell mobilization and interferon-lambda induction, ramped up only after the initiation of cilia damage.", "Analysis of SARS-CoV-2 infection in Syrian hamsters further demonstrated the loss of motile cilia in vivo.", "This study identifies cilia damage as a pathogenic mechanism that could facilitate SARS-CoV-2 spread to the deeper lung parenchyma."], "title": "SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance"}
{"doc_id": 143, "abstract": ["Objective: To identify factors predicting symptomatic laboratory-positive SARS-COV-2 reinfection.", "Method: We conducted a nationwide retrospective cohort study and data from 99,993 confirmed cases of COVID-19 were analyzed.", "Results: The overall risk of reinfection (28 or more elapsed days between both episodes onset) was 0.21%, and older subjects and those with mild primary disease were at reduced risk of reinfection.", "Healthcare workers and immunosuppressed or renal patients had at greater risk of SARS-COV-2 reinfection.", "Conclusions: If replicated in other populations, these results may be useful to prioritize efforts focusing on the reduction of SARS-COV-2 spread and the related burden."], "title": "Predictors of symptomatic laboratory-confirmed SARS-COV-2 reinfection"}
{"doc_id": 144, "abstract": ["As new cases of COVID-19 are being confirmed pressure is mounting to increase understanding of the factors underlying the spread the disease.", "Using data on local transmissions until the 23rd of March 2020, we develop an ensemble of 200 ecological niche models to project monthly variation in climate suitability for spread of SARS-CoV-2 throughout a typical climatological year.", "Although cases of COVID-19 are reported all over the world, most outbreaks display a pattern of clustering in relatively cool and dry areas.", "The predecessor SARS-CoV-1 was linked to similar climate conditions.", "Should the spread of SARS CoV-2 continue to follow current trends, asynchronous seasonal global outbreaks could be expected.", "According to the models, temperate warm and cold climates are more favorable to spread of the virus, whereas arid and tropical climates are less favorable.", "However, model uncertainties are still high across much of sub-Saharan Africa, Latin America and South East Asia.", "While models of epidemic spread utilize human demography and mobility as predictors, climate can also help constrain the virus.", "This is because the environment can mediate human-to-human transmission of SARS-CoV-2, and unsuitable climates can cause the virus to destabilize quickly, hence reducing its capacity to become epidemic."], "title": "Spread of SARS-CoV-2 Coronavirus likely to be constrained by climate"}
{"doc_id": 145, "abstract": ["Here we adapt and evaluate a full-face snorkel mask for use as personal protective equipment (PPE) for health care workers, who lack appropriate alternatives during the COVID-19 crisis in the spring of 2020.", "The design (referred to as Pneumask) consists of a custom snorkel-specific adapter that couples the snorkel-port of the mask to a rated filter (either a medical-grade ventilator inline filter or an industrial filter).", "This design has been tested for the sealing capability of the mask, filter performance, CO2 buildup and clinical usability.", "These tests found the Pneumask capable of forming a seal that exceeds the standards required for half-face respirators or N95 respirators.", "Filter testing indicates a range of options with varying performance depending on the quality of filter selected, but with typical filter performance exceeding or comparable to the N95 standard.", "CO2 buildup was found to be roughly equivalent to levels found in half-face elastomeric respirators in literature.", "Clinical usability tests indicate sufficient visibility and, while speaking is somewhat muffled, this can be addressed via amplification (Bluetooth voice relay to cell phone speakers through an app) in noisy environments.", "We present guidance on the assembly, usage (donning and doffing) and decontamination protocols.", "The benefit of the Pneumask as PPE is that it is reusable for longer periods than typical disposable N95 respirators, as the snorkel mask can withstand rigorous decontamination protocols (that are standard to regular elastomeric respirators).", "With the dire worldwide shortage of PPE for medical personnel, our conclusions on the performance and efficacy of Pneumask as an N95-alternative technology are cautiously optimistic."], "title": "Modified full-face snorkel masks as reusable personal protective equipment for hospital personnel"}
{"doc_id": 146, "abstract": ["Individuals can test positive for SARS-CoV-2 by real-time polymerase chain reaction (RT-PCR) after no longer being infectious.1-8 Positive SARS-CoV-2 antigen-based testing exhibits a temporal pattern that corresponds with active, replicating virus and could therefore be a more accurate predictor of an individuals potential to transmit SARS-CoV-2.2,3,9 Using the BD Veritor System for Rapid Detection of SARS-CoV-2 later flow antigen detection test, we demonstrate a higher concordance of antigen-positive test results with the presence of cultured, infectious virus when compared to RT-PCR.", "When compared to infectious virus isolation, the sensitivity of antigen-based testing is similar to RT-PCR.", "The correlation between SARS-CoV-2 antigen and SARS-CoV-2 culture represents a significant advancement in determining the risk for potential transmissibility beyond that which can be achieved by detection of SARS-CoV-2 genomic RNA.", "Coupled with a rapid time-to-result, low cost, and scalability, antigen-based testing should facilitate effective implementation of testing and public health interventions that will better contain COVID-19."], "title": "Antigen-based testing but not real-time PCR correlates with SARS-CoV-2 virus culture"}
{"doc_id": 147, "abstract": ["Respiratory failure in the acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic is hypothesized to be driven by an overreacting innate immune response, where the complement system is a key player.", "In this prospective cohort study of 39 hospitalized coronavirus disease COVID-19 patients, we describe systemic complement activation and its association with development of respiratory failure.", "Clinical data and biological samples were obtained at admission, days 3 to 5, and days 7 to 10.", "Respiratory failure was defined as PO2/FiO2 ratio of &#8804;40 kPa.", "Complement activation products covering the classical/lectin (C4d), alternative (C3bBbP) and common pathway (C3bc, C5a, and sC5b-9), the lectin pathway recognition molecule MBL, and antibody serology were analyzed by enzyme-immunoassays; viral load by PCR.", "Controls comprised healthy blood donors.", "Consistently increased systemic complement activation was observed in the majority of COVID-19 patients during hospital stay.", "At admission, sC5b-9 and C4d were significantly higher in patients with than without respiratory failure (P = 0.008 and P = 0.034).", "Logistic regression showed increasing odds of respiratory failure with sC5b-9 (odds ratio 31.9, 95% CI 1.4 to 746, P = 0.03) and need for oxygen therapy with C4d (11.7, 1.1 to 130, P = 0.045).", "Admission sC5b-9 and C4d correlated significantly to ferritin (r = 0.64, P < 0.001; r = 0.69, P < 0.001).", "C4d, sC5b-9, and C5a correlated with antiviral antibodies, but not with viral load.", "Systemic complement activation is associated with respiratory failure in COVID-19 patients and provides a rationale for investigating complement inhibitors in future clinical trials."], "title": "Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients"}
{"doc_id": 148, "abstract": ["Containment of the COVID-19 pandemic requires reducing viral transmission.", "SARS-CoV-2 infection is initiated by membrane fusion between the viral and host cell membranes, mediated by the viral spike protein.", "We have designed a dimeric lipopeptide fusion inhibitor that blocks this critical first step of infection for emerging coronaviruses and document that it completely prevents SARS-CoV-2 infection in ferrets.", "Daily intranasal administration to ferrets completely prevented SARS-CoV-2 direct-contact transmission during 24-hour co-housing with infected animals, under stringent conditions that resulted in infection of 100% of untreated animals.", "These lipopeptides are highly stable and non-toxic and thus readily translate into a safe and effective intranasal prophylactic approach to reduce transmission of SARS-CoV-2."], "title": "Intranasal fusion inhibitory lipopeptide prevents direct contact SARS-CoV-2 transmission in ferrets"}
{"doc_id": 149, "abstract": ["The ongoing pandemic of COVID-19 alongside the outbreaks of SARS in 2003 and MERS in 2012 underscore the significance to understand betacoronaviruses as a global health challenge.", "SARS-CoV-2, the etiological agent for COVID-19, has infected more than 29 million individuals worldwide with nearly ~1 million fatalities.", "Understanding how SARS-CoV-2 initiates viral pathogenesis is of the utmost importance for development of antiviral drugs.", "Autophagy modulators have emerged as potential therapeutic candidates against SARS-CoV-2 but recent clinical setbacks underline the urgent need for better understanding the mechanism of viral subversion of autophagy.", "Using murine hepatitis virus-A59 (MHV-A59) as a model betacoronavirus, time-course infections revealed a significant loss in the protein level of ULK1, a canonical autophagy regulating serine-threonine kinase, and the concomitant appearance of a possible cleavage fragment.", "To investigate whether virus-encoded proteases target this protein, we conducted in vitro and cellular cleavage assays and identified ULK1 as a novel bona fide substrate of SARS-CoV-2 papain-like protease (PLpro).", "Mutagenesis studies discovered that ULK1 is cleaved at a conserved PLpro recognition sequence (LGGG) after G499, separating its N-terminal kinase domain from the C-terminal substrate recognition region.", "Consistent with this, over-expression of SARS-CoV-2 PLpro is sufficient to impair starvation-induced canonical autophagy and disrupt formation of ULK1-ATG13 complex.", "Finally, we demonstrated a dual role for ULK1 in MHV-A59 replication, serving a pro-viral functions during early replication that is inactivated at late stages of infection.", "In conclusion, our study identified a new mechanism by which PLpro of betacoronaviruses induces viral pathogenesis by targeting cellular autophagic pathway (Word count=250) IMPORTANCE The recent COVID-19 global pandemic alongside the 2003 SARS and 2012 MERS outbreaks underscore an urgent need to better understand betacoronaviruses as pathogens that pose global challenge to human health.", "Studying the underlying biology of how betacoronaviruses subvert innate cellular defense pathways such as autophagy will help to guide future efforts to develop anti-viral therapy.", "(Word count= 55)"], "title": "The papain-like protease of coronaviruses cleaves ULK1 to disrupt host autophagy"}
{"doc_id": 150, "abstract": ["Human coronaviruses are RNA viruses that are sensitive to ultraviolet (UV) radiation.", "Sunlight contains UVA (320-400 nm), UVB (260-320 nm) and UVC (200-260 nm) action spectra.", "UVC can inactivate coronaviruses, including severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).", "The incidence and mortality of coronavirus disease 2019 (COVID-19) are considered to be correlated with vitamin D levels.", "Vitamin D synthesis in human skin is closely related to exposure to UVB radiation.", "Therefore, the incidence and mortality of COVID-19 are also considered to be correlated with Vitamin D levels.", "In this study, Spearman and Kendall rank correlation analysis tests were used to analyze the correlation between the average percent positive of five human coronaviruses (SARS-CoV-2, CoVHKU1, CoVNL63, CoVOC43, and CoV229E) in the U.S. and the corresponding sunlight UV radiation dose The results indicated that the monthly average percent positive of four common coronaviruses was significantly negatively correlated with the sunlight UV radiation dose.", "The weekly percent positive of SARS-CoV-2 during April 17, 2020 to July 10, 2020 showed a significant negative correlation with the sunlight UV radiation dose in census regions 1 and 2 of the U.S. while no statistical significance in the other regions.", "Additionally, sunlight UV radiation also showed some negative effects with respect to the early SARS-CoV-2 transmission."], "title": "Sunlight ultraviolet radiation dose is negatively correlated with the percent positive of SARS-CoV-2 and four other common human coronaviruses in the U.S"}
{"doc_id": 151, "abstract": ["SARS-CoV-2 has resulted in a global pandemic and shutdown economies around the world.", "Sequence analysis indicates that the novel coronavirus (CoV) has an insertion of a furin cleavage site (PRRAR) in its spike protein.", "Absent in other group 2B CoVs, the insertion may be a key factor in the replication and virulence of SARS-CoV-2.", "To explore this question, we generated a SARS-CoV-2 mutant lacking the furin cleavage site (\u0394PRRA) in the spike protein.", "This mutant virus replicated with faster kinetics and improved fitness in Vero E6 cells.", "The mutant virus also had reduced spike protein processing as compared to wild-type SARS-CoV-2.", "In contrast, the \u0394PRRA had reduced replication in Calu3 cells, a human respiratory cell line, and had attenuated disease in a hamster pathogenesis model.", "Despite the reduced disease, the \u0394PRRA mutant offered robust protection from SARS-CoV-2 rechallenge.", "Importantly, plaque reduction neutralization tests (PRNT(50)) with COVID-19 patient sera and monoclonal antibodies against the receptor-binding domain found a shift, with the mutant virus resulting in consistently reduced PRNT(50) titers.", "Together, these results demonstrate a critical role for the furin cleavage site insertion in SARS-CoV-2 replication and pathogenesis.", "In addition, these findings illustrate the importance of this insertion in evaluating neutralization and other downstream SARS-CoV-2 assays."], "title": "Furin Cleavage Site Is Key to SARS-CoV-2 Pathogenesis"}
{"doc_id": 152, "abstract": ["The COVID-19 pandemic has created a public health crisis.", "Because SARS-CoV-2 can spread from individuals with pre-symptomatic, symptomatic, and asymptomatic infections, the re-opening of societies and the control of virus spread will be facilitated by robust surveillance, for which virus testing will often be central.", "After infection, individuals undergo a period of incubation during which viral titers are usually too low to detect, followed by an exponential growth of virus, leading to a peak viral load and infectiousness, and ending with declining viral levels and clearance.", "Given the pattern of viral load kinetics, we model surveillance effectiveness considering test sensitivities, frequency, and sample-to-answer reporting time.", "These results demonstrate that effective surveillance, including time to first detection and outbreak control, depends largely on frequency of testing and the speed of reporting, and is only marginally improved by high test sensitivity.", "We therefore conclude that surveillance should prioritize accessibility, frequency, and sample-to-answer time; analytical limits of detection should be secondary."], "title": "Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance"}
{"doc_id": 153, "abstract": ["The rising threat of pandemic viruses, such as SARS-CoV-2, requires development of new preclinical discovery platforms that can more rapidly identify therapeutics that are active in vitro and also translate in vivo.", "Here we show that human organ-on-a-chip (Organ Chip) microfluidic culture devices lined by highly differentiated human primary lung airway epithelium and endothelium can be used to model virus entry, replication, strain-dependent virulence, host cytokine production, and recruitment of circulating immune cells in response to infection by respiratory viruses with great pandemic potential.", "We provide a first demonstration of drug repurposing by using oseltamivir in influenza A virus-infected organ chip cultures and show that co-administration of the approved anticoagulant drug, nafamostat, can double oseltamivir\u2019s therapeutic time window.", "With the emergence of the COVID-19 pandemic, the Airway Chips were used to assess the inhibitory activities of approved drugs that showed inhibition in traditional cell culture assays only to find that most failed when tested in the Organ Chip platform.", "When administered in human Airway Chips under flow at a clinically relevant dose, one drug \u2013 amodiaquine-significantly inhibited infection by a pseudotyped SARS-CoV-2 virus.", "Proof of concept was provided by showing that amodiaquine and its active metabolite (desethylamodiaquine) also significantly reduce viral load in both direct infection and animal-to-animal transmission models of native SARS-CoV-2 infection in hamsters.", "These data highlight the value of Organ Chip technology as a more stringent and physiologically relevant platform for drug repurposing, and suggest that amodiaquine should be considered for future clinical testing."], "title": "Human organ chip-enabled pipeline to rapidly repurpose therapeutics during viral pandemics"}
{"doc_id": 154, "abstract": ["BACKGROUND: An unbiased approach to SARS-CoV-2-induced immune dysregulation has not been undertaken so far.", "We aimed to identify previously unreported immune markers able to discriminate COVID-19 patients from healthy controls and to predict mild and severe disease.", "METHODS: An observational, prospective, multicentric study was conducted in patients with confirmed mild/moderate (n = 7) and severe (n = 19) COVID-19.", "Immunophenotyping of whole-blood leukocytes was performed in patients upon hospital ward or intensive care unit admission and in healthy controls (n = 25).", "Clinically relevant associations were identified through unsupervised analysis.", "RESULTS: Granulocytic (neutrophil, eosinophil, and basophil) markers were enriched during COVID-19 and discriminated between patients with mild and severe disease.", "Increased counts of CD15+CD16+ neutrophils, decreased granulocytic expression of integrin CD11b, and Th2-related CRTH2 downregulation in eosinophils and basophils established a COVID-19 signature.", "Severity was associated with emergence of PD-L1 checkpoint expression in basophils and eosinophils.", "This granulocytic signature was accompanied by monocyte and lymphocyte immunoparalysis.", "Correlation with validated clinical scores supported pathophysiological relevance.", "CONCLUSIONS: Phenotypic markers of circulating granulocytes are strong discriminators between infected and uninfected individuals as well as between severity stages.", "COVID-19 alters the frequency and functional phenotypes of granulocyte subsets with emergence of CRTH2 as a disease biomarker."], "title": "A Granulocytic Signature Identifies COVID-19 and Its Severity"}
{"doc_id": 155, "abstract": ["Nearly every country is now combating the 2019 novel coronavirus (COVID-19).", "It has been hypothesized that if COVID-19 exhibits seasonality, changing temperatures in the coming months will shift transmission patterns around the world.", "Such projections, however, require an estimate of the relationship between COVID-19 and temperature at a global scale, and one that isolates the role of temperature from confounding factors, such as public health capacity.", "This paper provides the first plausibly causal estimates of the relationship between COVID-19 transmission and local temperature using a global sample comprising of 166,686 confirmed new COVID-19 cases from 134 countries from January 22, 2020 to March 15, 2020.", "We find robust statistical evidence that a 1\u00b0C increase in local temperature reduces transmission by 13% [-21%,-4%, 95%CI].", "In contrast, we do not find that specific humidity or precipitation influence transmission.", "Our statistical approach separates effects of climate variation on COVID-19 transmission from other potentially correlated factors, such as differences in public health responses across countries and heterogeneous population densities.", "Using constructions of expected seasonal temperatures, we project that changing temperatures between March 2020 and July 2020 will cause COVID-19 transmission to fall by 43% on average for Northern Hemisphere countries and to rise by 71% on average for Southern Hemisphere countries.", "However, these patterns reverse as the boreal winter approaches, with seasonal temperatures in January 2021 increasing average COVID-19 transmission by 59% relative to March 2020 in northern countries and lowering transmission by 2% in southern countries.", "These findings suggest that Southern Hemisphere countries should expect greater transmission in the coming months.", "Moreover, Northern Hemisphere countries face a crucial window of opportunity: if contagion-containing policy interventions can dramatically reduce COVID-19 cases with the aid of the approaching warmer months, it may be possible to avoid a second wave of COVID-19 next winter."], "title": "Causal empirical estimates suggest COVID-19 transmission rates are highly seasonal"}
{"doc_id": 156, "abstract": ["Extracellular vesicles (EVs) emerge as essential mediators of intercellular communication.", "DNA vaccines encoding antigens presented on EVs efficiently induce T-cell responses and EV-based vaccines containing the Spike (S) proteins of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) are highly immunogenic in mice.", "Thus, EVs may serve as vaccine platforms against emerging diseases, going beyond traditional strategies, with the antigen displayed identically to the original protein embedded in the viral membrane and presented as such to the immune system.", "Compared to their viral and pseudotyped counterparts, EV-based vaccines overcome many safety issues including pre-existing immunity against these vectors.", "Here, we applied our technology in natural EV\u2019s engineering, to express the S proteins of SARS-CoV-2 embedded in the EVs, which mimic the virus with its fully native spikes.", "Immunizations with a two component CoVEVax vaccine, comprising DNA vector (DNAS-EV) primes, allowing in situ production of Spike harbouring EVs, and a boost using S-EVs produced in mammalian cells, trigger potent neutralizing and cellular responses in mice, in the absence of any adjuvants.", "CoVEVax would be the prototype of vaccines, where the sole exchange of the envelope proteins on EVs leads to the generation of new vaccine candidates against emerging viruses."], "title": "Extracellular vesicle-based vaccine platform displaying native viral envelope proteins elicits a robust anti-SARS-CoV-2 response in mice"}
{"doc_id": 157, "abstract": ["Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), enters the host cells through two main pathways, both involving key interactions between viral envelope-anchored spike glycoprotein of the novel coronavirus and the host receptor, angiotensin-converting enzyme 2 (ACE2).", "To date, SARS-CoV-2 has infected up to 26 million people worldwide; yet, there is no clinically approved drug or vaccine available.", "Therefore, a rapid and coordinated effort to re-purpose clinically approved drugs that prevent or disrupt these critical entry pathways of SARS-CoV-2 spike glycoprotein interaction with human ACE2, could potentially accelerate the identification and clinical advancement of prophylactic and/or treatment options against COVID-19, thus providing possible countermeasures against viral entry, pathogenesis and survival.", "Herein, we discovered that Ambroxol hydrochloride (AMB), and its progenitor, Bromhexine hydrochloride (BHH), both clinically approved drugs are potent effective modulators of the key interaction between the receptor binding domain (RBD) of SARS-CoV-2 spike protein and human ACE2.", "We also found that both compounds inhibited SARS-CoV-2 infection-induced cytopathic effect at micromolar concentrations.", "Therefore, in addition to the known TMPRSS2 activity of BHH; we report for the first time that the BHH and AMB pharmacophore has the capacity to target and modulate yet another key protein-protein interaction essential for the two known SARS-CoV-2 entry pathways into host cells.", "Altogether, the potent efficacy, excellent safety and pharmacologic profile of both drugs along with their affordability and availability, makes them promising candidates for drug repurposing as possible prophylactic and/or treatment options against SARS-CoV-2 infection."], "title": "Ambroxol Hydrochloride Inhibits the Interaction between Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein\u2019s Receptor Binding Domain and Recombinant Human ACE2"}
{"doc_id": 158, "abstract": ["The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects millions of people and killed hundred-thousands of individuals.", "While acute and intermediate interactions between SARS-CoV-2 and the immune system have been studied extensively, long-term impacts on the cellular immune system remained to be analyzed.", "Here, we comprehensively characterized immunological changes in peripheral blood mononuclear cells in 49 COVID-19 convalescent individuals (CI) in comparison to 27 matched SARS-CoV-2 unexposed individuals (UI).", "Despite recovery from the disease for more than 2 months, CI showed significant decreases in frequencies of invariant NKT and NKT-like cells compared to UI.", "Concomitant with the decrease in NKT-like cells, an increase in the percentage of Annexin V and 7-AAD double positive NKT-like cells was detected, suggesting that the reduction in NKT-like cells results from cell death months after recovery.", "Significant increases in regulatory T cell frequencies, TIM-3 expression on CD4 and CD8 T cells, as well as PD-L1 expression on B cells were also observed in CI, while the cytotoxic potential of T cells and NKT-like cells, defined by GzmB expression, was significantly diminished.", "However, both CD4 and CD8 T cells of CI showed increased Ki67 expression and were fully capable to proliferate and produce effector cytokines upon TCR stimulation.", "Collectively, we provide the first comprehensive characterization of immune signatures in patients recovering from SARS-CoV-2 infection, suggesting that the cellular immune system of COVID-19 patients is still under a sustained influence even months after the recovery from disease."], "title": "The analysis of the long-term impact of SARS-CoV-2 on the cellular immune system in individuals recovering from COVID-19 reveals a profound NKT cell impairment"}
{"doc_id": 159, "abstract": ["An outbreak of the novel coronavirus SARS-CoV-2, the causative agent of Coronavirus Disease-2019 (COVID-19), a respiratory disease, has infected over 34,000,000 people since the end of 2019, killed over 1,000,000, and caused worldwide social and economic disruption.", "Due to the mechanisms of SARS-CoV-2 infection to host cells and its pathogenesis remain largely unclear, there are currently no antiviral drugs with proven efficacy nor are there vaccines for its prevention.", "Besides severe respiratory and systematic symptoms, several comorbidities may also increase risk of fatal disease outcome.", "Therefore, it is required to investigate the impacts of COVID-19 on pre-existing diseases of patients, such as cancer and other infectious diseases.", "In the current study, we have reported that SARS-CoV-2 encoded proteins and some anti-COVID-19 drugs currently used are able to induce lytic reactivation of Kaposi\u2019s sarcoma-associated herpesvirus (KSHV), one of major human oncogenic viruses through manipulation of intracellular signaling pathways.", "Our data indicate that those KSHV+ patients especially in endemic areas exposure to COVID-19 or undergoing the treatment may have increased risks to develop virus-associated cancers, even after they have fully recovered from COVID-19."], "title": "SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus"}
{"doc_id": 160, "abstract": ["The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has dramatically expedited global vaccine development efforts1-3, most targeting the viral 'spike' glycoprotein (S).", "S localizes on the virion surface and mediates recognition of cellular receptor angiotensin-converting enzyme 2 (ACE2)4-6.", "Eliciting neutralizing antibodies that block S-ACE2 interaction7-9, or indirectly prevent membrane fusion10, constitute an attractive modality for vaccine-elicited protection11.", "However, although prototypic S-based vaccines show promise in animal models12-14, the immunogenic properties of S in humans are poorly resolved.", "In this study, we characterized humoral and circulating follicular helper T cell (cTFH) immunity against spike in recovered patients with coronavirus disease 2019 (COVID-19).", "We found that S-specific antibodies, memory B cells and cTFH are consistently elicited after SARS-CoV-2 infection, demarking robust humoral immunity and positively associated with plasma neutralizing activity.", "Comparatively low frequencies of B cells or cTFH specific for the receptor binding domain of S were elicited.", "Notably, the phenotype of S-specific cTFH differentiated subjects with potent neutralizing responses, providing a potential biomarker of potency for S-based vaccines entering the clinic.", "Overall, although patients who recovered from COVID-19 displayed multiple hallmarks of effective immune recognition of S, the wide spectrum of neutralizing activity observed suggests that vaccines might require strategies to selectively target the most potent neutralizing epitopes."], "title": "Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19."}
{"doc_id": 161, "abstract": ["Background Some experts recently reported that SARS-CoV-2 lethality decreased considerably, but no evidence is yet available.", "This retrospective cohort study aimed to evaluate whether SARS-CoV-2 case-fatality rate decreased with time, adjusting for main potential confounders.", "Methods and findings We included all SARS-CoV-2 infected subjects diagnosed in Ferrara and Pescara provinces, Italy.", "Information were collected from local registries, clinical charts, and electronic health records.", "We compared the case-fatality rate of the subjects diagnosed during April and March, 2020.", "We used Cox proportional hazards analysis and random-effect logistic regression, adjusting for age, gender, hypertension, type II diabetes, major cardiovascular diseases (CVD), chronic obstructive pulmonary diseases (COPD), cancer and renal disease.", "The sample included 1946 subjects (mean age 58.8y; 45.7% males).", "177 persons deceased, after a mean of 11.7 days of follow-up.", "From March to April, the case-fatality rate significantly decreased in the total sample (10.8% versus 6.0%; p<0.001), and in any subgroup of patients.", "Large reductions of the lethality were observed among the elderly (from 30.0% to 13.4%), and subjects with hypertension (23.0% to 12.1%), diabetes (30.3% to 8.4%), CVD (31.5% to 12.1%), COPD (29.7% to 11.4%), and renal disease (32.3% to 11.5%).", "In April, the adjusted hazard ratio of death was 0.42 (95% Confidence Interval: 0.29-0.60).", "The mean age of those who died substantially increased from March (77.9y) to April (86.9y).", "Conclusions In this sample, SARS-CoV-2 case-fatality rate decreased considerably over time, supporting recent claims of a substantial improvement of SARS-CoV-2 clinical management.", "The findings are inevitably preliminary and require confirmation."], "title": "SARS-CoV-2 lethality decreased over time in two Italian Provinces"}
{"doc_id": 162, "abstract": ["Identification of risk factors for contracting and developing serious illness following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is of paramount interest.", "Here, we performed a retrospective cohort analysis of all Danish individuals tested for SARS-CoV-2 between 27 February 2020 and 30 July 2020, with a known ABO and RhD blood group, to determine the influence of common blood groups on virus susceptibility.", "Distribution of blood groups was compared with data from nontested individuals.", "Participants (29% of whom were male) included 473 654 individuals tested for SARS-CoV-2 using real-time polymerase chain reaction (7422 positive and 466 232 negative) and 2 204 742 nontested individuals, accounting for \u00e2\u0088\u00bc38% of the total Danish population.", "Hospitalization and death from COVID-19, age, cardiovascular comorbidities, and job status were also collected for confirmed infected cases.", "ABO blood groups varied significantly between patients and the reference group, with only 38.41% (95% confidence interval [CI], 37.30-39.50) of the patients belonging to blood group O compared with 41.70% (95% CI, 41.60-41.80) in the controls, corresponding to a relative risk of 0.87 (95% CI, 0.83-0.91) for acquiring COVID-19.", "This study identifies ABO blood group as a risk factor for SARS-CoV-2 infection but not for hospitalization or death from COVID-19."], "title": "Reduced prevalence of SARS-CoV-2 infection in ABO blood group O"}
{"doc_id": 163, "abstract": ["The SARS-CoV-2 pandemic currently prevails worldwide.", "To understand the immunological signature of SARS-CoV-2 infections and aid the search for treatments and vaccines, comprehensive characterization of adaptive immune responses towards SARS-CoV-2 is needed.", "We investigated the breadth and potency of antibody-, and T-cell immune responses, in 203 recovered SARS-CoV-2 infected patients who presented with asymptomatic to severe infections.", "We report very broad serological profiles with cross-reactivity to other human coronaviruses.", "Further, >99% had SARS-CoV-2 epitope specific antibodies, with SARS-CoV-2 neutralization and spike-ACE2 receptor interaction blocking observed in 95% of individuals.", "A significant positive correlation between spike-ACE2 blocking antibody titers and neutralization potency was observed.", "SARS-CoV-2 specific CD8+ T-cell responses were clear and quantifiable in 90% of HLA-A2+ individuals.", "The viral surface spike protein was identified as the dominant target for both neutralizing antibodies and CD8+ T cell responses.", "Overall, the majority of patients had robust adaptive immune responses, regardless of disease severity.", "Author summary SARS-CoV-2 can cause severe and deadly infections.", "However, the immunological understanding of this viral infection is limited.", "Currently, several vaccines are being developed to help limit transmission and prevent the current pandemic.", "However, basic understanding of the adaptive immune response developed during SARS-CoV-2 infections is needed to inform further vaccine development and to understand the protective properties of the developed immune response.", "We investigated, the adaptive immune response developed during SARS-CoV-2 infections in recovered patients experiencing a full spectrum of disease severity, from asymptomatic infections to severe cases requiring hospitalization.", "We used a novel multiplex serological platform, cell-based neutralization assays and dextramer flow cytometry assays to characterize a broad and robust humoral and cellular immune response towards SARS-CoV-2.", "We found that the vast majority of recovered individuals have clear detectable and functional SARS-CoV-2 spike specific adaptive immune responses, despite diverse disease severities.", "The detection of both a humoral and cellular functional spike specific immune response in the vast majority of the individuals, irrespective of asymptomatic manifestations, supports vaccine designs currently underway, and encourages further exploration of whether primary infections provide protection to reinfection."], "title": "SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity"}
{"doc_id": 164, "abstract": ["SARS-CoV-2 infection causes severe symptoms in a subset of patients, suggesting the presence of certain unknown risk factors.", "Although antibodies against the receptor-binding domain (RBD) of the SARS-CoV-2 spike have been shown prevent SARS-CoV-2 infection, the effects of antibodies against other spike protein domains are largely unknown.", "Here, we screened a series of anti-spike monoclonal antibodies from COVID-19 patients, and found that some of antibodies against the N-terminal domain (NTD) dramatically enhanced the binding capacity of the spike protein to ACE2, and thus increased SARS-CoV2 infectivity.", "Surprisingly, mutational analysis revealed that all the infectivity-enhancing antibodies recognized a specific site on the surface of the NTD.", "The antibodies against this infectivity-enhancing site were detected in all samples of hospitalized COVID-19 patients in the study.", "However, the ratio of infectivity-enhancing antibodies to neutralizing antibodies differed among patients.", "Furthermore, the antibodies against the infectivity-enhancing site were detected in 3 out of 48 uninfected donors, albeit at low levels.", "These findings suggest that the production of antibodies against SARS-CoV-2 infectivity-enhancing site could be considered as a possible exacerbating factors for COVID-19 and that a spike protein lacking such antibody epitopes may be required for safe vaccine development, especially for individuals with pre-existing enhancing antibodies."], "title": "An infectivity-enhancing site on the SARS-CoV-2 spike protein is targeted by COVID-19 patient antibodies"}
{"doc_id": 165, "abstract": ["Coronaviruses are enveloped, positive-stranded RNA viruses with a genome of approximately 30 kb.", "Based on genetic similarities, coronaviruses are classified into three groups.", "Two group 2 coronaviruses, human coronavirus OC43 (HCoV-OC43) and bovine coronavirus (BCoV), show remarkable antigenic and genetic similarities.", "In this study, we report the first complete genome sequence (30,738 nucleotides) of the prototype HCoV-OC43 strain (ATCC VR759).", "Complete genome and open reading frame (ORF) analyses were performed in comparison to the BCoV genome.", "In the region between the spike and membrane protein genes, a 290-nucleotide deletion is present, corresponding to the absence of BCoV ORFs ns4.9 and ns4.8.", "Nucleotide and amino acid similarity percentages were determined for the major HCoV-OC43 ORFs and for those of other group 2 coronaviruses.", "The highest degree of similarity is demonstrated between HCoV-OC43 and BCoV in all ORFs with the exception of the E gene.", "Molecular clock analysis of the spike gene sequences of BCoV and HCoV-OC43 suggests a relatively recent zoonotic transmission event and dates their most recent common ancestor to around 1890.", "An evolutionary rate in the order of 4 x 10(-4) nucleotide changes per site per year was estimated.", "This is the first animal-human zoonotic pair of coronaviruses that can be analyzed in order to gain insights into the processes of adaptation of a nonhuman coronavirus to a human host, which is important for understanding the interspecies transmission events that led to the origin of the severe acute respiratory syndrome outbreak."], "title": "Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event."}
{"doc_id": 166, "abstract": ["Plenty of serologic tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been developed so far, thus documenting the importance of evaluating the relevant features of the immune response to this viral agent.", "The performance of these assays is currently under investigation.", "Amongst them, LIAISON\u00ae SARS-CoV-2 S1/S2 IgG by DiaSorin and Elecsys Anti-SARS-CoV-2 cobas\u00ae by Roche are currently used by laboratory medicine hospital departments in Italy and many other countries.", "In the present study, we firstly compared two serologic tests on serum samples collected at two different time points from 46 laboratory-confirmed coronavirus disease-2019 (COVID-19) subjects.", "Secondly, 85 negative serum samples collected before the SARS-CoV-2 pandemic were analyzed.", "Thirdly, possible correlations between antibody levels and the resulting neutralizing activity against a clinical isolate of SARS-CoV-2 were evaluated.", "Results revealed that both tests are endowed with low sensitivity on the day of hospital admission, which increased to 97.8% and 100% for samples collected after 15 days for DiaSorin and Roche tests, respectively.", "The specificity evaluated for the two tests ranges from 96.5% to 100%, respectively.", "Importantly, a poor direct correlation between antibody titers and neutralizing activity levels was evidenced in the present study.", "These data further shed light on both potentials and possible limitations related to SARS-CoV-2 serology.", "In this context, great efforts are still necessary for investigating antibody kinetics to develop novel diagnostic algorithms.", "Moreover, further investigations on the role of neutralizing antibodies and their correlate of protection will be of paramount importance for the development of effective vaccines."], "title": "Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects"}
{"doc_id": 167, "abstract": ["Vitamin D deficiency, which impedes good immune function, is common during winter and spring in regions of high latitude.", "There is good evidence that vitamin D deficiency contributes to the seasonal increase of virus infections of the respiratory tract, from the common cold to influenza, and now possibly also COVID-19.", "This communication explores key factors that make it more likely, particularly in combination, that individuals are vitamin D deficient.", "These factors include old age, obesity, dark skin tone and common genetic variants that impede vitamin D status.", "Precision nutrition is an approach that aims to consider known personal risk factors and health circumstances to provide more effective nutrition guidance in health and disease.", "In regard to avoiding vitamin D deficiency, people with excess body fat, a dark skin tone or older age usually need to use a moderately dosed daily vitamin D supplement, particularly those living in a high-latitude region, getting little ultraviolet B exposure due to air pollution or staying mostly indoors.", "Carriers of the GC (group-specific component) rs4588 AA genotype also are more likely to become deficient.", "Very high-dosed supplements with more than 4000 IU vitamin D are rarely needed or justified.", "A state-by-state Mendelian randomisation analysis of excess COVID-19 mortality of African-Americans in the USA shows a greater disparity in northern states than in southern states.", "It is conceivable that vitamin D adequacy denies the virus easy footholds and thereby slows spreading of the contagion.", "This finding should drive home the message that vitamin D supplementation is particularly important for individuals with dark skin tones.", "Vitamin D deficiency, even for a few months during the winter and spring season, must be rigorously remedied because of its many adverse health impacts that include decreased life expectancy and increased mortality.", "Slowing the spread of COVID-19 would be an added bonus."], "title": "Avoidance of vitamin D deficiency to slow the COVID-19 pandemic"}
{"doc_id": 168, "abstract": ["A method is described for enabling safe transit of denatured virus samples for polymerase chain reaction (PCR) identification without the risk of unwanted viable viruses.", "Cotton swabs dipped in avian infectious bronchitis virus (IBV) or avian pneumovirus (APV) were allowed to dry.", "Newcastle disease virus and avian influenza viruses were used as controls.", "Autoclaving and microwave treatment for as little as 20 sec destroyed the infectivity of all four viruses.", "However, both IBV and APV could be detected by reverse transcriptase (RT)-PCR after autoclaving and as long as 5 min microwave treatment (Newcastle disease virus and avian influenza viruses were not tested).", "Double microwave treatment of IBV and APV with an interval of 2 to 7 days between was tested.", "After the second treatment, RT-PCR products were readily detected in all samples.", "Swabs from the tracheas and cloacas of chicks infected with IBV shown to contain infectious virus were microwaved.", "Swabs from both sources were positive by RT-PCR.", "Microwave treatment appears to be a satisfactory method of inactivating virus while preserving nucleic acid for PCR identification."], "title": "Microwave or autoclave treatments destroy the infectivity of infectious bronchitis virus and avian pneumovirus but allow detection by reverse transcriptase-polymerase chain reaction."}
{"doc_id": 169, "abstract": ["Objectives: The role of innate lymphoid cells (ILCs) in coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is unknown.", "Understanding the immune response in COVID-19 could contribute to unravel the pathogenesis and identification of treatment targets.", "To describe the phenotypic landscape of circulating ILCs in COVID-19 patients and to identify ILC phenotypes correlated to serum biomarkers, clinical markers, and laboratory parameters relevant in COVID-19.", "Methods: Blood samples collected from moderately (n=11) and severely ill (n=12) COVID-19 patients as well as healthy control donors (n=16), were analyzed with 18-parameter flow cytometry.", "Using supervised and unsupervised approaches, we examined the ILC activation status and homing profile.", "Clinical and laboratory parameters were obtained from all COVID-19 patients and serum biomarkers were analyzed with multiplex immunoassays.", "Results: ILCs were largely depleted from the circulation of COVID-19 patients compared with healthy controls.", "Remaining circulating ILCs from patients revealed increased frequencies of ILC2 in moderate COVID-19, with a concomitant decrease of ILC precursors (ILCp), as compared with controls.", "ILC2 and ILCp showed an activated phenotype with increased CD69 expression, whereas expression levels of the chemokine receptors CXCR3 and CCR4 were significantly altered in ILC2 and ILCp, and ILC1, respectively.", "The activated ILC profile of COVID-19 patients was associated with soluble inflammatory markers, while frequencies of ILC subsets were correlated with laboratory parameters that reflect the disease severity.", "Conclusion: This study provides insights into the potential role of ILCs in immune responses against SARS-CoV-2, particularly linked to the severity of COVID-19."], "title": "Innate lymphoid cell composition associates with COVID-19 disease severity"}
{"doc_id": 170, "abstract": ["The COVID-19 pandemic has caused significant morbidity and mortality.", "Currently, there is a critical shortage of proven treatment options and an urgent need to understand the pathogenesis of multi-organ failure and lung damage.", "Cytokine storm is associated with severe inflammation and organ damage during COVID-19.", "However, a detailed molecular pathway defining this cytokine storm is lacking, and gaining mechanistic understanding of how SARS-CoV-2 elicits a hyperactive inflammatory response is critical to develop effective therapeutics.", "Of the multiple inflammatory cytokines produced by innate immune cells during SARS-CoV-2 infection, we found that the combined production of TNF-\u03b1 and IFN-\u03b3 specifically induced inflammatory cell death, PANoptosis, characterized by gasdermin\u2013mediated pyroptosis, caspase-8\u2013mediated apoptosis, and MLKL\u2013mediated necroptosis.", "Deletion of pyroptosis, apoptosis, or necroptosis mediators individually was not sufficient to protect against cell death.", "However, cells deficient in both RIPK3 and caspase-8 or RIPK3 and FADD were resistant to this cell death.", "Mechanistically, the STAT1/IRF1 axis activated by TNF-\u03b1 and IFN-\u03b3 co-treatment induced iNOS for the production of nitric oxide.", "Pharmacological and genetic deletion of this pathway inhibited pyroptosis, apoptosis, and necroptosis in macrophages.", "Moreover, inhibition of PANoptosis protected mice from TNF-\u03b1 and IFN-\u03b3\u2013induced lethal cytokine shock that mirrors the pathological symptoms of COVID-19.", "In vivo neutralization of both TNF-\u03b1 and IFN-\u03b3 in multiple disease models associated with cytokine storm showed that this treatment provided substantial protection against not only SARS-CoV-2 infection, but also sepsis, hemophagocytic lymphohistiocytosis, and cytokine shock models, demonstrating the broad physiological relevance of this mechanism.", "Collectively, our findings reveal that blocking the COVID-19 cytokine-mediated inflammatory cell death signaling pathway identified in this study may benefit patients with COVID-19 or other cytokine storm-driven syndromes by limiting inflammation and tissue damage.", "The findings also provide a molecular and mechanistic description for the term cytokine storm.", "Additionally, these results open new avenues for the treatment of other infectious and autoinflammatory diseases and cancers where TNF-\u03b1 and IFN-\u03b3 synergism play key pathological roles."], "title": "COVID-19 cytokines and the hyperactive immune response: Synergism of TNF-\u03b1 and IFN-\u03b3 in triggering inflammation, tissue damage, and death"}
{"doc_id": 171, "abstract": ["The upcoming flu season in the northern hemisphere merging with the current COVID-19 pandemic raises a potentially severe threat to public health.", "Through experimental co-infection of IAV with either pseudotyped or SARS-CoV-2 live virus, we found that IAV pre-infection significantly promoted the infectivity of SARS-CoV-2 in a broad range of cell types.", "Remarkably, increased SARS-CoV-2 viral load and more severe lung damage were observed in mice co-infected with IAV in vivo.", "Moreover, such enhancement of SARS-CoV-2 infectivity was not seen with several other viruses probably due to a unique IAV segment as an inducer to elevate ACE2 expression.", "This study illustrates that IAV has a special nature to aggravate SARS-CoV-2 infection, and prevention of IAV is of great significance during the COVID-19 pandemic."], "title": "Co-infection of influenza A virus enhances SARS-CoV-2 infectivity"}
{"doc_id": 172, "abstract": ["BACKGROUND Conspiracy theories about the origins of COVID-19 are widespread and have even been propagated by highly ranked state officials and politicians in the US.", "Health authorities have cautioned that such theories, although not questioning the existence of the pandemic, may increase the spread of the virus by reducing people's efforts to socially distance.", "METHODS We test this proposition empirically using longitudinal survey data collected at five timepoints during the early outbreak of the virus in the US (N = 403).", "RESULTS Multivariate growth curve analyses showed that, although conspiracy beliefs decreased and social distancing increased over time, people holding more conspiracy beliefs at the beginning of the pandemic showed the lowest increase in social distancing.", "Moreover, cross-lagged analyses demonstrated that people who reported more conspiracy beliefs at any wave tended to report less social distancing at the following wave.", "CONCLUSIONS Our findings show that COVID-19 conspiracy theories pose a significant threat to public health as they may reduce adherence to social distancing measures."], "title": "Belief in COVID-19 Conspiracy Theories Reduces Social Distancing over Time."}
{"doc_id": 173, "abstract": ["Anti-inflammatory therapies such as IL-6 inhibition have been proposed for COVID-19 in a vacuum of evidence-based treatment.", "However, abrogating the inflammatory response in infectious diseases may impair a desired host response and predispose to secondary infection.", "To determine whether IL-6 inhibition is associated with an increased occurrence of secondary infections in patients admitted to the intensive care unit (ICU).", "We retrospectively reviewed the medical record of patients during an 8-week span and compared the incidence of secondary infection in patients who did and did not receive tocilizumab.", "The study was approved by the IRB.", "Additionally, we included representative histopathologic post-mortem findings from several COVID-19 cases that underwent autopsy at our institution.", "The study was conducted in a cohorted COVID-19 ICU at a tertiary care university medical center.", "Patients 18 years of age or older admitted to the adult COVID-19 intensive care unit with COVID-19 were randomly selected.", "We reviewed the occurrence and nature of secondary infections and clinical outcomes in patients who did and did not receive tocilizumab.", "Measures were formulated prior to the study.", "For autopsy findings, we were interested in the lung pathology.", "60 patients were selected of which 28 had received tocilizumab while 32 had not.", "Receiving tocilizumab was associated with a higher risk of secondary bacterial (64.3% vs. 31.3%, p=0.010) and fungal (7.1% vs. 0%, p=0.096) infections.", "7 cases underwent autopsy.", "In 3 cases, tocilizumab had previously been given.", "All 3 patients demonstrated evidence of pneumonia on pathology.", "Of the 4 cases that had not been given tocilizumab, 2 showed evidence of aspiration pneumonia and 2 exhibited diffuse alveolar damage.", "Experimental therapies are currently being applied to COVID-19 outside of clinical trials.", "Anti-inflammatory therapies such as anti-IL-6 therapy have the potential to impair viral clearance, predispose to secondary infection, and cause harm.", "We seek to raise physician awareness of these issues and highlight the need to better understand the immune response in COVID-19."], "title": "IL6 inhibition in critically ill COVID-19 patients is associated with increased secondary infections"}
{"doc_id": 174, "abstract": ["BackgroundThere is always an uncertainty of epidemiological, serological infectivity and virulence of the emerging novel coronavirus.", "Antibody test can be used for assessing whether immunity has developed in the infected person after 5-7 days of illness and understand cumulative exposure levels to the infection, make inferences on the actual burden of infection, its geographical spread, effect on specific demographic/risk groups, gaps in testing and infection fatality rates.", "ObjectiveTo estimate and compare the sero-prevalence, hidden prevalence and determine the demographic risk factors associated with SARS-CoV-2 infection among adults in three largest cities of Odisha, India.", "MethodologyThis was a population based cross sectional serological survey carried out in August 2020 in the three largest cities of the state of Odisha.", "Sample size per city was estimated to be 1500 and participants were enrolled from the community using multi-stage random sampling from 25 clusters from each city.", "Data was collected using ODK based tools by household visits and 3-4 ml of blood samples were collected after informed consent.", "Samples were transported to testing lab where Serum was separated and tested for anti-SARS CoV-2 antibodies using automated CLIA platform.", "Statistical analysis was done using R-software packages.", "ResultsA total of 4146 participants from the 3 cities of Bhubaneswar (BBS), Berhampur (BAM) and Rourkela (RKL) participated.", "A total of 5635 households were approached and the average non response rate in the community was 17.4%.", "The gender weighted seroprevalence across the three cities was 20.78% (95% CI: 19.56%-22.05%).", "Seroprevalence was highest in BAM at 31.14% (95% CI: 28.69-33.66%) followed by 24.59% (95% CI: 22.39-26.88%) in RKL and 5.24% (95% CI: 4.10-6.58%) in BBS.", "While females reported a higher seroprevalence (22.8%) as compared to males (18.8%), there was no significant difference in seroprevalence across age groups.", "A majority of the seropositive participants were asymptomatic (93.87%).", "Among those who reported symptoms, the most common symptom was fever (68.89%) followed by cough (46.06%) and myalgia (32.67%).", "The case to infection ratio on the date of serosurvey was 1: 6.6 in BBS, 1:61 in BAM and 1:29.8 in RKL.", "ConclusionThe study found a high seroprevalence against COVID-19 in urban Odisha as well as high numbers of asymptomatic infections."], "title": "Findings from serological surveys (in August 2020) to assess the exposure of adult population to SARS Cov-2 infection in three cities of Odisha, India"}
{"doc_id": 175, "abstract": ["COVID-19 caused by SARS-CoV-2 has become a global pandemic requiring the development of interventions for the prevention or treatment to curtail mortality and morbidity.", "No vaccine to boost mucosal immunity, or as a therapeutic, has yet been developed to SARS-CoV-2.", "In this study, we discover and characterize a cross-reactive human IgA monoclonal antibody, MAb362.", "MAb362 binds to both SARS-CoV and SARS-CoV-2 spike proteins and competitively blocks ACE2 receptor binding, by overlapping the ACE2 structural binding epitope.", "Furthermore, MAb362 IgA neutralizes both pseudotyped SARS-CoV and SARS-CoV-2 in 293 cells expressing ACE2.", "When converted to secretory IgA, MAb326 also neutralizes authentic SARS-CoV-2 virus while the IgG isotype shows no neutralization.", "Our results suggest that SARS-CoV-2 specific IgA antibodies, such as MAb362, may provide effective immunity against SARS-CoV-2 by inducing mucosal immunity within the respiratory system, a potentially critical feature of an effective vaccine."], "title": "A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction"}
{"doc_id": 176, "abstract": ["Viruses are a constant threat to global health as highlighted by the current COVID-19 pandemic.", "Currently, lack of data underlying how the human host interacts with viruses, including the SARS-CoV-2 virus, limits effective therapeutic intervention.", "We introduce Viral-Track, a computational method that globally scans unmapped single-cell RNA sequencing (scRNA-seq) data for the presence of viral RNA, enabling transcriptional cell sorting of infected versus bystander cells.", "We demonstrate the sensitivity and specificity of Viral-Track to systematically detect viruses from multiple models of infection, including hepatitis B virus, in an unsupervised manner.", "Applying Viral-Track to bronchoalveloar-lavage samples from severe and mild COVID-19 patients reveals a dramatic impact of the virus on the immune system of severe patients compared to mild cases.", "Viral-Track detects an unexpected co-infection of the human metapneumovirus, present mainly in monocytes perturbed in type-I interferon (IFN)-signaling.", "Viral-Track provides a robust technology for dissecting the mechanisms of viral-infection and pathology."], "title": "Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients"}
{"doc_id": 177, "abstract": ["Virus entry is a multistep process.", "It initiates when the virus attaches to the host cell and ends when the viral contents reach the cytosol.", "Genetically unrelated viruses can subvert analogous subcellular mechanisms and use similar trafficking pathways for successful entry.", "Antiviral strategies targeting early steps of infection are therefore appealing, particularly when the probability for successful interference through a common step is highest.", "We describe here potent inhibitory effects on content release and infection by chimeric vesicular stomatitis virus (VSV) containing the envelope proteins of Zaire ebolavirus (VSV-ZEBOV) or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (VSV-SARS-CoV-2) elicited by Apilimod and Vacuolin-1, small-molecule inhibitors of the main endosomal phosphatidylinositol-3-phosphate/phosphatidylinositol 5-kinase, PIKfyve.", "We also describe potent inhibition of SARS-CoV-2 strain 2019-nCoV/USA-WA1/2020 by Apilimod.", "These results define tools for studying the intracellular trafficking of pathogens elicited by inhibition of PIKfyve kinase and suggest the potential for targeting this kinase in developing small-molecule antivirals against SARS-CoV-2."], "title": "Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2"}
{"doc_id": 178, "abstract": ["Background An immediate unmet medical need exists to test and develop existing approved drugs against SARS-COV-2.", "Despite many efforts, very little progress has been made regarding finding low-cost oral medicines that can be made widely available worldwide to address the global pandemic.", "Methods We sought to examine if a triple combination of nitazoxanide (using its active metabolite tizoxanide), ribavirin, and hydroxychloroquine would lead to a multiplicative effects on viral replication of SARS-COV-2 resulting in a significant reduction of virus yield using VERO E6 cells as a model of viral replication.", "Results Virus yield measured in PFU/ml was ~ 2 logs lower with triple combination versus either drug alone, resulting in the prolongation of time to peak cytopathic effects (CPE).", "The time to produce 50% CPE increased from 2.8 days for viral controls versus 5.3 days for triple combination therapy.", "Finally, for each 1-log reduction in virus yield 24 hours post-infection, there was an additional 0.7-day delay in onset of CPE.", "Conclusions A triple combination of tizoxanide, ribavirin, and hydroxychloroquine produced a reduction in SARS-COV-2 viral replication in Vero E6 cells, warranting exploration in additional cell lines as well as human clinical trials."], "title": "Triple Combination Nitazoxanide, Ribavirin, and Hydroxychloroquine results in the multiplicative reduction of in vitro SARS-CoV-2 viral replication"}
{"doc_id": 179, "abstract": ["In COVID-19, the immune response largely determines disease severity and is key to therapeutic strategies.", "Cellular mechanisms contributing to inflammatory lung injury and tissue repair in SARS-CoV-2 infection, particularly endothelial cell involvement, remain ill-defined.", "We performed detailed spatiotemporal analyses of cellular and molecular processes in SARS-CoV-2 infected Syrian hamsters.", "Comparison of hamster single-cell sequencing and proteomics with data sets from COVID-19 patients demonstrated inter-species concordance of cellular and molecular host-pathogen interactions.", "In depth vascular and pulmonary compartment analyses (i) supported the hypothesis that monocyte-derived macrophages dominate inflammation, (ii) revealed endothelial inflammation status and T-cell attraction, and (iii) showed that CD4+ and CD8+ cytotoxic T-cell responses precede viral elimination.", "Using the Syrian hamster model of self-limited moderate COVID-19, we defined the specific roles of endothelial and epithelial cells, among other myeloid and non-myeloid lung cell subtypes, for determining the disease course."], "title": "Longitudinal omics in Syrian hamsters integrated with human data unravel complexity of moderate immune responses to SARS-CoV-2"}
{"doc_id": 180, "abstract": ["In recent years, viruses similar to those that cause serious disease in humans and other mammals have been detected in apparently healthy bats.", "These include filoviruses, paramyxoviruses, and coronaviruses that cause severe diseases such as Ebola virus disease, Marburg haemorrhagic fever and severe acute respiratory syndrome (SARS) in humans.", "The evolution of flight in bats seem to have selected for a unique set of antiviral immune responses that control virus propagation, while limiting self-damaging inflammatory responses.", "Here, we summarize our current understanding of antiviral immune responses in bats and discuss their ability to co-exist with emerging viruses that cause serious disease in other mammals.", "We highlight how this knowledge may help us to predict viral spillovers into new hosts and discuss future directions for the field."], "title": "Novel Insights Into Immune Systems of Bats"}
{"doc_id": 181, "abstract": ["The serious coronavirus disease-2019 (COVID-19) was first reported in December 2019 in Wuhan, China.", "COVID-19 is an infectious disease caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2).", "Angiotensin converting enzyme 2(ACE2) is the cellular receptor for SARS-CoV-2.", "Considering the critical roles of testicular cells for the transmission of genetic information between generations, we analyzed single-cell RNA-sequencing (scRNA-seq) data of adult human testis.", "The mRNA expression of ACE2 was expressed in both germ cells and somatic cells.", "Moreover, the positive rate of ACE2 in testes of infertile men was higher than normal, which indicates that SARS-CoV-2 may cause reproductive disorders through pathway activated by ACE2 and the men with reproductive disorder may easily to be infected by SARS-CoV-2.", "The expression level of ACE2 was related to the age, and the mid-aged with higher positive rate than young men testicular cells.", "Taken together, this research provides a biological background of the potential route for infection of SARS-CoV-2 and may enable rapid deciphering male-related reproductive disorders induced by COVID-19."], "title": "The ACE2 expression in Sertoli cells and germ cells may cause male reproductive disorder after SARS-CoV-2 infection"}
{"doc_id": 182, "abstract": ["SARS-CoV-2 primarily infects cells at mucosal surfaces.", "Serum neutralizing antibody responses are variable and generally low in individuals that suffer mild forms of the illness.", "Although potent IgG antibodies can neutralize the virus, less is known about secretory antibodies such as IgA that might impact the initial viral spread and transmissibility from the mucosa.", "Here we characterize the IgA response to SARS-CoV-2 in a cohort of 149 individuals.", "IgA responses in plasma generally correlate with IgG responses and clones of IgM, IgG and IgA producing B cells that are derived from common progenitors are evident.", "Plasma IgA monomers are 2-fold less potent than IgG equivalents.", "However, IgA dimers, the primary form in the nasopharynx, are on average 15 times more potent than IgA monomers.", "Thus, secretory IgA responses may be particularly valuable for protection against SARS-CoV-2 and for vaccine efficacy."], "title": "Enhanced SARS-CoV-2 Neutralization by Secretory IgA in vitro"}
{"doc_id": 183, "abstract": ["Viruses are obligate intracellular parasites that make use of the host metabolic machineries to meet their biosynthetic needs, identifying the host pathways essential for the virus replication may lead to potential targets for therapeutic intervention.", "The mechanisms and pathways explored by SARS-CoV-2 to support its replication within host cells are not fully known.", "Lipid droplets (LD) are organelles with major functions in lipid metabolism and energy homeostasis, and have multiple roles in infections and inflammation.", "Here we described that monocytes from COVID-19 patients have an increased LD accumulation compared to SARS-CoV-2 negative donors.", "In vitro, SARS-CoV-2 infection modulates pathways of lipid synthesis and uptake, including CD36, SREBP-1, PPAR{gamma} and DGAT-1 in monocytes and triggered LD formation in different human cells.", "LDs were found in close apposition with SARS-CoV-2 proteins and double-stranded (ds)-RNA in infected cells.", "Pharmacological modulation of LD formation by inhibition of DGAT-1 with A922500 significantly inhibited SARS-CoV-2 replication as well as reduced production of pro-inflammatory mediators.", "Taken together, we demonstrate the essential role of lipid metabolic reprograming and LD formation in SARS-CoV-2 replication and pathogenesis, opening new opportunities for therapeutic strategies to COVID-19."], "title": "Lipid droplets fuels SARS-CoV-2 replication and inflammatory response"}
{"doc_id": 184, "abstract": ["Aerosolized pathogens are a leading cause of respiratory infection and transmission.", "Currently used protective measures pose potential risk of primary/secondary infection and transmission.", "Here, we report the development of a universal, reusable virus deactivation system by functionalization of the main fibrous filtration unit of surgical mask with sodium chloride salt.", "The salt coating on the fiber surface dissolves upon exposure to virus aerosols and recrystallizes during drying, destroying the pathogens.", "When tested with tightly sealed sides, salt-coated filters showed remarkably higher filtration efficiency than conventional mask filtration layer, and 100% survival rate was observed in mice infected with virus penetrated through salt-coated filters.", "Viruses captured on salt-coated filters exhibited rapid infectivity loss compared to gradual decrease on bare filters.", "Salt-coated filters proved highly effective in deactivating influenza viruses regardless of subtypes and following storage in harsh environmental conditions.", "Our results can be applied in obtaining a broad-spectrum, airborne pathogen prevention device in preparation for epidemic and pandemic of respiratory diseases."], "title": "Universal and reusable virus deactivation system for respiratory protection"}
{"doc_id": 185, "abstract": ["Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19).", "The relentless spread and pathogenicity of the virus have become a global public health emergency.", "One of the striking features of this pandemic is the pronounced impact on specific regions and ethnic groups.", "In particular, compared with East Asia, where the virus first emerged, SARS-CoV-2 has caused high rates of morbidity and mortality in Europe.", "This has not been experienced in past global viral infections, such as influenza, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) and is unique to SARS-CoV-2.", "For this reason, we investigated the involvement of genetic factors associated with SARS-CoV-2 infection with a focus on angiotensin-converting enzyme (ACE)-related genes, because ACE2 is a receptor for SARS-CoV-2.", "We found that the ACE1 II genotype frequency in a population was significantly negatively correlated with the number of SARS-CoV-2 cases.", "Similarly, the ACE1 II genotype was negatively correlated with the number of deaths due to SARS-CoV-2 infection.", "These data suggest that the ACE1 II genotype may influence the prevalence and clinical outcome of COVID-19 and serve as a predictive marker for COVID-19 risk and severity."], "title": "SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype"}
{"doc_id": 186, "abstract": ["We remain largely without effective prophylactic/therapeutic interventions for COVID-19.", "Although many human clinical trials are ongoing, there remains a deficiency of supportive preclinical drug efficacy studies.", "Here we assessed the prophylactic/therapeutic efficacy of hydroxychloroquine (HCQ), a drug of interest for COVID-19 management, in two animal models.", "When used for prophylaxis or treatment neither the standard human malaria dose (6.5 mg/kg) nor a high dose (50 mg/kg) of HCQ had any beneficial effect on clinical disease or SARS-CoV-2 kinetics (replication/shedding) in the Syrian hamster disease model.", "Similarly, HCQ prophylaxis/treatment (6.5 mg/kg) did not significantly benefit clinical outcome nor reduce SARS-CoV-2 replication/shedding in the upper and lower respiratory tract in the rhesus macaque disease model.", "In conclusion, our preclinical animal studies do not support the use of HCQ in prophylaxis/treatment of COVID-19."], "title": "Hydroxychloroquine Proves Ineffective in Hamsters and Macaques Infected with SARS-CoV-2"}
{"doc_id": 187, "abstract": ["Coronavirus Disease 2019 (COVID-19) is a global public health threat.", "Genomic surveillance of SARS-CoV-2 was implemented in March of 2020 at a major diagnostic hub in Bangkok, Thailand.", "Several virus lineages supposedly originated in many countries were found, and a Thai-specific lineage, designated A/Thai-1, has expanded to be predominant in Thailand.", "A virus sample in the SARS-CoV-2 A/Thai-1 lineage contains a frame-shift deletion at ORF7a, encoding a putative host antagonizing factor of the virus."], "title": "Genomic surveillance of SARS-CoV-2 in Thailand reveals mixed imported populations, a local lineage expansion and a virus with truncated ORF7a"}
{"doc_id": 188, "abstract": ["To limit introduction of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), the United States restricted travel from China on February 2, 2020, and from Europe on March 13.", "To determine whether local transmission of SARS-CoV-2 could be detected, the New York City (NYC) Department of Health and Mental Hygiene (DOHMH) conducted deidentified sentinel surveillance at six NYC hospital emergency departments (EDs) during March 1-20.", "On March 8, while testing availability for SARS-CoV-2 was still limited, DOHMH announced sustained community transmission of SARS-CoV-2 (1).", "At this time, twenty-six NYC residents had confirmed COVID-19, and ED visits for influenza-like illness* increased, despite decreased influenza virus circulation.\u0086 The following week, on March 15, when only seven of the 56 (13%) patients with known exposure histories had exposure outside of NYC, the level of community SARS-CoV-2 transmission status was elevated from sustained community transmission to widespread community transmission (2).", "Through sentinel surveillance during March 1-20, DOHMH collected 544 specimens from patients with influenza-like symptoms (ILS)\u00a7 who had negative test results for influenza and, in some instances, other respiratory pathogens.\u00b6 All 544 specimens were tested for SARS-CoV-2 at CDC; 36 (6.6%) tested positive.", "Using genetic sequencing, CDC determined that the sequences of most SARS-CoV-2-positive specimens resembled those circulating in Europe, suggesting probable introductions of SARS-CoV-2 from Europe, from other U.S. locations, and local introductions from within New York.", "These findings demonstrate that partnering with health care facilities and developing the systems needed for rapid implementation of sentinel surveillance, coupled with capacity for genetic sequencing before an outbreak, can help inform timely containment and mitigation strategies."], "title": "Detection and Genetic Characterization of Community-Based SARS-CoV-2 Infections \u2014 New York City, March 2020"}
{"doc_id": 189, "abstract": ["BACKGROUND: Severe coronavirus disease 2019 (COVID-19) frequently entails complications that bear similarities to autoimmune diseases.", "To date, there is little data on possible IgA-mediated autoimmune responses.", "Here, we aim to determine whether COVID-19 is associated with a vigorous total IgA response and if IgA antibodies are associated with complications of severe illness.", "Since thrombotic events are frequent in severe COVID-19 and resemble hypercoagulation of antiphospholipid syndrome (APS), our approach focused on antiphospholipid antibodies (aPL).", "METHODS: In this retrospective cohort study clinical data and aPL from 64 patients with COVID-19 were compared from three independent tertiary hospitals (one in Liechtenstein, two in Switzerland).", "Samples were collected from April 9 th to May 1 st, 2020.", "RESULTS: Clinical records of 64 patients with COVID-19 were reviewed and divided into a cohort with mild illness (mCOVID) (41%), a discovery cohort with severe illness (sdCOVID) (22%) and a confirmation cohort with severe illness (scCOVID) (38%).", "Total IgA, IgG and aPL were measured with clinical diagnostic kits.", "Severe illness was significantly associated with increased total IgA (sdCOVID, P=0.01; scCOVID, p-value<0.001), but not total IgG. Among aPL, both cohorts with severe illness significantly correlated with elevated anti-Cardiolipin IgA (sdCOVID and scCOVID, p-value<0.001), anti-Cardiolipin IgM (sdCOVID, P=0.003; scCOVID, P<0.001), and anti-Beta2 Glycoprotein-1 IgA (sdCOVID and scCOVID, P<0.001).", "Systemic lupus erythematosus was excluded from all patients as a potential confounder.", "CONCLUSIONS: Higher total IgA and IgA-aPL were consistently associated with severe illness.", "These novel data strongly suggest that a vigorous antiviral IgA-response, possibly triggered in the bronchial mucosa, induces systemic autoimmunity."], "title": "Severe COVID-19 is associated with elevated serum IgA and antiphospholipid IgA-antibodies"}
{"doc_id": 190, "abstract": ["The clinical course of COVID-19 is very heterogeneous: Most infected individuals can be managed in an outpatient setting, but a substantial proportion of patients requires intensive care, resulting in a high rate of fatalities.", "Recently, an association between contact to small children and mild course of COVID-19 was reported.", "We performed an observational study to assess the impact of previous infections with seasonal coronaviruses on COVID-19 severity.", "60 patients with confirmed COVID-19 infections were included (age 30-82 years; 52 males, 8 females): 19 inpatients with critical disease, 16 inpatients with severe or moderate disease and 25 outpatients (age and gender matched to inpatients).", "Patients with critical disease had significantly lower levels of HCoV OC43-(p=0.016) and HCoV HKU1-specific (p=0.023) antibodies at the first encounter compared to other COVID-19 patients.", "Our results indicate that previous infections with seasonal coronaviruses might protect against a severe course of disease.", "This finding should be validated in other settings and could contribute to identify persons at risk before an infection."], "title": "Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1)"}
{"doc_id": 191, "abstract": ["A safe and effective vaccine that can provide herd immunity against severe acute respiratory syndrome coronavirus (SARS-CoV-2) is urgently needed to stop the spread of this virus among humans.", "Many human viral vaccines are live, attenuated forms of viruses that elicit humoral and cellular immunity.", "Here, we describe a cold-adapted live-attenuated vaccine (SARS-CoV-2/human/Korea/CNUHV03-CA22 \u00b0C/2020) developed by gradually adapting the growth of SARS-CoV-2 from 37 \u00b0C to 22 \u00b0C in Vero cells.", "This vaccine can be potentially administered to humans as a nasal spray.", "Its single dose strongly induced neutralising antibodies (titre > 640), cellular immunity, and mucosal IgA antibodies in intranasally immunised K18-hACE2 mice, which are very susceptible to SARS-CoV-2 and SARS-CoV infections.", "The one-dose vaccinated mice were completely protected from SARS-CoV-2 infection and did not show body weight loss, death, or the presence of virus in tissues, such as the nasal turbinates, brain, lungs, and kidneys.", "These results demonstrate that the cold-adapted live attenuated SARS-CoV-2 vaccine we have developed may be a candidate SARS-CoV-2 vaccine for humans."], "title": "Cold-Adapted Live Attenuated SARS-Cov-2 Vaccine Completely Protects Human ACE2 Transgenic Mice from SARS-Cov-2 Infection"}
{"doc_id": 192, "abstract": ["We randomized 115 children to trivalent inactivated influenza vaccine (TIV) or placebo.", "Over the following 9 months, TIV recipients had an increased risk of virologically-confirmed non-influenza infections (relative risk: 4.40; 95% confidence interval: 1.31-14.8).", "Being protected against influenza, TIV recipients may lack temporary non-specific immunity that protected against other respiratory viruses."], "title": "Increased Risk of Noninfluenza Respiratory Virus Infections Associated With Receipt of Inactivated Influenza Vaccine"}
{"doc_id": 193, "abstract": ["The immunopathology of COVID-19 remains enigmatic, exhibiting immunodysregulation and T cell lymphopenia.", "Monocytic myeloid-derived suppressor cells (M-MDSC) are T cell suppressors that expand in inflammatory conditions, but their role in acute respiratory infections remains unclear.", "We studied blood and airways of COVID-19 patients across disease severity at multiple timepoints.", "M-MDSC frequencies were elevated in blood but not in nasopharyngeal or endotracheal aspirates of COVID-19 patients compared to controls.", "M-MDSCs isolated from COVID-19 patients suppressed T cell proliferation and IFNg production partly via an arginase-1 (Arg-1) dependent mechanism.", "Furthermore, patients showed increased Arg-1 and IL-6 plasma levels.", "COVID-19 patients had fewer T cells, and displayed downregulated expression of the CD3\u03b6 chain.", "Ordinal regression showed that early M-MDSC frequency predicted subsequent disease severity.", "In conclusion, M-MDSCs expand in blood of COVID-19 patients, suppress T cells and strongly associate with disease severity, suggesting a role for M-MDSCs in the dysregulated COVID-19 immune response."], "title": "Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity."}
{"doc_id": 194, "abstract": ["Face masks are recommended to reduce community transmission of SARS-CoV-2.", "One of the primary benefits of face masks and other coverings is as source control devices to reduce the expulsion of respiratory aerosols during coughing, breathing, and speaking.", "Face shields and neck gaiters have been proposed as an alternative to face masks, but information about face shields and neck gaiters as source control devices is limited.", "We used a cough aerosol simulator with a pliable skin headform to propel small aerosol particles (0 to 7 {micro}m) into different face coverings.", "An N95 respirator blocked 99% of the cough aerosol, a medical grade procedure mask blocked 59%, a 3-ply cotton cloth face mask blocked 51%, and a polyester neck gaiter blocked 47% as a single layer and 60% when folded into a double layer.", "In contrast, the face shield blocked 2% of the cough aerosol.", "Our results suggest that face masks and neck gaiters are preferable to face shields as source control devices for cough aerosols."], "title": "Efficacy of face masks, neck gaiters and face shields for reducing the expulsion of simulated cough-generated aerosols"}
{"doc_id": 195, "abstract": ["Current COVID-19 pandemic poses an unprecedented threat to global health and healthcare systems.", "The most amount of the death toll is accounted by old people affected by age-related diseases that develop a hyper-inflammatory syndrome.", "In this regard, we hypothesized that COVID-19 severity may be linked to inflammaging.", "Here, we examined 30 serum samples from patients enrolled in the clinical trial NCT04315480 assessing the clinical response to a single-dose intravenous infusion of the anti-IL-6 receptor drug Tocilizumab (TCZ) in COVID-19 patients with multifocal interstitial pneumonia.", "In these serum samples, as well as in 29 age-and gender-matched healthy control subjects, we assessed a set of microRNAs that regulate inflammaging, i.e. miR-146a-5p, miR-21-5p, and miR-126-3p, which were quantified by RT-PCR and Droplet Digital PCR.", "We showed that COVID-19 patients who did not respond to TCZ have lower serum levels of miR-146a-5p after the treatment (p = 0.007).", "Among non-responders, those with the lowest serum levels of miR-146a-5p experienced the most adverse outcome (p = 0.008).", "Our data show that a blood-based biomarker, such as miR-146a-5p, can provide clues about the molecular link between inflammaging and COVID-19 clinical course, thus allowing to better understand the use of biologic drug armory against this worldwide health threat."], "title": "Decreased serum levels of the inflammaging marker miR-146a are associated with clinical response to tocilizumab in COVID-19 patients"}
{"doc_id": 196, "abstract": ["Coronavirus disease 2019 (COVID-19) is characterized by a high incidence of acute respiratory failure.", "The underlying immunopathology of that failure and how it compares to other causes of severe respiratory distress, such as influenza virus infection, are not fully understood.", "Here we addressed this by developing a prospective observational cohort of COVID-19 and influenza subjects with varying degrees of disease severity and assessing the quality and magnitude of their immune responses at the cellular and protein level.", "Additionally, we performed single-cell RNA transcriptional profiling of peripheral blood mononuclear cells from select subjects.", "The cohort consists of 79 COVID-19 subjects, 26 influenza subjects, and 15 control subjects, including 35 COVID-19 and 7 influenza subjects with acute respiratory failure.", "While COVID-19 subjects exhibited largely equivalent or greater activated lymphocyte counts compared to influenza subjects, they had fewer monocytes and lower surface HLA-class II expression on monocytes compared to influenza subjects and controls.", "At least two distinct immune profiles were observed by cytokine levels in severe COVID-19 patients: 3 of 71 patients were characterized by extreme inflammation, with greater than or equal to ~50% of the 35 cytokines measured greater than 2 standard deviations from the mean level of other severe patients (both influenza and COVID-19); the other immune profile, which characterized 68 of 71 subjects, had a mixed inflammatory signature, where 28 of 35 cytokines in COVID-19 patients had lower mean cytokine levels, though not all were statistically significant.", "Only 2 cytokines were higher in COVID-19 subjects compared to influenza subjects (IL-6 and IL-8).", "Influenza and COVID-19 patients could be distinguished statistically based on cytokine module expression, particularly after controlling for the significant effects of age on cytokine expression, but again with lower levels of most cytokines in COVID-19 subjects.", "Further, high circulating levels of IL-1RA and IL-6 were associated with increased odds of intubation in the combined influenza and COVID-19 cohort [OR = 3.93 and 4.30, respectively] as well as among only COVID-19 patients.", "Single cell transcriptional profiling of COVID-19 and influenza subjects with respiratory failure identified profound suppression in type I and type II interferon signaling in COVID-19 patients across multiple clusters.", "In contrast, COVID-19 cell clusters were enriched for alterations in metabolic, stress, and apoptotic pathways.", "These alterations were consistent with an increased glucocorticoid response in COVID-19 patients compared to influenza.", "When considered across the spectrum of innate and adaptive immune profiles, the immune pathologies underlying severe influenza and COVID-19 are substantially distinct.", "The majority of COVID-19 patients with acute respiratory failure do not have a cytokine storm phenotype but instead exhibit profound type I and type II IFN immunosuppression when compared to patients with acute influenza.", "Upregulation of a small number of inflammatory mediators, including IL-6, predicts acute respiratory failure in both COVID-19 and influenza patients."], "title": "Targeted Immunosuppression Distinguishes COVID-19 from Influenza in Moderate and Severe Disease"}
{"doc_id": 197, "abstract": ["The potential virucidal effects of UV-C irradiation on SARS-CoV-2 were experimentally evaluated for different illumination doses and virus concentrations (1000, 5, 0.05 MOI).", "Both virus inactivation and replication inhibition were investigated as a function of these parameters.", "At a virus density comparable to that observed in SARS-CoV-2 infection, an UV-C dose of just 3.7 mJ/cm2 was sufficient to achieve a 3-log inactivation, and complete inhibition of all viral concentrations was observed with 16.9 mJ/cm2.", "These results could explain the epidemiological trends of COVID-19 and are important for the development of novel sterilizing methods to contain SARS-CoV-2 infection."], "title": "UV-C irradiation is highly effective in inactivating and inhibiting SARS-CoV-2 replication"}
{"doc_id": 198, "abstract": ["Importance: Neurological manifestations have been reported in adults with coronavirus disease 2019 (COVID-19), which is caused by the highly pathogenic virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).", "Objective: To report the neurological manifestations of children with COVID-19.", "Design, Setting, and Participants: In this case-series study, patients younger than 18 years who presented with SARS-CoV-2 infection and neurological symptoms to Great Ormond Street Hospital for Children (London, UK) between March 1, 2020, and May 8, 2020, were included after infection was confirmed by either a quantitative reverse transcription-polymerase chain reaction assay by nasopharyngeal swab or a positive test result for IgG antibodies against SARS-CoV-2 in serum.", "Main Outcomes and Measures: Clinical and paraclinical features were retrieved from electronic patient records.", "Results: Of the 27 children with COVID-19 pediatric multisystem inflammatory syndrome, 4 patients (14.8%) who were previously healthy had new-onset neurological symptoms.", "Symptoms included encephalopathy, headaches, brainstem and cerebellar signs, muscle weakness, and reduced reflexes.", "All 4 patients required intensive care unit admission for the treatment of COVID-19 pediatric multisystem inflammatory syndrome.", "Splenium signal changes were seen in all 4 patients on magnetic resonance imaging of the brain.", "In the 2 patients whose cerebrospinal fluid was tested, samples were acellular, with no evidence of infection on polymerase chain reaction or culture (including negative SARS-CoV-2 polymerase chain reaction results) and negative oligoclonal band test results.", "In all 3 patients who underwent electroencephalography, a mild excess of slow activity was found.", "Tests for N-methyl-d-aspartate receptor, myelin oligodendrocyte glycoprotein, and aquaporin-4 autoantibodies had negative results in all patients.", "In all 3 patients who underwent nerve conduction studies and electromyography, mild myopathic and neuropathic changes were seen.", "Neurological improvement was seen in all patients, with 2 making a complete recovery by the end of the study.", "Conclusions and Relevance: In this case-series study, children with COVID-19 presented with new neurological symptoms involving both the central and peripheral nervous systems and splenial changes on imaging, in the absence of respiratory symptoms.", "Additional research is needed to assess the association of neurological symptoms with immune-mediated changes among children with COVID-19."], "title": "Neurologic and Radiographic Findings Associated With COVID-19 Infection in Children"}
{"doc_id": 199, "abstract": ["In the United States, state-level re-openings in spring 2020 presented an opportunity for the resurgence of SARS-CoV-2 transmission.", "One important question during this time was whether human contact and mixing patterns could increase gradually without increasing viral transmission, the rationale being that new mixing patterns would likely be associated with improved distancing, masking, and hygiene practices.", "A second key question to follow during this time was whether clinical characteristics of the epidemic would improve after the initial surge of cases.", "Here, we analyze age-structured case, hospitalization, and death time series from three states \u2013 Rhode Island, Massachusetts, and Pennsylvania \u2013 that had successful reopenings in May 2020 without summer waves of infection.", "Using a Bayesian inference framework on eleven daily data streams and flexible daily population contact parameters, we show that population-average mixing rates dropped by >50% during the lockdown period in March/April, and that the correlation between overall population mobility and transmission-capable mixing was broken in May as these states partially re-opened.", "We estimate the reporting rates (fraction of symptomatic cases reporting to health system) at 96.3% (RI), 62.5% (MA), and 98.9% (PA).", "We show that elderly individuals were less able to reduce contacts during the lockdown period when compared to younger individuals, leading to the outbreak being concentrated in elderly congregate settings despite the lockdown.", "Attack rate estimates through August 31 2020 are 6.2% (95% CI: 5.7% \u2013 6.8%) of the total population infected for Rhode Island, 6.7% (95% CI: 5.4% \u2013 7.6%) in Massachusetts, and 2.7% (95% CI: 2.5% \u2013 3.1%) in Pennsylvania, with some validation available through published seroprevalence studies.", "Infection fatality rates (IFR) estimates are higher in our analysis (>2%) than previously reported values, likely resulting from the epidemics in these three states affecting the most vulnerable sub-populations and the close matches between the states\u2019 reported COVID-19 deaths and excess deaths.", "Data in Pennsylvania may have been underreported for both non-hospitalized and hospitalized patients, casting substantial uncertainty on estimates of attack rate and infection fatality rate."], "title": "SARS-CoV-2 epidemic after social and economic reopening in three US states reveals shifts in age structure and clinical characteristics"}
{"doc_id": 200, "abstract": ["The SARS-CoV-2 pandemic, and the likelihood of future coronavirus pandemics, has rendered our understanding of coronavirus biology more essential than ever.", "Small molecule chemical probes offer to both reveal novel aspects of virus replication and to serve as leads for antiviral therapeutic development.", "The RNA-biased amiloride scaffold was recently tuned to target a viral RNA structure critical for translation in enterovirus 71, ultimately uncovering a novel mechanism to modulate positive-sense RNA viral translation and replication.", "Analysis of CoV RNA genomes reveal many conserved RNA structures in the 5\u2019-UTR and proximal region critical for viral translation and replication, including several containing bulge-like secondary structures suitable for small molecule targeting.", "Following phylogenetic conservation analysis of this region, we screened an amiloride-based small molecule library against a less virulent human coronavirus, OC43, to identify lead ligands.", "Amilorides inhibited OC43 replication as seen in viral plaque assays.", "Select amilorides also potently inhibited replication competent SARS-CoV-2 as evident in the decreased levels of cell free virions in cell culture supernatants of treated cells.", "Reporter screens confirmed the importance of RNA structures in the 5\u2019-end of the viral genome for small molecule activity.", "Finally, NMR chemical shift perturbation studies of the first six stem loops of the 5\u2019-end revealed specific amiloride interactions with stem loops 4, 5a, and 6, all of which contain bulge like structures and were predicted to be strongly bound by the lead amilorides in retrospective docking studies.", "Taken together, the use of multiple orthogonal approaches allowed us to identify the first small molecules aimed at targeting RNA structures within the 5\u2019-UTR and proximal region of the CoV genome.", "These molecules will serve as chemical probes to further understand CoV RNA biology and can pave the way for the development of specific CoV RNA-targeted antivirals."], "title": "Amilorides inhibit SARS-CoV-2 replication in vitro by targeting RNA structures"}
{"doc_id": 201, "abstract": ["A large proportion of SARS-CoV-2 infected individuals remains asymptomatic.", "Little is known about the extent and quality of their antiviral humoral response.", "Here, we analyze antibody functions in 52 asymptomatic infected individuals, 119 mild and 21 hospitalized COVID-19 patients.", "We measured anti-Spike IgG, IgA and IgM levels with the S-Flow assay and map IgG-targeted epitopes by Luminex.", "We also evaluated neutralization, complement deposition and Antibody-Dependent Cellular Cytotoxicity (ADCC) using replication-competent SARS-CoV-2 or reporter cell systems.", "We show that COVID-19 sera mediate complement deposition and kill infected cells by ADCC.", "Sera from asymptomatic individuals neutralize the virus, activate ADCC and trigger complement deposition.", "Antibody levels and functions are lower in asymptomatic individuals than in symptomatic cases.", "Antibody functions are correlated, regardless of disease severity.", "Longitudinal samplings show that antibody functions follow similar kinetics of induction and contraction.", "Overall, asymptomatic SARS-CoV-2 infection elicits polyfunctional antibodies neutralizing the virus and targeting infected cells."], "title": "Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies"}
{"doc_id": 202, "abstract": ["The current outbreak of novel coronavirus disease 2019 (COVID-19) poses an unprecedented global health and economic threat to interconnected human societies.", "Until a vaccine is developed, strategies for controlling the outbreak rely on aggressive social distancing.", "These measures largely disconnect the social network fabric of human societies, especially in urban areas.", "Here, we estimate the growth rates and reproductive numbers of COVID-19 in US cities from March 14th through March 19th to reveal a power-law scaling relationship to city population size.", "This means that COVID-19 is spreading faster on average in larger cities with the additional implication that, in an uncontrolled outbreak, larger fractions of the population are expected to become infected in more populous urban areas.", "We discuss the implications of these observations for controlling the COVID-19 outbreak, emphasizing the need to implement more aggressive distancing policies in larger cities while also preserving socioeconomic activity."], "title": "COVID-19 attack rate increases with city size"}
{"doc_id": 203, "abstract": ["Background In hospitalized patients with COVID-19 pneumonia, progression to acute respiratory failure requiring invasive mechanical ventilation (MV) is associated with significant morbidity and mortality.", "Severe dysregulated systemic inflammation is the putative mechanism.", "We hypothesize that early prolonged methylprednisolone (MP) treatment could accelerate disease resolution, decreasing the need for ICU and mortality.", "Methods We conducted a multicenter, observational study to explore the association between exposure to prolonged, low-dose, MP treatment and need for ICU referral, intubation or death within 28 days (composite primary endpoint) in patients with severe COVID-19 pneumonia admitted to Italian respiratory high-dependency units.", "Secondary outcomes were invasive MV-free days and changes in C-reactive protein (CRP) levels.", "Results Findings are reported as MP (n=83) vs. control (n=90).", "The composite primary endpoint was met by 19 vs. 40 [adjusted hazard ratio (HR) 0.41; 95% confidence interval (CI): 0.24-0.72].", "Transfer to ICU and need for invasive MV was necessary in 15 vs. 27 (p=0.07) and 14 vs. 26 (p=0.10), respectively.", "By day 28, the MP group had fewer deaths (6 vs. 21, adjusted HR=0.29; 95% CI: 0.12-0.73) and more days off invasive MV (24.0 plus-or-minus sign 9.0 vs. 17.5 plus-or-minus sign 12.8; p=0.001).", "Study treatment was associated with rapid improvement in PaO2:FiO2 and CRP levels.", "The complication rate was similar for the two groups (p=0.84).", "Conclusion In patients with severe COVID-19 pneumonia, early administration of prolonged MP treatment was associated with a significantly lower hazard of death (71%) and decreased ventilator dependence.", "Randomized controlled studies are needed to confirm these findings."], "title": "Prolonged low-dose methylprednisolone in patients with severe COVID-19 pneumonia"}
{"doc_id": 204, "abstract": ["The search for vaccines that protect from severe morbidity and mortality as a result of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19) is a race against the clock and the virus.", "Several vaccine candidates are currently being tested in the clinic.", "Inactivated virus and recombinant protein vaccines can be safe options but may require adjuvants to induce robust immune responses efficiently.", "In this work we describe the use of a novel amphiphilic imidazoquinoline (IMDQ-PEG-CHOL) TLR7/8 adjuvant, consisting of an imidazoquinoline conjugated to the chain end of a cholesterol-poly(ethylene glycol) macromolecular amphiphile).", "This amphiphile is water soluble and exhibits massive translocation to lymph nodes upon local administration, likely through binding to albumin.", "IMDQ-PEG-CHOL is used to induce a protective immune response against SARS-CoV-2 after single vaccination with trimeric recombinant SARS-CoV-2 spike protein in the BALB/c mouse model.", "Inclusion of amphiphilic IMDQ-PEG-CHOL in the SARS-CoV-2 spike vaccine formulation resulted in enhanced immune cell recruitment and activation in the draining lymph node.", "IMDQ-PEG-CHOL has a better safety profile compared to native soluble IMDQ as the former induces a more localized immune response upon local injection, preventing systemic inflammation.", "Moreover, IMDQ-PEG-CHOL adjuvanted vaccine induced enhanced ELISA and in vitro microneutralization titers, and a more balanced IgG2a/IgG1 response.", "To correlate vaccine responses with control of virus replication in vivo, vaccinated mice were challenged with SARS-CoV-2 virus after being sensitized by intranasal adenovirus-mediated expression of the human angiotensin converting enzyme 2 (ACE2) gene.", "Animals vaccinated with trimeric recombinant spike protein vaccine without adjuvant had lung virus titers comparable to non-vaccinated control mice, whereas animals vaccinated with IMDQ-PEG-CHOL-adjuvanted vaccine controlled viral replication and infectious viruses could not be recovered from their lungs at day 4 post infection.", "In order to test whether IMDQ-PEG-CHOL could also be used to adjuvant vaccines currently licensed for use in humans, proof of concept was also provided by using the same IMDQ-PEG-CHOL to adjuvant human quadrivalent inactivated influenza virus split vaccine, which resulted in enhanced hemagglutination inhibition titers and a more balanced IgG2a/IgG1 antibody response.", "Enhanced influenza vaccine responses correlated with better virus control when mice were given a lethal influenza virus challenge.", "Our results underscore the potential use of IMDQ-PEG-CHOL as an adjuvant to achieve protection after single immunization with recombinant protein and inactivated vaccines against respiratory viruses, such as SARS-CoV-2 and influenza viruses."], "title": "Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Modified Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine"}
{"doc_id": 205, "abstract": ["ImportanceThis study presents the first set of estimates of predicted health service utilization and deaths due to COVID-19 by day for the next 4 months for each state in the US.", "ObjectiveTo determine the extent and timing of deaths and excess demand for hospital services due to COVID-19 in the US.", "Design, Setting, and ParticipantsThis study used data on confirmed COVID-19 deaths by day from WHO websites and local and national governments; data on hospital capacity and utilization for US states; and observed COVID-19 utilization data from select locations to develop a statistical model forecasting deaths and hospital utilization against capacity by state for the US over the next 4 months.", "Exposure(s)COVID-19.", "Main outcome(s) and measure(s)Deaths, bed and ICU occupancy, and ventilator use.", "ResultsCompared to licensed capacity and average annual occupancy rates, excess demand from COVID-19 at the peak of the pandemic in the second week of April is predicted to be 64,175 (95% UI 7,977 to 251,059) total beds and 17,380 (95% UI 2,432 to 57,955) ICU beds.", "At the peak of the pandemic, ventilator use is predicted to be 19,481 (95% UI 9,767 to 39,674).", "The date of peak excess demand by state varies from the second week of April through May. We estimate that there will be a total of 81,114 (95% UI 38,242 to 162,106) deaths from COVID-19 over the next 4 months in the US.", "Deaths from COVID-19 are estimated to drop below 10 deaths per day between May 31 and June 6.", "Conclusions and RelevanceIn addition to a large number of deaths from COVID-19, the epidemic in the US will place a load well beyond the current capacity of hospitals to manage, especially for ICU care.", "These estimates can help inform the development and implementation of strategies to mitigate this gap, including reducing non-COVID-19 demand for services and temporarily increasing system capacity.", "These are urgently needed given that peak volumes are estimated to be only three weeks away.", "The estimated excess demand on hospital systems is predicated on the enactment of social distancing measures in all states that have not done so already within the next week and maintenance of these measures throughout the epidemic, emphasizing the importance of implementing, enforcing, and maintaining these measures to mitigate hospital system overload and prevent deaths.", "Data availability statementA full list of data citations are available by contacting the corresponding author.", "Funding StatementBill & Melinda Gates Foundation and the State of Washington Key PointsO_ST_ABSQuestionC_ST_ABSAssuming social distancing measures are maintained, what are the forecasted gaps in available health service resources and number of deaths from the COVID-19 pandemic for each state in the United States? FindingsUsing a statistical model, we predict excess demand will be 64,175 (95% UI 7,977 to 251,059) total beds and 17,380 (95% UI 2,432 to 57,955) ICU beds at the peak of COVID-19.", "Peak ventilator use is predicted to be 19,481 (95% UI 9,767 to 39,674) ventilators.", "Peak demand will be in the second week of April.", "We estimate 81,114 (95% UI 38,242 to 162,106) deaths in the United States from COVID-19 over the next 4 months.", "MeaningEven with social distancing measures enacted and sustained, the peak demand for hospital services due to the COVID-19 pandemic is likely going to exceed capacity substantially.", "Alongside the implementation and enforcement of social distancing measures, there is an urgent need to develop and implement plans to reduce non-COVID-19 demand for and temporarily increase capacity of health facilities."], "title": "Forecasting COVID-19 impact on hospital bed-days, ICU-days, ventilator-days and deaths by US state in the next 4 months"}
{"doc_id": 206, "abstract": ["Animal models recapitulating distinctive features of severe COVID-19 are critical to enhance our understanding of SARS-CoV-2 pathogenesis.", "Transgenic mice expressing human angiotensin-converting enzyme 2 (hACE2) under the cytokeratin 18 promoter (K18-hACE2) represent a lethal model of SARS-CoV-2 infection.", "The precise mechanisms of lethality in this mouse model remain unclear.", "Here, we evaluated the spatiotemporal dynamics of SARS-CoV-2 infection for up to 14 days post-infection.", "Despite infection and moderate pneumonia, rapid clinical decline or death of mice was invariably associated with viral neuroinvasion and direct neuronal injury (including brain and spinal neurons).", "Neuroinvasion was observed as early as 4 dpi, with virus initially restricted to the olfactory bulb supporting axonal transport via the olfactory neuroepithelium as the earliest portal of entry.", "No evidence of viremia was detected suggesting neuroinvasion occurs independently of entry across the blood brain barrier.", "SARS-CoV-2 tropism was not restricted to ACE2-expressing cells (e.g., AT1 pneumocytes), and some ACE2-positive lineages were not associated with the presence of viral antigen (e.g., bronchiolar epithelium and brain capillaries).", "Detectable ACE2 expression was not observed in neurons, supporting overexpression of ACE2 in the nasal passages and neuroepithelium as more likely determinants of neuroinvasion in the K18-hACE2 model.", "Although our work incites caution in the utility of the K18-hACE2 model to study global aspects of SARS-CoV-2 pathogenesis, it underscores this model as a unique platform for exploring the mechanisms of SARS-CoV-2 neuropathogenesis that may have clinical relevance acknowledging the growing body of evidence that suggests COVID-19 may result in long-standing neurologic consequences.", "IMPORTANCE COVID-19 is predominantly a respiratory disease caused by SARS-CoV-2 that has infected more than 191 million people with over 4 million fatalities (2021-07-20).", "The development of animal models recapitulating distinctive features of severe COVID-19 is critical to enhancing our understanding of SARS-CoV-2 pathogenesis and in the evaluation of vaccine and therapeutic efficacy.", "Transgenic mice expressing human angiotensin-converting enzyme 2 (hACE2) under the cytokeratin 18 promoter (K18-hACE2) represent a lethal model of SARS-CoV-2 infection.", "Here, we show lethality of this model is invariably associated with viral neuroinvasion linked with viral replication and assembly.", "Importantly, pneumonia albeit invariably present was generally moderate with the absence of culturable infectious virus at peak neuroinvasion.", "The dynamics of viral neuroinvasion and pneumonia were only partially dependent on hACE2.", "Overall, this study provides an in-depth sequential characterization of the K18-hACE2 model following SARS-CoV-2 infection, highlighting its significance to further study the mechanisms of SARS-CoV-2 neuropathogenesis."], "title": "Fatal neuroinvasion and SARS-CoV-2 tropism in K18-hACE2 mice is partially independent on hACE2 expression"}
{"doc_id": 207, "abstract": ["The outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a huge threat to many countries around the world.", "However, where is it origin and which animals are sensitive to cross-species transmission is unclear.", "The interaction of virus and cell receptor is a key determinant of host range for the novel coronavirus.", "Angiotensin-converting enzyme 2 (ACE2) is demonstrated as the primary entry receptor for SARS-CoV-2.", "In this study, we evaluated the SARS-CoV-2 entry mediated by ACE2 of 11 different species of animals, and discovered that ACE2 of Rhinolophus sinicus (Chinese horseshoe bat), Felis catus (domestic cat), Canis lupus familiaris (dog), Sus scrofa (pig), Capra hircus (goat) and especially Manis javanica (Malayan pangolin) were able to render SARS-CoV-2 entry in non-susceptible cells.", "This is the first report that ACE2 of Pangolin could mediate SARS-CoV-2 entry which increases the presume that SARS-CoV-2 may have a pangolin origin.", "However, none of the ACE2 proteins from Rhinolophus ferrumequinum (greater horseshoe bat), Gallus gallus (chicken), Notechis scutatus (mainland tiger snake), Mus musculus (house mouse) rendered SARS-CoV-2 entry.", "Specifically, a natural isoform of Macaca mulatta (Rhesus monkey) ACE2 with a mutation of Y217N was resistance to infection, which rises the possible impact of this type of ACE2 during monkey studies of SARS-CoV-2.", "Overall, these results clarify that SARS-CoV-2 could engage receptors of multiple species of animals and it is a perplexed work to track SARS-CoV-2 origin and its intermediate hosts.", "IMPORTANCE In this study, we illustrated that SARS-CoV-2 is able to engage receptors of multiple species of animals.", "This indicated that it may be a perplexed work to track SARS-CoV-2 origin and discover its intermediate hosts.", "This feature of virus is considered to potentiate its diverse cross-species transmissibility.", "Of note, here is the first report that ACE2 of Pangolin could mediate SARS-CoV-2 entry which increases the possibility that SARS-CoV-2 may have a pangolin origin. And we also demonstrated that not all species of bat were sensitive to SARS-CoV-2 infection.", "At last, it is also important to detect the expression ratio of the Y217N ACE2 to the prototype in Rhesus monkeys to be recruited for studies on SARS-CoV-2 infection."], "title": "Cell entry of SARS-CoV-2 conferred by angiotensin-converting enzyme 2 (ACE2) of different species"}
{"doc_id": 208, "abstract": ["There is an urgent need for the ability to rapidly develop effective countermeasures for emerging biological threats, such as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes the ongoing coronavirus disease 2019 (COVID-19) pandemic.", "We have developed a generalized computational design strategy to rapidly engineer de novo proteins that precisely recapitulate the protein surface targeted by biological agents, like viruses, to gain entry into cells.", "The designed proteins act as decoys that block cellular entry and aim to be resilient to viral mutational escape.", "Using our novel platform, in less than ten weeks, we engineered, validated, and optimized de novo protein decoys of human angiotensin-converting enzyme 2 (hACE2), the membrane-associated protein that SARS-CoV-2 exploits to infect cells.", "Our optimized designs are hyperstable de novo proteins (\u223c18-37 kDa), have high affinity for the SARS-CoV-2 receptor binding domain (RBD) and can potently inhibit the virus infection and replication in vitro.", "Future refinements to our strategy can enable the rapid development of other therapeutic de novo protein decoys, not limited to neutralizing viruses, but to combat any agent that explicitly interacts with cell surface proteins to cause disease."], "title": "De novo design of ACE2 protein decoys to neutralize SARS-CoV-2"}
{"doc_id": 209, "abstract": ["An ongoing outbreak of pneumonia associated with 2019 novel coronavirus was reported in China.", "It is unclear whether the virus is infective exists during the incubation period, although person-to-person transmission has been reported elsewhere.", "We report the epidemiological features of a familial cluster of 4 patients in Shanghai, including an 88-year-old man with limited mobility who was exposed only to asymptomatic family members whose symptoms developed later.", "The epidemiological evidence has shown possible transmission of 2019 novel coronavirus during the incubation period."], "title": "A Familial Cluster of Infection Associated With the 2019 Novel Coronavirus Indicating Possible Person-to-Person Transmission During the Incubation Period"}
{"doc_id": 210, "abstract": ["The novel coronavirus SARS-CoV2 has been observed to cause a higher incidence and greater severity of disease in males, as seen in multiple cohorts across the globe.", "The reasons for gender disparity in disease severity is unclear and can be due to host factors.", "To determine whether males have delayed viral clearance after infection, we evaluated the time to clearance in symptomatic patients tested by serial oropharyngeal/nasopharyngeal swabs followed by RT-PCR at a reference lab in Mumbai, India.", "A total of 68 subjects with median age of 37 years (3-75 range) were examined and included 48 (71%) males and 20 (29%) females.", "We observed that females were able to achieve viral clearance significantly earlier than males, with a median difference of 2 days in achieving a negative PCR result (P value = 0.038).", "Furthermore, examination of 3 families with both male and female patients followed serially, demonstrated that female members of the same household cleared the SARS-CoV2 infection earlier in each family.", "To determine reasons for delayed clearance in males, we examined the expression patterns of the SARS-CoV2 receptor, Angiotensin-converting enzyme 2 (ACE2), in tissue specific repositories.", "We observed that the testes was one of the highest sites of ACE2 expression in 3 independent RNA expression databases (Human Protein Atlas, FAMTOM5 and GETx).", "ACE2 was also determined to be highly expressed in testicular cells at the protein levels.", "Interestingly, very little expression of ACE2 was seen in ovarian tissue.", "Taken together, these observations demonstrate for the first time that male subjects have delayed viral clearance of SARS-CoV2.", "High expression of ACE2 in testes raises the possibility that testicular viral reservoirs may play a role in viral persistence in males and should be further investigated."], "title": "Delayed clearance of SARS-CoV2 in male compared to female patients: High ACE2 expression in testes suggests possible existence of gender-specific viral reservoirs"}
{"doc_id": 211, "abstract": ["We developed a global peptide vaccine against SARS-CoV-2 that addresses the dual challenges of heterogeneity in the immune responses of different individuals and potential heterogeneity of the infecting virus.", "PolyPEPI-SCoV-2 is a polypeptide vaccine containing nine 30-mer peptides derived from all four major structural proteins of the SARS-CoV-2.", "Vaccine peptides were selected based on their frequency as HLA class I and class II personal epitopes (PEPIs) restricted to multiple autologous HLA alleles of individuals in an in silico cohort of 433 subjects of different ethnicities.", "PolyPEPI-SCoV-2 vaccine administered with Montanide ISA 51VG adjuvant generated robust, Th1-biased CD8+ and CD4+ T cell responses against all four structural proteins of the virus, as well as binding antibodies upon subcutaneous injection into BALB/c and CD34+ transgenic mice.", "In addition, PolyPEPI-SCoV-2-specific, polyfunctional CD8+ and CD4+ T cells were detected ex vivo in each of the 17 asymptomatic/mild COVID-19 convalescents\u2019 blood investigated, 1\u20135 months after symptom onset.", "The PolyPEPI-SCoV-2-specific T cell repertoire used for recovery from COVID-19 was extremely diverse: donors had an average of seven different peptide-specific T cells, against the SARS-CoV-2 proteins; 87% of donors had multiple targets against at least three SARS-CoV-2 proteins and 53% against all four.", "In addition, PEPIs determined based on the complete HLA class I genotype of the convalescent donors were validated, with 84% accuracy, to predict PEPI-specific CD8+ T cell responses measured for the individuals.", "Extrapolation of the above findings to a US bone marrow donor cohort of 16,000 HLA-genotyped individuals with 16 different ethnicities (n=1,000 each ethnic group) suggest that PolyPEPI-SCoV-2 vaccination in a general population will likely elicit broad, multi-antigenic CD8+ and CD4+ T cell responses in 98% of individuals, independent of ethnicity, including Black, Asian, and Minority Ethnic (BAME) cohorts."], "title": "Peptide vaccine candidate mimics the heterogeneity of natural SARS-CoV-2 immunity in convalescent humans and induces broad T cell responses in mice models"}
{"doc_id": 212, "abstract": ["The causative agent of the current pandemic and coronavirus disease 2019 (COVID-19) is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)1.", "Understanding how SARS-CoV-2 enters and spreads within human organs is crucial for developing strategies to prevent viral dissemination.", "For many viruses, tissue tropism is determined by the availability of virus receptors on the surface of host cells2.", "Both SARS-CoV and SARS-CoV-2 use angiotensin-converting enzyme 2 (ACE2) as a host receptor, yet, their tropisms differ3-5.", "Here, we found that the cellular receptor neuropilin-1 (NRP1), known to bind furin-cleaved substrates, significantly potentiates SARS-CoV-2 infectivity, which was inhibited by a monoclonal blocking antibody against the extracellular b1b2 domain of NRP1.", "NRP1 is abundantly expressed in the respiratory and olfactory epithelium, with highest expression in endothelial cells and in the epithelial cells facing the nasal cavity.", "Neuropathological analysis of human COVID-19 autopsies revealed SARS-CoV-2 infected NRP1-positive cells in the olfactory epithelium and bulb.", "In the olfactory bulb infection was detected particularly within NRP1-positive endothelial cells of small capillaries and medium-sized vessels.", "Studies in mice demonstrated, after intranasal application, NRP1-mediated transport of virus-sized particles into the central nervous system.", "Thus, NRP1 could explain the enhanced tropism and spreading of SARS-CoV-2."], "title": "Neuropilin-1 facilitates SARS-CoV-2 cell entry and provides a possible pathway into the central nervous system"}
{"doc_id": 213, "abstract": ["To contain the coronavirus disease 2019 (COVID-19) pandemic, a safe and effective vaccine against the new severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is urgently needed in quantities sufficient to immunise large populations.", "In this study, we report the design, preclinical development, immunogenicity and anti-viral protective effect in rhesus macaques of the BNT162b2 vaccine candidate.", "BNT162b2 contains an LNP-formulated nucleoside-modified mRNA that encodes the spike glycoprotein captured in its prefusion conformation.", "After expression of the BNT162b2 coding sequence in cells, approximately 20% of the spike molecules are in the one-RBD \u2018up\u2019, two-RBD \u2018down\u2019 state.", "Immunisation of mice with a single dose of BNT162b2 induced dose level-dependent increases in pseudovirus neutralisation titers.", "Prime-boost vaccination of rhesus macaques elicited authentic SARS-CoV-2 neutralising geometric mean titers 10.2 to 18.0 times that of a SARS-CoV-2 convalescent human serum panel.", "BNT162b2 generated strong TH1 type CD4+ and IFN\u03b3+ CD8+ T-cell responses in mice and rhesus macaques.", "The BNT162b2 vaccine candidate fully protected the lungs of immunised rhesus macaques from infectious SARS-CoV-2 challenge.", "BNT162b2 is currently being evaluated in a global, pivotal Phase 2/3 trial (NCT04368728)."], "title": "A prefusion SARS-CoV-2 spike RNA vaccine is highly immunogenic and prevents lung infection in non-human primates"}
{"doc_id": 214, "abstract": ["Infections with SARS-CoV-2 lead to mild to severe coronavirus disease-19 (COVID-19) with systemic symptoms.", "Although the viral infection originates in the respiratory system, it is unclear how the virus can overcome the alveolar barrier, which is observed in severe COVID-19 disease courses.", "To elucidate the viral effects on the barrier integrity and immune reactions, we used mono-cell culture systems and a complex human alveolus-on-a-chip model composed of epithelial, endothelial, and mononuclear cells.", "Our data show that SARS-CoV-2 efficiently infected epithelial cells with high viral loads and inflammatory response, including the interferon expression.", "By contrast, the adjacent endothelial layer was no infected and did neither show productive virus replication or interferon release.", "With prolonged infection, both cell types are damaged, and the barrier function is deteriorated, allowing the viral particles to overbear.", "In our study, we demonstrate that although SARS-CoV-2 is dependent on the epithelium for efficient replication, the neighboring endothelial cells are affected, e.g., by the epithelial cytokine release, which results in the damage of the alveolar barrier function and viral dissemination."], "title": "SARS-CoV-2 causes severe alveolar inflammation and barrier dysfunction"}
{"doc_id": 215, "abstract": ["We describe a case of chronic COVID-19 in a patient with lymphoma and associated B-cell immunodeficiency.", "Viral cultures and sequence analysis demonstrate ongoing replication of infectious SARS-CoV-2 virus for at least 119 days.", "The patient had three admissions related to COVID-19 over a four-month period and was treated twice with remdesivir and convalescent plasma with resolution of symptoms.", "The patient's lack of seroconversion and prolonged course illustrate the importance of humoral immunity in resolving SARS-CoV-2 infection.", "This case highlights challenges in managing immunocompromised hosts, who may act as persistent shedders and sources of transmission."], "title": "Prolonged SARS-CoV-2 replication in an immunocompromised patient"}
{"doc_id": 216, "abstract": ["Importance Coronavirus disease 2019 (COVID-19) may lead to serious illness as a result of an excessive immune response.", "Fluvoxamine may prevent clinical deterioration by stimulating the \u03c3-1 receptor, which regulates cytokine production.", "Objective To determine whether fluvoxamine, given during mild COVID-19 illness, prevents clinical deterioration and decreases the severity of disease.", "Design, Setting, and Participants Double-blind, randomized, fully remote (contactless) clinical trial of fluvoxamine vs placebo.", "Participants were community-living, nonhospitalized adults with confirmed severe acute respiratory syndrome coronavirus 2 infection, with COVID-19 symptom onset within 7 days and oxygen saturation of 92% or greater.", "One hundred fifty-two participants were enrolled from the St Louis metropolitan area (Missouri and Illinois) from April 10, 2020, to August 5, 2020.", "The final date of follow-up was September 19, 2020.", "Interventions Participants were randomly assigned to receive 100 mg of fluvoxamine (n = 80) or placebo (n = 72) 3 times daily for 15 days.", "Main Outcomes and Measures The primary outcome was clinical deterioration within 15 days of randomization defined by meeting both criteria of (1) shortness of breath or hospitalization for shortness of breath or pneumonia and (2) oxygen saturation less than 92% on room air or need for supplemental oxygen to achieve oxygen saturation of 92% or greater.", "Results Of 152 patients who were randomized (mean [SD] age, 46 [13] years; 109 [72%] women), 115 (76%) completed the trial.", "Clinical deterioration occurred in 0 of 80 patients in the fluvoxamine group and in 6 of 72 patients in the placebo group (absolute difference, 8.7% [95% CI, 1.8%-16.4%] from survival analysis; log-rank P = .009).", "The fluvoxamine group had 1 serious adverse event and 11 other adverse events, whereas the placebo group had 6 serious adverse events and 12 other adverse events.", "Conclusions and Relevance In this preliminary study of adult outpatients with symptomatic COVID-19, patients treated with fluvoxamine, compared with placebo, had a lower likelihood of clinical deterioration over 15 days.", "However, the study is limited by a small sample size and short follow-up duration, and determination of clinical efficacy would require larger randomized trials with more definitive outcome measures.", "Trial Registration ClinicalTrials.gov Identifier: NCT04342663."], "title": "Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial."}
{"doc_id": 217, "abstract": ["Superspreaders, infected individuals who result in an outsized number of secondary cases, are believed to underlie a significant fraction of total SARS-CoV-2 transmission.", "Here, we combine empirical observations of SARS-CoV and SARS-CoV-2 transmission and extreme value statistics to show that the distribution of secondary cases is consistent with being fat-tailed, implying that large superspreading events are extremal, yet probable, occurrences.", "We integrate these results with interaction-based network models of disease transmission and show that superspreading, when it is fat-tailed, leads to pronounced transmission by increasing dispersion.", "Our findings indicate that large superspreading events should be the targets of interventions that minimize tail exposure."], "title": "Evidence that coronavirus superspreading is fat-tailed"}
{"doc_id": 218, "abstract": ["Objective: To evaluate differences by race/ethnicity in clinical characteristics and outcomes among hospitalized patients with Covid-19 at Massachusetts General Hospital (MGH).", "Methods: The MGH Covid-19 Registry includes confirmed SARS-CoV-2-infected patients hospitalized at MGH and is based on manual chart reviews and data extraction from electronic health records (EHRs).", "We evaluated differences between White/Non-Hispanic and Hispanic patients in demographics, complications and 14-day outcomes among the N=866 patients hospitalized with Covid-19 from March 11, 2020-May 4, 2020.", "Results: Overall, 43% of patients hospitalized with Covid-19 were women, median age was 60.4 [IQR = (48.2, 75)], 11.3% were Black/non-Hispanic and 35.2% were Hispanic.", "Hispanic patients, representing 35.2% of patients, were younger than White/non-Hispanic patients [median age 51y; IQR = (40.6, 61.6) versus 72y; (58.0, 81.7) (p<0.001)].", "Hispanic patients were symptomatic longer before presenting to care (median 5 vs 3d, p=0.039) but were more likely to be sent home with self-quarantine than be admitted to hospital (29% vs 16%, p<0.001).", "Hispanic patients had fewer comorbidities yet comparable rates of ICU or death (34% vs 36%).", "Nonetheless, a greater proportion of Hispanic patients recovered by 14 days after presentation (62% vs 45%, p<0.001; OR = 1.99, p = 0.011 in multivariable adjusted model) and fewer died (2% versus 18%, p<0.001).", "Conclusions: Hospitalized Hispanic patients were younger and had fewer comorbidities compared to White/non-Hispanic patients; despite comparable rates of ICU care or death, a greater proportion recovered.", "These results have implications for public health policy and the design and conduct of clinical trials."], "title": "Massachusetts General Hospital Covid-19 Registry reveals two distinct populations of hospitalized patients by race and ethnicity"}
{"doc_id": 219, "abstract": ["Background: Whether antibody levels measured by commercially-available enzyme or chemiluminescent immunoassays targeting the SARS-CoV-2 spike (S) protein can act as a proxy for serum neutralizing activity remains to be established for many of these assays.", "Objectives: To evaluate the degree of correlation between neutralizing antibodies (NtAb) binding the SARS-CoV-2 Spike (S) protein and SARS-CoV-2-S-IgG levels measured by four commercial immunoassays in sera drawn from hospitalized COVID-19 patients.", "Patients and Methods: Ninety sera from 51 hospitalized COVID-19 patients were assayed by a pseudotyped virus neutralization assay, the LIAISON SARS-CoV-2 S1/S2 IgG, the Euroimmun SARS-CoV-2 IgG ELISA, the MAGLUMI 2019-nCoV IgG and the COVID-19 ELISA IgG assays.", "Results: Overall, the results obtained with the COVID-19 ELISA IgG test showed the highest agreement with the NtAb assay ({kappa}, 0.85; 95% CI, 0.63-1).", "The most sensitive tests were the pseudotyped virus NtAb assay and the COVID-19 ELISA IgG assay (92.2% for both).", "Overall, the degree correlation between antibody titers resulting in 50% virus neutralization (NtAb50) in the pseudotyped virus assay and SARS-CoV-2 IgG levels was strong for the Euroimmun SARS-CoV-2 IgG ELISA (Rho=0.73) and moderate for the remaining assays (Rho=0.48 to 0.59).", "The kinetic profile of serum NtAb50 titers could not be reliably predicted by any of the SARS-CoV-2 IgG immunoassays.", "Conclusions: the suitability of SARS-CoV-2-S-IgG commercial immunoassays for inferring neutralizing activity of sera from hospitalized COVID-19 patients varies widely across tests and is influenced by the time of sera collection after the onset of symptoms."], "title": "Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays"}
{"doc_id": 220, "abstract": ["Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) has resulted in a pandemic and continues to spread around the globe at an unprecedented rate.", "To date, no effective therapeutic is available to fight its associated disease, COVID-19.", "Our discovery of a novel insertion of glycosaminoglycan (GAG)-binding motif at S1/S2 proteolytic cleavage site (681-686 (PRRARS)) and two other GAG-binding-like motifs within SARS-CoV-2 spike glycoprotein (SGP) led us to hypothesize that host cell surface GAGs might be involved in host cell entry of SARS-CoV-2.", "Using a surface plasmon resonance direct binding assay, we found that both monomeric and trimeric SARS-CoV-2 spike more tightly bind to immobilized heparin (KD = 40 pM and 73 pM, respectively) than the SARS-CoV and MERS-CoV SGPs (500 nM and 1 nM, respectively).", "In competitive binding studies, the IC50 of heparin, tri-sulfated non-anticoagulant heparan sulfate, and non-anticoagulant low molecular weight heparin against SARS-CoV-2 SGP binding to immobilized heparin were 0.056 \u03bcM, 0.12 \u03bcM, and 26.4 \u03bcM, respectively.", "Finally, unbiased computational ligand docking indicates that heparan sulfate interacts with the GAG-binding motif at the S1/S2 site on each monomer interface in the trimeric SARS-CoV-2 SGP, and at another site (453-459 (YRLFRKS)) when the receptor-binding domain is in an open conformation.", "Our study augments our knowledge in SARS-CoV-2 pathogenesis and advances carbohydrate-based COVID-19 therapeutic development."], "title": "Glycosaminoglycan binding motif at S1/S2 proteolytic cleavage site on spike glycoprotein may facilitate novel coronavirus (SARS-CoV-2) host cell entry"}
{"doc_id": 221, "abstract": ["Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) has resulted in a pandemic and continues to spread around the globe at an unprecedented rate.", "To date, no effective therapeutic is available to fight its associated disease, COVID-19.", "Our discovery of a novel insertion of glycosaminoglycan (GAG)-binding motif at S1/S2 proteolytic cleavage site (681-686 (PRRARS)) and two other GAG-binding-like motifs within SARS-CoV-2 spike glycoprotein (SGP) led us to hypothesize that host cell surface GAGs may interact SARS-CoV-2 SGPs to facilitate host cell entry.", "Using a surface plasmon resonance direct binding assay, we found that both monomeric and trimeric SARS-CoV-2 SGP bind more tightly to immobilized heparin (KD = 40 pM and 73 pM, respectively) than the SARS-CoV and MERS-CoV SGPs (500 nM and 1 nM, respectively).", "In competitive binding studies, the IC50 of heparin, tri-sulfated non-anticoagulant heparan sulfate, and non-anticoagulant low molecular weight heparin against SARS-CoV-2 SGP binding to immobilized heparin were 0.056 \u00b5M, 0.12 \u00b5M, and 26.4 \u00b5M, respectively.", "Finally, unbiased computational ligand docking indicates that heparan sulfate interacts with the GAG-binding motif at the S1/S2 site on each monomer interface in the trimeric SARS-CoV-2 SGP, and at another site (453-459 (YRLFRKS)) when the receptor-binding domain is in an open conformation.", "The current study serves a foundation to further investigate biological roles of GAGs in SARS-CoV-2 pathogenesis.", "Furthermore, our findings may provide additional basis for further heparin-based interventions for COVID-19 patients exhibiting thrombotic complications."], "title": "Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions"}
{"doc_id": 222, "abstract": ["BACKGROUND: The ongoing COVID-19 pandemic warrants accelerated efforts to test vaccine candidates.", "We aimed to assess the safety and immunogenicity of an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine candidate, BBIBP-CorV, in humans.", "METHODS: We did a randomised, double-blind, placebo-controlled, phase 1/2 trial at Shangqiu City Liangyuan District Center for Disease Control and Prevention in Henan Province, China.", "In phase 1, healthy people aged 18-80 years, who were negative for serum-specific IgM/IgG antibodies against SARS-CoV-2 at the time of screening, were separated into two age groups (18-59 years and &#8805;60 years) and randomly assigned to receive vaccine or placebo in a two-dose schedule of 2 \u00b5g, 4 \u00b5g, or 8 \u00b5g on days 0 and 28.", "In phase 2, healthy adults (aged 18-59 years) were randomly assigned (1:1:1:1) to receive vaccine or placebo on a single-dose schedule of 8 \u00b5g on day 0 or on a two-dose schedule of 4 \u00b5g on days 0 and 14, 0 and 21, or 0 and 28.", "Participants within each cohort were randomly assigned by stratified block randomisation (block size eight) and allocated (3:1) to receive vaccine or placebo.", "Group allocation was concealed from participants, investigators, and outcome assessors.", "The primary outcomes were safety and tolerability.", "The secondary outcome was immunogenicity, assessed as the neutralising antibody responses against infectious SARS-CoV-2.", "This study is registered with www.chictr.org.cn, ChiCTR2000032459.", "FINDINGS: In phase 1, 192 participants were enrolled (mean age 53\u00b77 years [SD 15\u00b76]) and were randomly assigned to receive vaccine (2 \u00b5g [n=24], 4 \u00b5g [n=24], or 8 \u00b5g [n=24] for both age groups [18-59 years and &#8805;60 years]) or placebo (n=24).", "At least one adverse reaction was reported within the first 7 days of inoculation in 42 (29%) of 144 vaccine recipients.", "The most common systematic adverse reaction was fever (18-59 years, one [4%] in the 2 \u00b5g group, one [4%] in the 4 \u00b5g group, and two [8%] in the 8 \u00b5g group; &#8805;60 years, one [4%] in the 8 \u00b5g group).", "All adverse reactions were mild or moderate in severity.", "No serious adverse event was reported within 28 days post vaccination.", "Neutralising antibody geometric mean titres were higher at day 42 in the group aged 18-59 years (87\u00b77 [95% CI 64\u00b79-118\u00b76], 2 \u00b5g group; 211\u00b72 [158\u00b79-280\u00b76], 4 \u00b5g group; and 228\u00b77 [186\u00b71-281\u00b71], 8 \u00b5g group) and the group aged 60 years and older (80\u00b77 [65\u00b74-99\u00b76], 2 \u00b5g group; 131\u00b75 [108\u00b72-159\u00b77], 4 \u00b5g group; and 170\u00b787 [133\u00b70-219\u00b75], 8 \u00b5g group) compared with the placebo group (2\u00b70 [2\u00b70-2\u00b70]).", "In phase 2, 448 participants were enrolled (mean age 41\u00b77 years [SD 9\u00b79]) and were randomly assigned to receive the vaccine (8 \u00b5g on day 0 [n=84] or 4 \u00b5g on days 0 and 14 [n=84], days 0 and 21 [n=84], or days 0 and 28 [n=84]) or placebo on the same schedules (n=112).", "At least one adverse reaction within the first 7 days was reported in 76 (23%) of 336 vaccine recipients (33 [39%], 8 \u00b5g day 0; 18 [21%], 4 \u00b5g days 0 and 14; 15 [18%], 4 \u00b5g days 0 and 21; and ten [12%], 4 \u00b5g days 0 and 28).", "One placebo recipient in the 4 \u00b5g days 0 and 21 group reported grade 3 fever, but was self-limited and recovered.", "All other adverse reactions were mild or moderate in severity.", "The most common systematic adverse reaction was fever (one [1%], 8 \u00b5g day 0; one [1%], 4 \u00b5g days 0 and 14; three [4%], 4 \u00b5g days 0 and 21; two [2%], 4 \u00b5g days 0 and 28).", "The vaccine-elicited neutralising antibody titres on day 28 were significantly greater in the 4 \u00b5g days 0 and 14 (169\u00b75, 95% CI 132\u00b72-217\u00b71), days 0 and 21 (282\u00b77, 221\u00b72-361\u00b74), and days 0 and 28 (218\u00b70, 181\u00b78-261\u00b73) schedules than the 8 \u00b5g day 0 schedule (14\u00b77, 11\u00b76-18\u00b78; all p<0\u00b7001).", "INTERPRETATION: The inactivated SARS-CoV-2 vaccine, BBIBP-CorV, is safe and well tolerated at all tested doses in two age groups.", "Humoral responses against SARS-CoV-2 were induced in all vaccine recipients on day 42.", "Two-dose immunisation with 4 \u00b5g vaccine on days 0 and 21 or days 0 and 28 achieved higher neutralising antibody titres than the single 8 \u00b5g dose or 4 \u00b5g dose on days 0 and 14.", "FUNDING: National Program on Key Research Project of China, National Mega projects of China for Major Infectious Diseases, National Mega Projects of China for New Drug Creation, and Beijing Science and Technology Plan."], "title": "Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial"}
{"doc_id": 223, "abstract": ["New Zealand responded to the COVID-19 pandemic with a combination of border restrictions and an Alert Level (AL) system that included strict stay-at-home orders.", "These interventions were successful in containing an outbreak and ultimately eliminating community transmission of COVID-19 in June 2020.", "The timing of interventions is crucial to their success.", "Delaying interventions may reduce their effectiveness and mean that they need to be maintained for a longer period.", "We use a stochastic branching process model of COVID-19 transmission and control to simulate the epidemic trajectory in New Zealand's March\u2013April 2020 outbreak and the effect of its interventions.", "We calculate key measures, including the number of reported cases and deaths, and the probability of elimination within a specified time frame.", "By comparing these measures under alternative timings of interventions, we show that changing the timing of AL4 (the strictest level of restrictions) has a far greater impact than the timing of border measures.", "Delaying AL4 restrictions results in considerably worse outcomes.", "Implementing border measures alone, without AL4 restrictions, is insufficient to control the outbreak.", "We conclude that the early introduction of stay-at-home orders was crucial in reducing the number of cases and deaths, enabling elimination."], "title": "Early intervention is the key to success in COVID-19 control"}
{"doc_id": 224, "abstract": ["COVID-19, which is a consequence of infection with the novel viral agent SARS-CoV-2, first identified in China (Hubei Province), has been declared a pandemic by the WHO.", "As of September 10, 2020, over 70,000 cases and over 2,000 deaths have been recorded in Poland.", "Of the many factors contributing to the level of transmission of the virus, the weather appears to be significant.", "In this work we analyse the impact of weather factors such as temperature, relative humidity, wind speed and ground level ozone concentration on the number of COVID-19 cases in Warsaw, Poland.", "The obtained results show an inverse correlation between ground level ozone concentration and the daily number of COVID-19 cases."], "title": "The ground level ozone concentration is inversely correlated with the number of COVID-19 cases in Warsaw, Poland"}
{"doc_id": 225, "abstract": ["Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), which was first reported in Wuhan, China in November 2019 has developed into a pandemic since March 2020, causing substantial human casualties and economic losses.", "Studies on SARS-CoV-2 are being carried out at an unprecedented rate to tackle this threat.", "Genomics studies, in particular, are indispensable to elucidate the dynamic nature of the RNA genome of SARS-CoV-2.", "RNA viruses are marked by their unique ability to undergo high rates of mutation in their genome, much more frequently than their hosts, which diversifies their strengths qualifying them to elude host immune response and amplify drug resistance.", "In this study, we sequenced and analyzed the genomic information of the SARS-CoV-2 isolates from two infected Indian patients and explored the possible implications of point mutations in its biology.", "In addition to multiple point mutations, we found a remarkable similarity between relatively common mutations of 36-nucleotide deletion in ORF8 of SARS-CoV-2.", "Our results corroborate with the earlier reported 29-nucleotide deletion in SARS, which was frequent during the early stage of human-to-human transmission.", "The results will be useful to understand the biology of SARS-CoV-2 and itsattenuation for vaccine development."], "title": "Identification of unique mutations in SARS-CoV-2 strains isolated from India suggests its attenuated pathotype"}
{"doc_id": 226, "abstract": ["The COVID-19 pandemic caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has led to more than 100,000 deaths in the United States.", "Several studies have revealed that the hyper-inflammatory response induced by SARS-CoV-2 is a major cause of disease severity and death in infected patients.", "However, predictive biomarkers of pathogenic inflammation to help guide targetable immune pathways are critically lacking.", "We implemented a rapid multiplex cytokine assay to measure serum IL-6, IL-8, TNF-, and IL-1{beta} in hospitalized COVID-19 patients upon admission to the Mount Sinai Health System in New York.", "Patients (n=1484) were followed up to 41 days (median 8 days) and clinical information, laboratory test results and patient outcomes were collected.", "In 244 patients, cytokine measurements were repeated over time, and effect of drugs could be assessed.", "Kaplan-Meier methods were used to compare survival by cytokine strata, followed by Cox regression models to evaluate the independent predictive value of baseline cytokines.", "We found that high serum IL-6, IL-8, and TNF-levels at the time of hospitalization were strong and independent predictors of patient survival.", "Importantly, when adjusting for disease severity score, common laboratory inflammation markers, hypoxia and other vitals, demographics, and a range of comorbidities, IL-6 and TNF-serum levels remained independent and significant predictors of disease severity and death.", "We propose that serum IL-6 and TNF-levels should be considered in the management and treatment of COVID-19 patients to stratify prospective clinical trials, guide resource allocation and inform therapeutic options.", "We also propose that patients with high IL-6 and TNF-levels should be assessed for combinatorial blockade of pathogenic inflammation in this disease."], "title": "An inflammatory cytokine signature helps predict COVID-19 severity and death"}
{"doc_id": 227, "abstract": ["Without an effective prophylactic solution, infections from SARS-CoV-2 continue to rise worldwide with devastating health and economic costs.", "SARS-CoV-2 gains entry into host cells via an interaction between its Spike protein and the host cell receptor angiotensin converting enzyme 2 (ACE2).", "Disruption of this interaction confers potent neutralization of viral entry, providing an avenue for vaccine design and for therapeutic antibodies.", "Here, we develop single-domain antibodies (nanobodies) that potently disrupt the interaction between the SARS-CoV-2 Spike and ACE2.", "By screening a yeast surface-displayed library of synthetic nanobody sequences, we identified a panel of nanobodies that bind to multiple epitopes on Spike and block ACE2 interaction via two distinct mechanisms.", "Cryogenic electron microscopy (cryo-EM) revealed that one exceptionally stable nanobody, Nb6, binds Spike in a fully inactive conformation with its receptor binding domains (RBDs) locked into their inaccessible down-state, incapable of binding ACE2.", "Affinity maturation and structure-guided design of multivalency yielded a trivalent nanobody, mNb6-tri, with femtomolar affinity for SARS-CoV-2 Spike and picomolar neutralization of SARS-CoV-2 infection.", "mNb6-tri retains stability and function after aerosolization, lyophilization, and heat treatment.", "These properties may enable aerosol-mediated delivery of this potent neutralizer directly to the airway epithelia, promising to yield a widely deployable, patient-friendly prophylactic and/or early infection therapeutic agent to stem the worst pandemic in a century."], "title": "An ultra-potent synthetic nanobody neutralizes SARS-CoV-2 by locking Spike into an inactive conformation"}
{"doc_id": 228, "abstract": ["Rationale: whether systemic dissemination of SARS-CoV-2 has any impact on COVID-19 severity and also on the immunological alterations observed in this disease is largely unknown.", "Objectives: We determined the association of plasma SARS-CoV-2 RNA with clinical severity, laboratory findings and immunological parameters in a cohort of 250 patients with confirmed COVID-19 infection.", "Methods: Three groups of patients were studied: 50 outpatients, 100 hospitalised ward patients, and 100 critically ill.", "The association between plasma SARS-CoV-2 RNA and severity was evaluated using multivariate ordinal logistic regression analysis and Generalized Linear Model (GLM) analysis with a binomial distribution.", "The association between plasma SARS-CoV-2 RNA and laboratory parameters was evaluated using multivariate GLM with a gamma distribution.", "Measurements and Main Results: The prevalence of SARS-CoV-2-RNA viremia increased in parallel with severity of infection (22% in outpatients, 36 % in those hospitalised in wards, and 82% in those at the ICU).", "In hospitalised patients, the presence of SARS-CoV-2-RNA viremia was independently associated to critical illness: (adjusted OR= 8.30 [CI95%=4.21-16.34], p < 0.001).", "SARS-CoV-2-RNA viremia was an independent predictor of higher levels of ferritin, LDH and cytokines (involving CXCL10, CCL-2, IL-15, IL-10, IL-1ra and GCS-F), and lower of lymphocytes, monocytes and platelets counts Conclusions: SARS-CoV-2-RNA viremia is a robust marker of critical illness in COVID-19.", "Our findings support that hypercytokinemia in COVID-19 is a reactive event in response to the dissemination of viral material at the systemic level."], "title": "SARS-CoV-2-RNA viremia is associated to hypercytokinemia and critical illness in COVID-19"}
{"doc_id": 229, "abstract": ["PURPOSE: Conjunctival signs and symptoms are observed in a subset of patients with COVID-19, and SARS-CoV-2 has been detected in tears, raising concerns regarding the eye both as a portal of entry and carrier of the virus.", "The purpose of this study was to determine whether ocular surface cells possess the key factors required for cellular susceptibility to SARS-CoV-2 entry/infection.", "METHODS: We analyzed human post-mortem eyes as well as surgical specimens for the expression of ACE2 (the receptor for SARS-CoV-2) and TMPRSS2, a cell surface-associated protease that facilitates viral entry following binding of the viral spike protein to ACE2.", "RESULTS: Across all eye specimens, immunohistochemical analysis revealed expression of ACE2 in the conjunctiva, limbus, and cornea, with especially prominent staining in the superficial conjunctival and corneal epithelial surface.", "Surgical conjunctival specimens also showed expression of ACE2 in the conjunctival epithelium, especially prominent in the superficial epithelium, as well as weak or focal expression in the substantia propria.", "All eye and conjunctival specimens also expressed TMPRSS2.", "Finally, Western blot analysis of protein lysates from human corneal epithelium obtained during refractive surgery confirmed expression of ACE2 and TMPRSS2.", "CONCLUSIONS: Together, these results suggest that ocular surface cells including conjunctiva are susceptible to infection by SARS-CoV-2, and could therefore serve as a portal of entry as well as a reservoir for person-to-person transmission of this virus.", "This highlights the importance of safety practices including face masks and ocular contact precautions in preventing the spread of COVID-19 disease."], "title": "ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection"}
{"doc_id": 230, "abstract": ["PURPOSE: Conjunctival signs and symptoms are observed in a subset of patients with COVID-19, and SARS-CoV-2 has been detected in tears, raising concerns regarding the eye both as a portal of entry and carrier of the virus.", "The purpose of this study was to determine whether ocular surface cells possess the key factors required for cellular susceptibility to SARS-CoV-2 entry/infection.", "METHODS: We analyzed human post-mortem eyes as well as surgical specimens for the expression of ACE2 (the receptor for SARS-CoV-2) and TMPRSS2, a cell surface-associated protease that facilitates viral entry following binding of the viral spike protein to ACE2.", "RESULTS: Across all eye specimens, immunohistochemical analysis revealed expression of ACE2 in the conjunctiva, limbus, and cornea, with especially prominent staining in the superficial conjunctival and corneal epithelial surface.", "Surgical conjunctival specimens also showed expression of ACE2 in the conjunctival epithelium, especially prominent in the superficial epithelium, as well as the substantia propria.", "All eye and conjunctival specimens also expressed TMPRSS2.", "Finally, Western blot analysis of protein lysates from human corneal epithelium obtained during refractive surgery confirmed expression of ACE2 and TMPRSS2.", "CONCLUSIONS: Together, these results suggest that ocular surface cells including conjunctiva are susceptible to infection by SARS-CoV-2, and could therefore serve as a portal of entry as well as a reservoir for person-to-person transmission of this virus.", "This highlights the importance of safety practices including face masks and ocular contact precautions in preventing the spread of COVID-19 disease."], "title": "ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection"}
{"doc_id": 231, "abstract": ["Purpose Conjunctival signs and symptoms are observed in a subset of patients with COVID-19, and SARS-CoV-2 has been detected in tears, raising concerns regarding the eye both as a portal of entry and carrier of the virus.", "The purpose of this study was to determine whether ocular surface cells possess the key factors required for cellular susceptibility to SARS-CoV-2 entry/infection.", "Methods We analyzed human post-mortem eyes as well as surgical specimens for the expression of ACE2 (the receptor for SARS-CoV-2) and TMPRSS2, a cell surface-associated protease that facilitates viral entry following binding of the viral spike protein to ACE2.", "Results Across all eye specimens, immunohistochemical analysis revealed expression of ACE2 in the conjunctiva, limbus, and cornea, with especially prominent staining in the superficial conjunctival and corneal epithelial surface.", "Surgical conjunctival specimens also showed expression of ACE2 in the conjunctival epithelium, especially prominent in the superficial epithelium, as well as the substantia propria.", "All eye and conjunctival specimens also expressed TMPRSS2.", "Finally, western blot analysis of protein lysates from human corneal epithelium obtained during refractive surgery confirmed expression of ACE2 and TMPRSS2.", "Conclusions Together, these results indicate that ocular surface cells including conjunctiva are susceptible to infection by SARS-CoV-2, and could therefore serve as a portal of entry as well as a reservoir for person-to-person transmission of this virus.", "This highlights the importance of safety practices including face masks and ocular contact precautions in preventing the spread of COVID-19 disease."], "title": "ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection"}
{"doc_id": 232, "abstract": ["Non-pharmaceutical interventions have been extensively used worldwide to limit the transmission of SARS-CoV-2, but they also place an enormous social and economic burden on populations .", "We report the results of recent mass testing for SARS-CoV-2 in Slovakia where rapid antigen tests were used to screen the whole population and to isolate infectious cases together with their household members.", "Prevalence of detected infections decreased by 58% (95% CI: 57-58%) within one week in the 45 counties that were subject to two rounds of mass testing.", "Adjusting for geographical clustering and differences in attendance rates and the epidemiological situation at the time of the first round, this changed to 61% (95% CI: 50-70%).", "Adjusting for an estimated growth rate in infections of 4.4% (1.1-6.9%) per day in the week preceding the mass testing campaign and the corresponding expected growth in infection prevalence, the estimated decrease in prevalence compared to a scenario of unmitigated growth was 70% (67-73%).", "Using a microsimulation model we find that this decrease can not be explained solely by infection control measures that were introduced in the weeks preceding the intervention, but requires the additional impact of isolation as well as quarantine of household members of those testing positive during the mass testing campaign."], "title": "The effectiveness of population-wide, rapid antigen test based screening in reducing SARS-CoV-2 infection prevalence in Slovakia"}
{"doc_id": 233, "abstract": ["Coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, has had a dramatic global impact on public health, social, and economic infrastructures.", "Here, we assess immunogenicity and anamnestic protective efficacy in rhesus macaques of the intradermal (ID)-delivered SARS-CoV-2 spike DNA vaccine, INO-4800.", "INO-4800 is an ID-delivered DNA vaccine currently being evaluated in clinical trials.", "Vaccination with INO-4800 induced T cell responses and neutralizing antibody responses against both the D614 and G614 SARS-CoV-2 spike proteins.", "Several months after vaccination, animals were challenged with SARS-CoV-2 resulting in rapid recall of anti-SARS-CoV-2 spike protein T and B cell responses.", "These responses were associated with lower viral loads in the lung and with faster nasal clearance of virus.", "These studies support the immune impact of INO-4800 for inducing both humoral and cellular arms of the adaptive immune system which are likely important for providing durable protection against COVID-19 disease."], "title": "Intradermal-delivered DNA vaccine provides anamnestic protection in a rhesus macaque SARS-CoV-2 challenge model"}
{"doc_id": 234, "abstract": ["BACKGROUND: In the context of the COVID-19 pandemic, numerous new serological test systems for the detection of anti-SARS-CoV-2 antibodies rapidly have become available.", "However, the clinical performance of many of these is still insufficiently described.", "Therefore, we compared three commercial, CE-marked, SARS-CoV-2 antibody assays side by side.", "METHODS: We included a total of 1,154 specimens from pre-COVID-19 times and 65 samples from COVID-19 patients (\u226514 days after symptom onset) to evaluate the test performance of SARS-CoV-2 serological assays by Abbott, Roche, and DiaSorin.", "RESULTS: All three assays presented with high specificities: 99.2% (98.6-99.7) for Abbott, 99.7% (99.2-100.0) for Roche, and 98.3% (97.3-98.9) for DiaSorin.", "In contrast to the manufacturers\u2019 specifications, sensitivities only ranged from 83.1% to 89.2%.", "Although the three methods were in good agreement (Cohen\u2019s Kappa 0.71-0.87), McNemar tests revealed significant differences between results obtained from Roche and DiaSorin.", "However, at low seroprevalences, the minor differences in specificity resulted in profound discrepancies of positive predictive values at 1% seroprevalence: 52.3% (36.2-67.9), 77.6% (52.8-91.5), and 32.6% (23.6-43.1) for Abbott, Roche, and DiaSorin, respectively.", "CONCLUSION: We found diagnostically relevant differences in specificities for the anti-SARS-CoV-2 antibody assays by Abbott, Roche, and DiaSorin that have a significant impact on the positive predictive values of these tests."], "title": "Side by side comparison of three fully automated SARS-CoV-2 antibody assays with a focus on specificity"}
{"doc_id": 235, "abstract": ["Understanding immune memory to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical for improving diagnostics and vaccines and for assessing the likely future course of the COVID-19 pandemic.", "We analyzed multiple compartments of circulating immune memory to SARS-CoV-2 in 254 samples from 188 COVID-19 cases, including 43 samples at &#8805;6 months after infection.", "Immunoglobulin G (IgG) to the spike protein was relatively stable over 6+ months.", "Spike-specific memory B cells were more abundant at 6 months than at 1 month after symptom onset.", "SARS-CoV-2-specific CD4+ T cells and CD8+ T cells declined with a half-life of 3 to 5 months.", "By studying antibody, memory B cell, CD4+ T cell, and CD8+ T cell memory to SARS-CoV-2 in an integrated manner, we observed that each component of SARS-CoV-2 immune memory exhibited distinct kinetics."], "title": "Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection"}
{"doc_id": 236, "abstract": ["Study Objective: The COVID-19 pandemic has resulted in widespread shortages in personal protective equipment, including N95 respirators.", "While basic surgical facemasks are more commonly available, their efficacy is limited due primarily to their poor face seal.", "This pilot study examined the impact of a rubber band mask brace on a basic surgical mask, as determined by quantitative fit testing.", "Methods: Subjects wearing a basic surgical facemask and the rubber band mask brace underwent quantitative fit testing using machinery designed to certify N95 mask fit.", "Subjects were tested with the brace anchored behind their eyes, with a paperclip behind the head, and on the side knobs of their face shields.", "The primary outcome measure was whether the subject passed the quantitative fit test at or above the OSHA verified standard for N95 masks.", "Results: Subjects (n=11) were 54.5% female, with a median height of 70 inches (IQR 68-74), weight of 170 lbs (IQR 145-215) and BMI of 24.6 (IQR 22.2-27.2), and encompassing 5 distinct N95 mask fit types.", "We found that 45%, 100% and 100% of subjects passed the quantitative fit test when the brace was anchored behind the ears, with a paperclip and on a face shield respectively.", "Conclusion: Of the 11 subjects included in the analysis, across a range of body habitus and N95 mask fit types, all passed the quantitative fit test when the mask brace was anchored on either face shield or with a paperclip.", "This data suggests the brace would offer an improved margin of safety when worn with a basic surgical mask."], "title": "The \"Double Eights Mask Brace\" Improves the Fit and Protection and Protection of a Basic Surgical Mask Amidst Covid-19 Pandemic"}
{"doc_id": 237, "abstract": ["The immune response to SARS-CoV-2 is critical in both controlling primary infection and preventing re-infection.", "However, there is concern that immune responses following natural infection may not be sustained and that this may predispose to recurrent infection.", "We analysed the magnitude and phenotype of the SARS-CoV-2 cellular immune response in 100 donors at six months following primary infection and related this to the profile of antibody level against spike, nucleoprotein and RBD over the previous six months.", "T-cell immune responses to SARS-CoV-2 were present by ELISPOT and/or ICS analysis in all donors and are characterised by predominant CD4+ T cell responses with strong IL-2 cytokine expression.", "Median T-cell responses were 50% higher in donors who had experienced an initial symptomatic infection indicating that the severity of primary infection establishes a \u2018setpoint\u2019 for cellular immunity that lasts for at least 6 months.", "The T-cell responses to both spike and nucleoprotein/membrane proteins were strongly correlated with the peak antibody level against each protein.", "The rate of decline in antibody level varied between individuals and higher levels of nucleoprotein-specific T cells were associated with preservation of NP-specific antibody level although no such correlation was observed in relation to spike-specific responses.", "In conclusion, our data are reassuring that functional SARS-CoV-2-specific T-cell responses are retained at six months following infection although the magnitude of this response is related to the clinical features of primary infection."], "title": "Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection"}
{"doc_id": 238, "abstract": ["During the evolution of SARS-CoV-2 in humans a D614G substitution in the spike (S) protein emerged and became the predominant circulating variant (S-614G) of the COVID-19 pandemic1.", "However, whether the increasing prevalence of the S-614G variant represents a fitness advantage that improves replication and/or transmission in humans or is merely due to founder effects remains elusive.", "Here, we generated isogenic SARS-CoV-2 variants and demonstrate that the S-614G variant has (i) enhanced binding to human host cell surface receptor angiotensin-converting enzyme 2 (ACE2), (ii) increased replication in primary human bronchial and nasal airway epithelial cultures as well as in a novel human ACE2 knock-in mouse model, and (iii) markedly increased replication and transmissibility in hamster and ferret models of SARS-CoV-2 infection.", "Collectively, our data show that while the S-614G substitution results in subtle increases in binding and replication in vitro, it provides a real competitive advantage in vivo, particularly during the transmission bottle neck, providing an explanation for the global predominance of S-614G variant among the SARS-CoV-2 viruses currently circulating."], "title": "SARS-CoV-2 spike D614G change enhances replication and transmission."}
{"doc_id": 239, "abstract": ["During the evolution of SARS-CoV-2 in humans a D614G substitution in the spike (S) protein emerged and became the predominant circulating variant (S-614G) of the COVID-19 pandemic(1).", "However, whether the increasing prevalence of the S-614G variant represents a fitness advantage that improves replication and/or transmission in humans or is merely due to founder effects remains elusive.", "Here, we generated isogenic SARS-CoV-2 variants and demonstrate that the S-614G variant has (i) enhanced binding to human ACE2, (ii) increased replication in primary human bronchial and nasal airway epithelial cultures as well as in a novel human ACE2 knock-in mouse model, and (iii) markedly increased replication and transmissibility in hamster and ferret models of SARS-CoV-2 infection.", "Collectively, our data show that while the S-614G substitution results in subtle increases in binding and replication in vitro, it provides a real competitive advantage in vivo, particularly during the transmission bottle neck, providing an explanation for the global predominance of S-614G variant among the SARS-CoV-2 viruses currently circulating."], "title": "SARS-CoV-2 spike D614G variant confers enhanced replication and transmissibility"}
{"doc_id": 240, "abstract": ["Prognostic models to predict the risk of clinical deterioration in acute COVID-19 are required to inform clinical management decisions.", "Among 75,016 consecutive adults across England, Scotland and Wales prospectively recruited to the ISARIC Coronavirus Clinical Characterisation Consortium (ISARIC4C) study, we developed and validated a multivariable logistic regression model for in-hospital clinical deterioration (defined as any requirement of ventilatory support or critical care, or death) using 11 routinely measured variables.", "We used internal-external cross-validation to show consistent measures of discrimination, calibration and clinical utility across eight geographical regions.", "We further validated the final model in held-out data from 8,252 individuals in London, with similarly consistent performance (C-statistic 0.77 (95% CI 0.75 to 0.78); calibration-in-the-large 0.01 (-0.04 to 0.06); calibration slope 0.96 (0.90 to 1.02)).", "Importantly, this model demonstrated higher net benefit than using other candidate scores to inform decision-making.", "Our 4C Deterioration model thus demonstrates unprecedented clinical utility and generalisability to predict clinical deterioration among adults hospitalised with COVID-19."], "title": "Development and validation of the 4C Deterioration model for adults hospitalised with COVID-19"}
{"doc_id": 241, "abstract": ["Many European countries underwent an unexpected spectacular boost of the daily reported new COVID-19 cases between September 20th and October 18th, imposing in emergency new confinement rules in order to prevent hospitals saturation.", "The present study shows no correlation between the country COVID-19 boost date and its 2 weeks preceding temperature, but shows an impressive correlation with the country latitude.", "As the daily UV insolation earlier decreases in autumn for higher latitudes, this is an additional observation supporting the impact of low vitamin blood D level on the respiratory impairment in COVID-19 disease."], "title": "The unexpected spectacular 2020 October COVID-19 boost in European countries correlated with the latitude, but not with the temperature."}
{"doc_id": 242, "abstract": ["Coronaviruses that infect humans belong to the Alpha-coronavirus (including HCoV-229E) and Beta-coronavirus (including SARS-CoV and SARS-CoV-2) genera.", "In particular, SARS-CoV-2 is currently a major threat to public health worldwide.", "However, no commercial vaccines against the coronaviruses that can infect humans are available.", "The spike (S) homotrimers bind to their receptors through the receptor-binding domain (RBD), which is believed to be a major target to block viral entry.", "In this study, we selected Alpha-coronavirus (HCoV-229E) and Beta-coronavirus (SARS-CoV and SARS-CoV-2) as models.", "Their RBDs were observed to adopt two different conformational states (lying or standing).", "Then, structural and immunological analyses were used to explore differences in the immune response with RBDs among these coronaviruses.", "Our results showed that more RBD-specific antibodies were induced by the S trimer with the RBD in the \u201cstanding\u201d state (SARS-CoV and SARS-CoV-2) than the S trimer with the RBD in the \u201clying\u201d state (HCoV-229E), and the affinity between the RBD-specific antibodies and S trimer was also higher in the SARS-CoV and SARS-CoV-2.", "In addition, we found that the ability of the HCoV-229E RBD to induce neutralizing antibodies was much lower and the intact and stable S1 subunit was essential for producing efficient neutralizing antibodies against HCoV-229E.", "Importantly, our results reveal different vaccine strategies for coronaviruses, and S-trimer is better than RBD as a target for vaccine development in Alpha-coronavirus.", "Our findings will provide important implications for future development of coronavirus vaccines.", "Importance Outbreak of coronaviruses, especially SARS-CoV-2, poses a serious threat to global public health.", "Development of vaccines to prevent the coronaviruses that can infect humans has always been a top priority.", "Coronavirus spike (S) protein is considered as a major target for vaccine development.", "Currently, structural studies have shown that Alpha-coronavirus (HCoV-229E) and Beta-coronavirus (SARS-CoV and SARS-CoV-2) RBDs are in lying and standing state, respectively.", "Here, we tested the ability of S-trimer and RBD to induce neutralizing antibodies among these coronaviruses.", "Our results showed that Beta-CoVs RBDs are in a standing state, and their S proteins can induce more neutralizing antibodies targeting RBD.", "However, HCoV-229E RBD is in a lying state, and its S protein induces a low level of neutralizing antibody targeting RBD.", "Our results indicate that Alpha-coronavirus is more conducive to escape host immune recognition, and also provide novel ideas for the development of vaccines targeting S protein."], "title": "Insight into vaccine development for Alpha-coronaviruses based on structural and immunological analyses of spike proteins"}
{"doc_id": 243, "abstract": ["Preliminary evidence suggests that climate may modulate the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).", "Yet it remains unclear whether seasonal and geographic variations in climate can substantially alter the pandemic trajectory, given that high susceptibility is a core driver.", "Here, we use a climate-dependent epidemic model to simulate the SARS-CoV-2 pandemic by probing different scenarios based on known coronavirus biology.", "We find that although variations in weather may be important for endemic infections, during the pandemic stage of an emerging pathogen, the climate drives only modest changes to pandemic size.", "A preliminary analysis of nonpharmaceutical control measures indicates that they may moderate the pandemic-climate interaction through susceptible depletion.", "Our findings suggest that without effective control measures, strong outbreaks are likely in more humid climates and summer weather will not substantially limit pandemic growth."], "title": "Susceptible supply limits the role of climate in the early SARS-CoV-2 pandemic"}
{"doc_id": 244, "abstract": ["The COVID-19 pandemic has created a public health crisis.", "Because SARS-CoV-2 can spread from individuals with pre-symptomatic, symptomatic, and asymptomatic infections, the re-opening of societies and the control of virus spread will be facilitated by robust population screening, for which virus testing will often be central.", "After infection, individuals undergo a period of incubation during which viral titers are usually too low to detect, followed by an exponential viral growth, leading to a peak viral load and infectiousness, and ending with declining viral levels and clearance.", "Given the pattern of viral load kinetics, we model the effectiveness of repeated population screening considering test sensitivities, frequency, and sample-to-answer reporting time.", "These results demonstrate that effective screening depends largely on frequency of testing and the speed of reporting, and is only marginally improved by high test sensitivity.", "We therefore conclude that screening should prioritize accessibility, frequency, and sample-to-answer time; analytical limits of detection should be secondary."], "title": "Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening"}
{"doc_id": 245, "abstract": ["The coronavirus disease 2019 (COVID-19) pandemic has highlighted the urgent need for effective preventive vaccination to reduce burden and spread of severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) in humans.", "Intranasal vaccination is an attractive strategy to prevent COVID-19 as the nasal mucosa represents the first-line barrier to SARS-CoV-2 entry before viral spread to the lung.", "Although SARS-CoV-2 vaccine development is rapidly progressing, the current intramuscular vaccines are designed to elicit systemic immunity without conferring mucosal immunity.", "Here, we show that AdCOVID, an intranasal adenovirus type 5 (Ad5)-vectored vaccine encoding the receptor binding domain (RBD) of the SARS-CoV-2 spike protein, elicits a strong and focused immune response against RBD through the induction of mucosal IgA, serum neutralizing antibodies and CD4+ and CD8+ T cells with a Th1-like cytokine expression profile.", "Therefore, AdCOVID, which promotes concomitant systemic and local mucosal immunity, represents a promising COVID-19 vaccine candidate."], "title": "Single-dose intranasal administration of AdCOVID elicits systemic and mucosal immunity against SARS-CoV-2 in mice"}
{"doc_id": 246, "abstract": ["A new type of pneumonia caused by a novel coronavirus SARS-CoV-2 outbreaks recently in China and spreads into many other countries.", "This disease, named as COVID-19, is similar to patients infected by SARS-CoV and MERS-CoV, and nearly 20% of patients developed severe condition.", "Cardiac injury is a prevalent complication of severe patients, exacerbating the disease severity in coronavirus disease 2019 (COVID-19) patients.", "Angiotensin-converting enzyme 2 (ACE2), the key host cellular receptor of SARS-CoV-2, has been identified in multiple organs, but its cellular distribution in human heart is not illuminated clearly.", "This study performed the first state-of-art single cell atlas of adult human heart, and revealed that pericytes with high expression of ACE2 might act as the target cardiac cell of SARS-CoV-2.", "The pericytes injury due to virus infection may result in capillary endothelial cells dysfunction, inducing microvascular dysfunction. And patients with basic heart failure disease showed increased ACE2 expression at both mRNA and protein levels, meaning that if infected by the virus these patients may have higher risk of heart attack and critically ill condition.", "The finding of this study explains the high rate of severe cases among COVID-19 patients with basic cardiovascular disease; and these results also perhaps provide important reference to clinical treatment of cardiac injury among severe patients infected by SARS-CoV-2."], "title": "The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2"}
{"doc_id": 247, "abstract": ["Objective Exacerbated pro-inflammatory immune response contributes to COVID-19 pathology.", "Despite the evidence about SARS-CoV-2 infecting the human gut, little is known about the importance of the enteric phase of SARS-CoV-2 for the viral lifecycle and for the development of COVID-19-associated pathologies.", "Similarly, it remains unknown whether the innate immune response triggered in this organ to combat viral infection is similar or distinct compared to the one triggered in other organs.", "Design We exploited human ileum-and colon-derived organoids as a non-transformed culture model supporting SARS-CoV-2 infection.", "We characterized the replication kinetics of SARS-CoV-2 in intestinal epithelial cells and correlated the expression of the viral receptor ACE2 with infection.", "We performed conventional and targeted single-cell transcriptomics and multiplex single-molecule RNA fluorescence in situ hybridization and used IFN-reporter bioassays to characterize the response of primary human intestinal epithelial cells to SARS-CoV-2 infection.", "Results We identified a subpopulation of enterocytes as the prime target of SARS-CoV-2.", "We found the lack of positive correlation between susceptibility to infection and the expression of ACE2 and revealed that SARS-CoV-2 downregulates ACE2 expression upon infection.", "Infected cells activated strong proinflammatory programs and produced interferon, while expression of interferon-stimulated genes was limited to bystander cells due to SARS-CoV-2 suppressing the autocrine action of interferon in infected cells.", "Conclusion Our findings reveal that SARS-CoV-2 curtails the immune response in primary human intestinal epithelial cells to promote its replication and spread and this highlights the gut as a proinflammatory reservoir that should be considered to fully understand SARS-CoV-2 pathogenesis.", "Significance of the study What is already known about this subject?", "COVID-19 patients have gastrointestinal symptoms which likely correlates with SARS-CoV-2 infection of the intestinal epithelium SARS-CoV-2 replicates in human intestinal epithelial cells.", "Intestinal organoids are a good model to study SARS-CoV-2 infection of the gastrointestinal tract There is a limited interferon response in human lung epithelial cells upon SARS-CoV-2 infection.", "What are the new findings?", "A specific subpopulation of enterocytes are the prime targets of SARS-CoV-2 infection of the human gut.", "There is a lack of correlation between ACE2 expression and susceptibility to SARS-CoV-2 infection.", "SARS-CoV-2 downregulates ACE2 expression upon infection.", "Human intestinal epithelium cells produce interferon upon SARS-CoV-2 infection.", "Interferon acts in a paracrine manner to induce interferon stimulated genes that control viral infection only in bystander cells.", "SARS-CoV-2 actively blocks interferon signaling in infected cells.", "How might it impact on clinical practice in the foreseeable future?", "The absence of correlation between ACE2 levels and susceptibility suggest that medications influencing ACE2 levels (e.g. high blood pressure drugs) will not make patients more susceptible to SARS-CoV-2 infection.", "The restricted cell tropism and the distinct immune response mounted by the GI tract, suggests that specific cellular restriction/replication factors and organ specific intrinsic innate immune pathways can represent unique therapeutic targets to treat COVD-19 patients by considering which organ is most infected/impacted by SARS-CoV-2.", "The strong pro-inflammatory signal mounted by the intestinal epithelium can fuel the systemic inflammation observed in COVID-19 patients and is likely participating in the lung specific pathology."], "title": "Single-cell analyses reveal SARS-CoV-2 interference with intrinsic immune response in the human gut"}
{"doc_id": 248, "abstract": ["SARS-CoV-2 coronavirus is responsible for Covid-19 pandemic.", "In the early phase of infection, the single-strand positive RNA genome is translated into non-structural proteins (NSP).", "One of the first proteins produced during viral infection, NSP1, binds to the host ribosome and blocks the mRNA entry channel.", "This triggers translation inhibition of cellular translation.", "In spite of the presence of NSP1 on the ribosome, viral translation proceeds however.", "The molecular mechanism of the so-called viral evasion to NSP1 inhibition remains elusive.", "Here, we confirm that viral translation is maintained in the presence of NSP1.", "The evasion to NSP1-inhibition is mediated by the cis-acting RNA hairpin SL1 in the 5'UTR of SARS-CoV-2.", "NSP1-evasion can be transferred on a reporter transcript by SL1 transplantation.", "The apical part of SL1 is only required for viral translation.", "We show that NSP1 remains bound on the ribosome during viral translation.", "We suggest that the interaction between NSP1 and SL1 frees the mRNA accommodation channel while maintaining NSP1 bound to the ribosome.", "Thus, NSP1 acts as a ribosome gatekeeper, shutting down host translation or fostering SARS-CoV-2 translation depending on the presence of the SL1 5'UTR hairpin.", "SL1 is also present and necessary for translation of sub-genomic RNAs in the late phase of the infectious program.", "Consequently, therapeutic strategies targeting SL1 should affect viral translation at early and late stages of infection.", "Therefore, SL1 might be seen as a genuine 'Achille heel' of the virus."], "title": "The viral protein NSP1 acts as a ribosome gatekeeper for shutting down host translation and fostering SARS-CoV-2 translation."}
{"doc_id": 249, "abstract": ["The Nsp1 protein of SARS-CoV-2 regulates the translation of host and viral mRNAs in cells.", "Nsp1 inhibits host translation initiation by occluding the entry channel of the 40S ribosome subunit.", "The structural study of SARS-CoV-2 Nsp1-ribosomal complexes reported post-termination 80S complex containing Nsp1 and the eRF1 and ABCE1 proteins.", "Considering the presence of Nsp1 in the post-termination 80S ribosomal complex simultaneously with eRF1, we hypothesized that Nsp1 may be involved in translation termination.", "Using a cell-free translation system and reconstituted in vitro translation system, we show that Nsp1 stimulates translation termination in the stop codon recognition stage at all three stop codons.", "This stimulation targets the release factor 1 (eRF1) and does not affect the release factor 3 (eRF3).", "The activity of Nsp1 in translation termination is provided by its N-terminal domain and the minimal required part of eRF1 is NM domain.", "We assume that biological meaning of Nsp1 activity in translation termination is binding with the 80S ribosomes translating host mRNAs and removal them from the pool of the active ribosomes."], "title": "Nsp1 of SARS-CoV-2 Stimulates Host Translation Termination"}
{"doc_id": 250, "abstract": ["STRUCTURED ABSTRACTO_ST_ABSBackgroundC_ST_ABSSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the sole causative agent of coronavirus infectious disease-19 (COVID-19).", "MethodsWe performed a retrospective single-center study of consecutively admitted patients between March 1st and May 15th, 2020, with a definitive diagnosis of SARS-CoV-2 infection.", "The primary end-point was to evaluate the association of lipid markers with 30-days all-cause mortality in COVID-19.", "ResultsA total of 654 patients were enrolled, with an estimated 30-day mortality of 22.8% (149 patients).", "Non-survivors had lower total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-c) levels during the entire course of the disease with complete resolution among survivors.", "Both showed a significant inverse correlation with inflammatory markers and a positive correlation with lymphocyte count.", "In a multivariate analysis, LDL-c [\u00e2\u0089\u00a4] 69 mg/dl (hazard ratio [HR] 1.94; 95% confidence interval [CI] 1.14-3.31), C-reactive protein > 88 mg/dl (HR 2.44; 95% CI, 1.41-4.23) and lymphopenia < 1,000 (HR 2.68; 95% CI, 1.91-3.78) at admission were independently associated with 30-day mortality.", "This association was maintained 7 days after admission.", "ConclusionHypolipidemia in SARS-CoV-2 infection may be secondary to an immune-inflammatory response, with complete recovery in survivors.", "Low LDL-c serum levels are independently associated with higher 30-day mortality in COVID-19 patients."], "title": "Low-density lipoprotein cholesterol levels are associated with poor clinical outcomes in COVID-19"}
{"doc_id": 251, "abstract": ["Importance: The spread of COVID-19 has led to a severe strain on hospital capacity in many countries.", "There is a need for a model to help planners assess expected COVID-19 hospital resource utilization.", "Objective: Provide publicly available tools for predicting future hospital-bed utilization given a succinct characterization of the status of currently hospitalized patients and scenarios for future incoming patients.", "Design: Retrospective cohort study following the day-by-day clinical status of all hospitalized COVID-19 patients in Israel from March 1st to May 2nd, 2020.", "Patient clinical course was modelled with a machine learning approach based on a set of multistate Cox regression-based models with adjustments for right censoring, recurrent events, competing events, left truncation, and time-dependent covariates.", "The model predicts the patient's entire disease course in terms of clinical states, from which we derive the patient's hospital length-of-stay, length-of-stay in critical state, risk of in-hospital mortality, and overall hospital-bed utilization.", "Accuracy assessed over 8 cross-validation cohorts of size 330, using per-day Mean Absolute Error (MAE) of predicted hospital utilization over time; and area under the receiver operating characteristics (AUROC) for individual risk of critical illness and in-hospital mortality, assessed on the first day of hospitalization.", "We present predicted hospital utilization under hypothetical incoming patient scenarios.", "Setting: 27 Israeli hospitals.", "Participants: During the study period, 2,703 confirmed COVID-19 patients were hospitalized in Israel for 1 day or more; 28 were excluded due to missing age or sex; the remaining 2,675 patients were included in the analysis.", "Main Outcomes and Measures: Primary outcome: per-day estimate of total number of hospitalized patients and number of patients in critical state; secondary outcome: risk of a single patient experiencing critical illness or in-hospital mortality.", "Results: For random validation samples of 330 patients, the per-day MAEs for total hospital-bed utilization and critical-bed utilization, averaged over 64 days, were 4.72 {+/-} 1.07 and $1.68 {+/-} 0.40 respectively; the AUROCs for prediction of the probabilities of critical illness and in-hospital mortality were 0.88 {+/-} 0.04 and 0.96 {+/-} 0.04, respectively.", "We further present the impact of several scenarios of patient influx on healthcare system utilization, demonstrating the ability to accurately plan ahead how to allocate healthcare resources.", "Conclusions and Relevance: We developed a model that, given basic easily obtained data as input, accurately predicts total and critical care hospital utilization.", "The model enables evaluating the impact of various patient influx scenarios on hospital utilization.", "Accurate predictions are also given for individual patients' probability of in-hospital mortality and critical illness.", "We further provide an R software package and a web-application for the model."], "title": "Predicting illness trajectory and hospital resource utilization of COVID-19 hospitalized patients - a nationwide study"}
{"doc_id": 252, "abstract": ["UNLABELLED The 5' cap structures of eukaryotic mRNAs are important for RNA stability and protein translation.", "Many viruses that replicate in the cytoplasm of eukaryotes have evolved 2'-O-methyltransferases (2'-O-MTase) to autonomously modify their mRNAs and carry a cap-1 structure (m7GpppNm) at the 5' end, thereby facilitating viral replication and escaping innate immune recognition in host cells.", "Previous studies showed that the 2'-O-MTase activity of severe acute respiratory syndrome coronavirus (SARS-CoV) nonstructural protein 16 (nsp16) needs to be activated by nsp10, whereas nsp16 of feline coronavirus (FCoV) alone possesses 2'-O-MTase activity (E. Decroly et al., J Virol 82:8071-8084, 2008, http://dx.doi.org/10.1128/JVI.00407-08; M. Bouvet et al., PLoS Pathog 6:e1000863, 2010, http://dx.doi.org/10.1371/journal.ppat.1000863; E. Decroly et al., PLoS Pathog 7:e1002059, 2011, http://dx.doi.org/10.1371/journal.ppat.1002059; Y. Chen et al., PLoS Pathog 7:e1002294, 2011, http://dx.doi.org/10.1371/journal.ppat.1002294) .", "In this study, we demonstrate that stimulation of nsp16 2'-O-MTase activity by nsp10 is a universal and conserved mechanism in coronaviruses, including FCoV, and that nsp10 is functionally interchangeable in the stimulation of nsp16 of different coronaviruses.", "Based on our current and previous studies, we designed a peptide (TP29) from the sequence of the interaction interface of mouse hepatitis virus (MHV) nsp10 and demonstrated that the peptide inhibits the 2'-O-MTase activity of different coronaviruses in biochemical assays and the viral replication in MHV infection and SARS-CoV replicon models.", "Interestingly, the peptide TP29 exerted robust inhibitory effects in vivo in MHV-infected mice by impairing MHV virulence and pathogenesis through suppressing virus replication and enhancing type I interferon production at an early stage of infection.", "Therefore, as a proof of principle, the current results indicate that coronavirus 2'-O-MTase activity can be targeted in vitro and in vivo.", "IMPORTANCE Coronaviruses are important pathogens of animals and human with high zoonotic potential.", "SARS-CoV encodes the 2'-O-MTase that is composed of the catalytic subunit nsp16 and the stimulatory subunit nsp10 and plays an important role in virus genome replication and evasion from innate immunity.", "Our current results demonstrate that stimulation of nsp16 2'-O-MTase activity by nsp10 is a common mechanism for coronaviruses, and nsp10 is functionally interchangeable in the stimulation of nsp16 among different coronaviruses, which underlies the rationale for developing inhibitory peptides.", "We demonstrate that a peptide derived from the nsp16-interacting domain of MHV nsp10 could inhibit 2'-O-MTase activity of different coronaviruses in vitro and viral replication of MHV and SARS-CoV replicon in cell culture, and it could strongly inhibit virus replication and pathogenesis in MHV-infected mice.", "This work makes it possible to develop broad-spectrum peptide inhibitors by targeting the nsp16/nsp10 2'-O-MTase of coronaviruses."], "title": "Coronavirus nsp10/nsp16 Methyltransferase Can Be Targeted by nsp10-Derived Peptide In Vitro and In Vivo To Reduce Replication and Pathogenesis."}
{"doc_id": 253, "abstract": ["Increasing age is the strongest predictor of risk of COVID-19 severity.", "Unregulated cytokine storm together with impaired immunometabolic response leads to highest mortality in elderly infected with SARS-CoV-2.", "To investigate how aging compromises defense against COVID-19, we developed a model of natural murine beta coronavirus (mCoV) infection with mouse hepatitis virus strain MHV-A59 (mCoV-A59) that recapitulated majority of clinical hallmarks of COVID-19.", "Aged mCoV-A59-infected mice have increased mortality and higher systemic inflammation in the heart, adipose tissue and hypothalamus, including neutrophilia and loss of \u03b3\u03b4 T cells in lungs.", "Ketogenic diet increases beta-hydroxybutyrate, expands tissue protective \u03b3\u03b4 T cells, deactivates the inflammasome and decreases pathogenic monocytes in lungs of infected aged mice.", "These data underscore the value of mCoV-A59 model to test mechanism and establishes harnessing of the ketogenic immunometabolic checkpoint as a potential treatment against COVID-19 in the elderly.", "Highlights-Natural MHV-A59 mouse coronavirus infection mimics COVID-19 in elderly.-Aged infected mice have systemic inflammation and inflammasome activation-Murine beta coronavirus (mCoV) infection results in loss of pulmonary \u03b3\u03b4 T cells.-Ketones protect aged mice from infection by reducing inflammation.", "eTOC Blurb Elderly have the greatest risk of death from COVID-19.", "Here, Ryu et al report an aging mouse model of coronavirus infection that recapitulates clinical hallmarks of COVID-19 seen in elderly.", "The increased severity of infection in aged animals involved increased inflammasome activation and loss of \u03b3\u03b4 T cells that was corrected by ketogenic diet."], "title": "Ketogenesis restrains aging-induced exacerbation of COVID in a mouse model"}
{"doc_id": 254, "abstract": ["The world is in the grip of the COVID-19 pandemic.", "Public health measures that can reduce the risk of infection and death in addition to quarantines are desperately needed.", "This article reviews the roles of vitamin D in reducing the risk of respiratory tract infections, knowledge about the epidemiology of influenza and COVID-19, and how vitamin D supplementation might be a useful measure to reduce risk.", "Through several mechanisms, vitamin D can reduce risk of infections.", "Those mechanisms include inducing cathelicidins and defensins that can lower viral replication rates and reducing concentrations of pro-inflammatory cytokines that produce the inflammation that injures the lining of the lungs, leading to pneumonia, as well as increasing concentrations of anti-inflammatory cytokines.", "Several observational studies and clinical trials reported that vitamin D supplementation reduced the risk of influenza, whereas others did not.", "Evidence supporting the role of vitamin D in reducing risk of COVID-19 includes that the outbreak occurred in winter, a time when 25-hydroxyvitamin D (25(OH)D) concentrations are lowest; that the number of cases in the Southern Hemisphere near the end of summer are low; that vitamin D deficiency has been found to contribute to acute respiratory distress syndrome; and that case-fatality rates increase with age and with chronic disease comorbidity, both of which are associated with lower 25(OH)D concentration.", "To reduce the risk of infection, it is recommended that people at risk of influenza and/or COVID-19 consider taking 10,000 IU/d of vitamin D3 for a few weeks to rapidly raise 25(OH)D concentrations, followed by 5000 IU/d.", "The goal should be to raise 25(OH)D concentrations above 40-60 ng/mL (100-150 nmol/L).", "For treatment of people who become infected with COVID-19, higher vitamin D3 doses might be useful.", "Randomized controlled trials and large population studies should be conducted to evaluate these recommendations."], "title": "Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths"}
{"doc_id": 255, "abstract": ["Effective therapies to treat coronavirus disease 2019 (COVID-19) are urgently needed.", "While many investigational, approved, and repurposed drugs have been suggested as potential treatments, preclinical data from animal models can guide the search for effective treatments by ruling out those that lack efficacy in vivo.", "Remdesivir (GS-5734) is a nucleotide analogue prodrug with broad antiviral activity1,2 that is currently being investigated in COVID-19 clinical trials and recently received Emergency Use Authorization from the US Food and Drug Administration3,4.", "In animal models, remdesivir was effective against infection with Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus (SARS-CoV)2,5,6.", "In vitro, remdesivir inhibited replication of SARS-CoV-27,8.", "Here we investigate the efficacy of remdesivir in a rhesus macaque model of SARS-CoV-2 infection9.", "Unlike vehicle-treated animals, macaques treated with remdesivir did not show signs of respiratory disease; they also showed reduced pulmonary infiltrates on radiographs and reduced virus titres in bronchoalveolar lavages twelve hours after the first dose.", "Virus shedding from the upper respiratory tract was not reduced by remdesivir treatment.", "At necropsy, remdesivir-treated animals had lower lung viral loads and reduced lung damage.", "Thus, treatment with remdesivir initiated early during infection had a clinical benefit in rhesus macaques infected with SARS-CoV-2.", "Although the rhesus macaque model does not represent the severe disease observed in some patients with COVID-19, our data support the early initiation of remdesivir treatment in patients with COVID-19 to prevent progression to pneumonia."], "title": "Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2"}
{"doc_id": 256, "abstract": ["MOTIVATION: The outbreak of COVID-2019 initiated at Wuhan, China has become a global threat by rapid transmission and severe fatalities.", "Recent studies have uncovered whole genome sequence of SARS-CoV-2 (causing COVID-2019).", "In addition, lung metagenomic studies on infected patients revealed overrepresented Prevotella spp.", "producing certain proteins in abundance.", "We performed host-pathogen protein-protein interaction analysis between SARS-CoV-2 and overrepresented Prevotella proteins with human proteome.", "We also performed functional overrepresentation analysis of interacting proteins to understand their role in COVID-2019 severity.", "RESULTS: It was found that over-expressed Prevotella proteins can promote viral infection.", "As per the results, Prevotella proteins, but not viral proteins are involved in multiple interactions with NF-kB, which is involved in increasing clinical severity of COVID-2019.", "Prevotella may have role in COVID-2019 outbreak and should be given importance for understanding disease mechanisms and improving treatment outcomes.", "SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online."], "title": "COVID-2019 associated overexpressed Prevotella proteins mediated host-pathogen interactions and their role in coronavirus outbreak"}
{"doc_id": 257, "abstract": ["MOTIVATION: The outbreak of COVID-2019 initiated at Wuhan, China has become a global threat by rapid transmission and severe fatalities.", "Recent studies have uncovered whole genome sequence of SARS-CoV-2 (causing COVID-2019).", "In addition, lung metagenomic studies on infected patients revealed overrepresented Prevotella spp.", "producing certain proteins in abundance.", "We performed host-pathogen protein-protein interaction analysis between SARS-CoV-2 and overrepresented Prevotella proteins with human proteome.", "We also performed functional overrepresentation analysis of interacting proteins to understand their role in COVID-2019 severity.", "RESULTS: It was found that overexpressed Prevotella proteins can promote viral infection.", "As per the results, Prevotella proteins, but not viral proteins, are involved in multiple interactions with NF-kB, which is involved in increasing clinical severity of COVID-2019.", "Prevotella may have role in COVID-2019 outbreak and should be given importance for understanding disease mechanisms and improving treatment outcomes.", "SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online."], "title": "COVID-2019-associated overexpressed Prevotella proteins mediated host-pathogen interactions and their role in coronavirus outbreak"}
{"doc_id": 258, "abstract": ["The coronavirus disease 2019 (COVID-19) virus is spreading rapidly, and scientists are endeavoring to discover drugs for its efficacious treatment in China.", "Chloroquine phosphate, an old drug for treatment of malaria, is shown to have apparent efficacy and acceptable safety against COVID-19 associated pneumonia in multicenter clinical trials conducted in China.", "The drug is recommended to be included in the next version of the Guidelines for the Prevention, Diagnosis, and Treatment of Pneumonia Caused by COVID-19 issued by the National Health Commission of the People's Republic of China for treatment of COVID-19 infection in larger populations in the future."], "title": "Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies."}
{"doc_id": 259, "abstract": ["Objective To evaluate factors predicting severe symptomatic laboratory-confirmed (reverse transcription-quantitative polymerase chain reaction, RT-qPCR) SARS-COV-2 (severe acute coronavirus-2) reinfection.", "Study design A nationwide retrospective cohort study was conducted in Mexico.", "Method Data from 258 reinfection cases (at least 28 days between both episodes onset) were analyzed.", "We used risk ratios (RR) and 95% confidence intervals (CI) to evaluate predictors of severe (dyspnea requiring hospital admission) secondary SARS-COV-2 infection.", "Results The risk of severe disease was 14.7% and the observed overall fatality rate was 4.3%.", "Patients with more serious primary disease were more likely to develop severe symptoms (39.5% vs. 5.5%, p < 0.001) during reinfection.", "In multiple analysis, factors associated with an increased risk of severe symptomatic SARS-COV-2 reinfection were increasing age (RR per year = 1.007, 95% CI 1.003-1.010), comorbidities (namely obesity [RR = 1.12, 95% CI 1.01-1.24], asthma [RR = 1.26, 95% CI 1.06-1.50], type 2 diabetes mellitus [RR = 1.22, 95% CI 1.07-1.38] and previous severe laboratory-confirmed COVID-19 (RR = 1.20, 95% CI 1.03-1.39).", "Conclusions To the best of our knowledge this is the first study evaluating disease outcomes in a large set of laboratory-positive cases of symptomatic SARS-COV-2 reinfection and factors associated with illness severity was characterized.", "Our results may contribute to the current knowledge of SARS-COV-2 pathogenicity and to identify populations at increased risk of a poorer outcome after reinfection."], "title": "Predictors of severe symptomatic laboratory-confirmed SARS-COV-2 reinfection"}
{"doc_id": 260, "abstract": ["BackgroundThere is a major concern regarding the prognosis of coronavirus disease 2019 (COVID-19) in patients who recovered to first-time illness.", "ObjectiveTo evaluate factors predicting severe symptomatic laboratory-confirmed (reverse transcription-quantitative polymerase chain reaction, RT-qPCR) SARS-COV-2 (severe acute coronavirus-2) reinfection.", "MethodWe conducted a nationwide retrospective cohort study in Mexico and data from 258 reinfection cases (at least 28 days between both episodes onset) were analyzed.", "We used risk ratios (RR) and 95% confidence intervals (CI) to evaluate predictors of severe (dyspnea requiring hospital admission) secondary SARS-COV-2 infection.", "ResultsThe risk of severe disease was 14.7% and the observed overall fatality rate was 4.3%.", "Patients with more serious primary disease were more likely to develop severe symptoms (39.5% vs. 5.5%, p < 0.001) during reinfection.", "In multiple analysis, factors associated with an increased risk of severe symptomatic SARS-COV-2 reinfection were increasing age (RR per year = 1.007, 95% CI 1.003-1.010), comorbidities (namely obesity [RR = 1.12, 95% CI 1.01-1.24], asthma [RR = 1.26, 95% CI 1.06-1.50], type 2 diabetes mellitus [RR = 1.22, 95% CI 1.07-1.38] and previous severe laboratory-confirmed COVID-19 (RR = 1.20, 95% CI 1.03-1.39).", "ConclusionsTo the best of our knowledge this is the first study evaluating disease outcomes in a large set of laboratory-positive cases of symptomatic SARS-COV-2 reinfection and factors associated with illness severity was characterized.", "Our results may contribute to the current knowledge of SARS-COV-2 pathogenicity and to identify populations at increased risk of a poorer outcome after reinfection."], "title": "Predictors of severe symptomatic laboratory-confirmed SARS-COV-2 reinfection"}
{"doc_id": 261, "abstract": ["As the COVID-19 pandemic evolves, human milk banks worldwide continue to provide donor human milk to vulnerable infants who lack access to mothers own milk.", "Under these circumstances, ensuring the safety of donor human milk is paramount, as the risk of vertical transmission of SARS-CoV-2 is not well understood.", "Here, we investigate the inactivation of SARS-CoV-2 in human milk by pasteurisation, and the stability of SARS-CoV-2 in human milk under cold storage (freezing or refrigeration).", "Following heating to 63{degrees}C or 56{degrees}C for 30 minutes, SARS-CoV-2 replication competent (i.e. live) virus was undetected in both human milk and the control medium.", "Cold storage of SARS-CoV-2 in human milk (either at 4{degrees}C or-30{degrees}C) did not significantly impact infectious viral load over a 48 hour period.", "Our findings demonstrate that SARS-CoV-2 can be effectively inactivated by Holder pasteurisation, and confirm that existing milk bank processes will effectively mitigate the risk of transmission of SARS-COV-2 to vulnerable infants through pasteurised donor human milk."], "title": "SARS-CoV-2 in human milk is inactivated by Holder pasteurization but not cold storage"}
{"doc_id": 262, "abstract": ["BACKGROUND: Severe acute respiratory syndrome (SARS) is caused by a newly discovered coronavirus (SARS-CoV).", "No effective prophylactic or post-exposure therapy is currently available.", "RESULTS: We report, however, that chloroquine has strong antiviral effects on SARS-CoV infection of primate cells.", "These inhibitory effects are observed when the cells are treated with the drug either before or after exposure to the virus, suggesting both prophylactic and therapeutic advantage.", "In addition to the well-known functions of chloroquine such as elevations of endosomal pH, the drug appears to interfere with terminal glycosylation of the cellular receptor, angiotensin-converting enzyme 2.", "This may negatively influence the virus-receptor binding and abrogate the infection, with further ramifications by the elevation of vesicular pH, resulting in the inhibition of infection and spread of SARS CoV at clinically admissible concentrations.", "CONCLUSION: Chloroquine is effective in preventing the spread of SARS CoV in cell culture.", "Favorable inhibition of virus spread was observed when the cells were either treated with chloroquine prior to or after SARS CoV infection.", "In addition, the indirect immunofluorescence assay described herein represents a simple and rapid method for screening SARS-CoV antiviral compounds."], "title": "Chloroquine is a potent inhibitor of SARS coronavirus infection and spread"}
{"doc_id": 263, "abstract": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is now pandemic with nearly three million cases reported to date.", "Although the majority of COVID-19 patients experience only mild or moderate symptoms, a subset will progress to severe disease with pneumonia and acute respiratory distress syndrome (ARDS) requiring mechanical ventilation.", "Emerging results indicate a dysregulated immune response characterized by runaway inflammation, including cytokine release syndrome (CRS), as the major driver of pathology in severe COVID-19.", "With no treatments currently approved for COVID-19, therapeutics to prevent or treat the excessive inflammation in severe disease caused by SARS-CoV-2 infection are urgently needed.", "Here, in 10 terminally-ill, critical COVID-19 patients we report profound elevation of plasma IL-6 and CCL5 (RANTES), decreased CD8+ T cell levels, and SARS-CoV-2 plasma viremia.", "Following compassionate care treatment with the CCR5 blocking antibody leronlimab, we observed complete CCR5 receptor occupancy on macrophage and T cells, rapid reduction of plasma IL-6, restoration of the CD4/CD8 ratio, and a significant decrease in SARS-CoV-2 plasma viremia.", "Consistent with reduction of plasma IL-6, single-cell RNA-sequencing revealed declines in transcriptomic myeloid cell clusters expressing IL-6 and interferon-related genes.", "These results demonstrate a novel approach to resolving unchecked inflammation, restoring immunologic deficiencies, and reducing SARS-CoV-2 plasma viral load via disruption of the CCL5-CCR5 axis, and support randomized clinical trials to assess clinical efficacy of leronlimab-mediated inhibition of CCR5 for COVID-19."], "title": "Disruption of the CCL5/RANTES-CCR5 Pathway Restores Immune Homeostasis and Reduces Plasma Viral Load in Critical COVID-19"}
{"doc_id": 264, "abstract": ["The relationship between SARS-CoV-2 viral load and risk of disease progression remains largely undefined in coronavirus disease 2019 (COVID-19).", "Here, we quantify SARS-CoV-2 viral load from participants with a diverse range of COVID-19 disease severity, including those requiring hospitalization, outpatients with mild disease, and individuals with resolved infection.", "We detected SARS-CoV-2 plasma RNA in 27% of hospitalized participants, and 13% of outpatients diagnosed with COVID-19.", "Amongst the participants hospitalized with COVID-19, we report that a higher prevalence of detectable SARS-CoV-2 plasma viral load is associated with worse respiratory disease severity, lower absolute lymphocyte counts, and increased markers of inflammation, including C-reactive protein and IL-6.", "SARS-CoV-2 viral loads, especially plasma viremia, are associated with increased risk of mortality.", "Our data show that SARS-CoV-2 viral loads may aid in the risk stratification of patients with COVID-19, and therefore its role in disease pathogenesis should be further explored."], "title": "SARS-CoV-2 viral load is associated with increased disease severity and mortality"}
{"doc_id": 265, "abstract": ["Repurposing clinically available drugs to treat the new coronavirus disease COVID-19 is an urgent need in these early stages of the SARS-CoV-2 pandemic, when very few treatment options are available.", "The iminosugar Miglustat is a well-characterized drug for the treatment of rare genetic lysosome storage diseases such as Gaucher and Niemann-Pick type C, and has also been described to be active against a variety of enveloped viruses.", "The activity of Miglustat is here demonstrated for SARS-CoV-2 at concentrations achievable in the plasma by current clinical regimens without cytotoxicity.", "The drug acts at the post-entry level and leads to a marked decrease of viral proteins and release of infectious virus.", "The mechanism resides in the inhibitory activity towards \u03b1-glucosidases that are involved in early stages of glycoprotein N-linked oligosaccharide processing in the endoplasmic reticulum, leading to a marked decrease of the viral Spike protein.", "The wealth of available data on the clinical use of Miglustat for the treatment of lysosomal storage disorders and the antiviral properties against SARS-CoV-2 make it an ideal candidate for drug repurposing."], "title": "Repurposing of Miglustat to inhibit the coronavirus Severe Acquired Respiratory Syndrome SARS-CoV-2"}
{"doc_id": 266, "abstract": ["Abstract Background: Cognitive impairment is common following critical illness.", "A number of case reports and case series have suggested that cognitive deficits occur in patients with COVID-19.", "This study evaluated the frequency, severity, and profile of cognitive dysfunction in hospitalized patients recovering from COVID-19.", "Methods: We obtained and analyzed cross-sectional neuropsychological data from a cohort of N=57 patients participating in inpatient rehabilitation.", "Our primary outcome measure was the Brief Memory and Executive Test (BMET).", "We calculated the frequency of impairment based on clinician diagnosis and by the BMET subtests using age-normed classification of impairment.", "We explored associations with intubation and extubation as markers of illness severity and complications, as well as psychiatric diagnosis.", "Results: Our sample was 75% male, 61% non-white, with a mean age of 64.5 (SD = 13.9) years.", "Patients were evaluated at a mean of 43.2 days post-admission.", "88% had documented hypoxemic respiratory failure and 77% required intubation.", "81% of patients had cognitive impairment, ranging from mild to severe.", "Deficits were most common in working memory (55% of patients impaired), set-shifting (47%), divided attention (46%), and processing speed (40%).", "Executive dysfunction was not significantly associated with intubation length or the time from extubation to assessment, nor was it associated with the presence of a psychiatric diagnosis.", "Discussion and Conclusion: Medically stable inpatients recovering from COVID-19 commonly have deficits in attention and executive functions.", "These deficits were not significantly correlated with length of intubation or time since extubation.", "Findings provide an early benchmark for studying the evolution of cognitive difficulties after COVID-19 and suggest that easy to disseminate interventions that remediate attention and executive dysfunctions may be important in this population."], "title": "Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19"}
{"doc_id": 267, "abstract": ["There are currently few approved effective treatments for SARS-CoV-2, the virus responsible for the COVID-19 pandemic.", "Nanobodies are 12-15 kDa single-domain antibody fragments that can be delivered by inhalation and are amenable to relatively inexpensive large scale production compared to other biologicals.", "We have isolated nanobodies that bind to the SARS-CoV-2 spike protein receptor binding domain and block spike protein interaction with the angiotensin converting enzyme 2 (ACE2) with 1-5 nM affinity.", "The lead nanobody candidate, NIH-CoVnb-112, blocks SARS-CoV-2 spike pseudotyped lentivirus infection of HEK293 cells expressing human ACE2 with an EC50 of 0.3 \u00b5g/mL. NIH-CoVnb-112 retains structural integrity and potency after nebulization.", "Furthermore, NIH-CoVnb-112 blocks interaction between ACE2 and several high affinity variant forms of the spike protein.", "These nanobodies and their derivatives have therapeutic, preventative, and diagnostic potential."], "title": "High affinity nanobodies block SARS-CoV-2 spike receptor binding domain interaction with human angiotensin converting enzyme"}
{"doc_id": 268, "abstract": ["The coronavirus disease-2019 (COVID-19) which caused by severe acute respiratory syndrome-related coronavirus (SARS-CoV-2), is a pandemic threat to global public health.", "It has a wide spectrum of clinical manifestations from mild to critical illness, the most serious of which is the complications of acute respiratory distress syndrome (ARDS).", "SARS-CoV-2 infection appears mild in infants and children, however, in adults, it can lead to serious consequences.", "In this review, we highlighted the differences between the immune responses of the lung in children and adults, immune dysregulation and their possible role in clinical manifestations in COVID-19.", "There is a reduction in population of immunocompetent cells during aging and subsequently induced ineffective inflammation in the faces of some infections.", "Dysregulation in the immune system can lead to an unappropriated local and systemic immune responses and subsequently the rapid spread of the virus, leading to severe COVID-19 disease.", "Therefore, recognizing the differences in the immune responses of various hosts as well as to improve the immune system disorder should always be part of research and treatment protocols."], "title": "The role of dysregulated immune responses in COVID-19 pathogenesis"}
{"doc_id": 269, "abstract": ["Objectives Limited SARS CoV 2 testing in many African countries has constrained availability of data on the impact of COVID-19 (CV19).", "To address this gap, we conducted a systematic post-mortem surveillance study to directly measure the fatal impact of CV19 in an urban African population.", "Design We enrolled deceased individuals at the University Teaching Hospital (UTH) Morgue in Lusaka, Zambia.", "We obtained nasopharyngeal swabs for testing via reverse-transcriptase quantitative PCR (RT-qPCR) against the SARS-2 Coronavirus.", "We stratified deaths by CV19 status, by location, age, sex, and underlying risk factors.", "Setting UTH is the largest tertiary care referral hospital in Zambia and its morgue registers ~80% of Lusaka's deaths.", "Participants Participants of all ages were enrolled if within 48 hours of death and if the next of kin or representative provided written informed consent.", "Results We enrolled 372 participants between June and September 2020, and had PCR results for 364 (99.5%).", "CV19 was detected in 70/364 (19.2%).", "The median age for CV19+ deaths was 48 years (IQR 36-72 years) and 70% were male.", "Most CV19+ deaths (51/70, 72.8%) occurred in the community; none had been tested for CV19 antemortem.", "Among the 19/70 facility deaths, six were tested antemortem.", "Among the 52/70 CV19 deaths with symptoms data, 44/52 had typical symptoms of CV19 (cough, fever, shortness of breath), of whom only five were tested antemortem.", "We identified CV19 among seven children; only one had been tested antemortem.", "The proportion of CV19+ deaths increased with age, but 75.7% of CV19+ deaths were aged <60 years.", "The five most common co-morbidities among CV19+ deaths were: tuberculosis (31.4%); hypertension (27.1%); HIV/AIDS (22.9%); alcohol use (17.1%); and diabetes (12.9%).", "Conclusions Contrary to expectations, CV19+ deaths were common in Lusaka.", "The majority occurred in the community where testing capacity is lacking.", "Yet few who died at facilities were tested, despite presenting with typical symptoms of CV19.", "Therefore, CV19 cases were under reported because testing was rarely done, not because CV19 was rare.", "If our data are generalizable, the impact of CV19 in Africa has been vastly underestimated."], "title": "COVID-19 deaths detected in a systematic post-mortem surveillance study in Africa"}
{"doc_id": 270, "abstract": ["BACKGROUND: Unprecedented demand for N95 respirators during the coronavirus disease 2019 (COVID-19) pandemic has led to a global shortage of these masks.", "We validated a rapidly applicable, low-cost decontamination protocol in compliance with regulatory standards to enable the safe reuse of N95 respirators.", "METHODS: We inoculated 4 common models of N95 respirators with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and evaluated viral inactivation after disinfection for 60 minutes at 70\u00b0C and 0% relative humidity.", "Similarly, we evaluated thermal disinfection at 0% to 70% relative humidity for masks inoculated with Escherichia coli.", "We assessed masks subjected to multiple cycles of thermal disinfection for structural integrity using scanning electron microscopy and for protective functions using standards of the United States National Institute for Occupational Safety and Health for particle filtration efficiency, breathing resistance and respirator fit.", "RESULTS: A single heat treatment rendered SARS-CoV-2 undetectable in all mask samples.", "Compared with untreated inoculated control masks, E. coli cultures at 24 hours were virtually undetectable from masks treated at 70\u00b0C and 50% relative humidity (optical density at 600 nm wavelength, 0.02 \u00b1 0.02 v. 2.77 \u00b1 0.09, p < 0.001), but contamination persisted for masks treated at lower relative humidity.", "After 10 disinfection cycles, masks maintained fibre diameters similar to untreated masks and continued to meet standards for fit, filtration efficiency and breathing resistance.", "INTERPRETATION: Thermal disinfection successfully decontaminated N95 respirators without impairing structural integrity or function.", "This process could be used in hospitals and long-term care facilities with commonly available equipment to mitigate the depletion of N95 masks."], "title": "Effect of moist heat reprocessing of N95 respirators on SARS-CoV-2 inactivation and respirator function"}
{"doc_id": 271, "abstract": ["The ongoing COVID-19 pandemic has caused an unprecedented need for rapid diagnostic testing.", "The Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) recommend a standard assay that includes an RNA extraction step from a nasopharyngeal (NP) swab followed by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) to detect the purified SARS-CoV-2 RNA.", "The current global shortage of RNA extraction kits has caused a severe bottleneck to COVID-19 testing.", "We hypothesized that SARS-CoV-2 RNA could be detected from NP samples via a direct RT-qPCR assay that omits the RNA extraction step altogether, and tested this hypothesis on a series of blinded clinical samples.", "The direct RT-qPCR approach correctly identified 92% of NP samples (n = 155) demonstrated to be positive for SARS-CoV-2 RNA by traditional clinical diagnostic RT-qPCR that included an RNA extraction.", "Thus, direct RT-qPCR could be a front-line approach to identify the substantial majority of COVID-19 patients, reserving a repeat test with RNA extraction for those individuals with high suspicion of infection but an initial negative result.", "This strategy would drastically ease supply chokepoints of COVID-19 testing and should be applicable throughout the world."], "title": "DIRECT RT-qPCR DETECTION OF SARS-CoV-2 RNA FROM PATIENT NASOPHARYNGEAL SWABS WITHOUT AN RNA EXTRACTION STEP"}
{"doc_id": 272, "abstract": ["It has recently been hypothesised that Vitamin K could play a role in COVID-19.", "We aimed to test the hypothesis that low vitamin K status is a common characteristic of patients hospitalized with COVID-19 compared to population controls; and that low vitamin K status predicts mortality in COVID-19 patients.", "In a cohort of 138 COVID-19 patients and 140 population controls, we measured plasma dephosphorylated-uncarboxylated Matrix Gla Protein (dp-ucMGP), which reflects the functional Vitamin K status in peripheral tissue.", "Fourty-three patients died within 90-days from admission.", "In patients, levels of dp-ucMGP differed significantly between survivors (mean 877; 95% CI: 778; 995) and non-survivors (mean 1445; 95% CI: 1148; 1820).", "Furthermore, levels of dp-ucMGP (pmol/L) were considerably higher in patients (mean 1022; 95% CI: 912; 1151) compared to controls (mean 509; 95% CI: 485; 540).", "Cox regression survival analysis showed that increasing levels of dp-ucMGP (reflecting low Vitamin K status) were associated with higher mortality risk (sex-and age-adjusted hazard ratio per doubling of dp-ucMGP was 1.50, 95% CI: 1.03; 2.18).", "In conclusion, we found that low Vitamin K status predicted mortality in patients with COVID-19 supporting a potential role of Vitamin K in COVID-19."], "title": "Low vitamin K status predicts mortality in a cohort of 138 hospitalized patients with COVID-19"}
{"doc_id": 273, "abstract": ["We have developed an analysis pipeline to facilitate real-time mutation tracking in SARS-CoV-2, focusing initially on the Spike (S) protein because it mediates infection of human cells and is the target of most vaccine strategies and antibody-based therapeutics.", "To date we have identified thirteen mutations in Spike that are accumulating.", "Mutations are considered in a broader phylogenetic context, geographically, and over time, to provide an early warning system to reveal mutations that may confer selective advantages in transmission or resistance to interventions.", "Each one is evaluated for evidence of positive selection, and the implications of the mutation are explored through structural modeling.", "The mutation Spike D614G is of urgent concern; it began spreading in Europe in early February, and when introduced to new regions it rapidly becomes the dominant form.", "Also, we present evidence of recombination between locally circulating strains, indicative of multiple strain infections.", "These finding have important implications for SARS-CoV-2 transmission, pathogenesis and immune interventions."], "title": "Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2"}
{"doc_id": 274, "abstract": ["As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spreads, the susceptible subpopulation declines causing the rate at which new infections occur to slow down.", "Variation in individual susceptibility or exposure to infection exacerbates this effect.", "Individuals that are more susceptible or more exposed tend to be infected and removed from the susceptible subpopulation earlier.", "This selective depletion of susceptibles intensifies the deceleration in incidence.", "Eventually, susceptible numbers become low enough to prevent epidemic growth or, in other words, the herd immunity threshold is reached.", "Here we fit epidemiological models with inbuilt distributions of susceptibility or exposure to SARS-CoV-2 outbreaks to estimate basic reproduction numbers (R_0) alongside coefficients of individual variation (CV) and the effects of containment strategies.", "Herd immunity thresholds are then calculated as 1-(1/R_0 )^(1/((1+CV^2 ) )) or 1-(1/R_0 )^(1/((1+2CV^2 ) )), depending on whether variation is on susceptibility or exposure.", "Our inferences result in herd immunity thresholds around 10-20%, considerably lower than the minimum coverage needed to interrupt transmission by random vaccination, which for R_0 higher than 2.5 is estimated above 60%.", "We emphasize that the classical formula, 1-1/R_0 , remains applicable to describe herd immunity thresholds for random vaccination, but not for immunity induced by infection which is naturally selective.", "These findings have profound consequences for the governance of the current pandemic given that some populations may be close to achieving herd immunity despite being under more or less strict social distancing measures."], "title": "Herd immunity thresholds for SARS-CoV-2 estimated from unfolding epidemics"}
{"doc_id": 275, "abstract": ["We present here the design of the Mechanical Ventilator Milano (MVM), a novel mechan-ical ventilator designed for mass scale production in response to the COVID-19 pandemics, to compensate for the dramatic shortage of such ventilators in many countries.", "This venti-lator is an electro-mechanical equivalent of the old, reliable Manley Ventilator.", "Our design is optimized to permit large sale production in short time and at a limited cost, relying on off-the-shelf components, readily available worldwide from hardware suppliers.", "Operation of the MVM requires only a source of compressed oxygen (or compressed medical air) and electrical power.", "The MVM control and monitoring unit can be connected and networked via WiFi so that no additional electrical connections are necessary other than the connection to the electrical power.", "At this stage the MVM is not a certified medical device.", "Construction of the first proto-types is starting with a team of engineers, scientists and computing experts.", "The purpose of this paper is to disseminate the conceptual design of the MVM broadly and to solicit feed-back from the scientific and medical community to speed the process of review, improvement and possible implementation."], "title": "Mechanical Ventilator Milano (MVM):A Novel Mechanical Ventilator Designed for Mass Scale Production in response to the COVID-19 Pandemics"}
{"doc_id": 276, "abstract": ["Curtailing the Spring 2020 COVID-19 surge required sweeping and stringent interventions by governments across the world.", "Wastewater-based COVID-19 epidemiology programs have been initiated in many countries to provide public health agencies with a complementary disease tracking metric and facile surveillance tool.", "However, their efficacy in prospectively capturing resurgence following a period of low prevalence is unclear.", "In this study, the SARS-CoV-2 viral signal was measured in primary clarified sludge harvested every two days at the City of Ottawa's water resource recovery facility during the summer of 2020, when clinical testing recorded daily percent positivity below 1%.", "In late July, increases of >400% in normalized SARS-CoV-2 RNA signal in wastewater were identified 48 hours prior to reported >300% increases in positive cases that were retrospectively attributed to community-acquired infections.", "During this resurgence period, SARS-CoV-2 RNA signal in wastewater preceded the reported >160% increase in community hospitalizations by approximately 96 hours.", "This study supports wastewater-based COVID-19 surveillance of populations in augmenting the efficacy of diagnostic testing, which can suffer from sampling biases or timely reporting as in the case of hospitalization census."], "title": "Catching a resurgence: Increase in SARS-CoV-2 viral RNA identified in wastewater 48 hours before COVID-19 clinical tests and 96 hours before hospitalizations"}
{"doc_id": 277, "abstract": ["In December 2019 and January 2020, novel coronavirus (2019-nCoV)-infected pneumonia (NCIP) occurred in Wuhan, and has already posed a serious threat to public health.", "ACE2 (Angiotensin Converting Enzyme 2) has been shown to be one of the major receptors that mediate the entry of 2019-nCoV into human cells, which also happens in severe acute respiratory syndrome coronavirus (SARS).", "Several researches have indicated that some patients have abnormal renal function or even kidney damage in addition to injury in respiratory system, and the related mechanism is unknown.", "This arouses our interest in whether coronavirus infection will affect the urinary and male reproductive systems.", "Here in this study, we used the online datasets to analyze ACE2 expression in different human organs.", "The results indicate that ACE2 highly expresses in renal tubular cells, Leydig cells and cells in seminiferous ducts in testis.", "Therefore, virus might directly bind to such ACE2 positive cells and damage the kidney and testicular tissue of patients.", "Our results indicate that renal function evaluation and special care should be performed in 2019-nCoV patients during clinical work, because of the kidney damage caused by virus and antiviral drugs with certain renal toxicity.", "In addition, due to the potential pathogenicity of the virus to testicular tissues, clinicians should pay attention to the risk of testicular lesions in patients during hospitalization and later clinical follow-up, especially the assessment and appropriate intervention in young patients' fertility."], "title": "ACE2 Expression in Kidney and Testis May Cause Kidney and Testis Damage After 2019-nCoV Infection"}
{"doc_id": 278, "abstract": ["BACKGROUND: The detection of SARS-CoV-2 RNA by real-time polymerase chain reaction (PCR) in respiratory samples collected from persons recovered from COVID-19 does not necessarily indicate shedding of infective virions.", "By contrast, the isolation of SARS-CoV-2 using cell-based culture likely indicates infectivity, but there are limited data on the correlation between SARS-CoV-2 culture and PCR.", "METHODS: One hundred and ninety-five patients with varying severity of COVID-19 were tested (outpatients [n=178]), inpatients [n=12] and critically unwell patients admitted to the intensive care unit [ICU; n=5]).", "SARS-CoV-2 PCR positive samples were cultured in Vero C1008 cells and inspected daily for cytopathic effect (CPE).", "SARS-CoV-2-induced CPE was confirmed by PCR of culture supernatant.", "Where no CPE was observed, PCR was performed on day four to confirm absence of virus replication.", "Cycle threshold (Ct) of the day four PCR (Ctculture) and the PCR of the original clinical sample (Ctsample) were compared, and positive cultures were defined where Ctsample-Ctculture was &#8805;3.", "FINDINGS: Of 234 samples collected, 228 (97%) were from the upper respiratory tract.", "SARS-CoV-2 was only successfully isolated from samples with Ctsample &#8804;32, including in 28/181 (15%), 19/42 (45%) and 9/11 samples (82%) collected from outpatients, inpatients, and ICU patients, respectively.", "The mean duration from symptom onset to culture positivity was 4.5 days (range 0-18).", "SARS-CoV-2 was significantly more likely to be isolated from samples collected from inpatients (p<0\u00e2\u0088\u0099001) and ICU patients (p<0\u00e2\u0088\u00990001) compared with outpatients respectively, and in samples with lower Ctsample.", "CONCLUSION: SARS-CoV-2 culture may be used as a surrogate marker for infectivity and inform de-isolation protocols."], "title": "Cell-based culture of SARS-CoV-2 informs infectivity and safe de-isolation assessments during COVID-19"}
{"doc_id": 279, "abstract": ["Coronavirus disease 2019 (COVID-19) is a serious illness that has rapidly spread throughout the globe.", "The seriousness of complications puts significant pressures on hospital resources, especially the availability of ICU and ventilators.", "Current evidence suggests that COVID-19 pathogenesis majorly involves microvascular injury induced by hypercytokinemia, namely interleukin 6 (IL-6).", "We recount the suggested inflammatory pathway for COVID-19 and its effects on various organ systems, including respiratory, cardiac, hematologic, reproductive, and nervous organ systems, as well examine the role of hypercytokinemia in the at-risk geriatric and obesity subgroups with upregulated cytokines' profile.", "In view of these findings, we strongly encourage the conduction of prospective studies to determine the baseline levels of IL-6 in infected patients, which can predict a negative outcome in COVID-19 cases, with subsequent early administration of IL-6 inhibitors, to decrease the need for ICU admission and the pressure on healthcare systems.", "Video abstract: http://links.lww.com/CAEN/A24."], "title": "Is it infection or rather vascular inflammation? Game-changer insights and recommendations from patterns of multi-organ involvement and affected subgroups in COVID-19."}
{"doc_id": 280, "abstract": ["Rapid spread of COVID-19 has caused an unprecedented pandemic worldwide, and an inserted furin site in SARS-CoV-2 spike protein (S) may account for increased transmissibility.", "Plasmin, and other host proteases, may cleave the furin site of SARS-CoV-2 S protein and \u03b3 subunits of epithelial sodium channels (\u03b3 ENaC), resulting in an increment in virus infectivity and channel activity.", "As for the importance of ENaC in the regulation of airway surface and alveolar fluid homeostasis, whether SARS-CoV-2 will share and strengthen the cleavage network with ENaC proteins at the single-cell level is urgently worthy of consideration.", "To address this issue, we analyzed single-cell RNA sequence (scRNA-seq) datasets, and found the PLAU (encoding urokinase plasminogen activator), SCNN1G (\u03b3ENaC), and ACE2 (SARS-CoV-2 receptor) were co-expressed in alveolar epithelial, basal, club, and ciliated epithelial cells.", "The relative expression level of PLAU, TMPRSS2, and ACE2 were significantly upregulated in severe COVID-19 patients and SARS-CoV-2 infected cell lines using Seurat and DESeq2 R packages.", "Moreover, the increments in PLAU, FURIN, TMPRSS2, and ACE2 were predominately observed in different epithelial cells and leukocytes.", "Accordingly, SARS-CoV-2 may share and strengthen the ENaC fibrinolytic proteases network in ACE2 positive airway and alveolar epithelial cells, which may expedite virus infusion into the susceptible cells and bring about ENaC associated edematous respiratory condition."], "title": "Fibrinolysis influences SARS-CoV-2 infection in ciliated cells"}
{"doc_id": 281, "abstract": ["Although the profile of immune cells changes during the natural course of SARS-CoV-2 inflection in human patients, few studies have used a longitudinal approach to reveal their dynamic features.", "Here, we performed single-cell RNA sequencing of bronchoalveolar lavage fluid cells longitudinally obtained from SARS-CoV-2-infected ferrets.", "Landscape analysis of the lung immune microenvironment showed dynamic changes in cell proportions and characteristics in uninfected control, at 2 days post-infection (dpi) (early stage of SARS-CoV-2 infection with peak viral titer), and 5 dpi (resolution phase).", "NK cells and CD8+ T cells exhibited activated subclusters with interferon-stimulated features, which were peaked at 2 dpi.", "Intriguingly, macrophages were classified into 10 distinct subpopulations, and their relative proportions changed over the time.", "We observed prominent transcriptome changes among monocyte-derived infiltrating macrophages and differentiated M1/M2 macrophages, especially at 2 dpi.", "Moreover, trajectory analysis revealed gene expression changes from monocyte-derived infiltrating macrophages toward M1 or M2 macrophages and identified the distinct macrophage subpopulation that had rapidly undergone SARS-CoV-2-mediated activation of inflammatory responses.", "Finally, we found that different spectrums of M1 or M2 macrophages showed distinct patterns of gene modules downregulated by immune-modulatory drugs.", "Overall, these results elucidate fundamental aspects of the immune response dynamics provoked by SARS-CoV-2 infection."], "title": "Single-cell Transcriptome of Bronchoalveolar Lavage Fluid Reveals Dynamic Change of Macrophages During SARS-CoV-2 Infection in Ferrets"}
{"doc_id": 282, "abstract": ["Hydroxychloroquine, used to treat malaria and some autoimmune disorders, potently inhibits viral infection of SARS coronavirus (SARS-CoV-1) and SARS-CoV-2 in cell-culture studies.", "However, human clinical trials of hydroxychloroquine failed to establish its usefulness as treatment for COVID-19.", "This compound is known to interfere with endosomal acidification necessary to the proteolytic activity of cathepsins.", "Following receptor binding and endocytosis, cathepsin L can cleave the SARS-CoV-1 and SARS-CoV-2 spike (S) proteins, thereby activating membrane fusion for cell entry.", "The plasma membrane-associated protease TMPRSS2 can similarly cleave these S proteins and activate viral entry at the cell surface.", "Here we show that the SARS-CoV-2 entry process is more dependent than that of SARS-CoV-1 on TMPRSS2 expression.", "This difference can be reversed when the furin-cleavage site of the SARS-CoV-2 S protein is ablated.", "We also show that hydroxychloroquine efficiently blocks viral entry mediated by cathepsin L, but not by TMPRSS2, and that a combination of hydroxychloroquine and a clinically-tested TMPRSS2 inhibitor prevents SARS-CoV-2 infection more potently than either drug alone.", "These studies identify functional differences between SARS-CoV-1 and-2 entry processes, and provide a mechanistic explanation for the limited in vivo utility of hydroxychloroquine as a treatment for COVID-19.", "Author SummaryThe novel pathogenic coronavirus SARS-CoV-2 causes COVID-19 and remains a threat to global public health.", "Chloroquine and hydroxychloroquine have been shown to prevent viral infection in cell-culture systems, but human clinical trials did not observe a significant improvement in COVID-19 patients treated with these compounds.", "Here we show that hydroxychloroquine interferes with only one of two somewhat redundant pathways by which the SARS-CoV-2 spike (S) protein is activated to mediate infection.", "The first pathway is dependent on the endosomal protease cathepsin L and sensitive to hydroxychloroquine, whereas the second pathway is dependent on TMPRSS2, which is unaffected by this compound.", "We further show that SARS-CoV-2 is more reliant than SARS coronavirus (SARS-CoV-1) on the TMPRSS2 pathway, and that this difference is due to a furin cleavage site present in the SARS-CoV-2 S protein.", "Finally, we show that combinations of hydroxychloroquine and a clinically tested TMPRSS2 inhibitor work together to effectively inhibit SARS-CoV-2 entry.", "Thus TMPRSS2 expression on physiologically relevant SARS-CoV-2 target cells may bypass the antiviral activities of hydroxychloroquine, and explain its lack of in vivo efficacy."], "title": "Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2"}
{"doc_id": 283, "abstract": ["The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes Coronavirus Disease 2019 (COVID-19), has caused a global pandemic.", "Antibodies are powerful biotherapeutics to fight viral infections; however, discovery of the most potent and broadly acting clones can be lengthy.", "Here, we used the human apoferritin protomer as a modular subunit to drive oligomerization of antibody fragments and transform antibodies targeting SARS-CoV-2 into exceptionally potent neutralizers.", "Using this platform, half-maximal inhibitory concentration (IC50) values as low as 9 \u00d7 10\u221214 M were achieved as a result of up to 10,000-fold potency enhancements.", "Combination of three different antibody specificities and the fragment crystallizable (Fc) domain on a single multivalent molecule conferred the ability to overcome viral sequence variability together with outstanding potency and Ig-like in vivo bioavailability.", "This MULTi-specific, multi-Affinity antiBODY (Multabody; or MB) platform contributes a new class of medical countermeasures against COVID-19 and an efficient approach to rapidly deploy potent and broadly-acting therapeutics against infectious diseases of global health importance.", "One Sentence Summary multimerization platform transforms antibodies emerging from discovery screens into potent neutralizers that can overcome SARS-CoV-2 sequence diversity."], "title": "Multivalency transforms SARS-CoV-2 antibodies into broad and ultrapotent neutralizers"}
{"doc_id": 284, "abstract": ["Many countries have applied lockdown that helped suppress COVID-19, but with devastating economic consequences.", "Here we propose exit strategies from lockdown that provide sustainable, albeit reduced, economic activity.", "We use mathematical models to show that a cyclic schedule of 4-day work and 10-day lockdown, or similar variants, can prevent resurgence of the epidemic while providing part-time employment.", "The cycle pushes the reproduction number R below one by reduced exposure time and by exploiting the virus latent period: those infected during work days reach peak infectiousness during lockdown days.", "The number of work days can be adapted in response to observations.", "Throughout, full epidemiological measures need to continue including hygiene, physical distancing, compartmentalization, testing and contact tracing.", "This conceptual framework, when combined with other interventions to control the epidemic, can offer the beginnings of predictability to many economic sectors."], "title": "Adaptive cyclic exit strategies from lockdown to suppress COVID-19 and allow economic activity"}
{"doc_id": 285, "abstract": ["Estimating the key epidemiological features of the novel coronavirus (2019-nCoV) epidemic proves to be challenging, given incompleteness and delays in early data reporting, in particular, the severe under-reporting bias in the epicenter, Wuhan, Hubei Province, China.", "As a result, the current literature reports widely varying estimates.", "We developed an alternative geo-stratified debiasing estimation framework by incorporating human mobility with case reporting data in three stratified zones, i.e., Wuhan, Hubei Province excluding Wuhan, and mainland China excluding Hubei.", "We estimated the latent infection ratio to be around 0.12% (18,556 people) and the basic reproduction number to be 3.24 in Wuhan before the city's lockdown on January 23, 2020.", "The findings based on this debiasing framework have important implications to prioritization of control and prevention efforts."], "title": "Incorporating Human Movement Data to Improve Epidemiological Estimates for 2019-nCoV"}
{"doc_id": 286, "abstract": ["We identify a mutation in the N gene of SARS-CoV-2 that adversely affects annealing of a commonly used RT-PCR primer; epidemiologic evidence suggests the virus retains pathogenicity and competence for spread.", "This reinforces the importance of using multiple targets, preferably in at least 2 genes, for robust SARS-CoV-2 detection.", "Article Summary Line A SARS-CoV-2 variant that occurs worldwide and has spread in California significantly affects diagnostic sensitivity of an N gene assay, highlighting the need to employ multiple viral targets for detection."], "title": "Identification of a polymorphism in the N gene of SARS-CoV-2 that adversely impacts detection by a widely-used RT-PCR assay"}
{"doc_id": 287, "abstract": ["BACKGROUND: The pandemic of new severe acute respiratory syndrome (SARS) due to coronavirus (CoV) 2 (SARS-CoV-2) has stressed the importance of effective diagnostic and prognostic biomarkers of clinical worsening and mortality.", "Epidemiological data showing a differential impact of SARS-CoV-2 infection on women and men have suggested a potential role for testosterone (T) in determining gender disparity in the SARS-CoV-2 clinical outcomes.", "OBJECTIVES: To estimate the association between T level and SARS-CoV-2 clinical outcomes (defined as conditions requiring transfer to higher or lower intensity of care or death) in a cohort of patients admitted in the respiratory intensive care unit (RICU).", "MATERIALS AND METHODS: A consecutive series of 31 male patients affected by SARS-CoV-2 pneumonia and recovered in the respiratory intensive care unit (RICU) of the \"Carlo Poma\" Hospital in Mantua were analyzed.", "Several biochemical risk factors (ie, blood count and leukocyte formula, C-reactive protein (CRP), procalcitonin (PCT), lactate dehydrogenase (LDH), ferritin, D-dimer, fibrinogen, interleukin 6 (IL-6)) as well as total testosterone (TT), calculated free T (cFT), sex hormone-binding globulin (SHBG), and luteinizing hormone (LH) were determined.", "RESULTS: Lower TT and cFT were found in the transferred to ICU/deceased in RICU group vs groups of patients transferred to IM or maintained in the RICU in stable condition.", "Both TT and cFT showed a negative significant correlation with biochemical risk factors (ie, the neutrophil count, LDH, and PCT) but a positive association with the lymphocyte count.", "Likewise, TT was also negatively associated with CRP and ferritin levels.", "A steep increase in both ICU transfer and mortality risk was observed in men with TT < 5 nmol/L or cFT < 100 pmol/L. DISCUSSION AND CONCLUSION: Our study demonstrates for the first time that lower baseline levels of TT and cFT levels predict poor prognosis and mortality in SARS-CoV-2-infected men admitted to RICU."], "title": "Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients"}
{"doc_id": 288, "abstract": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is already responsible for far more deaths than previous pathogenic coronaviruses (CoVs) from 2002 and 2012.", "The identification of clinically approved drugs to be repurposed to combat 2019 CoV disease (COVID-19) would allow the rapid implementation of potentially life-saving procedures.", "The major protease (Mpro) of SARS-CoV-2 is considered a promising target, based on previous results from related CoVs with lopinavir (LPV), an HIV protease inhibitor.", "However, limited evidence exists for other clinically approved antiretroviral protease inhibitors, such as atazanavir (ATV).", "ATV is of high interest because of its bioavailability within the respiratory tract.", "Our results show that ATV could dock in the active site of SARS-CoV-2 Mpro, with greater strength than LPV.", "ATV blocked Mpro activity.", "We confirmed that ATV inhibits SARS-CoV-2 replication, alone or in combination with ritonavir (RTV) in Vero cells, human pulmonary epithelial cell line and primary monocytes, impairing virus-induced enhancement of IL-6 and TNF-\u03b1 levels.", "Together, our data strongly suggest that ATV and ATV/RTV should be considered among the candidate repurposed drugs undergoing clinical trials in the fight against COVID-19."], "title": "Atazanavir inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production"}
{"doc_id": 289, "abstract": ["INTRODUCTION: The population and spatial characteristics of COVID-19 infections are poorly understood, but there is increasing evidence that in addition to individual clinical factors, demographic, socioeconomic and racial characteristics play an important role.", "METHODS: We analyzed positive COVID-19 testing results counts within New York City ZIP Code Tabulation Areas (ZCTA) with Bayesian hierarchical Poisson spatial models using integrated nested Laplace approximations.", "RESULTS: Spatial clustering accounted for approximately 32% of the variation in the data.", "There was a nearly five-fold increase in the risk of a positive COVID-19 test.", "(IDR = 4.8, 95% Cr I 2.4, 9.7) associated with the proportion of Black / African American residents.", "Increases in the proportion of residents older than 65 years, housing density and the proportion of residents with heart disease were each associated with an approximate doubling of risk.", "In a multivariable model including estimates for age, COPD, heart disease, housing density and Black/African American race, the only variables that remained associated with positive COVID-19 testing with a probability greater than chance were the proportion of Black/African American residents and proportion of older persons.", "CONCLUSIONS: Areas with large proportions of Black/African American residents are at markedly higher risk that is not fully explained by characteristics of the environment and pre-existing conditions in the population."], "title": "Blacks/African American Communities are at Highest Risk of COVID-19: Spatial Modeling of New York City ZIP Code-Level Testing Results"}
{"doc_id": 290, "abstract": ["While changes in SARS-CoV-2 viral load over time have been documented, detailed information on the impact of remdesivir and how it might alter intra-host viral evolution is limited.", "Sequential viral loads and deep sequencing of SARS-CoV-2 recovered from the upper respiratory tract of hospitalised children revealed that remdesivir treatment suppressed viral RNA levels in one patient but not in a second infected with an identical strain.", "Evidence of drug resistance to explain this difference was not found.", "Reduced levels of subgenomic (sg) RNA during treatment of the second patient, suggest an additional effect of remdesivir on viral replication that is independent of viral RNA levels.", "Haplotype reconstruction uncovered persistent SARS-CoV-2 variant genotypes in four patients.", "We conclude that these are likely to have arisen from within-host evolution, and not co-transmission, although superinfection cannot be excluded in one case.", "Sample-to-sample heterogeneity in the abundances of variant genotypes is best explained by the presence of discrete viral populations in the lung with incomplete population sampling in diagnostic swabs.", "Such compartmentalisation is well described in serious lung infections caused by influenza and Mycobacterium tuberculosis and has been associated with poor drug penetration, suboptimal treatment and drug resistance.", "Our data provide evidence that remdesivir is able to suppress SARS-CoV-2 replication in vivo but that its efficacy may be compromised by factors reducing penetration into the lung.", "Based on data from influenza and Mycobacterium tuberculosis lung infections we conclude that early use of remdesivir combined with other agents should now be evaluated."], "title": "Remdesivir induced viral RNA and subgenomic RNA suppression, and evolution of viral variants in SARS-CoV-2 infected patients."}
{"doc_id": 291, "abstract": ["As we enter a chronic phase of the SARS-CoV-2 pandemic, with uncontrolled infection rates in many places, relative regional susceptibilities are a critical unknown for policy planning.", "Tests for SARS-CoV-2 infection or antibodies are indicative but unreliable measures of exposure.", "Here instead, for four highly-affected countries, we determine population susceptibilities by directly comparing country-wide observed epidemic dynamics data with that of their main metropolitan regions.", "We find significant susceptibility reductions in the metropolitan regions as a result of earlier seeding, with a relatively longer phase of exponential growth before the introduction of public health interventions.", "During the post-growth phase, the lower susceptibility of these regions contributed to the decline in cases, independent of intervention effects.", "Forward projections indicate that non-metropolitan regions will be more affected during recurrent epidemic waves compared with the initially heavier-hit metropolitan regions.", "Our findings have consequences for disease forecasts and resource utilisation."], "title": "Impact of reduction of susceptibility to SARS-CoV-2 on epidemic dynamics in four early-seeded metropolitan regions"}
{"doc_id": 292, "abstract": ["Metformin was proposed to be a candidate for host-directed therapy for COVID-19.", "However, its efficacy remains to be validated.", "In this study, we compared the outcome of metformin users and nonusers in hospitalized COVID-19 patients with diabetes.", "Hospitalized diabetic patients with confirmed COVID-19 in the Tongji Hospital of Wuhan, China, from January 27, 2020 to March 24, 2020, were grouped into metformin and no-metformin groups according to the diabetic medications used.", "The demographics, characteristics, laboratory parameters, treatments, and clinical outcome in these patients were retrospectively assessed.", "A total of 283 patients (104 in the metformin and 179 in the no-metformin group) were included in this study.", "There were no significant differences between the two groups in gender, age, underlying diseases, clinical severity, and oxygen-support category at admission.", "The fasting blood glucose level of the metformin group was higher than that of the no-metformin group at admission and was under effective control in both groups after admission.", "Other laboratory parameters at admission and treatments after admission were not different between the two groups.", "The length of hospital stay did not differ between the two groups (21.0 days for metformin versus 19.5 days for no metformin, P = 0.74).", "However, in-hospital mortality was significantly lower in the metformin group (3/104 (2.9%) versus 22/179 (12.3%), P = 0.01).", "Antidiabetic treatment with metformin was associated with decreased mortality compared with diabetics not receiving metformin.", "This retrospective analysis suggests that metformin may offer benefits in patients with COVID-19 and that further study is indicated."], "title": "Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis"}
{"doc_id": 293, "abstract": ["Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged in December 20191,2 and is responsible for the COVID-19 pandemic3.", "Vaccines are an essential countermeasure urgently needed to control the pandemic4.", "Here, we show that the adenovirus-vectored vaccine ChAdOx1 nCoV-19, encoding the spike protein of SARS-CoV-2, is immunogenic in mice, eliciting a robust humoral and cell-mediated response.", "This response was not Th2 dominated, as demonstrated by IgG subclass and cytokine expression profiling.", "A single vaccination with ChAdOx1 nCoV-19 induced a humoral and cellular immune response in rhesus macaques.", "We observed a significantly reduced viral load in bronchoalveolar lavage fluid and respiratory tract tissue of vaccinated animals challenged with SARS-CoV-2 compared with control animals, and no pneumonia was observed in vaccinated rhesus macaques.", "Importantly, no evidence of immune-enhanced disease following viral challenge in vaccinated animals was observed.", "ChAdOx1 nCoV-19 is currently under investigation in a phase I clinical trial.", "Safety, immunogenicity and efficacy against symptomatic PCR-positive COVID-19 disease will now be assessed in randomised controlled human clinical trials."], "title": "ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques"}
{"doc_id": 294, "abstract": ["Background Coronavirus disease 2019 (COVID-19), caused by novel coronavirus SARS-CoV-2, has to date affected over 13.3 million globally.", "Although high rates of venous thromboembolism and evidence of COVID-19-induced endothelial dysfunction have been reported, the precise aetiology of the increased thrombotic risk associated with COVID-19 infection remains to be fully elucidated.", "Objectives Here, we assessed clinical platelet parameters and circulating platelet activity in patients with severe and non-severe COVID-19.", "Methods An assessment of clinical blood parameters in patients with severe COVID-19 disease (requiring intensive care), patients with non-severe disease (not requiring intensive care), general medical in-patients without COVID-19 and healthy donors was undertaken.", "Platelet function and activity were also assessed by secretion and specific marker analysis.", "Results We show that routine clinical blood parameters including increased MPV and decreased platelet:neutrophil ratio are associated with disease severity in COVID-19 upon hospitalisation and intensive care unit admission.", "Strikingly, agonist-induced ADP release was dramatically higher in COVID-19 patients compared with non-COVID-19 hospitalized patients and circulating levels of PF4, sP-selectin and TPO were also significantly elevated in COVID-19.", "Conclusion Distinct differences exist in routine full blood count and other clinical laboratory parameters between patients with severe and non-severe COVID-19.", "Moreover, we have determined that COVID-19 patients possess hyperactive circulating platelets.", "These data suggest that abnormal platelet reactivity may contribute to hypercoagulability in COVID-19.", "Further investigation of platelet function in COVID-19 may provide additional insights into the aetiology of thrombotic risk in this disease and may contribute to the optimisation of thrombosis prevention and treatment strategies."], "title": "COVID-19 induces a hyperactive phenotype in circulating platelets"}
{"doc_id": 295, "abstract": ["Lower respiratory viral infections, such as influenza virus and severe acute respiratory syndrome coronavirus 2 infections, often cause severe viral pneumonia in aged individuals.", "Here, we report that influenza viral pneumonia leads to chronic nonresolving lung pathology and exacerbated accumulation of CD8+ tissue-resident memory T cells (TRM) in the respiratory tract of aged hosts.", "TRM cell accumulation relies on elevated TGF-\u03b2 present in aged tissues.", "Further, we show that TRM cells isolated from aged lungs lack a subpopulation characterized by expression of molecules involved in TCR signaling and effector function.", "Consequently, TRM cells from aged lungs were insufficient to provide heterologous protective immunity.", "The depletion of CD8+ TRM cells dampens persistent chronic lung inflammation and ameliorates tissue fibrosis in aged, but not young, animals.", "Collectively, our data demonstrate that age-associated TRM cell malfunction supports chronic lung inflammatory and fibrotic sequelae after viral pneumonia."], "title": "Tissue-resident CD8+ T cells drive age-associated chronic lung sequelae after viral pneumonia."}
{"doc_id": 296, "abstract": ["Antibodies are becoming a frontline therapy for SARS-CoV-2, but the risk of viral evolutionary escape remains unclear.", "Here we map how all mutations to SARS-CoV-2\u2019s receptor-binding domain (RBD) affect binding by the antibodies in Regeneron\u2019s REGN-COV2 cocktail and Eli Lilly\u2019s LY-CoV016.", "These complete maps uncover a single amino-acid mutation that fully escapes the REGN-COV2 cocktail, which consists of two antibodies targeting distinct structural epitopes.", "The maps also identify viral mutations that are selected in a persistently infected patient treated with REGN-COV2, as well as in lab viral escape selections.", "Finally, the maps reveal that mutations escaping each individual antibody are already present in circulating SARS-CoV-2 strains.", "Overall, these complete escape maps enable immediate interpretation of the consequences of mutations observed during viral surveillance."], "title": "Prospective mapping of viral mutations that escape antibodies used to treat COVID-19"}
{"doc_id": 297, "abstract": ["Mitochondrial DNA (MT-DNA) are intrinsically inflammatory nucleic acids released by damaged solid organs.", "Whether the appearance of cell-free MT-DNA is linked to poor COVID-19 outcomes remains undetermined.", "Here, we quantified circulating MT-DNA in prospectively collected, cell-free plasma samples from 97 subjects with COVID-19 at the time of hospital presentation.", "Circulating MT-DNA were sharply elevated in patients who eventually died, required ICU admission or intubation.", "Multivariate regression analysis revealed that high circulating MT-DNA levels is an independent risk factor for all of these outcomes after adjusting for age, sex and comorbidities.", "Additionally, we found that circulating MT-DNA has a similar or superior area-under-the curve when compared to clinically established measures of systemic inflammation, as well as emerging markers currently of interest as investigational targets for COVID-19 therapy.", "These results show that high circulating MT-DNA levels is a potential indicator for poor COVID-19 outcomes."], "title": "Circulating Mitochondrial DNA is an Early Indicator of Severe Illness and Mortality from COVID-19."}
{"doc_id": 298, "abstract": ["Residual SARS-CoV-2 RNA has been detected in stool samples and gastrointestinal tissues during the convalescence phase of COVID-19 infection.", "This raises concern for persistence of SARS-CoV-2 virus particles and faecal-oral transmissibility in recovered COVID-19 patients.", "Using multiplex immunohistochemistry, we unexpectedly detected SARS-CoV-2 viral antigens in intestinal and liver tissues, in surgical samples obtained from two patients who recovered from COVID-19.", "We further validated the presence of virus by RT-PCR and flow cytometry to detect SARS-CoV-2-specific immunity in the tissues.", "These findings might have important implications in terms of disease management and public health policy regarding transmission of COVID-19 via faecal-oral and iatrogenic routes during the convalescence phase."], "title": "Residual SARS-CoV-2 viral antigens detected in gastrointestinal and hepatic tissues from two recovered COVID-19 patients"}
{"doc_id": 299, "abstract": ["Background The association between cardiovascular (CV) risk factors, such as hypertension and diabetes, established CV disease (CVD), and susceptibility to CV complications or mortality in COVID-19 remains unclear.", "Methods We conducted a cohort study of consecutive adults hospitalised for severe COVID-19 between 1st March and 30th June 2020.", "Pre-existing CVD, CV risk factors and associations with mortality and CV complications were ascertained.", "Findings Among 1,721 patients (median age 71 years, 57% male), 349 (20.3%) had pre-existing CVD (CVD), 888 (51.6%) had CV risk factors without CVD (RF-CVD), 484 (28.1%) had neither.", "Patients with CVD were older with a higher burden of non-CV comorbidities.", "During follow-up, 438 (25.5%) patients died: 37% with CVD, 25.7% with RF-CVD and 16.5% with neither.", "CVD was independently associated with in-hospital mortality among patients <70 years of age (adjusted HR 2.43 [95%CI 1.16-5.07]), but not in those [\u2265]70 years (aHR 1.14 [95%CI 0.77-1.69]).", "RF-CVD were not independently associated with mortality in either age group (<70y aHR 1.21 [95%CI 0.72-2.01], [\u2265]70y aHR 1.07 [95%CI 0.76-1.52]).", "Most CV complications occurred in patients with CVD (66%) versus RF-CVD (17%) or neither (11%; p<0.001).", "213 [12.4%] patients developed venous thromboembolism (VTE).", "CVD was not an independent predictor of VTE.", "Interpretation In patients hospitalised with COVID-19, pre-existing established CVD appears to be a more important contributor to mortality than CV risk factors in the absence of CVD.", "CVD-related hazard may be mediated, in part, by new CV complications.", "Optimal care and vigilance for destabilised CVD are essential in this patient group."], "title": "Pre-existing cardiovascular disease rather than cardiovascular risk factors drives mortality in COVID-19"}
{"doc_id": 300, "abstract": ["Dysfunctional immune response in the COVID-19 patients is a recurrent theme impacting symptoms and mortality, yet the detailed understanding of pertinent immune cells is not complete.", "We applied single-cell RNA sequencing to 284 samples from 205 COVID-19 patients and controls to create a comprehensive immune landscape.", "Lymphopenia and active T and B cell responses were found to coexist and associated with age, sex and their interactions with COVID-19.", "Diverse epithelial and immune cell types were observed to be virus-positive and showed dramatic transcriptomic changes.", "Elevation of ANXA1 and S100A9 in virus-positive squamous epithelial cells may enable the initiation of neutrophil and macrophage responses via the ANXA1-FPR1 and S100A8/9-TLR4 axes.", "Systemic upregulation of S100A8/A9, mainly by megakaryocytes and monocytes in the peripheral blood, may contribute to the cytokine storms frequently observed in severe patients.", "Our data provide a rich resource for understanding the pathogenesis and designing effective therapeutic strategies for COVID-19.", "HIGHLIGHTS Large-scale scRNA-seq analysis depicts the immune landscape of COVID-19 Lymphopenia and active T and B cell responses coexist and are shaped by age and sex SARS-CoV-2 infects diverse epithelial and immune cells, inducing distinct responses Cytokine storms with systemic S100A8/A9 are associated with COVID-19 severity"], "title": "Large-scale single-cell analysis reveals critical immune characteristics of COVID-19 patients"}
{"doc_id": 301, "abstract": ["Background: COVID-19 is a major pandemic that has killed more than 196,000 people.", "The COVID-19 disease course is strikingly divergent.", "Approximately 80-85% of patients experience mild or no symptoms, while the remainder develop severe disease.", "The mechanisms underlying these divergent outcomes are unclear.", "Emerging health disparities data regarding African American and homeless populations suggest that vitamin D insufficiency (VDI) may be an underlying driver of COVID-19 severity.", "To better define the VDI-COVID-19 link, we determined the prevalence of VDI among our COVID-19 intensive care unit (ICU) patients.", "Methods: In an Institutional Review Board approved study performed at a single, tertiary care academic medical center, the medical records of COVID-19 patients were retrospectively reviewed.", "Subjects were included for whom serum 25-hydroxycholecalcifoerol (25OHD) levels were determined.", "COVID-19-relevant data were compiled and analyzed.", "We determined the frequency of VDI among COVID-19 patients to evaluate the likelihood of a VDI-COVID-19 relationship.", "Results: Twenty COVID-19 patients with serum 25OHD levels were identified; 65.0% required ICU admission.", "The VDI prevalence in ICU patients was 84.6%, vs. 57.1% in floor patients.", "Strikingly, 100% of ICU patients less than 75 years old had VDI.", "Coagulopathy was present in 62.5% of ICU COVID-19 patients, and 92.3% were lymphocytopenic.", "Conclusions: VDI is highly prevalent in severe COVID-19 patients.", "VDI and severe COVID-19 share numerous associations including hypertension, obesity, male sex, advanced age, concentration in northern climates, coagulopathy, and immune dysfunction.", "Thus, we suggest that prospective, randomized controlled studies of VDI in COVID-19 patients are warranted."], "title": "Vitamin D Insufficiency is Prevalent in Severe COVID-19"}
{"doc_id": 302, "abstract": ["The urgent need for large-scale diagnostic testing for SARS-CoV-2 has prompted pursuit of sample-collection methods of sufficient sensitivity to replace sampling of the nasopharynx (NP).", "Among these alternatives is collection of nasal-swab samples, which can be performed by the patient, avoiding the need for healthcare personnel and personal protective equipment.", "Previous studies have reached opposing conclusions regarding whether nasal sampling is concordant or discordant with NP.", "To resolve this disagreement, we compared nasal and NP specimens collected by healthcare workers in a cohort consisting of individuals clinically suspected of COVID-19 and outpatients known to be SARS-CoV-2 RT-PCR positive undergoing follow-up.", "We investigated three different transport conditions, including traditional viral transport media (VTM) and dry swabs, for each of two different nasal-swab collection protocols on a total of 308 study participants, and compared categorical results and Ct values to those from standard NP swabs collected at the same time from the same patients.", "All testing was performed by RT-PCR on the Abbott SARS-CoV-2 RealTime EUA (limit of detection [LoD], 100 copies viral genomic RNA/mL transport medium).", "We found high concordance (Cohen\u2019s kappa >0.8) only for patients with viral loads above 1,000 copies/mL. Those with viral loads below 1,000 copies/mL, the majority in our cohort, exhibited low concordance (Cohen\u2019s kappa = 0.49); most of these would have been missed by nasal testing alone.", "Previous reports of high concordance may have resulted from use of assays with higher LoD (\u22651,000 copies/mL).", "These findings counsel caution in use of nasal testing in healthcare settings and contact-tracing efforts, as opposed to screening of asymptomatic, low-prevalence, low-risk populations.", "Nasal testing is an adjunct, not a replacement, for NP."], "title": "Nasal-Swab Testing Misses Patients with Low SARS-CoV-2 Viral Loads"}
{"doc_id": 303, "abstract": ["Background: Excessive monocyte/macrophage activation with the development of a cytokine storm and subsequent acute lung injury, leading to acute respiratory distress syndrome (ARDS) is a feared consequence of infection with COVID-19.", "The ability to recognize and potentially intervene early in those patients at greatest risk of developing this complication could be of great clinical utility.", "Methods: We performed detailed flow cytometric analysis of peripheral blood samples from 28 COVID-19 patients treated at Xian No.8 Hospital and the First Affiliated Hospital of Xian Jiaotong University in early 2020 in an attempt to identify factors that could help predict severity of disease and patient outcome.", "Findings: While we did not detect significant differences in the number of monocytes between patients with COVID-19 and normal healthy individuals,we did identify significant morphological and functional differences, which are more pronounced in patients requiring prolonged hospitalization and ICU admission.", "Patients with COVID-19 have larger than normal monocytes, easily identified on forward scatter, side scatter analysis by routine flow cytometry,with the presence of a distinct population of monocytes with high forward scatter (FSC-high).", "On more detailed analysis, these FSC-high monocytes are CD11b+, CD14+, CD16+, CD68+, CD80+, CD163+, CD206+ and secrete IL-6, IL-10 and TNF-alpha, consistent with an inflammatory phenotype.", "Conclusions: The detection and serial monitoring of this subset of inflammatory monocytes using flow cytometry could be of great help in guiding the prognostication and treatment of patients with COVID-19 and merits further evaluation."], "title": "COVID-19 infection induces readily detectable morphological and inflammation-related phenotypic changes in peripheral blood monocytes, the severity of which correlate with patient outcome"}
{"doc_id": 304, "abstract": ["BACKGROUND The characteristics of COVID-19 outbreak and high fatality rate of COVID-19 infection have attracted the attention of scientists due to the strong interactions between components of metabolic syndrome, metabolic abnormalities, and viral pathobiology of COVID-19.", "Combined metabolic cofactors supplementation (CMCS) consisting of L-serine, N-acetyl-L-cysteine (NAC), nicotinamide riboside (NR), and L-carnitine tartrate is being studied for the treatment of patients with COVID-19.", "METHODS We conducted a placebo-controlled, phase-2 clinical trial involving ambulatory COVID-19 patients.", "A total of 100 patients were randomly assigned on a 3:1 basis to hydroxychloroquine plus CMCS or hydroxychloroquine plus placebo.", "The total treatment period for the hydroxychloroquine was 5 days, and for the CMCS/placebo was 14 days.", "Clinical status was evaluated daily by phone, using a binomial scale for subject reported presence or absence for multiple COVID-19 related symptoms.", "Plasma samples for clinical chemistry analyses were collected on day 0 and day 14.", "RESULTS A total of 93 patients completed the trial.", "The combination of CMCS and hydroxychloroquine significantly reduced the average complete recovery time compared with hydroxychloroquine and placebo (6.6 days vs 9.3 days, respectively).", "Moreover, there was a significant reduction in ALT, AST and LDH levels on day 14 compared to day 0 in the hydroxychloroquine plus CMCS group.", "The adverse effects were uncommon and self-limiting.", "CONCLUSIONS In patients with mild-to-moderate COVID-19, CMCS resulted in a significant reduction in recovery time and liver enzymes associated with hepatic function compared to placebo.", "We observed that CMSC is associated with a low incidence of adverse events."], "title": "Combined metabolic cofactor supplementation accelerates recovery in mild-to-moderate COVID-19"}
{"doc_id": 305, "abstract": ["The human microbiota has a close relationship with human disease and it remodels components of the glycocalyx including heparan sulfate (HS).", "Studies of the severe acute respiratory syndrome coronavirus (SARS-CoV-2) spike protein receptor binding domain suggest that infection requires binding to HS and angiotensin converting enzyme 2 (ACE2) in a codependent manner.", "Here, we show that commensal host bacterial communities can modify HS and thereby modulate SARS-CoV-2 spike protein binding and that these communities change with host age and sex.", "Common human-associated commensal bacteria whose genomes encode HS-modifying enzymes were identified.", "The prevalence of these bacteria and the expression of key microbial glycosidases in bronchoalveolar lavage fluid (BALF) was lower in adult COVID-19 patients than in healthy controls.", "The presence of HS-modifying bacteria decreased with age in two large survey datasets, FINRISK 2002 and American Gut, revealing one possible mechanism for the observed increase in COVID-19 susceptibility with age.", "In vitro, bacterial glycosidases from unpurified culture media supernatants fully blocked SARS-CoV-2 spike binding to human H1299 protein lung adenocarcinoma cells.", "HS-modifying bacteria in human microbial communities may regulate viral adhesion, and loss of these commensals could predispose individuals to infection.", "Understanding the impact of shifts in microbial community composition and bacterial lyases on SARS-CoV-2 infection may lead to new therapeutics and diagnosis of susceptibility.", "Graphical Abstract.", "Diagram of hypothesis for bacterial mediation of SARS-CoV-2 infection through heparan sulfate (HS).", "It is well known that host microbes groom the mucosa where they reside.", "Recent investigations have shown that HS, a major component of mucosal layers, is necessary for SARS-CoV-2 infection.", "In this study we examine the impact of microbial modification of HS on viral attachment."], "title": "Bacterial modification of the host glycosaminoglycan heparan sulfate modulates SARS-CoV-2 infectivity"}
{"doc_id": 306, "abstract": ["Early in the current pandemic, the D614G mutation arose in the Spike protein of SARS-CoV-2 and quickly became the dominant variant globally.", "Mounting evidence suggests D614G enhances viral entry.", "Here we use a direct competition assay with single-cycle viruses to show that D614G outcompetes the wildtype.", "We developed a cell line with inducible ACE2 expression to confirm that D614G more efficiently enters cells with ACE2 levels spanning the different primary cells targeted by SARS-CoV-2.", "Using a new assay for crosslinking and directly extracting Spike trimers from the pseudovirus surface, we found an increase in trimerization efficiency and viral incorporation of D614G protomers.", "Our findings suggest that D614G increases infection of cells expressing a wide range of ACE2, and informs the mechanism underlying enhanced entry.", "The tools developed here can be broadly applied to study other Spike variants and SARS-CoV-2 entry, to inform functional studies of viral evolution and vaccine development."], "title": "The SARS-CoV-2 Spike mutation D614G increases entry fitness across a range of ACE2 levels, directly outcompetes the wild type, and is preferentially incorporated into trimers"}
{"doc_id": 307, "abstract": ["Recently, a new SARS-CoV-2 lineage called B.1.1.7 has emerged in the United Kingdom that was reported to spread more efficiently than other strains.", "This variant has an unusually large number of mutations with 10 amino acid changes in the spike protein, raising concerns that its recognition by neutralizing antibodies may be affected.", "Here, we investigated SARS-CoV-2-S pseudoviruses bearing either the Wuhan reference strain or the B.1.1.7 lineage spike protein with sera of 16 participants in a previously reported trial with the mRNA-based COVID-19 vaccine BNT162b2.", "The immune sera had equivalent neutralizing titers to both variants.", "These data, together with the combined immunity involving humoral and cellular effectors induced by this vaccine, make it unlikely that the B.1.1.7 lineage will escape BNT162b2-mediated protection."], "title": "Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera"}
{"doc_id": 308, "abstract": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first detected in Wuhan in December 2019 and caused coronavirus disease 2019 (COVID-19)1,2.", "In 2003, the closely related SARS-CoV had been detected in domestic cats and a dog3.", "However, little is known about the susceptibility of domestic pet mammals to SARS-CoV-2.", "Here, using PCR with reverse transcription, serology, sequencing the viral genome and virus isolation, we show that 2 out of 15 dogs from households with confirmed human cases of COVID-19 in Hong Kong were found to be infected with SARS-CoV-2.", "SARS-CoV-2 RNA was detected in five nasal swabs collected over a 13-day period from a 17-year-old neutered male Pomeranian.", "A 2.5-year-old male German shepherd was positive for SARS-CoV-2 RNA on two occasions and virus was isolated from nasal and oral swabs.", "Antibody responses were detected in both dogs using plaque-reduction-neutralization assays.", "Viral genetic sequences of viruses from the two dogs were identical to the virus detected in the respective human cases.", "The dogs remained asymptomatic during quarantine.", "The evidence suggests that these are instances of human-to-animal transmission of SARS-CoV-2.", "It is unclear whether infected dogs can transmit the virus to other animals or back to humans."], "title": "Infection of dogs with SARS-CoV-2"}
{"doc_id": 309, "abstract": ["In the past two decades, the world has faced several infectious disease outbreaks.", "Ebola, Influenza A (H1N1), SARS, MERS, and Zika virus have had a massive global impact in terms of economic disruption, the strain on local and global public health.", "Most recently, the global outbreak of novel coronavirus 2019 (SARS-CoV-2) that causes COVID-19 is a newly discovered virus from the coronavirus family in Wuhan city, China, known to be a great threat to the public health systems.", "As of 15 April 2020, The Johns Hopkins University estimated that the COVID-19 affected more than two million people, resulting in a death toll above 130,000 around the world.", "Infected people in Europe and America correspond about 40% and 30% of the total reported cases respectively.", "At this moment only few Asian countries have controlled the disease, but a second wave of new infections is expected.", "Predicting inhibitor and target to the COVID-19 is an urgent need to protect human from the disease.", "Therefore, a protocol to identify anti-COVID-19 candidate based on computer-aided drug design is urgently needed.", "Thousands of compounds including approved drugs and drugs in the clinical trial are available in the literature.", "In practice, experimental techniques can measure the time and space average properties but they cannot be captured the structural variation of the COVID-19 during the interaction of inhibitor.", "Computer simulation is particularly suitable to complement experiments to elucidate conformational changes at the molecular level which are related to inhibition process of the COVID-19.", "Therefore, computational simulation is essential tool to elucidate the phenomenon.", "The structure-based virtual screening computational approach will be used to filter the best drugs from the literature, the investigate the structural variation of COVID-19 with the interaction of the best inhibitor is a fundamental step to design new drugs and vaccines which can combat the coronavirus.", "This mini-review will address novel coronavirus structure, mechanism of action, and trial test of antiviral drugs in the lab and patients with COVID-19."], "title": "Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment"}
{"doc_id": 310, "abstract": ["Observational data on COVID-19 including hypothesised risk factors for infection and progression are accruing rapidly, often from non-random sampling such as hospital admissions, targeted testing or voluntary participation.", "Here, we highlight the challenge of interpreting observational evidence from such samples of the population, which may be affected by collider bias.", "We illustrate these issues using data from the UK Biobank in which individuals tested for COVID-19 are highly selected for a wide range of genetic, behavioural, cardiovascular, demographic, and anthropometric traits.", "We discuss the sampling mechanisms that leave aetiological studies of COVID-19 infection and progression particularly susceptible to collider bias.", "We also describe several tools and strategies that could help mitigate the effects of collider bias in extant studies of COVID-19 and make available a web app for performing sensitivity analyses.", "While bias due to non-random sampling should be explored in existing studies, the optimal way to mitigate the problem is to use appropriate sampling strategies at the study design stage."], "title": "Collider bias undermines our understanding of COVID-19 disease risk and severity"}
{"doc_id": 311, "abstract": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for millions of infections and hundreds of thousands of deaths globally.", "There are no widely available licensed therapeutics against SARS-CoV-2, highlighting an urgent need for effective interventions.", "The virus enters host cells through binding of a receptor-binding domain within its trimeric spike glycoprotein to human angiotensin-converting enzyme 2.", "In this article, we describe the generation and characterization of a panel of murine mAbs directed against the receptor-binding domain.", "One mAb, 2B04, neutralized wild-type SARS-CoV-2 in vitro with remarkable potency (half-maximal inhibitory concentration of <2 ng/ml).", "In a murine model of SARS-CoV-2 infection, 2B04 protected challenged animals from weight loss, reduced lung viral load, and blocked systemic dissemination.", "Thus, 2B04 is a promising candidate for an effective antiviral that can be used to prevent SARS-CoV-2 infection."], "title": "A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection."}
{"doc_id": 312, "abstract": ["As the SARS-Cov-2 virus spreads around the world afflicting millions of people, it has undergone divergent genetic mutations.", "Although most of these mutations are expected to be inconsequential, some mutations in the spike protein structure have been hypothesized to affect the critical stage at which the virus invades human cells, which could affect transmission probability and disease expression.", "If true, then we expect an increased growth rate of reported COVID-19 cases in regions dominated by viruses with these altered proteins.", "We modeled early global infection dynamics based on clade assignment along with other demographic and meteorological factors previously found to be important.", "Clade, but not variant D614G which has been associated with increased viral load, enhanced our ability to describe early COVID-19 growth dynamics.", "Including clade identity in models significantly improved predictions over earlier work based only on weather and demographic variables.", "In particular, higher proportions of clade 19A and 19B were negatively correlated with COVID-19 growth rate, whereas higher proportions of 20A and 20C were positively correlated with growth rate.", "A strong interaction between the prevalence of clade 20C and relative humidity suggests that the impact of clade identity might be more important when coupled with certain weather conditions.", "In particular, 20C an 20A generate the highest growth rates when coupled with low humidity.", "Projections based on data through April 2020 suggest that, without intervention, COVID-19 has the potential to grow more quickly in regions dominated by the 20A and 20C clades, including most of South and North America."], "title": "Virus evolution affected early COVID-19 spread"}
{"doc_id": 313, "abstract": ["The rapid outbreak of the new Coronavirus (COVID-19) pandemic and the spread of the virus worldwide, especially in the Northern Hemisphere, have prompted various investigations about the impact of environmental factors on the rate of development of this epidemic.", "Different studies have called the attention to various parameters that may have influenced the spread of the virus, and in particular, the impact of climatic parameters has been emphasized.", "The main purpose of this study is to investigate the correlation between the average daily temperature and the rate of coronavirus epidemic growth in the infected regions.", "The main hypothesis object of our research is that between regions exhibiting a significant difference in the mean daily temperature, a significant difference is also observed in the average cumulative daily rate of confirmed cases, and that this does not happen if there is no significant difference in mean daily temperature.", "To test this research hypothesis, we carried on the case study of three regions in each of five countries and analyzed the correlation through F-test, and Independent-Samples T-Test.", "In all five selected countries, we found that when there is a significant difference in the daily mean temperature between two regions of a country, a significant difference exists also in the average cumulative daily rate of confirmed cases.", "Conversely, if there are no significant differences in the mean daily temperature of two regions in the same country, no significant difference is observed in the average cumulative daily rate of confirmed cases for these regions."], "title": "Relationship between Average Daily Temperature and Average Cumulative Daily Rate of Confirmed Cases of COVID-19"}
{"doc_id": 314, "abstract": ["Objective To estimate the infection fatality rate of coronavirus disease 2019 (COVID-19) from data of seroprevalence studies.", "Methods Population studies with sample size of at least 500 and published as peer-reviewed papers or preprints as of May 12, 2020 were retrieved from PubMed, preprint servers, and communications with experts.", "Studies on blood donors were included, but studies on healthcare workers were excluded.", "The studies were assessed for design features and seroprevalence estimates.", "Infection fatality rate was estimated from each study dividing the number of COVID-19 deaths at a relevant time point by the number of estimated people infected in each relevant region.", "Correction was also attempted accounting for the types of antibodies assessed.", "Results Twelve studies were identified with usable data to enter into calculations.", "Seroprevalence estimates ranged from 0.113% to 25.9% and adjusted seroprevalence estimates ranged from 0.309% to 33%.", "Infection fatality rates ranged from 0.03% to 0.50% and corrected values ranged from 0.02% to 0.40%.", "Conclusions The infection fatality rate of COVID-19 can vary substantially across different locations and this may reflect differences in population age structure and case-mix of infected and deceased patients as well as multiple other factors.", "Estimates of infection fatality rates inferred from seroprevalence studies tend to be much lower than original speculations made in the early days of the pandemic."], "title": "The infection fatality rate of COVID-19 inferred from seroprevalence data"}
{"doc_id": 315, "abstract": ["Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) infects cells by binding to the host cell receptor ACE2 and undergoing virus-host membrane fusion.", "Fusion is triggered by the protease TMPRSS2, which processes the viral Spike (S) protein to reveal the fusion peptide.", "SARS-CoV-2 has evolved a multibasic site at the S1-S2 boundary, which is thought to be cleaved by furin in order to prime S protein for TMPRSS2 processing.", "Here we show that CRISPR-Cas9 knockout of furin reduces, but does not prevent, the production of infectious SARS-CoV-2 virus.", "Comparing S processing in furin knockout cells to multibasic site mutants reveals that while loss of furin substantially reduces S1-S2 cleavage it does not prevent it.", "SARS-CoV-2 S protein also mediates cell-cell fusion, potentially allowing virus to spread virion-independently.", "We show that loss of furin in either donor or acceptor cells reduces, but does not prevent, TMPRSS2-dependent cell-cell fusion, unlike mutation of the multibasic site that completely prevents syncytia formation.", "Our results show that while furin promotes both SARS-CoV-2 infectivity and cell-cell spread it is not essential, suggesting furin inhibitors may reduce but not abolish viral spread."], "title": "Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion"}
{"doc_id": 316, "abstract": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects cells by binding to the host cell receptor Ace2 and undergoing virus-host membrane fusion.", "Fusion is triggered by the protease TMPRSS2, which processes the viral Spike (S) protein to reveal the fusion peptide.", "SARS-CoV-2 has evolved a multibasic site at the S1-S2 boundary, which is thought to be cleaved by furin in order to prime S protein for TMPRSS2 processing.", "Here we show that CRISPR-Cas9 knockout of furin reduces, but does not prevent, the production of infectious SARS-CoV-2 virus.", "Comparing S processing in furin knockout cells to multibasic site mutants reveals that while loss of furin substantially reduces S1-S2 cleavage it does not prevent it.", "SARS-CoV-2 S protein also mediates cell-cell fusion, potentially allowing virus to spread virion-independently.", "We show that loss of furin in either donor or acceptor cells reduces, but does not prevent, TMPRSS2-dependent cell-cell fusion, unlike mutation of the multibasic site that completely prevents syncytia formation.", "Our results show that while furin promotes both SARS-CoV-2 infectivity and cell-cell spread it is not essential, suggesting furin inhibitors will not prevent viral spread."], "title": "Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion"}
{"doc_id": 317, "abstract": ["The production of SARS-CoV-2-specific neutralizing antibodies is widely considered as a key mechanism for COVID-19 resolution and protection.", "However, beyond their protective function, antibodies to SARS-CoV-2 may also participate in disease pathogenesis.", "To explore the potential relationship between virus-specific humoral responses and COVID-19 immunopathology, we measured serum antibody classes and subclasses to the receptor-binding domain of the SARS-CoV-2 spike protein and the nucleoprotein in a cohort of hospitalized COVID-19 patients with moderate to severe disease.", "We found that RBD-specific IgG1 and IgG3 dominated the humoral response to SARS-CoV-2, were more abundant in severe patients, and positively correlated with several clinical parameters of inflammation.", "In contrast, a virus-specific IgA2 response skewed toward RBD rather than NP associated with a more favorable clinical course.", "Interestingly, RBD-dominant IgA2 responses were mostly detected in patients with gastrointestinal symptoms, suggesting the possible involvement of intrinsically tolerogenic gut immune pathways in the attenuation of virus-induced inflammation and disease resolution."], "title": "SARS-CoV-2-Specific Antibody Profiles Distinguish Patients with Moderate from Severe COVID-19"}
{"doc_id": 318, "abstract": ["Environmental factors are well known to affect spatio-temporal patterns of infectious disease outbreaks, but whether the rapid spread of COVID-19 across the globe is related to local environmental conditions is highly debated.", "We assessed the impact of environmental factors (temperature, humidity and air pollution) on the global patterns of COVID-19 early outbreak dynamics during January-May 2020, controlling for several key socio-economic factors and airport connections.", "We showed that during the earliest phase of the global outbreak (January-March), COVID-19 growth rates were non-linearly related to climate, with fastest spread in regions with a mean temperature of ca.", "5 \u00b0C, and in the most polluted regions.", "However, environmental effects faded almost completely when considering later outbreaks, in keeping with the progressive enforcement of containment actions.", "Accordingly, COVID-19 growth rates consistently decreased with stringent containment actions during both early and late outbreaks.", "Our findings indicate that environmental drivers may have played a role in explaining the early variation among regions in disease spread.", "With limited policy interventions, seasonal patterns of disease spread might emerge, with temperate regions of both hemispheres being most at risk of severe outbreaks during colder months.", "Nevertheless, containment measures play a much stronger role and overwhelm impacts of environmental variation, highlighting the key role for policy interventions in curbing COVID-19 diffusion within a given region.", "If the disease will become seasonal in the next years, information on environmental drivers of COVID-19 can be integrated with epidemiological models to inform forecasting of future outbreak risks and improve management plans."], "title": "Containment measures limit environmental effects on COVID-19 early outbreak dynamics"}
{"doc_id": 319, "abstract": ["Importance: The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) threatens global public health.", "The association between clinical characteristics of the virus and neutralizing antibodies (NAbs) against this virus have not been well studied.", "Objective: To examine the association between clinical characteristics and levels of NAbs in patients who recovered from COVID-19.", "Design, Setting, and Participants: In this cohort study, a total of 175 patients with mild symptoms of COVID-19 who were hospitalized from January 24 to February 26, 2020, were followed up until March 16, 2020, at Shanghai Public Health Clinical Center, Shanghai, China.", "Exposures: SARS-CoV-2 infections were diagnosed and confirmed by reverse transcriptase-polymerase chain reaction testing of nasopharyngeal samples.", "Main Outcomes and Measures: The primary outcome was SARS-CoV-2-specific NAb titers.", "Secondary outcomes included spike-binding antibodies, cross-reactivity against SARS-associated CoV, kinetics of NAb development, and clinical information, including age, sex, disease duration, length of stay, lymphocyte counts, and blood C-reactive protein level.", "Results: Of the 175 patients with COVID-19, 93 were female (53%); the median age was 50 (interquartile range [IQR], 37-63) years.", "The median length of hospital stay was 16 (IQR, 13-21) days, and the median disease duration was 22 (IQR, 18-26) days.", "Variable levels of SARS-CoV-2-specific NAbs were observed at the time of discharge (50% inhibitory dose [ID50], 1076 [IQR, 448-2048]).", "There were 10 patients whose NAb titers were less than the detectable level of the assay (ID50, <40), and 2 patients who showed very high titers of NAbs, with ID50 levels of 15 989 and 21 567.", "NAbs were detected in patients from day 4 to 6 and reached peak levels from day 10 to 15 after disease onset.", "NAbs were unable to cross-react with SARS-associated CoV and NAb titers correlated with the spike-binding antibodies targeting S1 (r = 0.451; 95% CI, 0.320-0.564; P < .001), receptor binding domain (r = 0.484; 95% CI, 0.358-0.592; P < .001), and S2 regions (r = 0.346; 95% CI, 0.204-0.473; P < .001).", "NAb titers at the time of discharge were significantly higher in the 82 men (1417 [IQR, 541-2253]) than those in the 93 women (905 [IQR, 371-1687]) (median difference, 512; 95% CI, 82-688; P = .01) and at the time of follow-up in 56 male patients (1049 [IQR, 552-2454]) vs 61 female patients (751 [IQR, 216-1301]) (median difference, 298; 95% CI, 86-732; P = .009).", "Plasma NAb titers were significantly higher in 56 older (1537 [IQR, 877-2427) and 63 middle-aged (1291 [IQR, 504-2126]) patients than in 56 younger patients (459 [IQR, 225-998]) (older vs younger: median difference, 1078; 95% CI, 548-1287; P < .001; middle-aged vs younger: median difference, 832; 95% CI, 284-1013; P < .001).", "The NAb titers were correlated with plasma C-reactive protein levels (r = 0.508; 95% CI, 0.386-0.614; P < .001) and negatively correlated with lymphocyte counts (r =-0.427; 95% CI,-0.544 to-0.293; P < .001) at the time of admission.", "Conclusions and Relevance: In this cohort study, among 175 patients who recovered from mild COVID-19 in Shanghai, China, NAb titers to SARS-CoV-2 appeared to vary substantially.", "Further research is needed to understand the clinical implications of differing NAb titers for protection against future infection."], "title": "Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China"}
{"doc_id": 320, "abstract": ["In this paper we develop an agent-based model for a fine-grained computational simulation of the ongoing COVID-19 pandemic in Australia.", "This model is calibrated to reproduce several characteristics of COVID-19 transmission, accounting for its reproductive number, the length of incubation and generation periods, age-dependent attack rates, and the growth rate of cumulative incidence during a sustained and unmitigated local transmission.", "An important calibration outcome is the age-dependent fraction of symptomatic cases, with this fraction for children found to be one-fifth of such fraction for adults.", "We then apply the model to compare several intervention strategies, including restrictions on international air travel, case isolation, social distancing with varying levels of compliance, and school closures.", "School closures are not found to bring decisive benefits.", "We report an important transition across the levels of social distancing compliance, in the range between 70% and 80% levels.", "This suggests that a compliance of below 70% is unlikely to succeed for any duration of social distancing, while a compliance at the 90% level is likely to control the disease within 13-14 weeks, when coupled with effective case isolation and international travel restrictions."], "title": "Modelling transmission and control of the COVID-19 pandemic in Australia"}
{"doc_id": 321, "abstract": ["The spread of SARS-CoV-2 has caused a global pandemic that has affected almost every aspect of human life.", "The development of an effective COVID-19 vaccine could limit the morbidity and mortality caused by infection, and may enable the relaxation of social distancing measures.", "Age is one of the most significant risk factors for poor health outcomes after SARS-CoV-2 infection, therefore it is desirable that any new vaccine candidates should elicit a robust immune response in older adults.", "Here, we test the immunogenicity of the adenoviral vectored vaccine ChAdOx1 nCoV-19 (AZD-1222) in aged mice.", "We find that a single dose of this vaccine induces cellular and humoral immunity in aged mice, but at a reduced magnitude than in younger adult mice.", "Furthermore, we report that a second dose enhances the immune response to this vaccine in aged mice, indicating that a primeboost strategy may be a rational approach to enhance immunogenicity in older persons."], "title": "A booster dose enhances immunogenicity of the COVID-19 vaccine candidate ChAdOx1 nCoV-19 in aged mice"}
{"doc_id": 322, "abstract": ["We performed comparative lower respiratory tract transcriptional profiling of 52 critically ill patients with the acute respiratory distress syndrome (ARDS) from COVID-19 or from other etiologies, as well as controls without ARDS.", "In contrast to a cytokine storm, we observed reduced proinflammatory gene expression in COVID-19 ARDS when compared to ARDS due to other causes.", "COVID-19 ARDS was characterized by a dysregulated host response with increased PTEN signaling and elevated expression of genes with non-canonical roles in inflammation and immunity that were predicted to be modulated by dexamethasone and granulocyte colony stimulating factor.", "Compared to ARDS due to other types of viral pneumonia, COVID-19 was characterized by impaired interferon-stimulated gene expression (ISG).", "We found that the relationship between SARS-CoV-2 viral load and expression of ISGs was decoupled in patients with COVID-19 ARDS when compared to patients with mild COVID-19.", "In summary, assessment of host gene expression in the lower airways of patients with COVID-19 ARDS did not demonstrate cytokine storm but instead revealed a unique and dysregulated host response predicted to be modified by dexamethasone."], "title": "COVID-19 ARDS is characterized by a dysregulated host response that differs from cytokine storm and is modified by dexamethasone"}
{"doc_id": 323, "abstract": ["Purpose: The genetic locus 3p21.31 has been associated with severe coronavirus disease 2019 (COVID-19), but the underlying pathophysiological mechanism is unknown.", "Methods: To identify intermediate traits of the COVID-19 risk variant, we performed a phenome-wide association study (PheWAS) with 923 phenotypes in 310,999 European individuals from UK Biobank.", "For candidate target genes, we examined associations between their expression and the polygenic score (PGS) of 1,263 complex traits in a meta-analysis of 31,684 blood samples.", "Results: Our PheWAS identified and replicated multiple blood cell traits to be associated with the COVID-19 risk variant, including monocyte count and percentage (p = 1.07e-8, 4.09e-13), eosinophil count and percentage (p = 5.73e-3, 2.20e-3), and neutrophil percentage (p = 3.23e-3).", "The PGS analysis revealed positive associations between the expression of candidate genes and genetically predicted counts of specific blood cells: CCR3 with eosinophil and basophil (p = 5.73e-21, 5.08e-19); CCR2 with monocytes (p = 2.40e-10); and CCR1 with monocytes and neutrophil (p = 1.78e-6, 7.17e-5).", "Conclusions: Multiple blood cell traits, especially monocyte, eosinophil, and neutrophil numbers, are associated with the COVID-19 risk variant and the expression of its candidate target genes, representing probable mechanistic links between the genetic locus 3p21.31 and severe COVID-19."], "title": "Altered blood cell traits underlie a major genetic locus of severe COVID-19"}
{"doc_id": 324, "abstract": ["The rapid rise of coronavirus disease 2019 patients who suffer from vascular events after their initial recovery is expected to lead to a worldwide shift in disease burden.", "We aim to investigate the impact of COVID-19 on the pathophysiological state of blood vessels in convalescent patients.", "Here, convalescent COVID-19 patients with or without preexisting conditions (i.e. hypertension, diabetes, hyperlipidemia) were compared to non-COVID-19 patients with matched cardiovascular risk factors or healthy participants.", "Convalescent patients had elevated circulating endothelial cells (CECs), and those with underlying cardiovascular risk had more pronounced endothelial activation hallmarks (ICAM1, P-selectin or CX3CL1) expressed by CECs.", "Multiplex microbead-based immunoassays revealed some levels of cytokine production sustained from acute infection to recovery phase.", "Several proinflammatory and activated T lymphocyte-associated cytokines correlated positively with CEC measures, implicating cytokine-driven endothelial dysfunction.", "Finally, the activation markers detected on CECs mapped to the counter receptors (i.e. ITGAL, SELPLG, and CX3CR1) found primarily on CD8+ T cells and natural killer cells, suggesting that activated endothelial cells could be targeted by cytotoxic effector cells.", "Clinical trials in preventive therapy for post-COVID-19 vascular complications may be needed."], "title": "Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation"}
{"doc_id": 325, "abstract": ["The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the agent of a major global outbreak of respiratory tract disease known as coronavirus disease-2019 (COVID-19).", "SARS-CoV-2 infects the lungs and may cause several immune-related complications such as lymphocytopenia and cytokine storm which are associated with the severity of the disease and predict mortality .", "The mechanism by which SARS-CoV-2 infection may result in immune system dysfunction is not fully understood.", "Here we show that SARS-CoV-2 infects human CD4+ T helper cells, but not CD8+ T cells, and is present in blood and bronchoalveolar lavage T helper cells of severe COVID-19 patients.", "We demonstrated that SARS-CoV-2 spike glycoprotein (S) directly binds to the CD4 molecule, which in turn mediates the entry of SARS-CoV-2 in T helper cells in a mechanism that also requires ACE2 and TMPRSS2.", "Once inside T helper cells, SARS-CoV-2 assembles viral factories, impairs cell function and may cause cell death.", "SARS-CoV-2 infected T helper cells express higher amounts of IL-10, which is associated with viral persistence and disease severity.", "Thus, CD4-mediated SARS-CoV-2 infection of T helper cells may explain the poor adaptive immune response of many COVID-19 patients."], "title": "SARS-CoV-2 Uses CD4 to Infect T Helper Lymphocytes"}
{"doc_id": 326, "abstract": ["BACKGROUND: Detecting antibody responses during and after SARS-CoV-2 infection is essential in determining the seroepidemiology of the virus and the potential role of antibody in disease.", "Scalable, sensitive and specific serological assays are essential to this process.", "The detection of antibody in hospitalized patients with severe disease has proven straightforward; detecting responses in subjects with mild disease and asymptomatic infections has proven less reliable.", "We hypothesized that the suboptimal sensitivity of antibody assays and the compartmentalization of the antibody response may contribute to this effect.", "METHODS: We systemically developed an ELISA assay, optimising different antigens and amplification steps, in serum and saliva from symptomatic and asymptomatic SARS-CoV-2-infected subjects.", "RESULTS: Using trimeric spike glycoprotein, rather than nucleocapsid enabled detection of responses in individuals with low antibody responses.", "IgG1 and IgG3 predominate to both antigens, but more antispike IgG1 than IgG3 was detectable.", "All antigens were effective for detecting responses in hospitalized patients.", "Anti-spike, but not nucleocapsid, IgG, IgA and IgM antibody responses were readily detectable in saliva from non-hospitalized symptomatic and asymptomatic individuals.", "Antibody responses in saliva and serum were largely independent of each other and symptom reporting.", "CONCLUSIONS.", "Detecting antibody responses in both saliva and serum is optimal for determining virus exposure and understanding immune responses after SARS-CoV-2 infection.", "FUNDING.", "This work was funded by the University of Birmingham, the National Institute for Health Research (UK), the NIH National Institute for Allergy and Infectious Diseases, the Bill and Melinda Gates Foundation and the University of Southampton."], "title": "Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infection"}
{"doc_id": 327, "abstract": ["Background: Children have a lower rate of COVID-19, potentially related to cross-protective immunity conferred by seasonal coronaviruses (HCoVs).", "We tested if prior infections with seasonal coronaviruses impacted SARS-CoV-2 infections and related Multisystem Inflammatory Syndrome (MIS).", "Methods: This cross-sectional observational study in Paris hospitals enrolled 739 pauci or asymptomatic children (HOS group) plus 36 children with suspected MIS (MIS group).", "Prevalence, antigen specificity and neutralizing capability of SARS-CoV-2 antibodies were tested.", "Antibody frequency and titres against Nucleocapsid (N) and Spike (S) of the four seasonal coronaviruses (NL63, HKU1, 229E, OC43) were measured in a subset of seropositive patients (54 SARS-CoV-2 (HOS-P subgroup) and 15 MIS (MIS-P subgroup)), and in 118 matched SARS-CoV-2 seronegative patients (CTL subgroup).", "Findings: SARS-CoV-2 mean prevalence rate in HOSP children was 11.7% from April 1 to June 1.", "Neutralizing antibodies were found in 55.6% of seropositive children, and their relative frequency increased with time (up to 100 % by mid-May).", "A majority of MIS children (25/36) were SARS-CoV-2 seropositive, of which all tested (n=15) had neutralizing antibodies.", "On average, seropositive MIS children had higher N and S1 SARS-CoV-2 titres as compared to HOS children.", "Patients from HOS-P, MIS-P, and CTL subgroups had a similar prevalence of antibodies against the four seasonal HCoVs (66.9-100%).", "The level of anti-SARS-CoV-2 antibodies was not significantly different in children who had prior seasonal coronavirus infection.", "Interpretation: Prior infection with HCoVs does not prevent SARS-CoV-2 infection and related MIS in children.", "Children develop neutralizing antibodies after SARS-CoV-2 infection."], "title": "Prior infection by seasonal coronaviruses does not prevent SARS-CoV-2 infection and associated Multisystem Inflammatory Syndrome in children"}
{"doc_id": 328, "abstract": ["An accurate understanding of why zoonoses such as SARS-CoV-2 are emerging at an increased rate, is vital to prevent future pandemics from the approximately 700,000 viruses with zoonotic potential.", "Certain authors have argued that the consumption of wildlife, or human contact with bats was responsible for the emergence of SARS-CoV-2.", "Others argue that a range of anthropogenic environmental degradations have played a vital role in the emergence of SARS-CoV-2 and other zoonoses.", "In this opinion piece, I argue that these divergent viewpoints stem, in part, from different foundational conceptual frameworks-biomedical individualist and eco-social frameworks, respectively.", "Based on the fact that the eco-social framework provides a more complete account of the different types of causal factors underpinning the emergence of zoonoses, I propose that the COVID-19 pandemic provides an additional reason for the health sciences to ground its theory of health and disease in an eco-social conceptual framework."], "title": "Emergence of zoonoses such as COVID-19 reveals the need for health sciences to embrace an explicit eco-social conceptual framework of health and disease"}
{"doc_id": 329, "abstract": ["In testimony before US Congress on March 11, 2020, members of the House Oversight and Reform Committee were informed that estimated mortality for the novel coronavirus was 10-times higher than for seasonal influenza.", "Additional evidence, however, suggests the validity of this estimation could benefit from vetting for biases and miscalculations.", "The main objective of this article is to critically appraise the coronavirus mortality estimation presented to Congress.", "Informational texts from the World Health Organization and the Centers for Disease Control and Prevention are compared with coronavirus mortality calculations in Congressional testimony.", "Results of this critical appraisal reveal information bias and selection bias in coronavirus mortality overestimation, most likely caused by misclassifying an influenza infection fatality rate as a case fatality rate.", "Public health lessons learned for future infectious disease pandemics include: safeguarding against research biases that may underestimate or overestimate an associated risk of disease and mortality; reassessing the ethics of fear-based public health campaigns; and providing full public disclosure of adverse effects from severe mitigation measures to contain viral transmission."], "title": "Public Health Lessons Learned From Biases in Coronavirus Mortality Overestimation"}
{"doc_id": 330, "abstract": ["The oral cavity, as the entry point to the body, may play a critical role in the pathogenesis of SARS-CoV-2 infection that has caused a global outbreak of the coronavirus disease 2019 (COVID-19).", "Available data indicate that the oral cavity may be an active site of infection and an important reservoir of SARS-CoV-2.", "Considering that the oral surfaces are colonized by a diverse microbial community, it is likely that viruses have interactions with the host microbiota.", "Patients infected by SARS-CoV-2 may have alterations in the oral and gut microbiota, while oral species have been found in the lung of COVID-19 patients.", "Furthermore, interactions between the oral, lung, and gut microbiomes appear to occur dynamically whereby a dysbiotic oral microbial community could influence respiratory and gastrointestinal diseases.", "However, it is unclear whether SARS-CoV-2 infection can alter the local homeostasis of the resident microbiota, actively cause dysbiosis, or influence cross-body sites interactions.", "Here, we provide a conceptual framework on the potential impact of SARS-CoV-2 oral infection on the local and distant microbiomes across the respiratory and gastrointestinal tracts (\u2018oral-tract axes\u2019), which remains largely unexplored.", "Studies in this area could further elucidate the pathogenic mechanism of SARS-CoV-2 and the course of infection as well as the clinical symptoms of COVID-19 across different sites in the human host."], "title": "Potential implications of SARS-CoV-2 oral infection in the host microbiota"}
{"doc_id": 331, "abstract": ["Objective: To identify common features of cases with novel coronavirus disease (COVID-19) so as to better understand what factors promote secondary transmission including superspreading events.", "Methods: A total of 110 cases were examined among eleven clusters and sporadic cases, and investigated who acquired infection from whom.", "The clusters included four in Tokyo and one each in Aichi, Fukuoka, Hokkaido, Ishikawa, Kanagawa and Wakayama prefectures.", "The number of secondary cases generated by each primary case was calculated using contact tracing data.", "Results: Of the 110 cases examined, 27 (24.6%) were primary cases who generated secondary cases.", "The odds that a primary case transmitted COVID-19 in a closed environment was 18.7 times greater compared to an open-air environment (95% confidence interval [CI]: 6.0, 57.9).", "Conclusions: It is plausible that closed environments contribute to secondary transmission of COVID-19 and promote superspreading events.", "Our findings are also consistent with the declining incidence of COVID-19 cases in China, as gathering in closed environments was prohibited in the wake of the rapid spread of the disease."], "title": "Closed environments facilitate secondary transmission of coronavirus disease 2019 (COVID-19)"}
{"doc_id": 332, "abstract": ["Coronavirus disease 2019 (COVID-19) can lead to severe pneumonia and hyperinflammation.", "So far, insufficient or excessive T cell responses were described in patients.", "We applied novel approaches to analyze T cell reactivity and showed that T anergy is already present in non-ventilated COVID-19 patients, very pronounced in ventilated patients, strongly associated with virus persistence and reversible with clinical recovery.", "T cell activation was measured by downstream effects on responder cells like basophils, plasmacytoid dendritic cells, monocytes and neutrophils in whole blood and proved to be much more meaningful than classical readouts with PBMCs.", "Monocytes responded stronger in males than females and IL-2 partially reversed T cell anergy.", "Downstream markers of T cell anergy were also found in fresh blood samples of critically ill patients with severe T cell anergy.", "Based on our data we were able to develop a score to predict fatal outcomes and to identify patients that may benefit from strategies to overcome T cell anergy."], "title": "T cell anergy in COVID-19 reflects virus persistence and poor outcomes"}
{"doc_id": 333, "abstract": ["In response to the SARS-CoV-2 pandemic, unprecedented policies of travel restrictions and stay-at-home orders were enacted around the world.", "Ultimately, the public's response to announcements of lockdowns-defined here as restrictions on both local movement or long distance travel-will determine how effective these kinds of interventions are.", "Here, we measure the impact of the announcement and implementation of lockdowns on human mobility patterns by analyzing aggregated mobility data from mobile phones.", "We find that following the announcement of lockdowns, both local and long distance movement increased.", "To examine how these behavioral responses to lockdown policies may contribute to epidemic spread, we developed a simple agent-based spatial model.", "We find that travel surges following announcements of lockdowns can increase seeding of the epidemic in rural areas, undermining the goal of the lockdown of preventing disease spread.", "Appropriate messaging surrounding the announcement of lockdowns and measures to decrease unnecessary travel are important for preventing these unintended consequences of lockdowns."], "title": "Lockdown related travel behavior undermines thecontainment of SARS-CoV-2"}
{"doc_id": 334, "abstract": ["We describe the antiviral activity of plant lectins with specificity for different glycan structures against the severe acute respiratory syndrome coronavirus (SARS-CoV) and the feline infectious peritonitis virus (FIPV) in vitro.", "The SARS-CoV emerged in 2002 as an important cause of severe lower respiratory tract infection in humans, and FIPV infection causes a chronic and often fatal peritonitis in cats.", "A unique collection of 33 plant lectins with different specificities were evaluated.", "The plant lectins possessed marked antiviral properties against both coronaviruses with EC(50) values in the lower microgram/ml range (middle nanomolar range), being non-toxic (CC(50)) at 50\u2013100 \u03bcg/ml.", "The strongest anti-coronavirus activity was found predominantly among the mannose-binding lectins.", "In addition, a number of galactose-, N-acetylgalactosamine-, glucose-, and N-acetylglucosamine-specific plant agglutinines exhibited anti-coronaviral activity.", "A significant correlation (with an r-value of 0.70) between the EC(50) values of the 10 mannose-specific plant lectins effective against the two coronaviruses was found.", "In contrast, little correlation was seen between the activity of other types of lectins.", "Two targets of possible antiviral intervention were identified in the replication cycle of SARS-CoV. The first target is located early in the replication cycle, most probably viral attachment, and the second target is located at the end of the infectious virus cycle."], "title": "Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle"}
{"doc_id": 335, "abstract": ["Background Most of epidemiological models applied for COVID-19 do not consider heterogeneity in infectiousness and impact of superspreaders, despite the broad viral loading distributions amongst COVID-19 positive people (1-1 000 000 per mL).", "Also, mass group testing is not used regardless to existing shortage of tests.", "I propose new strategy for early detection of superspreaders with reasonable number of RT-PCR tests, which can dramatically mitigate development COVID-19 pandemic and even turn it endemic.", "Methods I used stochastic social-epidemiological SEIAR model, where S-suspected, E-exposed, I-infectious, A-admitted (confirmed COVID-19 positive, who are admitted to hospital or completely isolated), R-recovered.", "The model was applied to real COVID-19 dynamics in London, Moscow and New York City.", "Findings Viral loading data measured by RT-PCR were fitted by broad log-normal distribution, which governed high importance of superspreaders.", "The proposed full scale model of a metropolis shows that top 10% spreaders (100+ higher viral loading than median infector) transmit 45% of new cases.", "Rapid isolation of superspreaders leads to 4-8 fold mitigation of pandemic depending on applied quarantine strength and amount of currently infected people.", "High viral loading allows efficient group matrix pool testing of population focused on detection of the superspreaders requiring remarkably small amount of tests.", "Interpretation The model and new testing strategy may prevent thousand or millions COVID-19 deaths requiring just about 5000 daily RT-PCR test for big 12 million city such as Moscow.", "Though applied to COVID-19 pandemic the results are universal and can be used for other infectious heterogenous epidemics.", "Funding No funding"], "title": "Early detection of superspreaders by mass group pool testing can mitigate COVID-19 pandemic"}
{"doc_id": 336, "abstract": ["Severe SARS-CoV-2 infection is linked to the presence of autoantibodies against multiple targets, including phospholipids and type-I interferons.", "We recently identified activation of an autoimmune-prone B cell response pathway as correlate of severe COVID-19, raising the possibility of de novo autoreactive antibody production during the antiviral response.", "Here, we identify autoreactive antibodies as a common feature of severe COVID-19, identifying biomarkers of tolerance breaks that may indicate aggressive immunomodulation."], "title": "Broadly-targeted autoreactivity is common in severe SARS-CoV-2 Infection"}
{"doc_id": 337, "abstract": ["The magnitude of the COVID-19 pandemic underscores the urgency for a safe and effective vaccine.", "Here we analyzed SARS-CoV-2 sequence diversity across 5,700 sequences sampled since December 2019.", "The Spike protein, which is the target immunogen of most vaccine candidates, showed 93 sites with shared polymorphisms; only one of these mutations was found in more than 1% of currently circulating sequences.", "The minimal diversity found among SARS-CoV-2 sequences can be explained by drift and bottleneck events as the virus spread away from its original epicenter in Wuhan, China.", "Importantly, there is little evidence that the virus has adapted to its human host since December 2019.", "Our findings suggest that a single vaccine should be efficacious against current global strains.", "One Sentence Summary The limited diversification of SARS-CoV-2 reflects drift and bottleneck events rather than adaptation to humans as the virus spread."], "title": "A SARS-CoV-2 vaccine candidate would likely match all currently circulating strains"}
{"doc_id": 338, "abstract": ["Hospitalized patients with COVID-19 experiencing respiratory symptoms have different complications (inflammatory, co-infection and thrombotic) that are identifiable by analytics patterns.", "Personalized treatment decisions decreased early mortality (OR 0.144, CI 0.03-0.686; p=0.015).", "Increasing age (OR 1.06; p=0.038) and therapeutic effort limitation (OR 9.684; p<0.001) were associated with higher mortality."], "title": "Personalized therapy approach for hospitalized patients with COVID-19"}
{"doc_id": 339, "abstract": ["An outbreak of coronavirus disease 2019 (COVID-19)1-3, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)4, has spread globally.", "Countermeasures are needed to treat and prevent further dissemination of the virus.", "Here we report the isolation of two specific human monoclonal antibodies (termed CA1 and CB6) from a patient convalescing from COVID-19.", "CA1 and CB6 demonstrated potent SARS-CoV-2-specific neutralization activity in vitro.", "In addition, CB6 inhibited infection with SARS-CoV-2 in rhesus monkeys in both prophylactic and treatment settings.", "We also performed structural studies, which revealed that CB6 recognizes an epitope that overlaps with angiotensin-converting enzyme 2 (ACE2)-binding sites in the SARS-CoV-2 receptor-binding domain, and thereby interferes with virus-receptor interactions by both steric hindrance and direct competition for interface residues.", "Our results suggest that CB6 deserves further study as a candidate for translation to the clinic."], "title": "A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2"}
{"doc_id": 340, "abstract": ["We studied COVID-19 case mortality in Florida among four successive cohorts of persons at least 50 years of age, each of whom we followed for 28 to 48 days from date of diagnosis.", "The cohorts were separated by date of diagnosis into four nonoverlapping intervals: March 29-April 18; April 29-May 19; May 21-June 10; and June 14-July 4, 2020.", "Case mortality rates declined consistently and significantly over the course of the four intervals: 57% among those aged 50-59 years; 62% among those aged 60-69 years; 52% among those aged 70-79 years; and 34% among those aged 80 or more years.", "These findings were consistent with progressive improvements in the medical care of COVID-19 patients.", "We further studied case mortality by hospitalization status.", "The case mortality rate among hospitalized patients aged 60-69 years fell significantly from the first to the third interval.", "During the fourth interval, an apparent rise in mortality among hospitalized patients in the same age group was mirrored by a significant decline in mortality among those not hospitalized.", "These findings were consistent with the out-of-hospital treatment of some patients who would have previously been hospitalized."], "title": "COVID-19 Case Mortality Rates Continue to Decline in Florida"}
{"doc_id": 341, "abstract": ["Poor outcomes after SARS-CoV-2 infection are difficult to predict.", "Survivors may develop pulmonary fibrosis.", "We previously identified a 52-gene signature in peripheral blood, predictive of mortality in Idiopathic Pulmonary Fibrosis.", "In this study, we analyzed this signature in SARS-CoV-2 infected individuals and identified genomic risk profiles with significant differences in outcomes.", "Analysis of single cell expression data shows that monocytes, red blood cells, neutrophils and dendritic cells are the cellular source of the high risk gene signature."], "title": "A repurposed, blood gene signature is associated with poor outcomes in SARS-CoV-2"}
{"doc_id": 342, "abstract": ["Recent reports that antibodies to SARS-CoV-2 are not maintained in the serum following recovery from the virus have caused alarm.", "However, the absence of specific antibodies in the serum does not necessarily mean an absence of immune memory.", "Here, we discuss our current understanding of the relative contribution of B cells and T cells to immunity to SARS-CoV-2 and the implications for the development of effective treatments and vaccines for COVID-19."], "title": "Not just antibodies: B cells and T cells mediate immunity to COVID-19"}
{"doc_id": 343, "abstract": ["While the COVID-19 pandemic advances, the scientific community struggles in the search for treatments.", "Several improvements have been made, including the discovery of clinical efficacy of chloroquine (CQ) in COVID-19 patients, but the effective treatment protocols are still missing.", "In order to find novel treatment options many scientists utilize the in silico approach to identify compounds that could interfere with the key molecules involved in entrance, replication, or dissemination of the SARS-CoV-2.", "However, most of the identified molecules are currently not available as pharmacological agents, and assessing their safety and efficacy could take many months.", "Here, we took a different approach based on the proposed pharmacodynamic model of CQ in COVID-19.", "The main mechanism of action responsible for the favourable outcome of COVID-19 patients treated with CQ seems to be related to pH modulation-mediated effect on the endolysosomal trafficking, a characteristic of chemical compounds often called lysosomotropic agents because of the physico-chemical properties that enable them to passively diffuse through the endosomal membrane and undergo protonation-based trapping in the lumen of the acidic vesicles.", "In this review, we discuss lysosomotropic and lysosome targeting drugs that are already in clinical use and are characterized by good safety profiles, low cost, and wide availability.", "We emphasize that some of these drugs, in particular azithromycin and other macrolide antibiotics, indomethacin and some other non-steroidal anti-inflammatory drugs, proton pump inhibitors, and fluoxetine could provide additional therapeutic benefits in addition to the potential antiviral effect that still has to be confirmed by well-controlled clinical trials.", "As some of these drugs, mostly antibiotics, were already empirically used in the treatment of COVID-19, we encourage our colleagues all over the world to publish patient data so potential efficacy of these agents can be evaluated in the clinical context and rapidly implemented in the therapeutic protocols if the beneficial effect on clinical outcome is observed."], "title": "Widely available lysosome targeting agents should be considered as a potential therapy for COVID-19"}
{"doc_id": 344, "abstract": ["Severe acute respiratory syndrome coronavirus (SARS-CoV) is a highly pathogenic emergent virus which replicates in cells that can express ABH histo-blood group antigens.", "The heavily glycosylated SARS-CoV spike (S) protein binds to angiotensin-converting enzyme 2 which serves as a cellular receptor.", "Epidemiological analysis of a hospital outbreak in Hong Kong revealed that blood group O was associated with a low risk of infection.", "In this study, we used a cellular model of adhesion to investigate whether natural antibodies of the ABO system could block the S protein and angiotensin-converting enzyme 2 interaction.", "To this aim, a C-terminally EGFP-tagged S protein was expressed in chinese hamster ovary cells cotransfected with an \u03b11,2-fucosyltransferase and an A-transferase in order to coexpress the S glycoprotein ectodomain and the A antigen at the cell surface.", "We observed that the S protein/angiotensin-converting enzyme 2-dependent adhesion of these cells to an angiotensin-converting enzyme 2 expressing cell line was specifically inhibited by either a monoclonal or human natural anti-A antibodies, indicating that these antibodies may block the interaction between the virus and its receptor, thereby providing protection.", "In order to more fully appreciate the potential effect of the ABO polymorphism on the epidemiology of SARS, we built a mathematical model of the virus transmission dynamics that takes into account the protective effect of ABO natural antibodies.", "The model indicated that the ABO polymorphism could contribute to substantially reduce the virus transmission, affecting both the number of infected individuals and the kinetics of the epidemic."], "title": "Inhibition of the interaction between the SARS-CoV Spike protein and its cellular receptor by anti-histo-blood group antibodies"}
{"doc_id": 345, "abstract": ["Blood myeloid cells are known to be dysregulated in coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2.", "It is unknown whether the innate myeloid response differs with disease severity and whether markers of innate immunity discriminate high-risk patients.", "Thus, we performed high-dimensional flow cytometry and single-cell RNA sequencing of COVID-19 patient peripheral blood cells and detected disappearance of non-classical CD14LowCD16High monocytes, accumulation of HLA-DRLow classical monocytes (Human Leukocyte Antigen-DR isotype), and release of massive amounts of calprotectin (S100A8/S100A9) in severe cases.", "Immature CD10LowCD101-CXCR4+/-neutrophils with an immunosuppressive profile accumulated in the blood and lungs, suggesting emergency myelopoiesis.", "Finally, we show that calprotectin plasma level and a routine flow cytometry assay detecting decreased frequencies of non-classical monocytes could discriminate patients who develop a severe form of COVID-19, suggesting a predictive value that deserves prospective evaluation."], "title": "Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19"}
{"doc_id": 346, "abstract": ["The COVID-19 pandemic has prompted a lockdown in many countries to control the exponential spread of the SARS-CoV-2 virus.", "This resulted in curbing the epidemic by reducing the time-varying basic reproduction number (Rt) to below one.", "Governments are looking for evidence to balance the demand of their citizens to ease some of the restriction, against the fear of a second peak in infections.", "More details on the specific circumstances that promote exponential spread (i.e. Rt>1) and the measures that contributed most to a reduction in Rt are needed.", "Here we show that in 33 of 35 Western countries (32 European, plus Israel, USA and Canada), Rt fell to around or below one during lockdown (March-May 2020).", "One third of the effect happened already on average 6 days before the lockdown, with lockdown itself causing another major drop in transmission.", "Country-wide compulsory usage of masks was implemented only in Slovakia 10 days into lockdown, and on its own reduced transmission by half.", "During lockdown, decreased mobility in retail and recreation was an independent predictor of lower Rt during lockdown, while changes in other types of mobility were not.", "These results are consistent with anecdotal evidence that large recreational gatherings are super-spreading events, and may even suggest that infections during day-to-day contact at work are not sufficient to spark exponential growth.", "Our data suggest measures that will contribute to avoiding a second peak include a tight control on circumstances that facilitate massive spread such as large gatherings especially indoors, physical distancing, and mask use."], "title": "Behavioral changes before lockdown, and decreased retail and recreation mobility during lockdown, contributed most to the successful control of the COVID-19 epidemic in 35 Western countries"}
{"doc_id": 347, "abstract": ["CD8+ T cell immunity to SARS-CoV-2 has been implicated in COVID-19 severity and virus control, though direct evidence has been lacking so far.", "Here, we identified non-synonymous mutations in MHC-I restricted CD8+ T cell epitopes after deep sequencing of 747 SARS-CoV-2 virus isolates.", "Mutant peptides exhibited diminished or abrogated MHC-I binding, which was associated with a loss of recognition and functional responses by CD8+ T cells isolated from HLA-matched COVID-19 patients.", "Our findings highlight the capacity of SARS-CoV-2 to subvert CD8+ T cell surveillance through escape mutations in MHCI-restricted viral epitopes.", "This provides evolutionary evidence for CD8+ T cell immunity controlling SARS-CoV-2 with consequences for COVID-19 vaccine design."], "title": "SARS-CoV-2 escapes CD8 T cell surveillance via mutations in MHC-I restricted epitopes"}
{"doc_id": 348, "abstract": ["One of the significant unanswered questions about COVID-19 epidemiology relates to the role of children in transmission.", "This study uses data on infections within households in order to estimate the susceptibility and infectivity of children compared to those of adults.", "The data were collected from households in the city of Bnei Brak, Israel, in which all household members were tested for COVID-19 using PCR (637 households, average household size of 5.3).", "In addition, serological tests were performed on a subset of the individuals in the study.", "Inspection of the PCR data shows that children are less likely to be tested positive compared to adults (25% of children positive over all households, 44% of adults positive over all households, excluding index cases), and the chance of being positive increases with age.", "Analysis of joint PCR/serological data shows that there is under-detection of infections in the PCR testing, which is more substantial in children.", "However, the differences in detection rates are not sufficient to account for the differences in PCR positive rates in the two age groups.", "To estimate relative transmission parameters, we employ a discrete stochastic model of the spread of infection within a household, allowing for susceptibility and infectivity parameters to differ among children and adults.", "The model is fitted to the household data using a simulated maximum likelihood approach.", "To adjust parameter estimates for under-detection of infections in the PCR results, we employ a multiple imputation procedure using estimates of under-detection in children and adults, based on the available serological data.", "We estimate that the susceptibility of children (under 20 years old) is 43% (95% CI: [31%, 55%]) of the susceptibility of adults.", "The infectivity of children was estimated to be 63% (95% CI: [37%, 88%]) relative to that of adults."], "title": "The role of children in the spread of COVID-19: Using household data from Bnei Brak, Israel, to estimate the relative susceptibility and infectivity of children"}
{"doc_id": 349, "abstract": ["We developed a de novo protein design strategy to swiftly engineer decoys for neutralizing pathogens that exploit extracellular host proteins to infect the cell.", "Our pipeline allowed the design, validation, and optimization of de novo human angiotensin-converting enzyme 2 (hACE2) decoys to neutralize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).", "The best monovalent decoy, CTC-445.2, bound with low nanomolar affinity and high specificity to the receptor-binding domain (RBD) of the spike protein.", "Cryo\u2013electron microscopy (cryo-EM) showed that the design is accurate and can simultaneously bind to all three RBDs of a single spike protein.", "Because the decoy replicates the spike protein target interface in hACE2, it is intrinsically resilient to viral mutational escape.", "A bivalent decoy, CTC-445.2d, showed ~10-fold improvement in binding.", "CTC-445.2d potently neutralized SARS-CoV-2 infection of cells in vitro, and a single intranasal prophylactic dose of decoy protected Syrian hamsters from a subsequent lethal SARS-CoV-2 challenge."], "title": "De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2"}
{"doc_id": 350, "abstract": ["Recent evidence shows that the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is highly sensitive to interferons (IFNs).", "However, the underlying antiviral effectors remain to be defined.", "Here, we show that Zinc finger antiviral protein (ZAP) that specifically targets CpG dinucleotides in viral RNA sequences restricts SARS-CoV-2.", "We demonstrate that ZAP and its cofactors KHNYN and TRIM25 are expressed in human lung cells.", "Type I, II and III IFNs all strongly inhibited SARS-CoV-2 and further induced ZAP expression.", "Strikingly, SARS-CoV-2 and its closest relatives from bats show the strongest CpG suppression among all known human and bat coronaviruses, respectively.", "Nevertheless, knock-down of ZAP significantly increased SARS-CoV-2 production in lung cells, particularly upon treatment with IFN-or IFN-{gamma}. Thus, our results identify ZAP as an effector of the IFN response against SARS-CoV-2, although this pandemic pathogen may be preadapted to the low CpG environment in humans.", "HighlightsO_LISARS-CoV-2 and its closest bat relatives show strong CpG suppression C_LIO_LIIFN-{beta},-{gamma} and-{lambda} inhibit SARS-CoV-2 with high efficiency C_LIO_LIZAP restricts SARS-CoV-2 and contributes to the antiviral effect of IFNs C_LI"], "title": "The Zinc Finger Antiviral Protein restricts SARS-CoV-2"}
{"doc_id": 351, "abstract": ["The pathophysiology of COVID-19 associated thrombosis seems to be multifactorial, involving interplay between cellular and plasmatic elements of the hemostasis.", "We hypothesized that COVID-19 is accompanied by platelet apoptosis with subsequent alteration of the coagulation system.", "We investigated depolarization of mitochondrial inner transmembrane potential ({Delta}{Psi}m), cytosolic calcium (Ca2+) concentration, and phosphatidylserine (PS) externalization by flow cytometry.", "Platelets from intensive care unit (ICU) COVID-19 patients (n=21) showed higher {Delta}{Psi}m depolarization, cytosolic Ca2+ concentration and PS externalization, compared to healthy controls (n=18) and COVID-19 non-ICU patients (n=4).", "Moreover significant higher cytosolic Ca2+ concentration and PS was observed compared to septic ICU control group (ICU control).", "In ICU control group (n=5; non-COVID-19 ICU) cytosolic Ca2+ concentration and PS externalization was comparable to healthy control, with an increase in {Delta}{Psi}m depolarization.", "Sera from ICU COVID-19 patients induced significant increase in apoptosis markers ({Delta}{Psi}m depolarization, cytosolic Ca2+ concentration and PS externalization) compared to healthy volunteer and septic ICU control.", "Interestingly, immunoglobulin G (IgG) fractions from COVID-19 patients induced an Fc gamma receptor IIA dependent platelet apoptosis ({Delta}{Psi}m depolarization, cytosolic Ca2+ concentration and PS externalization).", "Enhanced PS externalization in platelets from ICU COVID-19 patients was associated with increased sequential organ failure assessment (SOFA) score (r=0.5635) and D-Dimer (r=0.4473).", "Most importantly, patients with thrombosis had significantly higher PS externalization compared to those without.", "The strong correlations between apoptosis markers and increased D-Dimer levels as well as the incidence of thrombosis may indicate that antibody-mediated platelet apoptosis potentially contributes to sustained increased thromboembolic risk in ICU COVID-19 patients."], "title": "Severe COVID-19 infection is associated with increased antibody-mediated platelet apoptosis"}
{"doc_id": 352, "abstract": ["Multiple clinical studies are ongoing to assess whether existing vaccines may afford protection against SARS-CoV-2 infection through trained immunity.", "In this exploratory study, we analyze immunization records from 137,037 individuals who received SARS-CoV-2 PCR tests.", "We find that polio, Hemophilus influenzae type-B (HIB), measles-mumps-rubella (MMR), varicella, pneumococcal conjugate (PCV13), geriatric flu, and hepatitis A / hepatitis B (HepA-HepB) vaccines administered in the past 1, 2, and 5 years are associated with decreased SARS-CoV-2 infection rates, even after adjusting for geographic SARS-CoV-2 incidence and testing rates, demographics, comorbidities, and number of other vaccinations.", "Furthermore, age, race/ethnicity, and blood group stratified analyses reveal significantly lower SARS-CoV-2 rate among black individuals who have taken the PCV13 vaccine, with relative risk of 0.45 at the 5 year time horizon (n: 653, 95% CI: (0.32, 0.64), p-value: 6.9e-05).", "These findings suggest that additional pre-clinical and clinical studies are warranted to assess the protective effects of existing non-COVID-19 vaccines and explore underlying immunologic mechanisms.", "We note that the findings in this study are preliminary and are subject to change as more data becomes available and as further analysis is conducted."], "title": "Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations"}
{"doc_id": 353, "abstract": ["In current severe global emergency situation of 2019-nCov outbreak, it is imperative to identify vulnerable and susceptible groups for effective protection and care.", "Recently, studies found that 2019-nCov and SARS-nCov share the same receptor, ACE2.", "In this study, we analyzed five large-scale bulk transcriptomic datasets of normal lung tissue and two single-cell transcriptomic datasets to investigate the disparities related to race, age, gender and smoking status in ACE2 gene expression and its distribution among cell types.", "We didn't find significant disparities in ACE2 gene expression between racial groups (Asian vs Caucasian), age groups (>60 vs <60) or gender groups (male vs female).", "However, we observed significantly higher ACE2 gene expression in former smoker's lung compared to non-smoker's lung.", "Also, we found higher ACE2 gene expression in Asian current smokers compared to non-smokers but not in Caucasian current smokers, which may indicate an existence of gene-smoking interaction.", "In addition, we found that ACE2 gene is expressed in specific cell types related to smoking history and location.", "In bronchial epithelium, ACE2 is actively expressed in goblet cells of current smokers and club cells of non-smokers.", "In alveoli, ACE2 is actively expressed in remodelled AT2 cells of former smokers.", "Together, this study indicates that smokers especially former smokers may be more susceptible to 2019-nCov and have infection paths different with non-smokers.", "Thus, smoking history may provide valuable information in identifying susceptible population and standardizing treatment regimen."], "title": "Bulk and single-cell transcriptomics identify tobacco-use disparity in lung gene expression of ACE2, the receptor of 2019-nCov"}
{"doc_id": 354, "abstract": ["The World Health Organization has declared SARS-CoV-2 virus outbreak a world-wide pandemic.", "Individuals infected by the virus exhibited different degrees of symptoms, the basis of which remains largely unclear.", "Currently, though convalescent individuals have been shown with both cellular and humoral immune responses, there is very limited understanding on the immune responses, especially adaptive immune responses, in patients with severe COVID-19.", "Here, we examined 10 blood samples from COVID-19 patients with acute respiratory distress syndrome (ARDS).", "The majority of them (70%) mounted SARS-CoV-2-specific humoral immunity with production of neutralizing antibodies.", "However, compared to healthy controls, the percentages and absolute numbers of both NK cells and CD8+ T cells were significantly reduced, accompanied with decreased IFNg expression in CD4+ T cells in peripheral blood from severe patients.", "Most notably, we failed in detecting SARS-CoV-2-specific IFNg production by peripheral blood lymphocytes from these patients.", "Our work thus indicates that COVID-19 patients with severe symptoms are associated with defective cellular immunity, which not only provides insights on understanding the pathogenesis of COVID-19, but also has implications in developing an effective vaccine to SARS-CoV-2."], "title": "Impaired cellular immunity to SARS-CoV-2 in severe COVID-19 patients"}
{"doc_id": 355, "abstract": ["Passive transfer of convalescent plasma or serum is a time-honored strategy for treating infectious diseases.", "Human convalescent plasma containing antibodies against SARS-CoV-2 is currently being used to treat COVID-19 patients.", "However, most patients have been treated outside of randomized clinical trials making it difficult to determine the efficacy of this approach.", "Here, we assessed the efficacy of convalescent sera in a newly developed African green monkey model of COVID-19.", "Groups of SARS-CoV-2-infected animals were treated with pooled convalescent sera containing either high or low to moderate anti-SARS-CoV-2 neutralizing antibody titers.", "Differences in viral load and disease pathology were minimal between monkeys that received the lower titer convalescent sera and untreated controls.", "However, and importantly, lower levels of SARS-CoV-2 in respiratory compartments, reduced gross and histopathological lesion severity in the lungs, and reductions in several parameters associated with coagulation and inflammatory processes were observed in monkeys that received convalescent sera versus untreated controls.", "Our data support human studies suggesting that convalescent plasma therapy is an effective strategy if donors with high level of antibodies against SARS-CoV-2 are employed and if recipients are at an early stage of disease."], "title": "Use of convalescent serum reduces severity of COVID-19 in nonhuman primates"}
{"doc_id": 356, "abstract": ["Understanding which arms of the immune response are responsible for protection against SARS-CoV-2 infection is key to predicting long-term immunity and to inform vaccine design.", "Two studies in this issue of Cell collectively suggest that, although SARS-CoV-2 infection may blunt long-lived antibody responses, immune memory might still be achieved through virus-specific memory T cells."], "title": "COVID-19 Makes B Cells Forget, but T Cells Remember"}
{"doc_id": 357, "abstract": ["SARS-CoV-2 can infect multiple organs, including lung, intestine, kidney, heart, liver, and brain.", "The molecular details of how the virus navigates through diverse cellular environments and establishes replication are poorly defined.", "Here, we performed global proteomic analysis of the virus-host interface in a newly established panel of phenotypically diverse, SARS-CoV-2-infectable human cell lines representing different body organs.", "This revealed universal inhibition of interferon signaling across cell types following SARS-CoV-2 infection.", "We performed systematic analyses of the JAK-STAT pathway in a broad range of cellular systems, including immortalized cell lines and primary-like cardiomyocytes, and found that several pathway components were targeted by SARS-CoV-2 leading to cellular desensitization to interferon.", "These findings indicate that the suppression of interferon signaling is a mechanism widely used by SARS-CoV-2 in diverse tissues to evade antiviral innate immunity, and that targeting the viral mediators of immune evasion may help block virus replication in patients with COVID-19."], "title": "SARS-CoV-2 desensitizes host cells to interferon through inhibition of the JAK-STAT pathway"}
{"doc_id": 358, "abstract": ["SARS-CoV-2 can infect multiple organs, including lung, intestine, kidney, heart, liver, and brain.", "The molecular details of how the virus navigates through diverse cellular environments and establishes replication are poorly defined.", "Here, we generated a panel of phenotypically diverse, SARS-CoV-2-infectible human cell lines representing different body organs and performed longitudinal survey of cellular proteins and pathways broadly affected by the virus.", "This revealed universal inhibition of interferon signaling across cell types following SARS-CoV-2 infection.", "We performed systematic analyses of the JAK-STAT pathway in a broad range of cellular systems, including immortalized cells and primary-like cardiomyocytes, and found that SARS-CoV-2 targeted the proximal pathway components, including Janus kinase 1 (JAK1), tyrosine kinase 2 (Tyk2), and the interferon receptor subunit 1 (IFNAR1), resulting in cellular desensitization to type I IFN.", "Detailed mechanistic investigation of IFNAR1 showed that the protein underwent ubiquitination upon SARS-CoV-2 infection.", "Furthermore, chemical inhibition of JAK kinases enhanced infection of stem cell-derived cultures, indicating that the virus benefits from inhibiting the JAK-STAT pathway.", "These findings suggest that the suppression of interferon signaling is a mechanism widely used by the virus to evade antiviral innate immunity, and that targeting the viral mediators of immune evasion may help block virus replication in patients with COVID-19.", "IMPORTANCE SARS-CoV-2 can infect various organs in the human body, but the molecular interface between the virus and these organs remains unexplored.", "In this study, we generated a panel of highly infectible human cell lines originating from various body organs and employed these cells to identify cellular processes commonly or distinctly disrupted by SARS-CoV-2 in different cell types.", "One among the universally impaired processes was interferon signaling.", "Systematic analysis of this pathway in diverse culture systems showed that SARS-CoV-2 targets the proximal JAK-STAT pathway components, destabilizes the type I interferon receptor though ubiquitination, and consequently renders the infected cells resistant to type I interferon.", "These findings illuminate how SARS-CoV-2 can continue to propagate in different tissues even in the presence of a disseminated innate immune response."], "title": "SARS-CoV-2 Disrupts Proximal Elements in the JAK-STAT Pathway"}
{"doc_id": 359, "abstract": ["Viral pandemics, such as the one caused by SARS-CoV-2, pose an imminent threat to humanity.", "Because of its recent emergence, there is a paucity of information regarding viral behavior and host response following SARS-CoV-2 infection.", "Here we offer an in-depth analysis of the transcriptional response to SARS-CoV-2 compared with other respiratory viruses.", "Cell and animal models of SARS-CoV-2 infection, in addition to transcriptional and serum profiling of COVID-19 patients, consistently revealed a unique and inappropriate inflammatory response.", "This response is defined by low levels of type I and III interferons juxtaposed to elevated chemokines and high expression of IL-6.", "We propose that reduced innate antiviral defenses coupled with exuberant inflammatory cytokine production are the defining and driving features of COVID-19."], "title": "Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19"}
{"doc_id": 360, "abstract": ["Summary Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the newly emergent causative agent of coronavirus disease-19 (COVID-19), has resulted in more than one million deaths worldwide since it was first detected in 2019.", "There is a critical global need for therapeutic intervention strategies that can be deployed to safely treat COVID-19 disease and reduce associated morbidity and mortality.", "Increasing evidence shows that both natural and synthetic antimicrobial peptides (AMPs), also referred to as Host Defense Proteins/Peptides (HDPs), can inhibit SARS-CoV-2, paving the way for the potential clinical use of these molecules as therapeutic options.", "In this manuscript, we describe the potent antiviral activity exerted by brilacidin\u2014a de novo designed synthetic small molecule that captures the biological properties of HDPs\u2014on SARS-CoV-2 in a human lung cell line (Calu-3) and a monkey cell line (Vero).", "These data suggest that SARS-CoV-2 inhibition in these cell culture models is primarily a result of the impact of brilacidin on viral entry and its disruption of viral integrity.", "Brilacidin has demonstrated synergistic antiviral activity when combined with remdesivir.", "Collectively, our data demonstrate that brilacidin exerts potent inhibition of SARS-CoV-2 and thus supports brilacidin as a promising COVID-19 drug candidate.", "Highlights Brilacidin potently inhibits SARS-CoV-2 in an ACE2 positive human lung cell line.", "Brilacidin achieved a high Selectivity Index of 426 (CC50=241\u03bcM/IC50=0.565\u03bcM).", "Brilacidin\u2019s main mechanism appears to disrupt viral integrity and impact viral entry.", "Brilacidin and remdesivir exhibit excellent synergistic activity against SARS-CoV-2.", "Significance Statement SARS-CoV-2, the emergent novel coronavirus, has led to the current global COVID-19 pandemic, characterized by extreme contagiousness and high mortality rates.", "There is an urgent need for effective therapeutic strategies to safely and effectively treat SARS-CoV-2 infection.", "We demonstrate that brilacidin, a synthetic small molecule with peptide-like properties, is capable of exerting potent in vitro antiviral activity against SARS-CoV-2, both as a standalone treatment and in combination with remdesivir, which is currently the only FDA-approved drug for the treatment of COVID-19."], "title": "Brilacidin, a COVID-19 Drug Candidate, Exhibits Potent In Vitro Antiviral Activity Against SARS-CoV-2"}
{"doc_id": 361, "abstract": ["COVID-19, the disease caused by the SARS-CoV-2 virus, can progress to multi-organ failure characterized by respiratory insufficiency, arrhythmias, thromboembolic complications and shock.", "The mortality of patients hospitalized with COVID-19 is unacceptably high and new strategies are urgently needed to rapidly identify and treat patients at risk for organ failure.", "Clinical epidemiologic studies demonstrate that vulnerability to organ failure is greatest after viral clearance from the upper airway, which suggests that dysregulation of the host immune response is a critical mediator of clinical deterioration and death.", "Autopsy and pre-clinical evidence implicate aberrant complement activation in endothelial injury and organ failure.", "A potential therapeutic strategy warranting investigation is to inhibit complement, with case reports of successful treatment of COVID-19 with inhibitors of complement.", "However, this approach requires careful balance between the host protective and potential injurious effects of complement activation, and biomarkers to identify the optimal timing and candidates for therapy are lacking.", "Here we report the presence of complement activation products on circulating erythrocytes from hospitalized COVID-19 patients using flow cytometry.", "These findings suggest that novel erythrocyte-based diagnostics provide a method to identify patients with dysregulated complement activation."], "title": "Erythrocytes Reveal Complement Activation in Patients with COVID-19"}
{"doc_id": 362, "abstract": ["A safe and effective SARS-CoV-2 vaccine is essential to avert the on-going COVID-19 pandemic.", "Here, we developed a subunit vaccine, which is comprised of CHO-expressed spike ectodomain protein (StriFK) and nitrogen bisphosphonates-modified zinc-aluminum hybrid adjuvant (FH002C).", "This vaccine candidate rapidly elicited the robust humoral response, Th1/Th2 balanced helper CD4 T cell and CD8 T cell immune response in animal models.", "In mice, hamsters, and non-human primates, 2-shot and 3-shot immunization of StriFK-FH002C generated 28-to 38-fold and 47-to 269-fold higher neutralizing antibody titers than the human COVID-19 convalescent plasmas, respectively.", "More importantly, the StriFK-FH002C immunization conferred sterilizing immunity to prevent SARS-CoV-2 infection and transmission, which also protected animals from virus-induced weight loss, COVID-19-like symptoms, and pneumonia in hamsters.", "Vaccine-induced neutralizing and cell-based receptor-blocking antibody titers correlated well with protective efficacy in hamsters, suggesting vaccine-elicited protection is immune-associated.", "The StriFK-FH002C provided a promising SARS-CoV-2 vaccine candidate for further clinical evaluation."], "title": "Sterilizing immunity against SARS-CoV-2 in hamsters conferred by a novel recombinant subunit vaccine"}
{"doc_id": 363, "abstract": ["Background: The Coronavirus disease (COVID-19) pandemic is causing millions of infections and hundreds of thousands of deaths worldwide.", "Cumulative clinical and laboratory evidence suggest that a subset of patients with severe COVID-19 may develop a cytokine storm syndrome during the course of the disease, with severe respiratory impairment requiring ventilatory support.", "One field of research nowadays is to identify and treat viral-induced hyperinflammation with drugs used in other clinical conditions characterized by an hyperinflammation status.", "These drugs might help to reduce COVID19 mortality.", "Methods: Ruxolitinib, a JAK1 and JAK2 inhibitor, has been successfully used to treat severe immune-mediated diseases, such as graft vs. host disease and Hemophagocytic lymphohistiocytosis.", "We used ruxolitinib in 18 patients with clinically progressive COVID-19 related acute respiratory distress syndrome, with a primary endpoint to rapidly reduce the degree of respiratory impairment and as a secondary endpoint to rapidly restore the PaO(2)/FiO(2) ratio, as an evaluation of clinical status, and monitoring of drug related Adverse Events.", "Parameters of inflammation responses and organ functions were assessed and monitored.", "The treatment plan was ruxolitinib 20 mg bid for the first 48 h and subsequent two-step de-escalation at 10 mg bid and 5 mg bid for a maximum of 14 days of treatment.", "Results: Our data collection shows a rapid clinical response with no evolution from non-invasive ventilation to mechanical ventilation in 16/18 patients and no response in two patients (overall response rate\u2014ORR 89%).", "Already after 48 h of ruxolitinib treatment 16/18 patients showed evident clinical improvement, and after 7 days of treatment 11/18 patients showed fully recovered respiratory function (pO(2) > 98% in spontaneous breathing), 4/18 patients had minimal oxygen requirement (2\u20134 L/m), 1/18 patient showed stable disease, and 2/18 patient showed progressive disease.", "After 14 days, 16/18 patients showed complete recovery of respiratory function (ORR 89%).", "Compliance to ruxolitinib planned treatment was 100% and no serious adverse event was recorded.", "In our case series of 18 critically ill patients with COVID-19 and ARDS, administration of ruxolitinib resulted in a clinical improvement that concurred to modify the standard course of disease.", "Ruxolitinib can be a therapeutic option for patients with respiratory insufficiency in COVID-19 related ARDS.", "RESPIRE Study (Ruxolitinib for the treatment of acute rESPIratory distREss syndrome, ClinicalTrials.gov Identifier: NCT04361903)."], "title": "Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE Protocol"}
{"doc_id": 364, "abstract": ["Background: We investigated six London care homes experiencing a COVID-19 outbreak and found very high rates of SARS-CoV-2 infection among residents and staff.", "Here we report follow-up serological analysis in these care homes five weeks later.", "Methods: Residents and staff had a convalescent blood sample for SARS-CoV-2 antibody levels and neutralising antibodies by SARS-COV-2 RT-PCR five weeks after the primary COVID-19 outbreak investigation.", "Results: Of the 518 residents and staff in the initial investigation, 208/241 (86.3%) surviving residents and 186/254 (73.2%) staff underwent serological testing.", "Almost all SARS-CoV-2 RT-PCR positive residents and staff were antibody positive five weeks later, whether symptomatic (residents 35/35, 100%; staff, 22/22, 100%) or asymptomatic (residents 32/33, 97.0%; staff 21/22, 95.1%).", "Symptomatic but SARS-CoV-2 RT-PCR negative residents and staff also had high seropositivity rates (residents 23/27, 85.2%; staff 18/21, 85.7%), as did asymptomatic RT-PCR negative individuals (residents 62/92, 67.3%; staff 95/143, 66.4%).", "Neutralising antibody was present in 118/132 (89.4%) seropositive individuals and was not associated with age or symptoms.", "Ten residents (10/108, 9.3%) remained RT-PCR positive, but with lower RT-PCR cycle threshold values; all 7 tested were seropositive.", "New infections were detected in three residents and one staff member.", "Conclusions: RT-PCR testing for SARS-CoV-2 significantly underestimates the true extent of an outbreak in institutional settings.", "Elderly frail residents and younger healthier staff were equally able to mount robust and neutralizing antibody responses to SARS-CoV-2.", "More than two-thirds of residents and staff members had detectable antibodies against SARS-CoV-2 irrespective of their nasal swab RT-PCR positivity or symptoms status."], "title": "High prevalence of SARS-CoV-2 antibodies in care homes affected by COVID-19; a prospective cohort study in England"}
{"doc_id": 365, "abstract": ["The novel betacoronavirus SARS-CoV-2 is the etiological agent of the current pandemic COVID-19.", "Like other coronaviruses, this novel virus relies on the surface Spike glycoprotein to access the host cells, mainly through the interaction of its Receptor Binding Domain (RBD) with the human angiotensin-converting enzyme 2 (ACE2).", "Therefore, molecular entities able to interfere with binding of the SARS-CoV-2 Spike protein to ACE2 have a great potential to inhibit viral entry.", "Starting from the available structural data on the interaction between SARS-CoV-2 Spike protein and the host ACE2 receptor, we here engineered a mini-protein with the aim of creating a soluble and stable Spike interactor.", "This mini-protein, which was recombinantly produced in high yields, possesses a stable \u03b1 helical conformation and is able to interact with the RBD of glycosylated Spike protein from SARS-CoV-2 with nanomolar affinity, as measured by microscale thermophoresis.", "By plugging the Spike protein, our mini-protein constitutes a valid tool for the development of treatments against different types of coronavirus."], "title": "An engineered stable mini-protein to plug SARS-Cov-2 Spikes"}
{"doc_id": 366, "abstract": ["The coronavirus disease 2019 (COVID-19) pandemic is having a catastrophic impact on human health1.", "Widespread community transmission has triggered stringent distancing measures with severe socio-economic consequences.", "Gaining control of the pandemic will depend on the interruption of transmission chains until vaccine-induced or naturally acquired protective herd immunity arises.", "However, approved antiviral treatments such as remdesivir and reconvalescent serum cannot be delivered orally2,3, making them poorly suitable for transmission control.", "We previously reported the development of an orally efficacious ribonucleoside analogue inhibitor of influenza viruses, MK-4482/EIDD-2801 (refs.", "4,5), that was repurposed for use against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and is currently in phase II/III clinical trials (NCT04405570 and NCT04405739).", "Here, we explored the efficacy of therapeutically administered MK-4482/EIDD-2801 to mitigate SARS-CoV-2 infection and block transmission in the ferret model, given that ferrets and related members of the weasel genus transmit the virus efficiently with minimal clinical signs6-9, which resembles the spread in the human young-adult population.", "We demonstrate high SARS-CoV-2 burden in nasal tissues and secretions, which coincided with efficient transmission through direct contact.", "Therapeutic treatment of infected animals with MK-4482/EIDD-2801 twice a day significantly reduced the SARS-CoV-2 load in the upper respiratory tract and completely suppressed spread to untreated contact animals.", "This study identified oral MK-4482/EIDD-2801 as a promising antiviral countermeasure to break SARS-CoV-2 community transmission chains."], "title": "Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets"}
{"doc_id": 367, "abstract": ["Human coronaviruses (HCoV) are common causes of respiratory illnesses (RI) despite preexisting humoral immunity.", "Sera were obtained near the onset of RI and 3 to 4 weeks later as part of a prospective study of 200 subjects evaluated for RI from 2009 to 2013.", "Antibodies against common HCoV strains were measured by enzyme-linked immunosorbent assay and neutralization assay comparing older adults with cardiopulmonary diseases (99 subjects) to younger, healthy adults (101 subjects).", "Virus shedding was detected in respiratory secretions by polymerase chain reaction.", "Of 43 HCoV-associated illnesses, 15 (35%) occurred in 14 older adults (aged &#8805;60 years) and 28 (65%) in 28 younger adults (aged 21-40 years).", "Binding and neutralizing antibodies were higher in older adults.", "Only 16 (35.7%) of RI with increases in binding antibodies also had increases in neutralizing antibodies to HCoV. Increases in binding antibodies with RI were more frequent than increased neutralizing antibodies and virus shedding, and more frequent in younger compared to older adults.", "Functional neutralizing antibodies were not stimulated as often as binding antibodies, explaining in part a susceptibility to reinfection with HCoV. Monitoring binding antibodies may be more sensitive for the serologic detection of HCoV infections."], "title": "Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus-associated illnesses"}
{"doc_id": 368, "abstract": ["Background: Initial reports indicate adequate performance of some serological-based SARS-CoV-2 assays.", "However, additional studies are required to facilitate interpretation of results, including how antibody levels impact immunity and disease course.", "Methods: In this study, a total of 968 subjects were tested for IgG antibodies reactive to SARS-CoV-2.", "We confirmed analytic specificity using 656 plasma samples from healthy donors, 49 sera from patients with rheumatic disease, and 90 specimens from individuals positive for PCR-based respiratory viral panel.", "One-hundred seventy-three cases of confirmed or suspected SARS-CoV-2 were tested for IgG. A subgroup of 37 SARS-CoV-2 PCR-positive cases was tested for nucleocapsid-specific IgM antibody using an in-house developed microarray method.", "Antibody levels were compared between disease severity groups.", "Results: All specificity specimens were negative for SARS-CoV-2 IgG antibodies (0/656, 0%).", "Cross reactivity was not detected in specimens with antinuclear antibodies and rheumatoid factor, or cases with previous diagnosis of viral infection including human coronavirus.", "Positive agreement of IgG with PCR was 83% of samples confirmed to be more than 14 days from symptom onset, with less than 100% sensitivity attributable to a case with severe immunosuppression.", "Virus-specific IgM was positive in a higher proportion of cases less than 3 days from symptom onset.", "No association was observed between mild and severe disease course with respect to IgG and IgM levels.", "Conclusions: The studied SARS-CoV-2 IgG assay had 100% specificity and no adverse cross-reactivity.", "Index values of IgG and IgM antibodies did not predict disease severity in our patient population."], "title": "SARS-CoV-2 Antibody responses do not predict COVID-19 disease severity"}
{"doc_id": 369, "abstract": ["An ongoing pandemic of coronavirus disease (COVID-19) is caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).", "Characterization of the histopathology and cellular localization of SARS-CoV-2 in the tissues of patients with fatal COVID-19 is critical to further understand its pathogenesis and transmission and for public health prevention measures.", "We report clinicopathologic, immunohistochemical, and electron microscopic findings in tissues from 8 fatal laboratory-confirmed cases of SARS-CoV-2 infection in the United States.", "All cases except 1 were in residents of long-term care facilities.", "In these patients, SARS-CoV-2 infected epithelium of the upper and lower airways with diffuse alveolar damage as the predominant pulmonary pathology.", "SARS-CoV-2 was detectable by immunohistochemistry and electron microscopy in conducting airways, pneumocytes, alveolar macrophages, and a hilar lymph node but was not identified in other extrapulmonary tissues.", "Respiratory viral co-infections were identified in 3 cases; 3 cases had evidence of bacterial co-infection."], "title": "Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States"}
{"doc_id": 370, "abstract": ["As part of any plan to lift or ease the confinement restrictions that are in place in many different countries, there is an urgent need to increase the capacity of laboratory testing for SARS CoV-2.", "Detection of the viral genome through RT-qPCR is the golden standard for this test, however, the high demand of the materials and reagents needed to sample individuals, purify the viral RNA, and perform the RT-qPCR test has resulted in a worldwide shortage of several of these supplies.", "Here, we show that directly lysed saliva samples can serve as a suitable source for viral RNA detection that is cheaper and can be as efficient as the classical protocol that involves column purification of the viral RNA.", "In addition, it surpasses the need for swab sampling, decreases the risk of the healthcare personnel involved in this process, and accelerates the diagnostic procedure."], "title": "Saliva sampling is an excellent option to increase the number of SARS CoV2 diagnostic tests in settings with supply shortages"}
{"doc_id": 371, "abstract": ["We measured severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA concentrations in primary sewage sludge in the New Haven, Connecticut, USA, metropolitan area during the Coronavirus Disease 2019 (COVID-19) outbreak in Spring 2020.", "SARS-CoV-2 RNA was detected throughout the more than 10-week study and, when adjusted for time lags, tracked the rise and fall of cases seen in SARS-CoV-2 clinical test results and local COVID-19 hospital admissions.", "Relative to these indicators, SARS-CoV-2 RNA concentrations in sludge were 0-2 d ahead of SARS-CoV-2 positive test results by date of specimen collection, 0-2 d ahead of the percentage of positive tests by date of specimen collection, 1-4 d ahead of local hospital admissions and 6-8 d ahead of SARS-CoV-2 positive test results by reporting date.", "Our data show the utility of viral RNA monitoring in municipal wastewater for SARS-CoV-2 infection surveillance at a population-wide level.", "In communities facing a delay between specimen collection and the reporting of test results, immediate wastewater results can provide considerable advance notice of infection dynamics."], "title": "Measurement of SARS-CoV-2 RNA in wastewater tracks community infection dynamics."}
{"doc_id": 372, "abstract": ["SARS-CoV-2 RNA can be detected in respiratory samples for weeks or even months after onset of COVID-19 disease.", "Therefore, one of the diagnostic challenges of PCR positive cases is differentiating between acute COVID-19 disease and convalescent phase.", "Recently, the presence of SARS-CoV-2 nucleocapsid antigen in serum samples of COVID-19 patients was published [Le Hingrat et al. Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives, Clinical Microbiology and Infection, 2020].", "Our study aimed to characterize the analytical specificity and sensitivity of an enzyme-linked immunosorbent assay (Salocor SARS-CoV-2 Antigen Quantitative Assay Kit (Salofa Ltd, Salo, Finland)) for the detection of SARS-CoV-2 antigen in serum, and to characterize the kinetics of antigenemia.", "The evaluation material included a negative serum panel of 155 samples, and 126 serum samples from patients with a PCR-confirmed COVID-19.", "The specificity of the Salocor SARS-CoV-2 serum N antigen test was 98.0%.", "In comparison with simultaneous positive PCR from upper respiratory tract (URT) specimens, the test sensitivity was 91.7%.", "In a serum panel in which the earliest serum sample was collected two days before the collection of positive URT specimen, and the latest 48 days after (median 1 day post URT sample collection), the serum N antigen test sensitivity was 94% within 14 days post onset of symptoms.", "The antigenemia resolved approximately two weeks after the onset of disease and diagnostic PCR.", "The combination of simultaneous SARS-CoV-2 antigen and antibody testing appeared to provide useful information for timing of COVID-19.", "Our results suggest that SARS-CoV-2 N-antigenemia may be used as a diagnostic marker in acute COVID-19."], "title": "Detection of SARS-CoV-2 nucleocapsid antigen from serum can aid in timing of COVID-19 infection"}
{"doc_id": 373, "abstract": ["The SARS-CoV2 coronavirus responsible for the current COVID19 pandemic has been reported to have a relatively low mutation rate.", "Nevertheless, a few prevalent variants have arisen that give the appearance of undergoing positive selection as they are becoming increasingly widespread over time.", "Most prominent among these is the D614G amino acid substitution in the SARS-CoV2 Spike protein, which mediates viral entry.", "The D614G substitution, however, is in linkage disequilibrium with the ORF1b P314L mutation where both mutations almost invariably co-occur, making functional inferences problematic.", "In addition, the possibility of repeated new introductions of the mutant strain does not allow one to distinguish between a founder effect and an intrinsic genetic property of the virus.", "Here, we synthesized and expressed the WT and D614G variant SARS-Cov2 Spike protein, and report that using a SARS-CoV2 Spike protein pseudotyped lentiviral vector we observe that the D614G variant Spike has >1/2 log(10) increased infectivity in human cells expressing the human ACE2 protein as the viral receptor.", "The increased binding/fusion activity of the D614G Spike protein was corroborated in a cell fusion assay using Spike and ACE2 proteins expressed in different cells.", "These results are consistent with the possibility that the Spike D614G mutant increases the infectivity of SARS-CoV2."], "title": "The D614G mutation in the SARS-CoV2 Spike protein increases infectivity in an ACE2 receptor dependent manner."}
{"doc_id": 374, "abstract": ["Background: The novel human coronavirus disease 2019 (COVID-19) pandemic has claimed more than 600,000 lives worldwide, causing tremendous public health, social, and economic damages.", "While the risk factors of COVID-19 are still under investigation, environmental factors, such as urban air pollution, may play an important role in increasing population susceptibility to COVID-19 pathogenesis.", "Methods: We conducted a cross-sectional nationwide study using zero-inflated negative binomial models to estimate the association between long-term (2010-2016) county-level exposures to NO2, PM2.5 and O3 and county-level COVID-19 case-fatality and mortality rates in the US.", "We used both single and multipollutant models and controlled for spatial trends and a comprehensive set of potential confounders, including state-level test positive rate, county-level healthcare capacity, phase-of-epidemic, population mobility, population density, sociodemographics, socioeconomic status, race and ethnicity, behavioral risk factors, and meteorology.", "Results: 3,659,828 COVID-19 cases and 138,552 deaths were reported in 3,076 US counties from January 22, 2020 to July 17, 2020, with an overall observed case-fatality rate of 3.8%.", "County-level average NO2 concentrations were positively associated with both COVID-19 case-fatality rate and mortality rate in single-, bi-, and tri-pollutant models.", "When adjusted for co-pollutants, per inter-quartile range (IQR) increase in NO2 (4.6 ppb), COVID-19 case-fatality rate and mortality rate were associated with an increase of 11.3% (95% CI 4.9% to 18.2%) and 16.2% (95% CI 8.7% to 24.0%), respectively.", "We did not observe significant associations between COVID-19 case-fatality rate and long-term exposure to PM2.5 or O3, although per IQR increase in PM2.5 (2.6 ug/m3) was marginally associated with 14.9% (95% CI: 0.0% to 31.9%) increase in COVID-19 mortality rate when adjusted for co-pollutants.", "Discussion: Long-term exposure to NO2, which largely arises from urban combustion sources such as traffic, may enhance susceptibility to severe COVID-19 outcomes, independent of long-term PM2.5 and O3 exposure.", "The results support targeted public health actions to protect residents from COVID-19 in heavily polluted regions with historically high NO2 levels.", "Continuation of current efforts to lower traffic emissions and ambient air pollution may be an important component of reducing population-level risk of COVID-19 case-fatality and mortality."], "title": "Urban Air Pollution May Enhance COVID-19 Case-Fatality and Mortality Rates in the United States"}
{"doc_id": 375, "abstract": ["BACKGROUND: The novel human coronavirus disease 2019 (COVID-19) pandemic has claimed more than 240,000 lives worldwide, causing tremendous public health, social, and economic damages.", "While the risk factors of COVID-19 are still under investigation, environmental factors, such as urban air pollution, may play an important role in increasing population susceptibility to COVID-19 pathogenesis.", "METHODS: We conducted a cross-sectional nationwide study using zero-inflated negative binomial models to estimate the association between long-term (2010\u20132016) county-level exposures to NO(2), PM(2.5) and O(3) and county-level COVID-19 case-fatality and mortality rates in the US.", "We used both single and multipollutant models and controlled for spatial trends and a comprehensive set of potential confounders, including state-level test positive rate, county-level healthcare capacity, phase-of-epidemic, population mobility, sociodemographic, socioeconomic status, behavior risk factors, and meteorological factors.", "RESULTS: 1,027,799 COVID-19 cases and 58,489 deaths were reported in 3,122 US counties from January 22, 2020 to April 29, 2020, with an overall observed case-fatality rate of 5.8%.", "Spatial variations were observed for both COVID-19 death outcomes and long-term ambient air pollutant levels.", "County-level average NO(2) concentrations were positively associated with both COVID-19 case-fatality rate and mortality rate in single-, bi-, and tri-pollutant models (p-values<0.05).", "Per inter-quartile range (IQR) increase in NO(2) (4.6 ppb), COVID-19 case-fatality rate and mortality rate were associated with an increase of 7.1% (95% CI 1.2% to 13.4%) and 11.2% (95% CI 3.4% to 19.5%), respectively.", "We did not observe significant associations between long-term exposures to PM(2.5) or O(3) and COVID-19 death outcomes (p-values>0.05), although per IQR increase in PM(2.5) (3.4 ug/m(3)) was marginally associated with 10.8% (95% CI: \u22121.1% to 24.1%) increase in COVID-19 mortality rate.", "DISCUSSIONS AND CONCLUSIONS: Long-term exposure to NO(2), which largely arises from urban combustion sources such as traffic, may enhance susceptibility to severe COVID-19 outcomes, independent of long-term PM(2.5) and O(3) exposure.", "The results support targeted public health actions to protect residents from COVID-19 in heavily polluted regions with historically high NO(2) levels.", "Moreover, continuation of current efforts to lower traffic emissions and ambient air pollution levels may be an important component of reducing population-level risk of COVID-19 deaths."], "title": "Urban Air Pollution May Enhance COVID-19 Case-Fatality and Mortality Rates in the United States"}
{"doc_id": 376, "abstract": ["The current pandemic is caused by the SARS-CoV-2 virus and large progress in understanding the pathology of the virus has been made since its emergence in late 2019.", "Several reports indicate short lasting immunity against endemic coronaviruses, which contrasts repeated reports that biobanked venous blood contains SARS-CoV-2 reactive T cells even before the outbreak in Wuhan.", "This suggests there exists a preformed T cell memory in individuals not exposed to the pandemic virus.", "Given the similarity of SARS-CoV-2 to other members of the Coronaviridae family, the endemic coronaviruses appear likely candidates to generate this T cell memory.", "However, given the apparent poor immunological memory created by the endemic coronaviruses, other immunity against other common pathogens might offer an alternative explanation.", "Here, we utilize a combination of epitope prediction and similarity to common human pathogens to identify potential sources of the SARS-CoV-2 T cell memory.", "We find that no common human virus, other than beta-coronaviruses, can explain the pre-existing SARS-CoV-2 reactive T cells in uninfected individuals.", "Our study suggests OC43 and HKU1 are the most likely pathogens giving rise to SARS-CoV-2 preformed immunity."], "title": "SARS-CoV-2 reactive T cells in uninfected individuals are likely expanded by beta-coronaviruses"}
{"doc_id": 377, "abstract": ["Detected in December 2019, the coronavirus disease 2019 (COVID-19) has since spread all over the world, resulting in a global pandemic.", "The disease is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), and its symptoms usually include cough, fever, and gastrointestinal problems.", "Although the prevalence of rheumatoid arthritis (RA) is about 1 % of the global population and RA patients naturally have a chance of acquiring COVID-19 in this pandemic, no studies have considered the expression of angiotensin-converting enzyme 2 (ACE2) (a receptor for SARS-CoV-2) in synovial tissues.", "Our presenting data revealed that ACE2 expression was elevated in active rheumatoid synovium, and siRNA against STAT3 was able to downregulate ACE2 expression, which was in turn induced by IL-6 signaling."], "title": "Angiotensin-converting enzyme 2, a SARS-CoV-2 receptor, is upregulated by interleukin-6 via STAT3 signaling in rheumatoid synovium"}
{"doc_id": 378, "abstract": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent of COVID-19, is considered a zoonotic pathogen mainly transmitted human to human.", "Few reports indicate that pets may be exposed to the virus.", "The present report describes a cat suffering from severe respiratory distress and thrombocytopenia living with a family with several members affected by COVID-19.", "Clinical signs of the cat prompted humanitarian euthanasia and a detailed postmortem investigation to assess whether a COVID-19-like disease was causing the condition.", "Necropsy results showed the animal suffered from feline hypertrophic cardiomyopathy and severe pulmonary edema and thrombosis.", "SARS-CoV-2 RNA was only detected in nasal swab, nasal turbinates, and mesenteric lymph node, but no evidence of histopathological lesions compatible with a viral infection were detected.", "The cat seroconverted against SARS-CoV-2, further evidencing a productive infection in this animal.", "We conclude that the animal had a subclinical SARS-CoV-2 infection concomitant to an unrelated cardiomyopathy that led to euthanasia."], "title": "Detection of SARS-CoV-2 in a cat owned by a COVID-19-affected patient in Spain"}
{"doc_id": 379, "abstract": ["Asymptomatic infections and limited testing capacity have led to under-reporting of SARS-CoV-2 cases.", "This has hampered the ability to ascertain true infection numbers, evaluate the effectiveness of surveillance strategies, determine transmission dynamics, and estimate reproductive numbers.", "Leveraging both viral genomic and time series case data offers methods to estimate these parameters.", "Using a Bayesian inference framework to fit a branching process model to viral phylogeny and time series case data, we estimated time-varying reproductive numbers and their variance, the total numbers of infected individuals, the probability of case detection over time, and the estimated time to detection of an outbreak for 12 locations in Europe, China, and the United States.", "The median percentage of undetected infections ranged from 13% in New York to 92% in Shanghai, China, with the length of local transmission prior to two cases being detected ranging from 11 days (95% CI: 4-21) in California to 37 days (9-100) in Minnesota.", "The probability of detection was as low as 1% at the start of local epidemics, increasing as the number of reported cases increased exponentially.", "The precision of estimates increased with the number of full-length viral genomes in a location.", "The viral phylogeny was informative of the variance in the reproductive number with the 32% most infectious individuals contributing 80% of total transmission events.", "This is the first study that incorporates both the viral genomes and time series case data in the estimation of undetected COVID-19 infections.", "Our findings suggest the presence of undetected infections broadly and that superspreading events are contributing less to observed dynamics than during the SARS epidemic in 2003.", "This genomics-informed modeling approach could estimate in near real-time critical surveillance metrics to inform ongoing COVID-19 response efforts."], "title": "Using viral genomics to estimate undetected infections and extent of superspreading events for COVID-19"}
{"doc_id": 380, "abstract": ["It is currently unknown whether acquired immunity to common alpha-and beta-coronaviruses provides cross-protection against SARS-CoV-2.", "In this study, we found that certain patient sera and intravenous immunoglobulins (IVIG) collected prior to the COVID-19 outbreak were cross-reactive to SARS-CoV-2 full-length Spike, S2 domain, and nucleoprotein.", "However, their presence did not translate into neutralizing activity against SARS-CoV-2 in vitro.", "Importantly, we detected serum IgG reactivity to common coronaviruses in the early sera of patients with severe COVID-19 before the appearance of anti-SARS-CoV-2 antibodies.", "Collectively, the results of our study indicate that pre-existing immunity to common coronaviruses does not confer cross-protection against SARS-CoV-2 in vivo."], "title": "Pre-COVID-19 humoral immunity to common coronaviruses does not confer cross-protection against SARS-CoV-2"}
{"doc_id": 381, "abstract": ["Severe acute respiratory coronavirus 2 (SARS-CoV-2), the agent of the ongoing COVID-19 pandemic, jumped into humans from an unknown animal reservoir in late 2019.", "In line with other coronaviruses, SARS-CoV-2 has the potential to infect a broad range of hosts.", "SARS-CoV-2 genomes have now been isolated from cats, dogs, lions, tigers and minks.", "SARS-CoV-2 seems to transmit particularly well in mink farms with outbreaks reported in Spain, Sweden, the Netherlands, Italy, the USA and Denmark.", "Genomic data from SARS-CoV-2 isolated from infected minks provides a natural case study of a secondary host jump of the virus, in this case from humans to animals, and occasionally back again.", "We screened published SARS-CoV-2 genomes isolated from minks for the presence of recurrent mutations common in mink but infrequent in SARS-CoV-2 genomes isolated from human infections.", "We identify 23 recurrent mutations including three nonsynonymous mutations in the Receptor Binding Domain of the SARS-CoV-2 spike protein that independently emerged at least four times but are only rarely observed in human lineages.", "The repeat emergence of mutations across phylogenetically distinct lineages of the virus isolated from minks points to ongoing adaptation of SARS-CoV-2 to a new host.", "The rapid acquisition and spread of SARS-CoV-2 mutations in minks suggests that if a similar phenomenon of host adaptation had occurred upon its jump into humans, those human-specific mutations would likely have reached fixation already before the first SARS-CoV-2 genomes were generated.", "Data Summary All genome assemblies considered in this manuscript are openly available on registration with GISAID (https://www.gisaid.org).", "Information on the included assemblies, including the accessions used in the global analysis are provided in Tables S1-S2."], "title": "Recurrent mutations in SARS-CoV-2 genomes isolated from mink point to rapid host-adaptation"}
{"doc_id": 382, "abstract": ["TOPIC: Cardiovascular Disease TYPE: Medical Student/Resident Case Reports INTRODUCTION: COVID-19 (Coronavirus Disease of 2019) is a global pandemic caused by the rapidly spreading SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2).", "Although COVID-19 primarily affects the respiratory system, evidence suggests a strong predisposition for pro-thrombotic states with COVID-19 infection, manifesting as both venous and arterial thromboembolism.", "COVID-19 associated coagulopathy and its varying complications contribute to a significant portion or morbidity and mortality in addition to respiratory failure.", "CASE PRESENTATION: A 75-year-old woman with stage IV colorectal carcinoma, rheumatic mitral valve stenosis status-post recent balloon valvulotomy, and atrial fibrillation on warfarin presented with fever, cough, anosmia, ageusia, dyspnea, generalized weakness, and anorexia.", "She was admitted for neutropenic fever, acute hypoxic respiratory failure, and sepsis in the context of COVID-19 pneumonia.", "Computed tomography angiogram (CTA) of the chest showed bilateral infiltrates consistent with COVID-19 pneumonia, as well as a more unusual finding of a large 7 x 4 x 7 cm left atrial mass (Figure 1), consistent in appearance with a thrombus.", "Comparison with CTA chest one month prior confirmed that the thrombus was acute.", "On admission, the patient also had a supratherapeutic INR of 4.", "Echocardiography confirmed the suspicion for thrombus and redemonstrated restricted mitral valve leaflets consistent with rheumatic valvular stenosis.", "The patient was treated with supplemental oxygen, remdesivir, vancomycin, cefepime and filgrastim.", "She responded well and had resolution of her neutropenia, sepsis, and hypoxia.", "Because she formed the thrombus while on warfarin, decision was made to discontinue warfarin and transition to enoxaparin for anticoagulation.", "She was subsequently discharged home on hospice.", "DISCUSSION: Although venous thromboembolism is commonly encountered with COVID-19 patients, to our knowledge this case represents the first report of COVID-19 associated left atrial thrombus.", "Rheumatic mitral valve disease is a known risk factor for left atrial thrombus formation and colorectal carcinoma may have also contributed to hypercoagulability.", "However, the patient in our vignette had a supratherapeutic INR at the time of thrombus formation.", "Furthermore, the absence of thrombus on imaging one month prior confirms a temporal association with COVID-19 infection.", "As such, evidence suggests that hypercoagulability secondary to COVID-19 contributed to the formation of her left atrial thrombus.", "CONCLUSIONS: This case adds to the growing body of literature surrounding the profound hypercoagulability provoked by SARS-CoV-2 infection and reiterates the role of anticoagulation in the management of COVID-19 patients during the ongoing pandemic.", "REFERENCE #1: Rothan HA, Byrareddy SN.", "The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak.", "J Autoimmun.", "2020;109:102433.", "REFERENCE #2: Incidence of thrombotic complications in critically ill ICU patients with COVID-19.", "lok FA, Kruip MJHA, van der Meer NJM, et al. Thromb Res.", "2020;191:145\u2013147.", "REFERENCE #3: Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.", "J Thromb Haemost. 2020;18(4):844\u2013847.", "DISCLOSURES: No relevant relationships by Nikhila Janakiram, source=Web Response No relevant relationships by Eva Ma, source=Web Response No relevant relationships by Andreas Mauer, source=Web Response"], "title": "LEFT ATRIAL THROMBUS AND COVID-19-ASSOCIATED COAGULOPATHY"}
{"doc_id": 383, "abstract": ["The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that emerged in late 2019 has spread globally, causing a pandemic of respiratory illness designated coronavirus disease 2019 (COVID-19).", "Robust blood biomarkers that reflect tissue damage are urgently needed to better stratify and triage infected patients.", "Here, we use spatial transcriptomics to generate an in-depth picture of the pulmonary transcriptional landscape of COVID-19 (10 patients), pandemic H1N1 (pH1N1) influenza (5) and uninfected control patients (4).", "Host transcriptomics showed a significant upregulation of genes associated with inflammation, type I interferon production, coagulation and angiogenesis in the lungs of COVID-19 patients compared to non-infected controls.", "SARS-CoV-2 was non-uniformly distributed in lungs with few areas of high viral load and these were largely only associated with an increased type I interferon response.", "A very limited number of genes were differentially expressed between the lungs of influenza and COVID-19 patients.", "Specific interferon-associated genes (including IFI27) were identified as candidate novel biomarkers for COVID-19 differentiating this COVID-19 from influenza.", "Collectively, these data demonstrate that spatial transcriptomics is a powerful tool to identify novel gene signatures within tissues, offering new insights into the pathogenesis of SARS-COV-2 to aid in patient triage and treatment."], "title": "Spatial Profiling of Lung SARS-CoV-2 and Influenza Virus Infection Dissects Virus-Specific Host Responses and Gene Signatures"}
{"doc_id": 384, "abstract": ["Phylogenomic analysis of SARS-CoV-2 as available from publicly available repositories suggests the presence of 3 prevalent groups of viral episomes (super-clades), which are mostly associated with outbreaks in distinct geographic locations (China, USA and Europe).", "While levels of genomic variability between SARS-CoV-2 isolates are limited, to our knowledge, it is not clear whether the observed patterns of variability in viral super-clades reflect ongoing adaptation of SARS-CoV-2, or merely genetic drift and founder effects.", "Here, we analyze more than 1100 complete, high quality SARS-CoV-2 genome sequences, and provide evidence for the absence of distinct evolutionary patterns/signatures in the genomes of the currently known major clades of SARS-CoV-2.", "Our analyses suggest that the presence of distinct viral episomes at different geographic locations are consistent with founder effects, coupled with the rapid spread of this novel virus.", "We observe that while cross species adaptation of the virus is associated with hypervariability of specific protein coding regions (including the RDB domain of the spike protein), the more variable genomic regions between extant SARS-CoV-2 episomes correspond with the 3\u2019 and 5\u2019 UTRs, suggesting that at present viral protein coding genes should not be subjected to different adaptive evolutionary pressures in different viral strains.", "Although this study can not be conclusive, we believe that the evidence presented here is strongly consistent with the notion that the biased geographic distribution of SARS-CoV-2 isolates should not be associated with adaptive evolution of this novel pathogen."], "title": "Comparative genomics suggests limited variability and similar evolutionary patterns between major clades of SARS-CoV-2"}
{"doc_id": 385, "abstract": ["While several clinical and immunological parameters correlate with disease severity and mortality in SARS-CoV-2 infection, work remains in identifying unifying correlates of coronavirus disease 2019 (COVID-19) that can be used to guide clinical practice.", "Here, we examine saliva and nasopharyngeal (NP) viral load over time and correlate them with patient demographics, and cellular and immune profiling.", "We found that saliva viral load was significantly higher in those with COVID-19 risk factors; that it correlated with increasing levels of disease severity and showed a superior ability over nasopharyngeal viral load as a predictor of mortality over time (AUC=0.90).", "A comprehensive analysis of immune factors and cell subsets revealed strong predictors of high and low saliva viral load, which were associated with increased disease severity or better overall outcomes, respectively.", "Saliva viral load was positively associated with many known COVID-19 inflammatory markers such as IL-6, IL-18, IL-10, and CXCL10, as well as type 1 immune response cytokines.", "Higher saliva viral loads strongly correlated with the progressive depletion of platelets, lymphocytes, and effector T cell subsets including circulating follicular CD4 T cells (cTfh).", "Anti-spike (S) and anti-receptor binding domain (RBD) IgG levels were negatively correlated with saliva viral load showing a strong temporal association that could help distinguish severity and mortality in COVID-19.", "Finally, patients with fatal COVID-19 exhibited higher viral loads, which correlated with the depletion of cTfh cells, and lower production of anti-RBD and anti-S IgG levels.", "Together these results demonstrated that viral load \u2013 as measured by saliva but not nasopharyngeal \u2014 is a dynamic unifying correlate of disease presentation, severity, and mortality over time."], "title": "Saliva viral load is a dynamic unifying correlate of COVID-19 severity and mortality"}
{"doc_id": 386, "abstract": ["As researchers across the globe have focused their attention on understanding SARS-CoV-2, the picture that is emerging is that of a virus that has serious effects on the vasculature in multiple organ systems including the cerebral vasculature.", "Observed effects on the central nervous system includes neurological symptoms (headache, nausea, dizziness), fatal microclot formation and in rare cases encephalitis.", "However, our understanding of how the virus causes these mild to severe neurological symptoms and how the cerebral vasculature is impacted remains unclear.", "Thus, the results presented in this report explored whether deleterious outcomes from the SARS-COV-2 viral spike protein on primary human brain microvascular endothelial cells (hBMVECs) could be observed.", "First, using postmortem brain tissue, we show that the angiotensin converting enzyme 2 or ACE2 (a known binding target for the SARS-CoV-2 spike protein), is expressed throughout various caliber vessels in the frontal cortex.", "Additionally, ACE2 was also detectable in primary human brain microvascular endothelial (hBMVEC) maintained under cell culture conditions.", "Analysis for cell viability revealed that neither the S1, S2 or a truncated form of the S1 containing only the RBD had minimal effects on hBMVEC viability within a 48hr exposure window.", "However, when the viral spike proteins were introduced into model systems that recapitulate the essential features of the Blood-Brain Barrier (BBB), breach to the barrier was evident in various degrees depending on the spike protein subunit tested.", "Key to our findings is the demonstration that S1 promotes loss of barrier integrity in an advanced 3D microfluid model of the human BBB, a platform that most closely resembles the human physiological conditions at this CNS interface.", "Subsequent analysis also showed the ability for SARS-CoV-2 spike proteins to trigger a pro-inflammatory response on brain endothelial cells that may contribute to an altered state of BBB function.", "Together, these results are the first to show the direct impact that the SARS-CoV-2 spike protein could have on brain endothelial cells; thereby offering a plausible explanation for the neurological consequences seen in COVID-19 patients."], "title": "The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in vitro models of the human blood\u2013brain barrier"}
{"doc_id": 387, "abstract": ["As researchers across the globe have focused their attention on understanding SARS-CoV-2, the picture that is emerging is that of a virus that has serious effects on the vasculature in multiple organ systems including the cerebral vasculature.", "Observed effects on the central nervous system include neurological symptoms (headache, nausea, dizziness), fatal microclot formation and in rare cases encephalitis.", "However, our understanding of how the virus causes these mild to severe neurological symptoms and how the cerebral vasculature is impacted remains unclear.", "Thus, the results presented in this report explored whether deleterious outcomes from the SARS-CoV-2 viral spike protein on primary human brain microvascular endothelial cells (hBMVECs) could be observed.", "The spike protein, which plays a key role in receptor recognition, is formed by the S1 subunit containing a receptor binding domain (RBD) and the S2 subunit.", "First, using postmortem brain tissue, we show that the angiotensin converting enzyme 2 or ACE2 (a known binding target for the SARS-CoV-2 spike protein), is ubiquitously expressed throughout various vessel calibers in the frontal cortex.", "Moreover, ACE2 expression was upregulated in cases of hypertension and dementia.", "ACE2 was also detectable in primary hBMVECs maintained under cell culture conditions.", "Analysis of cell viability revealed that neither the S1, S2 or a truncated form of the S1 containing only the RBD had minimal effects on hBMVEC viability within a 48 h exposure window.", "Introduction of spike proteins to invitro models of the blood-brain barrier (BBB) showed significant changes to barrier properties.", "Key to our findings is the demonstration that S1 promotes loss of barrier integrity in an advanced 3D microfluidic model of the human BBB, a platform that more closely resembles the physiological conditions at this CNS interface.", "Evidence provided suggests that the SARS-CoV-2 spike proteins trigger a pro-inflammatory response on brain endothelial cells that may contribute to an altered state of BBB function.", "Together, these results are the first to show the direct impact that the SARS-CoV-2 spike protein could have on brain endothelial cells; thereby offering a plausible explanation for the neurological consequences seen in COVID-19 patients."], "title": "The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier"}
{"doc_id": 388, "abstract": ["Background.", "To date the description of mechanically ventilated patients with Coronavirus Disease 2019 (COVID-19) has focussed on admission characteristics with no consideration of the dynamic course of the disease.", "Here, we present a data-driven analysis of granular, daily data from a representative proportion of patients undergoing invasive mechanical ventilation (IMV) within the United Kingdom (UK) to evaluate the complete natural history of COVID-19.", "Methods.", "We included adult patients undergoing IMV within 48 hours of ICU admission with complete clinical data until death or ICU discharge.", "We examined factors and trajectories that determined disease progression and responsiveness to ARDS interventions.", "Our data visualisation tool is available as a web-based widget (https://www.", "CovidUK.ICU).", "Findings.", "Data for 623 adults with COVID-19 who were mechanically ventilated between 01 March 2020 and 31 August 2020 were analysed.", "Mortality, intensity of mechanical ventilation and severity of organ injury increased with severity of hypoxaemia.", "Median tidal volume per kg across all mandatory breaths was 5.6 [IQR 4.7-6.6] mL/kg based on reported body weight, but 7.0 [IQR 6.0-8.4] mL/kg based on calculated ideal body weight.", "Non-resolution of hypoxaemia over the first week of IMV was associated with higher ICU mortality (59.4% versus 16.3%; P<0.001).", "Of patients ventilated in prone position only 44% showed a positive oxygenation response.", "Non-responders to prone position show higher D-Dimers, troponin, cardiovascular SOFA, and higher ICU mortality (68.9% versus 29.7%; P<0.001).", "Multivariate analysis showed prone non-responsiveness being independently associated with higher lactate (hazard ratio 1.41, 95% CI 1.03-1.93), respiratory SOFA (hazard ratio 3.59, 95% CI 1.83-7.04); and cardiovascular SOFA score (hazard ratio 1.37, 95% CI 1.05-1.80).", "Interpretation.", "A sizeable proportion of patients with progressive worsening of hypoxaemia were also refractory to evidence-based ARDS strategies and showed a higher mortality.", "Strategies for early recognition and management of COVID19 patients refractory to conventional management strategies will be critical to improving future outcomes."], "title": "Natural history, trajectory, and management of mechanically ventilated COVID-19 patients in the United Kingdom."}
{"doc_id": 389, "abstract": ["The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic is continuing to disrupt personal lives, global healthcare systems, and economies.", "Hence, there is an urgent need for a vaccine that prevents viral infection, transmission, and disease.", "Here, we present a two-component protein-based nanoparticle vaccine that displays multiple copies of the SARS-CoV-2 spike protein.", "Immunization studies show that this vaccine induces potent neutralizing antibody responses in mice, rabbits, and cynomolgus macaques.", "The vaccine-induced immunity protects macaques against a high-dose challenge, resulting in strongly reduced viral infection and replication in the upper and lower airways.", "These nanoparticles are a promising vaccine candidate to curtail the SARS-CoV-2 pandemic."], "title": "Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection"}
{"doc_id": 390, "abstract": ["Emerging clinical data demonstrates that COVID-19, the disease caused by SARS-CoV2, is a syndrome that variably affects nearly every organ system.", "Indeed, the clinical heterogeneity of COVID-19 ranges from relatively asymptomatic to severe disease with death resultant from multiple constellations of organ failures.", "In addition to genetics and host characteristics, it is likely that viral dissemination is a key determinant of disease manifestation.", "Given the complexity of disease expression, one major limitation in current animal models is the ability to capture this clinical heterogeneity due to technical limitations related to murinizing SARS-CoV2 or humanizing mice to render susceptible to infection.", "Here we describe a murine model of COVID-19 using respiratory infection with the native mouse betacoronavirus MHV-A59.", "We find that whereas high viral inoculums uniformly led to hypoxemic respiratory failure and death, lethal dose 50% (LD50) inoculums led to a recapitulation of most hallmark clinical features of COVID-19, including lymphocytopenias, heart and liver damage, and autonomic dysfunction.", "We find that extrapulmonary manifestations are due to viral metastasis and identify a critical role for type-I but not type-III interferons in preventing systemic viral dissemination.", "Early, but not late treatment with intrapulmonary type-I interferon, as well as convalescent serum, provided significant protection from lethality by limiting viral dissemination.", "We thus establish a Biosafety Level II model that may be a useful addition to the current pre-clinical animal models of COVID-19 for understanding disease pathogenesis and facilitating therapeutic development for human translation."], "title": "Type I Interferon Limits Viral Dissemination-Driven Clinical Heterogeneity in a Native Murine Betacoronavirus Model of COVID-19"}
{"doc_id": 391, "abstract": ["Background: A recently emerging respiratory disease named coronavirus disease 2019 (COVID-19) has quickly spread across the world.", "This disease is initiated by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and uncontrolled cytokine storm, but it remains unknown as to whether a robust antibody response is related to clinical deterioration and poor outcome in laboratory-confirmed COVID-19 patients.", "Methods: Anti-SARS-CoV-2 IgG and IgM antibodies were determined by chemiluminescence analysis (CLIA) in COVID-19 patients from a single center in Wuhan.", "Median IgG and IgM levels in acute and convalescent-phase sera (within 35 days) for all included patients were calculated and compared among severe and nonsevere patients.", "Immune response phenotyping based on late IgG levels and neutrophil-to-lymphocyte ratio (NLR) was characterized to stratify patients with different disease severities and outcome.", "Laboratory parameters in patients with different immune response phenotypes and disease severities were analyzed.", "Findings: A total of 222 patients were included in this study.", "IgG was first detected on day 4 of illness, and its peak levels occurred in the fourth week.", "Severe cases were more frequently found in patients with high IgG levels, compared to those who with low IgG levels (51.8% versus 32.3%; p=0.008).", "Severity rates for patients with NLRhiIgGhi, NLRhiIgGlo, NLRloIgGhi, and NLRloIgGlo phenotype was 72.3%, 48.5%, 33.3%, and 15.6%, respectively (p<0.0001).", "Furthermore, severe patients with NLRhiIgGhi, NLRhiIgGlo had higher proinflammatory cytokines levels including IL-2, IL-6 and IL-10, and decreased CD4+ T cell count compared to those with NLRloIgGlo phenotype (p<0.05).", "Recovery rate for severe patients with NLRhiIgGhi, NLRhiIgGlo, NLRloIgGhi, and NLRloIgGlo phenotype was 58.8% (20/34), 68.8% (11/16), 80.0% (4/5), and 100% (12/12), respectively (p=0.0592).", "Dead cases only occurred in NLRhiIgGhi and NLRhiIgGlo phenotypes.", "Interpretation: COVID-19 severity is associated with increased IgG response, and an immune response phenotyping based on late IgG response and NLR could act as a simple complementary tool to discriminate between severe and nonsevere COVID-19 patients, and further predict their clinical outcome."], "title": "Immune phenotyping based on neutrophil-to-lymphocyte ratio and IgG predicts disease severity and outcome for patients with COVID-19"}
{"doc_id": 392, "abstract": ["A new SARS-CoV-2 clade (GV) characterized by S substitution A222V, first reported from Spain in March, is rapidly spreading across Europe.", "To establish the A222V variant involvement in the infection rise in Italy, all GISAID sequences from Italy and those from our Laboratory (Lazio) in the period June-October were analysed.", "A222V, first recognized in August, represents 11.2% of sequences in this period, reaching 100% of autochthonous sequences in October, supporting increased GV circulation in Italy."], "title": "The newly introduced SARS-CoV-2 variant A222V is rapidly spreading in Lazio region, Italy"}
{"doc_id": 393, "abstract": ["Susceptibility to infection such as SARS-CoV-2 may be influenced by host genotype.", "TwinsUK volunteers (n=2633) completing the C-19 Covid symptom tracker app allowed classical twin studies of covid-19 symptoms including predicted covid-19, a symptom-based algorithm predicting true infection derived in app users tested for SARS-CoV-2.", "We found heritability for fever = 41 (95% confidence intervals 12-70)%; anosmia 47 (27-67)%; delirium 49 (24-75)%; and predicted covid-19 gave heritability = 50 (29-70)%."], "title": "Self-reported symptoms of covid-19 including symptoms most predictive of SARS-CoV-2 infection, are heritable"}
{"doc_id": 394, "abstract": ["Identification of host genes essential for SARS-CoV-2 infection may reveal novel therapeutic targets and inform our understanding of COVID-19 pathogenesis.", "Here we performed a genome-wide CRISPR screen with SARS-CoV-2 and identified known SARS-CoV-2 host factors including the receptor ACE2 and protease Cathepsin L. We additionally discovered novel pro-viral genes and pathways including the SWI/SNF chromatin remodeling complex and key components of the TGF-\u03b2 signaling pathway.", "Small molecule inhibitors of these pathways prevented SARS-CoV-2-induced cell death.", "We also revealed that the alarmin HMGB1 is critical for SARS-CoV-2 replication.", "In contrast, loss of the histone H3.3 chaperone complex sensitized cells to virus-induced death.", "Together this study reveals potential therapeutic targets for SARS-CoV-2 and highlights host genes that may regulate COVID-19 pathogenesis."], "title": "Genome-wide CRISPR screen reveals host genes that regulate SARS-CoV-2 infection"}
{"doc_id": 395, "abstract": ["BACKGROUND: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is believed to be mostly transmitted by medium-to large-sized respiratory droplets, although airborne transmission may be possible in healthcare settings involving aerosol-generating procedures.", "Exposure to respiratory droplets can theoretically be reduced by surgical mask usage.", "However, there is a lack of experimental evidence supporting surgical mask usage for prevention of COVID-19.", "METHODS: We used a well-established golden Syrian hamster SARS-CoV-2 model.", "We placed SARS-CoV-2-challenged index hamsters and naive hamsters into closed system units each comprising 2 different cages separated by a polyvinyl chloride air porous partition with unidirectional airflow within the isolator.", "The effect of a surgical mask partition placed between the cages was investigated.", "Besides clinical scoring, hamster specimens were tested for viral load, histopathology, and viral nucleocapsid antigen expression.", "RESULTS: Noncontact transmission was found in 66.7% (10/15) of exposed naive hamsters.", "Surgical mask partition for challenged index or naive hamsters significantly reduced transmission to 25% (6/24, P = .018).", "Surgical mask partition for challenged index hamsters significantly reduced transmission to only 16.7% (2/12, P = .019) of exposed naive hamsters.", "Unlike the severe manifestations of challenged hamsters, infected naive hamsters had lower clinical scores, milder histopathological changes, and lower viral nucleocapsid antigen expression in respiratory tract tissues.", "CONCLUSIONS: SARS-CoV-2 could be transmitted by respiratory droplets or airborne droplet nuclei which could be reduced by surgical mask partition in the hamster model.", "This is the first in vivo experimental evidence to support the possible benefit of surgical mask in prevention of COVID-19 transmission, especially when masks were worn by infected individuals."], "title": "Surgical Mask Partition Reduces the Risk of Noncontact Transmission in a Golden Syrian Hamster Model for Coronavirus Disease 2019 (COVID-19)"}
{"doc_id": 396, "abstract": ["The high transmissibility of SARS-CoV-2 is related to abundant replication in the upper airways, which is not observed for the other highly pathogenic coronaviruses SARS-CoV-1 and MERS-CoV. We here reveal features of the coronavirus spike (S) protein, which optimize the virus towards different parts of the respiratory tract.", "First, the SARS-CoV-2 spike (SARS-2-S) reached higher levels in pseudoparticles when produced at 33\u00b0C instead of 37\u00b0C.", "Even stronger preference for the upper airway temperature of 33\u00b0C was evident for the S protein of HCoV-229E, a common cold coronavirus.", "In contrast, the S proteins of SARS-CoV-1 and MERS-CoV favored 37\u00b0C, in accordance with their preference for the lower airways.", "Next, SARS-2-S proved efficiently activated by TMPRSS13, besides the previously identified host cell protease TMPRSS2, which may broaden the cell tropism of SARS-CoV-2.", "TMPRSS13 was found to be an effective spike activator for the virulent coronaviruses but not the common cold HCoV-229E virus.", "Activation by these proteases requires pre-cleavage of the SARS-2-S S1/S2 cleavage loop, and both its furin motif and extended loop length proved critical to achieve virus entry into airway epithelial cells.", "Finally, we show that the D614G mutation in SARS-2-S increases S protein stability and expression at 37\u00b0C, and promotes virus entry via cathepsin B/L activation.", "These spike properties might promote virus spread, potentially explaining why the G614 variant is currently predominating worldwide.", "Collectively, our findings indicate how the coronavirus spike protein is fine-tuned towards the temperature and protease conditions of the airways, to enhance virus transmission and pathology.", "SIGNIFICANCE STATEMENT The rapid spread of SARS-CoV-2, the cause of COVID-19, is related to abundant replication in the upper airways, which is not observed for other highly pathogenic human coronaviruses.", "We here reveal features of the coronavirus spike (S) protein, which optimize the virus towards different parts of the respiratory tract.", "Coronavirus spikes exhibit distinct temperature preference to precisely match the upper (~33\u00b0C) or lower (37\u00b0C) airways.", "We identified airway proteases that activate the spike for virus entry into cells, including one protease that may mediate coronavirus virulence.", "Also, a link was seen between spike stability and entry via endosomal proteases.", "This mechanism of spike fine-tuning could explain why the SARS-CoV-2 spike-D614G mutant is more transmissible and therefore globally predominant."], "title": "The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways"}
{"doc_id": 397, "abstract": ["Angiotensin-converting enzyme 2 (ACE2) has been suggested as a receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) entry to cause coronavirus disease 2019 (COVID-19).", "However, no ACE2 inhibitors have shown definite beneficiaries for COVID-19 patients, applying the presence of another receptor for SARS-CoV-2 entry.", "Here we show that ACE2 knockout dose not completely block virus entry, while TfR directly interacts with virus Spike protein to mediate virus entry and SARS-CoV-2 can infect mice with over-expressed humanized transferrin receptor (TfR) and without humanized ACE2.", "TfR-virus co-localization is found both on the membranes and in the cytoplasma, suggesting SARS-CoV-2 transporting by TfR, the iron-transporting receptor shuttling between cell membranes and cytoplasma.", "Interfering TfR-Spike interaction blocks virus entry to exert significant anti-viral effects.", "Anti-TfR antibody (EC50 ~16.6 nM) shows promising anti-viral effects in mouse model.", "Collectively, this report indicates that TfR is another receptor for SARS-CoV-2 entry and a promising anti-COVID-19 target."], "title": "Transferrin receptor is another receptor for SARS-CoV-2 entry"}
{"doc_id": 398, "abstract": ["SARS-CoV-2 has caused a global pandemic with millions infected and numerous fatalities.", "Questions regarding the robustness, functionality and longevity of the antibody response to the virus remain unanswered.", "Here we report that the vast majority of infected individuals with mild-to-moderate COVID-19 experience robust IgG antibody responses against the viral spike protein, based on a dataset of 19,860 individuals screened at Mount Sinai Health System in New York City.", "We also show that titers are stable for at least a period approximating three months, and that anti-spike binding titers significantly correlate with neutralization of authentic SARS-CoV-2.", "Our data suggests that more than 90% of seroconverters make detectible neutralizing antibody responses and that these titers are stable for at least the near-term future."], "title": "SARS-CoV-2 infection induces robust, neutralizing antibody responses that are stable for at least three months"}
{"doc_id": 399, "abstract": ["The impact of the COVID-19 pandemic continues to be significant and global.", "As the global community learns more about the novel coronavirus SARS-CoV-2, there is strong evidence that a significant modality of transmission is via the long-range airborne route, referred to here as aerosol transmission.", "In this paper, we evaluate the efficacy of ventilation, mask effective filtration efficiency, and the combined effect of the two on the reduction of aerosol infection probability for COVID-19 in a classroom setting.", "The Wells-Riley equation is used to predict the conditional probability of infection for three distinct airborne exposure scenarios: (1) an infectious instructor exposing susceptible students; (2) an infectious student exposing other susceptible students; and (3) an infectious student exposing a susceptible instructor.", "Field measurements were performed in a classroom using a polydisperse neutralized salt (NaCl) aerosol, generated in a size range consistent with human-generated SARS-CoV-2 containing bioaerosols, as a safe surrogate.", "Measurements included time-resolved and size-resolved NaCl aerosol concentration distributions and size-resolved effective filtration efficiency of different masks with and without mask fitters.", "The measurements were used to validate assumptions and inputs for the Wells-Riley model.", "Aerosol dynamics and distribution measurements confirmed that the majority of the classroom space is uniform in aerosol concentration within a factor of 2 or better for distances > 2 m from the aerosol source.", "Mask effective filtration efficiency measurements show that most masks fit poorly with estimated leakage rates typically > 50%, resulting in significantly reduced effective filtration efficiency.", "However, effective filtration efficiencies approaching the mask material filtration efficiency were achievable using simple mask fitters.", "Wells-Riley model results for the different scenarios suggest that ventilation of the classroom alone is not able to achieve infection probabilities less than 0.01 (1%) for air exchanges rates up to 10 1/h and an event duration of one hour.", "The use of moderate to high effective filtration efficiency masks by all individuals present, on the other hand, was able to significantly reduce infection probability and could achieve reductions in infection probability by 5x, 10x, or even >100x dependent on the mask used and use of a mask fitter.", "This enables conditional infection probabilities <0.001 (0.1%) or even < 0.0001 (0.01%) to be reached with the use of masks and mask fitters alone.", "Finally, the results demonstrate that the reductions provided by ventilation and masks are synergistic and multiplicative.", "The results reinforce the use of properly donned masks to achieve reduced aerosol transmission of SARS-CoV-2 and other infectious diseases transmitted via respiratory aerosol indoors and provide new motivation to further improve the effective filtration efficiency of common face coverings through improved design, and/or the use of mask fitters."], "title": "Strategies to minimize SARS-CoV-2 transmission in classroom settings: Combined impacts of ventilation and mask effective filtration efficiency"}
{"doc_id": 400, "abstract": ["TOPIC: Cardiovascular Disease TYPE: Medical Student/Resident Case Reports INTRODUCTION: Myocarditis is becoming a more recognized complication of COVID-19 with a recent uptrend in cases around the world.", "This mostly affects individuals with comorbid conditions with a mean age of diagnosis of 50.4 years.", "Despite a recent increase in the number of COVID-19 related myocarditis, only a handful of cases in North America have been identified in younger individuals, especially with findings consistent with STEMI on electrocardiogram.", "CASE PRESENTATION: A 21-year-old man with no significant past medical history presented with sudden onset sharp, substernal, non-radiating chest pain of 30 minutes duration.", "He reported no associated fever, shortness of breath, dizziness or lightheadedness.", "He was diagnosed with COVID-19 infection two weeks prior to presentation.", "Initial work-up in the ED showed sinus bradycardia with ST elevation of 2mm in the inferior leads along with elevated troponin of 52 ng/L. Chest x-ray was unremarkable.", "Aspirin, ticagrelor, atorvastatin and bivalirudin was started.", "Emergent coronary angiography showed mildly impaired left ventricle systolic function with non-occlusive coronary arteries.", "A cardiac MRI showed hypokinesis of the inferior wall of the left ventricle, consistent with acute myocarditis.", "An echocardiogram at four weeks follow-up showed mild/moderate LV systolic dysfunction with EF of 45%.", "Patient was started on carvedilol and captopril, with complete resolution of symptoms reported on subsequent visit.", "DISCUSSION: COVID-19 related myocarditis has seen recent upward trends;however, little is known about the pathophysiologic mechanisms.", "Likely possibilities include a combination of direct viral injury as well as cardiac damage secondary to the host's immune response.", "Diagnosis is based on clinical findings including changes in EKG and cardiac biomarkers with impaired cardiac performance on echocardiography and/or cardiac MRI.", "EKG is non-sensitive for diagnosis and can present with variable findings including bundle branch block, QT prolongation, bradyarrhythmia with advanced atrioventricular nodal block and ST elevation or depression, which can be confused as acute myocardial infarction.", "CONCLUSIONS: COVID 19 related myocarditis is becoming increasingly common, however little is known about pathophysiologic mechanism.", "Troponin, which has been found elevated in most cases of cases of COVID related myocarditis, making it difficult to distinguish from acute coronary syndrome.", "Moreover, in severe patients, both ACS and acute myocarditis may present together because of procoagulant and inflammatory nature of COVID-19 infection REFERENCE #1: COVID-19 and Myocarditis: What Do We Know So Far?o Ashar Pirzada, MD, MSc, a Ahmed T. Mokhtar, MBBS, FRCPC, a, b,\u2217 and Andrew D. Moeller, MD, MASc, FRCPCa REFERENCE #2: Recognizing COVID-19\u2013related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and managemento Bhurint Siripanthong, BA(Cantab),\u2217 Saman Nazarian, MD, PhD, FHRS,\u2020 Daniele Muser, MD,\u2020 Rajat Deo, MD, MTR,\u2020 Pasquale Santangeli, MD, PhD,\u2020 Mohammed Y. Khanji, MBBCh, MRCP, PhD,\u2021\u00a7 Leslie T. Cooper, Jr., MD,# and C. Anwar A. Chahal, MBChB, MRCP, PhD\u2020\u00b6\u2016\u2217 REFERENCE #3: COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?o http://orcid.org/0000-0002-5722-0245Massimo Imazio1,2, Karin Klingel3, Ingrid Kindermann4, Antonio Brucato5, Francesco Giuseppe De Rosa6, Yehuda Adler7, Gaetano Maria De Ferrari8 DISCLOSURES: No relevant relationships by Ahsan Alam, source=Web Response No relevant relationships by Dilpat Kumar, source=Web Response"], "title": "A CASE OF COVID-19 MYOCARDITIS PRESENTING AS INFERIOR WALL MI"}
{"doc_id": 401, "abstract": ["Background Respiratory distress requiring intubation is the most serious complication associated with coronavirus disease 2019 (COVID-19).", "Methods In this retrospective study, we used survival analysis to determine whether or not mortality following intubation was associated with hormone exposure in patients treated at New York Presbyterian/ Columbia University Irving Medical Center.", "Here, we report the overall hazards ratio for each hormone for exposure before and after intubation for intubated and mechanically ventilated patients.", "Results Among the 189,987 patients, we identified 948 intubation periods across 791 patients who were diagnosed with COVID-19 or infected with SARS-CoV2 and 3,497 intubation periods across 2,981 patients who were not.", "Melatonin exposure after intubation was statistically associated with a positive outcome in COVID-19 (demographics and comorbidities adjusted HR: 0.131, 95% CI: 7.76E-02-0.223, p-value = 8.19E-14) and non-COVID-19 (demographics and comorbidities adjusted HR: 0.278, 95% CI: 0.142-0.542, p-value = 1.72E-04) intubated patients.", "Additionally, melatonin exposure after intubation was statically associated with a positive outcome in COVID-19 patients (demographics and comorbidities adjusted HR: 0.127, 95% CI: 6.01E-02-0.269, p-value = 7.15E-08).", "Conclusions Melatonin exposure after intubation is significantly associated with a positive outcome in COVID-19 and non-COVID-19 patients.", "Additionally, melatonin exposure after intubation is significantly associated with a positive outcome in COVID-19 patients requiring mechanical ventilation.", "While our models account for many covariates, including clinical history and demographics, it is impossible to rule out confounding or collider biases within our population.", "Further study into the possible mechanism of this observation is warranted."], "title": "Melatonin is significantly associated with survival of intubated COVID-19 patients"}
{"doc_id": 402, "abstract": ["An effective vaccine is essential for controlling the spread of the SARS-CoV-2 virus.", "Here, we describe an influenza virus-based vaccine for SARS-CoV-2.", "We incorporated a membrane-anchored form of the SARS-CoV-2 spike receptor binding domain (RBD) in place of the neuraminidase (NA) coding sequence in an influenza virus also possessing a mutation that reduces the affinity of hemagglutinin for its sialic acid receptor.", "The resulting \u0394NA(RBD)-Flu virus can be generated by reverse genetics and grown to high titers in cell culture.", "A single-dose intranasal inoculation of mice with \u0394NA(RBD)-Flu elicits serum neutralizing antibody titers against SAR-CoV-2 comparable to those observed in humans following natural infection (~1:200).", "Furthermore, \u0394NA(RBD)-Flu itself causes no apparent disease in mice.", "It might be possible to produce a vaccine similar to \u0394NA(RBD)-Flu at scale by leveraging existing platforms for the production of influenza vaccines."], "title": "Attenuated Influenza Virions Expressing the SARS-CoV-2 Receptor-Binding Domain Induce Neutralizing Antibodies in Mice"}
{"doc_id": 403, "abstract": ["An effective vaccine is essential to controlling the spread of SARS-CoV-2 virus.", "Here, we describe an influenza-virus-based vaccine for SARS-CoV-2.", "We incorporated a membrane-anchored form of the SARS-CoV-2 Spike receptor binding domain (RBD) in place of the neuraminidase (NA) coding sequence in an influenza virus also possessing a mutation that reduces the affinity of hemagglutinin for its sialic acid receptor.", "The resulting \u0394NA(RBD)-Flu virus can be generated by reverse genetics and grown to high titers in cell culture.", "A single-dose intranasal inoculation of mice with \u0394NA(RBD)-Flu elicits serum neutralizing antibody titers against SAR-CoV-2 comparable to those observed in humans following natural infection (~1:250).", "Furthermore, \u0394NA(RBD)-Flu itself causes no apparent disease in mice.", "It might be possible to produce a vaccine similar to \u0394NA(RBD)-Flu at scale by leveraging existing platforms for production of influenza vaccines."], "title": "Attenuated influenza virions expressing the SARS-CoV-2 receptor-binding domain induce neutralizing antibodies in mice"}
{"doc_id": 404, "abstract": ["BACKGROUND: The novel human coronavirus SARS-CoV-2 is a major ongoing global threat with huge economic burden.", "Like all respiratory viruses, SARS-CoV-2 initiates infection in the upper respiratory tract (URT).", "Infected individuals are often asymptomatic, yet highly infectious and readily transmit virus.", "A therapy that restricts initial replication in the URT has the potential to prevent progression of severe lower respiratory tract disease as well as limiting person-to-person transmission.", "METHODS: SARS-CoV-2 Victoria/01/2020 was passaged in Vero/hSLAM cells and virus titre determined by plaque assay.", "Challenge virus was delivered by intranasal instillation to female ferrets at 5.0 \u00d7 106 pfu/ml.", "Treatment groups received intranasal INNA-051, developed by Ena Respiratory.", "SARS-CoV-2 RNA was detected using the 2019-nCoV CDC RUO Kit and QuantStudio&#8482; 7 Flex Real-Time PCR System.", "Histopathological analysis was performed using cut tissues stained with haematoxylin and eosin (H&E).", "FINDINGS: We show that prophylactic intra-nasal administration of the TLR2/6 agonist INNA-051 in a SARS-CoV-2 ferret infection model effectively reduces levels of viral RNA in the nose and throat.", "After 5 days post-exposure to SARS-CoV-2, INNA-051 significantly reduced virus in throat swabs (p=<0.0001) by up to a 24 fold (96% reduction) and in nasal wash (p=0.0107) up to a 15 fold (93% reduction) in comparison to untreated animals.", "INTERPRETATION: The results of our study support clinical development of a therapy based on prophylactic TLR2/6 innate immune activation in the URT, to reduce SARS-CoV-2 transmission and provide protection against COVID-19.", "FUNDING: This work was funded by Ena Respiratory, Melbourne, Australia."], "title": "Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model"}
{"doc_id": 405, "abstract": ["BackgroundIt is critical to understand whether infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) protects from subsequent reinfection.", "MethodsWe investigated the incidence of SARS-CoV-2 PCR-positive results in seropositive and seronegative healthcare workers (HCWs) attending asymptomatic and symptomatic staff testing at Oxford University Hospitals, UK.", "Baseline antibody status was determined using anti-spike and/or anti-nucleocapsid IgG assays and staff followed for up to 30 weeks.", "We used Poisson regression to estimate the relative incidence of PCR-positive results and new symptomatic infection by antibody status, accounting for age, gender and changes in incidence over time.", "ResultsA total of 12219 HCWs participated and had anti-spike IgG measured, 11052 were followed up after negative and 1246 after positive antibody results including 79 who seroconverted during follow up.", "89 PCR-confirmed symptomatic infections occurred in seronegative individuals (0.46 cases per 10,000 days at risk) and no symptomatic infections in those with anti-spike antibodies.", "Additionally, 76 (0.40/10,000 days at risk) anti-spike IgG seronegative individuals had PCR-positive tests in asymptomatic screening, compared to 3 (0.21/10,000 days at risk) seropositive individuals.", "Overall, positive baseline anti-spike antibodies were associated with lower rates of PCR-positivity (with or without symptoms) (adjusted rate ratio 0.24 [95%CI 0.08-0.76, p=0.015]).", "Rate ratios were similar using anti-nucleocapsid IgG alone or combined with anti-spike IgG to determine baseline status.", "ConclusionsPrior SARS-CoV-2 infection that generated antibody responses offered protection from reinfection for most people in the six months following infection.", "Further work is required to determine the long-term duration and correlates of post-infection immunity."], "title": "Antibodies to SARS-CoV-2 are associated with protection against reinfection"}
{"doc_id": 406, "abstract": ["BACKGROUND Viral epidemics or pandemics of acute respiratory infections like influenza or severe acute respiratory syndrome pose a global threat.", "Antiviral drugs and vaccinations may be insufficient to prevent their spread.", "OBJECTIVES To review the effectiveness of physical interventions to interrupt or reduce the spread of respiratory viruses.", "SEARCH STRATEGY We searched The Cochrane Library, the Cochrane Central Register of Controlled Trials (CENTRAL 2010, Issue 3), which includes the Acute Respiratory Infections Group's Specialised Register, MEDLINE (1966 to October 2010), OLDMEDLINE (1950 to 1965), EMBASE (1990 to October 2010), CINAHL (1982 to October 2010), LILACS (2008 to October 2010), Indian MEDLARS (2008 to October 2010) and IMSEAR (2008 to October 2010).", "SELECTION CRITERIA In this update, two review authors independently applied the inclusion criteria to all identified and retrieved articles and extracted data.", "We scanned 3775 titles, excluded 3560 and retrieved full papers of 215 studies, to include 66 papers of 67 studies.", "We included physical interventions (screening at entry ports, isolation, quarantine, social distancing, barriers, personal protection, hand hygiene) to prevent respiratory virus transmission.", "We included randomised controlled trials (RCTs), cohorts, case-controls, before-after and time series studies.", "DATA COLLECTION AND ANALYSIS We used a standardised form to assess trial eligibility.", "We assessed RCTs by randomisation method, allocation generation, concealment, blinding and follow up.", "We assessed non-RCTs for potential confounders and classified them as low, medium and high risk of bias.", "MAIN RESULTS We included 67 studies including randomised controlled trials and observational studies with a mixed risk of bias.", "A total number of participants is not included as the total would be made up of a heterogenous set of observations (participant people, observations on participants and countries (object of some studies)).", "The risk of bias for five RCTs and most cluster-RCTs was high.", "Observational studies were of mixed quality.", "Only case-control data were sufficiently homogeneous to allow meta-analysis.", "The highest quality cluster-RCTs suggest respiratory virus spread can be prevented by hygienic measures, such as handwashing, especially around younger children.", "Benefit from reduced transmission from children to household members is broadly supported also in other study designs where the potential for confounding is greater.", "Nine case-control studies suggested implementing transmission barriers, isolation and hygienic measures are effective at containing respiratory virus epidemics.", "Surgical masks or N95 respirators were the most consistent and comprehensive supportive measures.", "N95 respirators were non-inferior to simple surgical masks but more expensive, uncomfortable and irritating to skin.", "Adding virucidals or antiseptics to normal handwashing to decrease respiratory disease transmission remains uncertain.", "Global measures, such as screening at entry ports, led to a non-significant marginal delay in spread.", "There was limited evidence that social distancing was effective, especially if related to the risk of exposure.", "AUTHORS' CONCLUSIONS Simple and low-cost interventions would be useful for reducing transmission of epidemic respiratory viruses.", "Routine long-term implementation of some measures assessed might be difficult without the threat of an epidemic."], "title": "Physical interventions to interrupt or reduce the spread of respiratory viruses."}
{"doc_id": 407, "abstract": ["The ongoing Corona Virus Disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has emphasized the urgent need for antiviral therapeutics.", "The viral RNA-dependent-RNA-polymerase (RdRp) is a promising target with polymerase inhibitors successfully used for the treatment of several viral diseases.", "Here we show that Favipiravir exerts an antiviral effect as a nucleotide analogue through a combination of chain termination, slowed RNA synthesis and lethal mutagenesis.", "The SARS-CoV RdRp complex is at least 10-fold more active than any other viral RdRp known.", "It possesses both unusually high nucleotide incorporation rates and high-error rates allowing facile insertion of Favipiravir into viral RNA, provoking C-to-U and G-to-A transitions in the already low cytosine content SARS-CoV-2 genome.", "The coronavirus RdRp complex represents an Achilles heel for SARS-CoV, supporting nucleoside analogues as promising candidates for the treatment of COVID-19."], "title": "Favipiravir strikes the SARS-CoV-2 at its Achilles heel, the RNA polymerase"}
{"doc_id": 408, "abstract": ["Epidemiological and genetic studies on COVID-19 are hindered by inconsistent and limited testing policies to confirm SARS-CoV-2 infection.", "Recently, it was shown that it is possible to predict potential COVID-19 cases using cross-sectional self-reported disease-related symptoms.", "Using a previously reported COVID-19 prediction model, we show that it is possible to conduct a GWAS on predicted COVID-19 which benefits from a larger sample size in order to gain new insights into the genetic susceptibility of the disease.", "Furthermore, we find suggestive evidence that genetic variants for other viral infectious diseases do not overlap with COVID-19 susceptibility and that severity of COVID-19 may have a different genetic architecture compared to COVID-19 susceptibility.", "Our findings demonstrate the added value of using self-reported symptom assessments to quickly monitor novel endemic viral outbreaks in a scenario of limited testing.", "Should there be another outbreak of a novel infectious disease, then we recommend repeatedly collecting data of disease-related symptoms."], "title": "Using symptom-based case predictions to identify host genetic factors that contribute to COVID-19 susceptibility"}
